Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
AC006538.2		ENSG00000267001	"Novel protein"		19	2717769-2740048	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA058526	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"				"HPA058526: AB_2683743"																		5.0	0.0	0.4	0.7	0.4	1.3	1.0	0.2	1.4	1.1	0.3	2.7	2.6	0.7	0.0	0.2	1.2	0.3	0.2	0.5	0.5	1.2	1.8	1.6	0.7	0.4	0.3	0.0	0.0	2.6	0.0	0.3	0.4	1.4	0.6	0.1	2.2	2.3	6.5	1.2	0.7	2.4	0.5	1.2	1.8	2.8	0.5	0.9	0.1	2.9	0.3	0.9	0.0	0.6	9.8	13.0	2.3	0.0	10.4	11.1	7.1	7.1	5.2	6.2	11.4	12.7	0.7	7.7	8.6	6.0	4.8	3.6	0.0	3.1	0.0	0.0	9.3	24.6	9.1	17.4	22.0	6.4	3.4	6.0	7.2	11.5	0.4	1.8	2.7	8.5	23.5	4.1	1.7	11.7	3.2	3.4	2.1	1.3	16.2	3.9	2.2	7.9	0.0	5.9	3.6	6.1	10.1	1.8	9.5	0.0	3.2	17.8	1.9	1.6	2.8	11.2	8.2	11.6	16.4	5.0	1.0	26.0	1.7	7.1	8.8	12.5	8.0	8.0	7.9	7.7	7.4	7.6	12.5	6.9	5.5	6.7	3.1	6.5	8.5	15.0	4.5	7.4	0.4	0.4	0.2	1.4	0.5	0.5	0.4	0.3	0.4	0.5	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC093323.1		ENSG00000170846	"Novel protein, similar to Morf4 family associated protein 1"	B2RBV5	4	6663396-6676755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 12.7;Cytotrophoblasts: 18.9;Distal tubular cells: 13.7;Glandular and luminal cells: 13.7;Granulosa cells: 12.2;Theca cells: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"									NA	NA					"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (9.08e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.33e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-3)"	1.7	3.0	3.4	2.5	3.6	3.6	3.8	2.4	3.7	1.8	2.5	3.2	1.5	3.5	3.6	2.2	2.3	2.2	2.3	3.5	4.5	2.8	2.9	2.7	4.1	2.3	2.8	3.9	2.1	3.2		2.5	2.7	3.6	4.1	2.0	3.2	2.5	4.3	6.9	2.3	2.5	2.6	4.2	4.2	2.6	4.9	3.2	2.0	4.3	4.4	2.1		2.8	4.0	5.0	7.4	7.6	3.5	4.5	7.0	6.0	2.6	4.7	3.8	5.8	5.7	3.8	3.1	2.9	4.8	5.1	5.8	4.2	8.0	1.6	8.2	16.5	7.6	4.4	1.2	17.6	10.0	2.0	3.8	4.6	4.2	6.6	3.1	7.3	12.3	1.3	4.0	7.9	12.0	16.1	7.7	6.0	7.6	5.6	4.9	1.9	1.6	2.8	16.6	5.8	5.1	3.2	2.6	2.6	16.1	5.4	4.2	3.5	0.0	2.6	8.3	2.5	5.8	1.3	1.0	19.3	5.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	3.6	2.4	3.7	3.5	4.5	2.3	2.8	2.7	2.6	4.9	2.8	4.3	6.4	12.7	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.6	9.8	0.0	0.0	4.3	5.5	0.0	18.9	7.2	0.0	13.7	2.1	0.0	9.8	11.0	2.2	0.0	0.0	0.0	3.2	7.0	3.4	0.0	13.7	1.3	12.2	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.3	3.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.6	5.2	19.5	0.0	0.0
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 440.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		1100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	85.3	88.6	39.9	76.9	45.0	74.3	80.4	44.1	49.0	79.6	49.8	117.2	140.0	58.6	52.1	108.5	65.3	49.0	114.1	38.8	43.8	181.6	172.9	59.3	73.3	48.5	42.8	59.9	78.9	123.6	49.4	68.4	50.4	63.2	114.0	51.0	81.1	55.5	154.2	74.4	139.4	68.1	44.0	57.2	92.7	54.8	44.3	85.9	86.6	122.9	113.4	84.2	76.9	49.3	339.1	153.4	131.6	149.7	94.9	116.6	132.8	185.0	143.5	267.7	280.2	283.2	311.9	602.1	218.4	139.8	204.2	235.4	312.5	327.0	276.6	261.6	229.3	396.2	270.0	219.9	218.2	712.5	222.2	118.1	238.2	232.7	471.2	163.3	190.2	245.7	436.9	230.4	165.0	174.2	273.0	392.8	181.2	337.4	222.4	314.7	222.2	415.6	286.2	205.1	190.8	114.8	205.4	235.0	584.8	151.4	194.5	517.2	138.9	165.5	194.3	259.4	357.5	238.0	324.7	565.7	232.4	664.6	195.5	49.2	158.8	198.0	77.1	145.5	81.8	122.3	72.7	74.0	195.8	105.8	72.9	67.9	42.1	115.3	130.4	154.2	96.8	188.1	39.9	45.0	44.1	49.0	38.8	43.8	48.5	42.8	50.4	44.0	44.3	49.3	60.5	51.3	79.0	19.6	44.0	125.2	101.4	228.1	63.7	21.1	66.5	72.6	106.9	71.4	142.8	112.2	83.4	158.0	37.0	109.6	256.3	120.2	108.3	50.0	42.1	70.7	50.4	50.9	16.2	123.7	164.6	58.0	66.3	47.0	40.0	38.8	41.4	135.5	96.1	8.4	19.7	84.7	89.5	44.8	60.1	42.8	46.9	48.4	87.2	12.2	67.3	22.1	48.4	14.1	22.0	110.5	67.2	44.0	55.7	109.0	236.9	440.0	67.0	41.8	52.6	34.1	108.4	91.0	31.6	88.6	122.7	216.6	40.7	72.2	122.6	120.5
ANKLE1	"ANKRD41, FLJ39369, LEMD6"	ENSG00000160117	"Ankyrin repeat and LEM domain containing 1"	Q8NAG6	19	17281645-17287646	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.6;brain: 8.8"	"Cell type enriched"	"Detected in some"	10	"Erythroid cells: 70.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 77.2;HL-60: 34.6;NB-4: 41.7;U-937: 57.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA026789, HPA073498"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA026789: AB_10611675, HPA073498: AB_2686612"	"unprognostic (5.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.90e-2)"	"prognostic unfavorable (4.86e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.89e-4)"	"unprognostic (5.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.30e-2)"	0.7	0.9	4.5	2.3	2.7	25.6	0.6	8.8	5.5	0.7	0.6	0.5	0.9	1.0	1.2	0.7	0.6	0.7	1.0	3.2	2.3	0.4	0.6	0.8	4.1	1.6	1.4	1.5	1.7	0.4	0.5	1.2	1.7	0.7	0.5	3.6	1.5	0.6	0.3	2.4	0.8	0.8	0.4	2.2	0.8	1.5	3.3	1.3	0.9	0.5	3.1	0.7	0.4	2.7	0.9	0.8	3.7	1.7	0.4	0.6	3.2	1.1	0.3	0.6	0.6	17.1	1.5	77.2	0.7	0.5	0.6	1.5	28.4	0.4	0.6	22.3	3.4	29.1	13.1	0.6	0.3	34.6	12.5	0.3	1.0	2.7	0.2	0.9	0.6	6.4	4.2	9.2	0.4	0.9	24.2	41.7	10.2	0.3	2.6	17.3	1.0	8.7	0.4	1.7	1.2	7.1	6.8	0.9	0.7	1.5	0.6	20.1	1.4	1.0	1.2	1.4	1.0	1.3	0.9	27.8	0.7	57.2	1.3	0.9	0.9	0.6	0.5	1.9	0.3	1.6	0.4	0.5	1.1	0.9	0.5	0.4	1.5	0.3	1.4	0.9	0.4	0.6	4.5	2.7	8.8	5.5	3.2	2.3	1.6	1.4	1.7	0.4	3.3	2.7	0.4	0.0	0.5	0.7	1.1	0.8	0.8	0.3	0.0	1.9	0.5	0.6	0.8	0.0	0.1	0.0	0.0	1.6	0.4	0.4	0.0	0.2	0.3	0.2	0.4	0.4	0.0	70.7	1.4	0.2	0.7	0.6	0.0	0.8	1.3	1.1	0.0	0.1	0.8	0.0	1.6	0.5	0.0	0.9	1.3	0.0	1.8	1.1	0.0	1.0	3.0	0.5	1.0	1.0	1.6	0.3	0.1	1.5	0.9	0.5	0.0	0.1	0.9	1.5	6.6	0.6	0.4	0.5	1.0	0.0	0.4	0.4	0.5	0.3	0.3	0.2
ANKRD35	FLJ25124	ENSG00000198483	"Ankyrin repeat domain 35"	Q8N283	1	145866560-145885866	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 60.8"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 56.4;Fibroblasts: 31.2;Leydig cells: 36.4;Muller glia cells: 57.7;Peritubular cells: 50.8;Skeletal myocytes: 29.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.6;THP-1: 6.8;TIME: 8.4;U-87 MG: 8.3;U-937: 7.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035453	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA035453: AB_10672864"	"prognostic favorable (9.35e-4)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.39e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.29e-10)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.92e-2)"	"unprognostic (8.69e-3)"	4.0	1.3	8.2	1.1	7.9	0.3	4.6	7.6	9.7	20.6	6.4	6.0	0.5	5.8	1.4	24.7	6.6	1.3	2.9	7.5	8.6	0.8	2.5	2.3	0.4	8.7	9.5	4.4	0.7	0.0	2.0	0.1	8.5	6.6	0.8	1.3	11.4	2.7	8.2	60.8	2.5	2.1	8.4	0.5	3.9	1.6	9.0	0.5	1.7	3.8	6.7	7.3	20.6	7.6	0.1	0.0	0.0	0.0	2.2	9.6	0.2	1.4	3.6	0.4	1.2	0.4	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.1	2.9	0.1	3.3	0.4	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.2	0.0	0.0	3.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.5	0.0	0.0	2.1	0.0	0.7	0.8	0.1	0.0	0.3	1.1	0.3	0.0	0.2	0.7	0.1	0.7	0.2	0.5	0.7	0.7	8.2	7.9	7.6	9.7	7.5	8.6	8.7	9.5	8.5	8.4	9.0	7.6	1.6	0.0	0.0	6.8	0.3	4.6	16.8	10.2	0.0	1.1	6.3	13.5	1.5	2.8	9.5	1.8	0.0	0.1	2.2	0.0	0.0	0.0	3.5	56.4	10.9	1.3	0.0	2.7	5.6	0.4	0.1	31.2	0.5	17.2	19.1	0.0	2.2	13.9	11.0	0.0	2.1	0.0	14.2	1.2	4.6	5.9	36.4	1.1	5.4	1.0	1.1	57.7	5.2	3.0	0.6	0.1	0.0	50.8	0.4	5.3	0.0	0.1	9.8	2.7	0.0	29.5	6.4	0.1	1.0	10.4	12.4	0.3	5.5	1.1	0.0	13.6
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
APPL1	APPL	ENSG00000157500	"Adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1"	Q9UKG1	3	57227726-57278105	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 28.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011138	Approved		Approved	"Vesicles,Plasma membrane,Actin filaments,Cytosol"		NA	No		10000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Vesicles, Plasma membrane"	"Actin filaments, Cytosol"	"HPA011138: AB_1844959"	"unprognostic (1.39e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.55e-2)"	"prognostic favorable (7.26e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.55e-1)"	15.6	11.6	9.5	14.8	9.7	15.1	18.9	12.9	11.3	17.1	6.8	14.2	12.6	17.1	10.6	16.9	11.7	13.0	24.7	9.7	11.3	16.5	12.9	13.6	16.7	9.8	10.1	22.7	29.6	25.1	7.8	14.3	10.1	15.0	14.0	13.5	15.2	14.4	44.2	20.1	14.6	15.3	10.4	15.8	15.2	8.0	10.2	18.9	19.8	26.6	19.6	13.4	11.9	10.7	30.2	12.9	12.2	45.4	21.2	29.7	26.2	15.5	9.5	15.4	17.8	14.9	17.5	47.3	6.2	24.6	24.7	5.9	33.7	27.3	26.6	36.1	15.0	27.6	19.5	16.1	22.7	59.6	19.1	21.8	24.3	19.3	21.3	31.3	25.3	30.2	9.0	30.0	17.8	10.4	48.7	15.4	19.5	21.6	21.7	1.7	49.1	26.1	27.7	16.7	12.5	26.5	21.1	32.3	21.0	16.7	15.7	39.6	23.4	25.1	17.5	37.4	29.9	27.0	41.8	33.2	27.4	29.1	17.1	2.0	5.3	3.8	3.7	4.5	4.9	17.9	3.8	3.3	10.9	28.3	3.3	2.5	1.4	7.4	3.6	18.0	1.9	2.7	9.5	9.7	12.9	11.3	9.7	11.3	9.8	10.1	10.1	10.4	10.2	10.7	82.9	51.3	45.5	19.6	106.6	52.9	47.3	46.9	83.6	40.5	67.2	92.8	100.1	47.1	47.4	42.3	31.3	46.9	70.9	29.0	58.7	58.6	42.5	35.4	92.8	66.2	45.6	20.0	49.7	60.3	44.7	68.6	40.2	59.4	23.4	60.8	40.0	44.1	52.2	52.2	50.4	36.2	42.7	68.6	50.6	22.1	73.0	71.0	19.6	33.7	87.8	56.6	56.7	43.2	62.2	51.7	25.5	76.0	62.8	38.7	41.0	58.8	18.1	55.4	52.6	94.3	61.2	64.9	44.2	105.7	69.6	28.0	45.4	73.7	49.1	25.8
ARMH1	"C1orf228, MGC33556, NCRNA00082, p40"	ENSG00000198520	"Armadillo like helical domain containing 1"	Q6PIY5	1	44674692-44725591	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.2;testis: 11.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.0;Collecting duct cells: 3.7;Endometrial ciliated cells: 13.1;Granulosa cells: 6.2;Hofbauer cells: 11.3;Macrophages: 5.1;T-cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;MOLT-4: 4.9;NB-4: 7.5;U-937: 9.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034769	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA034769: AB_10670979"	"unprognostic (2.01e-5)"	"unprognostic (4.28e-3)"	"unprognostic (7.27e-2)"	"prognostic favorable (8.64e-4)"	"unprognostic (9.23e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.22e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.25e-10)"	"unprognostic (1.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-3)"	0.4	1.1	1.7	0.2	2.2	2.2	0.7	1.1	2.6	0.8	4.5	0.5	0.2	1.7	3.5	0.5	8.2	0.7	0.2	2.3	1.3	0.9	4.2	1.0	0.6	2.6	4.0	2.6	0.5	1.9	3.3	0.3	2.1	0.8	0.3	4.2	0.7	0.6	0.1	0.8	0.3	0.3	1.8	0.3	0.7	11.7	1.9	0.4	0.6	0.0	0.3	0.3	0.3	2.2	0.2	0.3	1.8	0.1	0.5	2.1	0.5	0.0	0.2	0.5	0.3	0.4	3.8	0.2	0.2	0.8	0.9	0.5	0.0	0.0	0.0	1.0	0.2	0.9	2.6	0.6	0.2	6.9	4.1	1.7	0.2	0.7	0.0	1.3	0.2	0.3	0.1	0.7	0.2	0.0	4.9	7.5	0.1	0.5	0.0	2.7	0.1	2.2	0.7	0.0	1.2	0.8	0.0	1.2	0.9	1.2	0.3	3.6	0.0	0.3	0.3	0.3	0.0	0.3	0.1	0.2	0.3	9.9	0.4	8.7	2.1	6.1	0.2	0.7	0.1	0.6	1.1	0.8	1.0	0.9	1.6	1.5	1.0	0.4	0.0	4.8	0.0	1.4	1.7	2.2	1.1	2.6	2.3	1.3	2.6	4.0	2.1	1.8	1.9	2.2	0.5	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	3.7	0.0	0.4	1.3	0.0	1.9	0.7	0.0	13.1	0.6	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.7	0.0	6.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	5.2	0.9	0.0	0.0
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	65.8	10.7	50.9	23.7	61.3	80.0	49.8	52.9	67.2	31.7	34.2	30.8	12.2	22.8	7.7	22.1	27.7	22.8	34.4	43.2	48.4	32.9	20.4	75.0	38.7	64.7	61.1	13.7	16.5	71.6	17.2	14.4	58.0	33.6	12.1	1.3	44.2	18.8	204.8	30.7	43.4	11.1	50.4	58.4	27.7	5.2	53.1	24.8	44.0	49.3	35.0	32.6	32.0	81.3	12.1	21.2	0.4	10.6	8.5	7.8	8.4	6.8	19.3	5.6	5.5	4.8	22.9	22.1	18.9	5.8	9.1	7.9	8.4	6.2	4.4	14.5	12.3	16.8	18.0	6.8	7.8	12.9	24.0	8.4	9.6	6.5	9.9	10.5	9.6	13.9	19.7	0.6	5.4	18.4	9.8	35.6	2.7	26.4	34.9	57.7	0.2	16.8	8.1	11.0	5.0	5.2	11.1	11.0	11.5	1.7	6.7	32.5	21.1	9.7	7.5	32.9	8.6	1.6	0.1	24.8	15.5	48.6	7.7	3.7	5.8	3.6	3.6	4.8	2.5	3.4	6.1	4.6	3.0	5.3	14.1	7.5	2.3	6.6	5.7	1.8	5.1	4.4	50.9	61.3	52.9	67.2	43.2	48.4	64.7	61.1	58.0	50.4	53.1	81.3	114.2	16.0	15.5	1.6	80.3	6.4	19.8	14.0	13.1	0.4	16.7	11.0	7.3	64.3	15.8	9.2	0.0	0.7	47.7	12.7	1.9	10.8	0.8	10.7	13.0	29.9	18.5	44.6	3.8	6.2	7.8	9.2	23.4	29.8	26.6	3.3	17.2	7.0	17.9	0.0	0.5	12.3	16.2	31.0	58.7	1.2	4.7	50.3	5.4	9.4	14.5	1.1	13.4	0.5	20.0	15.4	9.4	7.5	13.6	24.9	3.5	0.5	15.9	0.4	13.1	14.0	15.9	0.5	3.9	7.6	7.1	1.2	38.6	5.0	5.6	26.7
ASB8	"FLJ21255, MGC5540"	ENSG00000177981	"Ankyrin repeat and SOCS box containing 8"	Q9H765	12	48147789-48181213	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 291.9;tongue: 184.4"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003299	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA003299: AB_1845072"	"unprognostic (1.35e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-3)"	"unprognostic (3.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.82e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (6.57e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.26e-2)"	19.7	22.6	21.1	20.1	22.9	61.6	21.2	35.1	28.2	15.8	18.3	22.0	21.6	19.2	21.5	22.7	18.6	15.9	45.4	22.6	22.5	27.8	28.2	17.4	23.1	21.4	20.2	22.1	21.8	33.4	16.7	15.5	23.1	20.7	26.6	73.1	21.2	21.8	291.9	21.4	20.5	24.4	20.9	22.7	21.4	17.2	20.9	29.4	18.7	184.4	26.8	17.8	13.2	24.7	19.3	16.1	17.6	26.9	26.9	23.9	12.7	33.1	23.1	23.1	20.6	24.4	23.4	31.5	26.6	30.4	12.7	16.5	28.3	19.8	26.2	37.3	24.9	38.9	22.1	12.8	20.4	36.5	33.9	23.4	18.8	29.5	17.1	39.6	23.3	35.5	29.5	38.6	20.9	18.2	33.8	25.8	6.6	24.1	28.4	21.7	27.1	32.6	18.3	19.6	27.6	17.6	18.9	24.5	21.2	16.3	45.7	24.8	17.9	19.4	14.0	19.9	15.0	33.1	41.4	27.1	24.6	81.6	11.0	91.7	23.2	117.0	30.8	26.3	28.5	28.6	32.8	31.4	22.8	20.9	32.9	34.3	53.5	36.7	35.8	24.4	33.7	23.1	21.1	22.9	35.1	28.2	22.6	22.5	21.4	20.2	23.1	20.9	20.9	24.7	26.7	22.4	22.6	11.8	26.9	7.0	9.1	15.4	17.6	63.4	18.5	22.4	68.4	27.1	16.1	16.5	62.6	23.2	35.3	29.5	41.1	22.6	24.0	10.4	17.0	23.1	18.6	40.8	19.2	21.8	12.8	22.5	20.9	12.4	20.3	25.5	23.2	31.7	24.6	40.4	21.0	24.3	12.2	24.8	11.8	75.3	24.2	22.9	21.4	7.5	33.5	55.8	46.4	15.6	19.1	19.1	24.3	27.8	25.4	10.8	31.2	42.0	16.0	120.0	52.6	37.4	24.0	35.9	21.1	22.9	11.1	17.1	29.3	37.0	22.1	9.2
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 1595.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 2375.2;Proximal tubular cells: 1906.2;Syncytiotrophoblasts: 708.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031069	Supported		Supported	Mitochondria		NA	NA		820000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favorable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	274.6	276.3	291.2	136.4	295.4	175.1	205.5	302.5	424.4	156.3	316.1	333.5	276.4	128.8	368.1	258.1	129.9	129.7	1052.1	295.2	306.2	489.5	756.3	110.8	166.4	299.3	297.8	127.2	188.2	458.8	140.4	171.5	295.7	160.1	314.4	249.5	214.6	228.5	1161.7	113.6	250.6	189.8	298.7	111.2	226.9	131.5	299.4	217.5	166.0	1595.8	210.9	194.9	138.4	299.6	355.9	260.0	314.5	351.4	344.8	313.5	389.4	305.8	373.0	305.8	300.8	607.6	274.4	439.3	194.2	312.9	467.8	191.5	441.3	379.2	339.2	373.1	441.1	910.6	520.6	618.4	386.8	673.2	284.5	303.1	471.2	284.0	258.6	399.9	363.0	412.2	582.2	522.9	458.2	416.3	468.6	683.2	562.3	824.0	460.7	358.0	606.5	840.0	669.8	504.6	360.2	394.1	516.5	521.7	493.0	449.4	376.5	590.5	260.6	219.6	266.6	209.3	265.9	501.7	954.7	568.2	341.5	707.8	283.1	444.8	447.0	443.7	293.3	487.1	316.1	475.1	385.5	368.6	531.9	399.7	377.4	370.7	292.3	389.9	505.7	504.0	520.3	661.3	291.2	295.4	302.5	424.4	295.2	306.2	299.3	297.8	295.7	298.7	299.4	299.6	532.1	169.9	179.3	0.0	56.0	0.0	0.0	0.0	0.0	0.0	346.3	468.4	0.0	0.0	105.9	419.3	0.0	652.7	116.4	0.0	2375.2	447.0	0.0	299.2	257.6	150.6	0.0	0.0	0.0	472.5	522.8	135.6	0.0	308.5	109.7	341.2	0.0	0.0	522.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.2	0.0	0.0	226.4	0.0	0.0	0.0	0.0	427.1	0.0	0.0	21.4	0.0	0.0	1906.2	142.1	0.0	0.0	0.0	161.4	0.0	0.0	0.0	0.0	708.2	79.2	387.8	0.0	0.0
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"bone marrow: 78.1"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 15.2;NK-cell: 11.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.2;NK-cells: 11.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	2.3	2.5	2.4	78.1	0.7	3.5	6.5	1.5	3.0	1.1	0.7	6.4	4.2	0.5	3.1	2.2	0.4	4.5	2.9	1.2	1.6	1.1	1.0	2.5	2.6	0.4	0.5	0.2	0.3	3.5	2.8	0.6	1.7	0.1	0.5	0.8	0.1	0.3	1.3	3.1	3.1	2.6	0.6	0.4	2.4	0.5	0.1	0.1	1.0	1.4	0.4	4.9	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.5	0.5	0.2	0.0	0.2	12.2	0.0	7.3	1.7	0.1	0.0	13.6	40.2	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	19.2	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.1	1.2	0.0	0.0	0.1	0.0	26.7	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.0	1.3	103.7	0.0	15.2	2.0	3.8	0.4	1.2	0.1	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.8	11.0	0.4	0.0	0.0	0.9	2.3	2.4	3.5	6.5	4.5	2.9	2.5	2.6	2.8	3.1	2.4	4.9	1.7	0.0	1.9	1.6	0.8	1.5	0.1	0.2	0.6	0.6	0.2	0.6	1.3	0.0	0.1	0.0	0.0	5.4	12.5	0.3	0.0	0.0	27.6	0.3	1.7	1.0	0.0	12.2	20.3	0.0	1.8	8.1	3.1	0.2	19.7	0.0	1.1	3.7	16.4	0.0	17.5	0.3	2.0	37.0	17.7	25.3	1.8	27.0	1.8	248.3	6.3	0.5	15.5	1.0	2.1	0.0	0.1	0.7	4.8	2.3	0.7	1.2	0.7	0.2	0.0	1.0	7.0	0.5	0.6	0.6	0.3	2.9	13.4	1.1	0.2	0.3
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
BDH1	"BDH, SDR9C1"	ENSG00000161267	"3-hydroxybutyrate dehydrogenase 1"	Q02338	3	197509783-197573323	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 324.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 44.2;U-937: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030947, HPA058709"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA030947: AB_10669548, HPA058709: AB_2683797"	"unprognostic (2.72e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.86e-7)"	"unprognostic (2.08e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (7.12e-8)"	"unprognostic (5.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.02e-1)"	9.6	6.8	14.4	4.1	17.9	7.3	9.7	18.4	19.8	6.8	30.8	45.1	17.4	6.3	3.9	48.0	9.7	3.8	52.4	16.5	14.3	19.2	324.0	5.2	3.9	14.3	13.8	8.2	7.0	15.5	12.6	0.3	14.4	16.2	19.8	9.3	25.3	4.1	21.5	30.4	28.1	2.2	12.9	7.9	16.6	4.5	16.3	6.1	17.7	22.8	7.1	9.9	14.7	14.2	23.7	2.9	1.2	11.3	1.9	0.1	0.0	2.8	2.2	11.4	6.3	20.5	7.5	0.2	33.0	0.7	0.9	10.3	10.0	5.4	4.2	0.3	0.0	12.0	8.3	7.0	8.3	27.0	12.3	3.4	6.0	4.4	9.4	1.2	2.8	13.7	0.0	8.4	0.2	40.9	20.5	18.8	8.2	44.2	4.2	19.6	4.1	31.5	12.3	9.9	20.1	8.8	8.2	1.1	4.5	0.5	26.3	22.7	0.3	0.7	3.9	0.1	21.6	10.4	20.5	0.3	0.7	75.8	1.5	2.9	1.3	0.6	4.6	0.2	6.4	5.1	5.1	4.2	3.5	4.6	7.6	4.7	0.0	4.5	0.2	3.8	3.7	3.4	14.4	17.9	18.4	19.8	16.5	14.3	14.3	13.8	14.4	12.9	16.3	14.2	0.4	3.2	9.4	27.7	7.0	9.3	8.5	10.0	16.5	21.3	20.3	14.7	36.7	17.2	13.8	12.9	20.9	2.0	7.1	68.9	52.8	6.6	9.5	34.1	3.6	2.2	27.2	6.7	60.5	5.6	5.1	2.8	17.3	16.5	1.3	6.6	5.0	112.3	8.9	18.5	58.0	43.2	10.2	5.4	8.5	13.9	5.6	3.5	16.0	8.4	1.0	17.5	11.3	27.2	12.5	3.0	36.4	4.1	5.4	6.5	62.8	30.2	48.0	33.6	0.0	2.4	3.7	16.8	4.9	36.3	10.9	1.9	8.5	10.0	68.7	13.1
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064171	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 439.4;pituitary gland: 399.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.5	83.8	253.7	3.8	260.1	42.7	2.5	201.9	317.4	5.5	142.9	10.5	5.0	15.6	55.5	0.8	21.4	1.3	16.7	274.9	439.4	10.7	4.2	2.8	1.2	222.6	248.2	20.2	71.6	112.0	399.2	0.4	261.1	6.7	4.3	173.0	2.3	3.6	0.6	1.0	6.3	4.8	203.1	2.5	8.6	92.9	265.5	3.5	26.0	0.8	0.4	0.8	2.9	223.9	0.7	0.0	37.6	0.1	0.0	0.1	1.1	21.6	0.0	412.1	607.0	0.0	0.1	0.1	0.8	158.1	130.0	0.4	0.0	0.5	680.4	0.2	1.2	129.2	0.0	85.2	6.9	1562.2	2.6	9.2	0.0	89.3	0.1	1044.5	0.1	120.8	0.2	0.2	84.6	0.0	294.7	0.2	337.9	97.8	62.0	0.2	0.7	7.6	0.0	0.3	465.3	266.6	0.5	0.6	1.9	5.9	0.3	432.4	0.0	0.1	140.2	1.1	16.7	71.9	2.9	0.7	54.4	484.1	27.2	0.4	0.2	3.4	0.3	0.0	0.3	0.5	0.9	0.5	0.0	1.0	1.4	0.6	0.5	0.9	0.2	0.1	0.4	0.7	253.7	260.1	201.9	317.4	274.9	439.4	222.6	248.2	261.1	203.1	265.5	223.9	1.1	0.0	0.5	16.3	1.2	8.7	11.1	0.0	1.2	354.2	7.2	32.5	9.6	31.5	0.7	5.5	39.6	0.2	0.2	0.4	72.4	6.1	12.1	1.4	0.6	5.3	79.6	0.8	64.6	13.8	0.2	3.9	8.2	2.8	0.0	260.7	30.4	1.2	1.4	363.4	56.1	6.9	10.2	4.0	1.2	31.8	8.1	2.2	7.2	12.2	1.5	716.1	0.0	32.6	20.9	6.3	3.3	2.6	0.0	7.5	0.8	19.5	0.0	142.2	0.0	15.9	14.4	38.5	13.8	0.0	6.5	0.5	2.0	0.2	3.5	1.7
BORA	"C13orf34, FLJ22624"	ENSG00000136122	"BORA aurora kinase A activator"	Q6PGQ7	13	72727749-72756198	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 13.5;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040866	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA040866: AB_10794868"	"unprognostic (9.93e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.32e-12)"	"unprognostic (7.04e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.28e-2)"	1.6	1.3	1.2	4.3	1.2	6.0	2.4	1.4	1.7	1.6	1.9	4.2	4.3	1.3	1.5	3.5	1.4	1.3	1.0	1.2	1.3	1.8	1.7	1.8	7.6	1.6	1.3	1.2	1.7	0.5	1.9	2.3	1.5	1.8	5.0	3.5	1.9	1.0	1.1	4.2	3.5	1.7	1.1	4.2	3.2	4.0	1.4	8.1	1.9	0.9	6.8	2.2	2.2	1.5	32.5	8.5	19.6	14.7	2.4	2.4	11.6	9.8	8.6	17.9	18.1	20.6	17.2	23.8	6.4	6.4	10.3	15.0	17.1	11.5	22.1	20.9	12.3	28.7	11.4	15.8	1.7	54.2	17.1	1.9	2.6	8.9	15.1	5.0	14.6	22.8	12.7	10.7	14.6	9.8	20.8	21.8	10.8	36.8	6.0	16.4	12.3	10.6	6.5	10.0	6.9	7.0	12.0	12.8	10.2	15.0	6.4	24.6	4.8	5.8	9.7	8.3	16.3	6.9	7.0	14.8	16.3	24.8	13.9	1.3	1.1	0.5	1.9	1.9	2.3	1.6	1.8	2.0	1.9	1.9	1.6	2.5	0.1	1.8	1.2	1.4	1.9	1.1	1.2	1.2	1.4	1.7	1.2	1.3	1.6	1.3	1.5	1.1	1.4	1.5	1.6	3.2	2.8	3.6	5.4	0.6	1.3	2.2	3.4	1.7	1.4	1.3	0.3	1.5	2.1	1.8	2.1	7.5	3.9	3.1	0.0	1.9	12.6	2.2	2.3	1.4	0.0	13.5	4.3	2.6	11.5	1.7	3.6	2.4	1.3	5.1	1.8	0.4	4.6	8.4	3.1	2.7	0.0	2.8	1.5	2.7	0.9	2.8	0.0	3.7	3.5	1.1	4.1	2.5	7.3	1.7	2.2	1.2	5.2	1.2	3.2	0.8	2.7	2.3	13.1	1.6	1.5	11.8	4.3	3.4	1.1	2.9	4.1	1.5	5.8	1.4
BPI	BPIFD1	ENSG00000101425	"Bactericidal permeability increasing protein"	P17213	20	38304150-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"bone marrow: 1503.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 14.5;neutrophil: 7.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 7.1;monocytes: 14.5"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061284	Enhanced				"Secreted to blood"	NA	NA	7290000	78000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.5	0.2	0.1	0.1	0.2	1503.7	0.6	0.1	0.4	2.6	0.2	0.2	0.0	0.7	1.0	0.1	0.4	0.5	0.5	0.1	0.2	3.4	0.8	3.7	0.3	0.2	0.2	1.7	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	1.4	1.2	0.1	1.8	0.1	0.2	0.2	13.0	0.1	17.1	0.2	3.7	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.1	0.0	0.6	0.0	0.0	9.8	0.1	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.0	0.4	3.7	0.0	0.0	0.0	0.0	9.8	0.0	201.8	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	20.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	220.6	17.7	1.3	1.8	0.0	7.1	0.0	1.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	99.7	0.3	0.0	0.0	0.2	0.4	2.1	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 68.1;dendritic cells: 29.4;Macrophages: 20.3;monocytes: 28.4;NK-cells: 47.4;T-cells: 16.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 51.7;HL-60: 19.7;NB-4: 18.4;THP-1: 12.7;U-937: 22.2"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.4	0.6	0.3	7.1	0.4	50.4	0.6	0.4	0.4	1.6	0.2	0.9	0.6	0.6	0.3	0.6	0.7	2.1	20.0	0.3	0.3	0.7	1.3	4.7	14.0	1.1	0.5	0.2	0.4	0.1	0.3	0.6	0.8	0.6	1.3	0.0	1.5	0.4	1.0	1.3	3.5	1.0	0.6	14.9	2.6	0.3	0.4	3.6	0.9	0.2	7.3	1.1	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	51.7	0.1	0.1	0.5	19.7	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	22.2	0.0	80.3	14.9	45.8	23.8	31.4	16.1	4.7	7.8	18.8	17.1	5.8	11.6	16.3	12.6	23.9	58.4	1.7	6.1	16.5	0.3	0.4	0.4	0.4	0.3	0.3	1.1	0.5	0.8	0.6	0.4	1.0	0.2	0.0	4.2	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.1	0.3	68.1	2.8	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	13.9	0.0	0.0	0.2	1.7	0.5	0.0	15.8	0.0	2.5	0.0	3.7	0.0	0.0	0.0	0.0	12.5	15.5	0.0	0.0	20.3	1.8	0.0	28.4	0.0	47.4	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.4	0.0	16.0	0.0	0.0	0.0
C12orf29	DKFZp434N2030	ENSG00000133641	"Chromosome 12 open reading frame 29"	Q8N999	12	88033846-88050160	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039663	Uncertain		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA039663: AB_10795253"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.80e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.75e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.81e-2)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	4.7	9.8	7.5	4.5	8.1	8.7	11.0	7.0	10.0	6.5	4.9	4.8	4.8	6.6	12.8	16.1	4.5	5.2	5.8	8.1	7.8	8.4	12.6	5.1	6.8	7.5	7.8	7.5	5.9	7.2	3.1	5.3	7.6	8.2	5.1	5.4	8.3	6.1	4.3	15.5	3.9	5.6	7.8	5.3	5.2	5.6	7.1	6.2	9.9	8.7	8.7	7.4	6.0	8.8	13.1	8.1	7.9	9.2	16.7	21.5	5.8	17.1	14.6	14.4	12.9	7.8	5.0	24.0	2.3	8.8	8.1	11.3	15.5	11.8	24.8	10.4	15.9	20.5	6.5	6.9	20.1	26.9	9.4	14.7	17.8	13.5	16.8	16.8	11.2	9.2	20.3	4.8	22.7	4.6	18.0	13.6	12.0	11.0	15.7	10.4	13.5	19.9	16.3	10.4	19.0	17.0	9.8	22.8	12.5	6.5	14.6	19.2	9.0	12.9	4.3	13.3	13.4	10.7	16.0	14.5	10.0	19.1	11.4	4.5	0.8	0.6	2.7	0.8	4.9	2.0	3.9	3.3	1.0	1.7	4.6	3.9	0.0	3.4	0.9	1.4	2.1	1.8	7.5	8.1	7.0	10.0	8.1	7.8	7.5	7.8	7.6	7.8	7.1	8.8	20.4	9.6	13.6	7.8	17.7	51.5	29.2	29.1	21.6	14.4	19.0	17.8	16.1	20.0	29.6	5.5	6.2	15.3	16.1	5.1	37.2	21.5	34.2	14.2	16.8	17.7	7.8	44.6	22.8	24.2	17.1	26.4	8.2	19.1	10.8	6.7	9.7	16.4	9.6	10.1	20.0	8.9	18.3	6.6	11.7	22.8	32.0	6.6	26.6	4.7	5.3	16.2	11.3	5.0	12.9	22.3	5.0	30.9	13.5	39.7	4.2	33.3	19.7	17.8	6.6	24.9	25.2	50.4	31.7	29.5	71.5	9.3	21.3	8.6	13.0	31.2
C16orf54	FLJ35681	ENSG00000185905	"Chromosome 16 open reading frame 54"	Q6UWD8	16	29742463-29745990	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 41.4;lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 36.6;dendritic cells: 60.4;granulocytes: 33.6;monocytes: 22.0;NK-cells: 55.6;Plasma cells: 37.1;T-cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 18.6;HL-60: 18.9;HMC-1: 11.7;MOLT-4: 15.7;NB-4: 12.8;REH: 8.8;THP-1: 22.1;U-937: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060546	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA060546: AB_2684317"	"unprognostic (2.09e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.92e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-1)"	3.8	0.7	0.7	15.2	1.0	41.4	2.3	1.1	1.1	4.1	0.8	3.5	3.0	0.8	0.7	2.1	0.9	2.9	0.6	0.8	0.9	0.7	1.3	5.6	21.1	1.4	1.0	0.6	1.2	0.2	0.1	0.7	1.3	1.5	3.6	0.3	2.2	0.5	2.3	0.9	6.3	1.7	0.9	14.9	5.7	0.5	1.1	13.2	0.5	1.0	20.4	4.4	0.3	1.8	5.4	0.0	0.3	0.2	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.4	0.1	0.0	18.9	11.7	0.4	0.0	0.0	0.0	0.1	0.0	6.5	0.1	5.1	0.0	0.2	15.7	12.8	1.1	0.0	0.0	8.8	0.1	0.1	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.2	22.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.8	0.2	10.3	0.1	294.4	101.8	380.2	224.8	100.4	212.8	142.8	219.8	196.0	77.4	116.6	178.2	187.4	557.0	224.5	128.3	87.5	129.3	188.0	0.7	1.0	1.1	1.1	0.8	0.9	1.4	1.0	1.3	0.9	1.1	1.8	0.3	3.2	4.7	0.0	36.6	0.5	0.1	0.2	0.0	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.2	60.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	10.8	5.0	0.0	0.0	0.1	0.7	1.5	0.1	33.6	0.1	1.8	0.6	6.2	0.0	0.0	0.8	0.0	18.7	8.7	0.0	0.0	12.5	5.4	2.8	22.0	0.0	55.6	0.5	0.0	0.0	0.0	0.0	37.1	0.0	0.1	0.5	5.5	0.0	0.0	0.5	0.3	0.1	0.2	0.0	0.9	1.4	52.3	0.0	0.6	0.1
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 98.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 90.1;Langerhans cells: 33.4;Macrophages: 59.2;monocytes: 86.7;Plasma cells: 24.7;Spermatocytes: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"classical monocyte: 282.3;eosinophil: 169.4;intermediate monocyte: 312.5;myeloid DC: 162.2;neutrophil: 230.1;non-classical monocyte: 392.8"	"Group enriched"	"Detected in all"	20	"dendritic cells: 162.2;granulocytes: 230.1;monocytes: 392.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 50.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	3.6	1.0	3.5	11.2	3.9	98.0	1.2	4.2	4.5	2.1	3.5	1.8	1.7	1.0	2.7	1.0	2.3	2.9	0.9	3.4	4.1	1.2	3.2	6.1	5.2	5.2	4.3	2.0	1.7	0.4	0.8	1.8	5.2	1.3	1.2	0.7	0.9	0.9	2.7	0.5	2.3	3.4	4.6	21.7	1.6	11.1	4.0	3.2	0.5	1.5	3.0	4.6	1.6	6.0	2.4	0.1	0.2	0.4	2.2	1.2	0.2	0.4	0.1	0.4	0.9	0.2	0.4	5.9	0.5	0.0	0.2	0.2	0.3	0.3	0.3	2.7	0.6	0.3	0.0	0.0	1.6	3.9	0.6	6.0	0.7	1.0	0.3	0.1	0.1	0.6	0.3	12.2	0.2	2.2	0.2	9.3	0.5	0.4	0.4	4.5	0.0	3.1	0.0	0.2	0.3	0.1	1.2	0.0	0.9	0.1	0.2	8.7	0.0	0.1	0.0	1.1	0.1	7.3	3.7	1.7	0.0	50.9	0.0	7.8	282.3	169.4	0.6	312.5	1.6	13.0	0.8	0.8	162.2	8.5	4.9	1.5	230.1	8.0	392.8	3.6	2.3	157.7	3.5	3.9	4.2	4.5	3.4	4.1	5.2	4.3	5.2	4.6	4.0	6.0	0.3	0.0	1.8	1.6	10.6	0.8	0.4	2.1	1.2	0.1	0.6	0.5	1.1	0.0	1.7	1.8	2.1	1.0	0.7	0.3	0.0	0.1	3.7	0.9	0.3	1.1	0.0	4.8	0.9	1.3	0.9	1.6	4.1	1.0	2.5	0.3	0.4	1.1	22.3	0.0	0.9	0.6	2.0	90.1	33.4	6.1	0.9	59.2	1.8	0.0	86.7	3.1	4.1	0.0	3.1	0.1	3.5	0.7	24.7	0.3	0.2	0.7	5.1	1.1	6.6	0.5	0.6	28.5	19.2	0.3	0.9	0.7	2.1	0.1	0.6	0.6
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 115.0;lymphoid tissue: 134.5"	"Cell type enhanced"	"Detected in many"		"granulocytes: 182.3;Hofbauer cells: 195.3;Kupffer cells: 797.4;Langerhans cells: 226.7;Macrophages: 413.5;monocytes: 278.6;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HDLM-2: 141.3;HL-60: 70.4;NB-4: 40.3;THP-1: 55.2;U-937: 117.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	45.4	23.6	16.3	70.8	16.2	115.0	22.3	17.2	29.0	13.2	19.6	15.8	7.3	11.5	6.3	9.8	22.5	31.2	18.1	16.3	18.4	12.5	41.9	85.7	70.4	20.6	17.3	9.4	9.4	4.8	9.1	15.2	19.7	11.7	17.9	9.5	11.2	6.6	10.1	7.8	21.2	37.6	16.7	134.5	12.5	7.6	23.3	27.7	10.0	7.4	55.9	25.1	10.8	21.4	0.3	0.1	0.5	1.1	0.4	0.6	0.6	0.9	0.1	0.3	0.3	0.2	0.4	0.5	0.5	0.2	0.1	0.2	0.8	0.5	0.6	141.3	0.4	0.4	0.5	0.0	0.4	70.4	11.1	0.0	2.6	0.8	0.9	1.0	2.0	0.7	0.5	0.4	0.5	0.5	0.6	40.3	0.2	0.7	0.8	0.1	0.7	0.1	0.3	0.1	0.5	0.2	0.5	0.6	0.8	0.6	0.3	55.2	0.0	0.8	1.0	0.7	0.6	0.6	0.1	0.6	0.3	117.9	1.2	1114.1	1026.8	1294.8	166.6	1529.2	47.6	231.0	206.5	97.3	1021.6	296.4	318.0	193.6	143.3	536.7	1173.4	302.8	66.7	1189.5	16.3	16.2	17.2	29.0	16.3	18.4	20.6	17.3	19.7	16.7	23.3	21.4	4.4	22.4	43.9	8.1	84.1	7.9	0.7	0.4	0.6	4.0	2.2	5.2	3.8	10.0	4.5	7.3	2.1	1.0	103.4	0.6	0.0	0.2	36.7	0.8	0.9	8.1	1.8	23.5	9.2	0.2	2.0	3.2	0.5	1.0	182.3	0.9	15.7	8.9	195.3	0.0	13.0	0.0	0.0	797.4	226.7	90.7	2.8	413.5	12.4	12.2	278.6	0.2	355.3	6.0	7.7	0.2	0.0	0.7	4.2	0.8	0.9	1.0	0.9	4.2	32.9	2.4	2.9	2.4	2.0	0.2	6.5	1.6	59.8	0.3	0.7	0.3
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.9;U-937: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	10.1	3.9	67.9	2.8	69.9	1.3	9.0	56.8	84.2	33.7	44.1	18.1	4.1	31.1	8.5	21.5	19.6	7.2	8.4	72.6	56.7	12.4	1.9	11.8	1.8	50.2	56.2	43.7	4.5	5.1	12.3	5.8	53.4	13.7	8.2	4.7	13.0	9.1	2.8	11.5	10.8	23.1	49.9	6.1	9.2	8.6	59.6	7.6	9.6	5.9	4.1	14.5	20.2	58.7	17.3	13.2	21.1	46.1	26.8	18.0	12.9	16.8	39.4	25.6	14.5	4.5	13.4	2.2	21.5	30.7	4.4	17.2	21.6	19.5	10.1	18.4	5.9	8.5	11.7	0.6	11.0	1.7	9.1	11.7	10.6	10.2	5.5	75.9	31.1	18.6	1.2	7.2	16.9	42.6	22.1	2.2	13.3	18.1	10.9	24.0	5.0	6.6	19.9	31.6	32.9	31.8	5.5	37.1	12.0	18.6	25.2	7.7	27.3	15.5	21.7	7.7	9.5	7.1	3.5	0.7	12.9	109.9	5.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.6	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	67.9	69.9	56.8	84.2	72.6	56.7	50.2	56.2	53.4	49.9	59.6	58.7	5.6	3.2	4.3	1.0	0.5	2.9	3.2	5.9	4.0	3.2	8.7	5.7	2.8	1.5	5.1	1.8	4.2	0.8	2.1	12.6	1.9	9.5	1.0	10.0	22.0	5.9	10.2	0.8	15.1	4.3	10.4	7.9	6.1	7.1	1.3	12.0	3.6	0.2	1.6	0.0	4.5	9.5	16.2	0.6	2.9	2.7	13.4	2.4	1.8	3.7	3.7	1.0	2.1	2.0	1.1	10.4	4.6	10.9	1.3	2.9	8.7	0.7	9.4	1.0	0.0	1.5	12.2	1.6	8.1	9.6	5.1	1.1	3.5	6.1	14.4	1.9
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1717.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		210000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	295.5	257.6	201.7	352.9	213.4	554.9	218.9	238.0	213.5	256.3	324.0	304.6	287.3	275.8	647.7	338.2	266.7	164.1	303.2	203.5	239.7	296.9	782.3	308.9	230.0	260.4	230.1	272.2	319.7	292.2	284.5	403.3	254.5	277.9	336.7	96.2	299.3	247.2	119.8	189.3	277.2	349.7	237.7	277.3	300.6	165.2	267.3	245.3	702.9	104.7	319.4	252.2	236.6	274.2	1681.4	673.6	832.5	1984.9	1110.8	861.5	724.6	2075.3	1160.8	839.6	1280.4	1044.2	1353.5	1087.2	1960.0	2528.4	1064.5	672.1	906.1	1476.5	800.7	730.0	588.1	894.3	689.0	1619.6	2667.5	3638.5	1171.8	946.8	638.7	1222.3	957.7	1472.5	1507.8	743.1	814.5	536.3	911.7	1222.3	1040.0	2511.9	808.7	952.0	970.1	777.0	770.8	1329.9	1138.3	846.9	312.4	668.4	1438.7	769.8	472.6	789.9	1014.4	1558.9	1460.6	1113.2	666.2	1533.6	938.3	644.3	569.7	985.8	1567.6	1616.3	1258.1	67.5	72.8	39.7	172.8	147.8	119.3	90.0	99.7	130.0	76.3	77.5	73.0	134.4	23.8	103.1	122.7	215.6	83.4	75.8	201.7	213.4	238.0	213.5	203.5	239.7	260.4	230.1	254.5	237.7	267.3	274.2	385.2	147.4	160.7	34.6	385.7	261.7	336.3	217.3	221.4	76.8	214.9	140.8	43.7	163.0	175.4	222.5	127.2	652.9	515.5	524.4	64.6	582.7	27.8	206.3	364.2	305.6	353.6	266.1	14.2	285.5	1717.5	422.5	289.5	348.2	207.4	341.6	312.7	612.4	789.3	35.3	23.8	595.1	93.6	208.8	433.2	30.6	318.7	378.4	213.5	31.9	229.9	316.5	360.5	28.6	31.1	410.2	462.8	311.1	1059.6	426.1	377.8	182.8	147.5	167.7	203.8	224.2	328.9	276.1	306.6	245.5	213.5	964.4	345.8	399.4	471.4	329.6
CAPZA1		ENSG00000116489	"Capping actin protein of muscle Z-line subunit alpha 1"	P52907	1	112619805-112671616	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB045963	Approved					NA	NA		16000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB045963: AB_11126023"	"unprognostic (7.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (1.17e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.59e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-1)"	73.7	49.1	42.5	115.3	43.6	156.4	55.7	46.4	51.7	48.3	45.7	86.1	67.9	43.1	61.5	96.3	42.9	59.1	27.9	40.5	49.7	41.1	73.1	65.4	154.0	51.6	49.3	30.6	35.5	39.6	21.4	85.4	51.2	42.4	95.0	37.2	38.5	37.4	25.4	92.4	70.8	63.9	49.1	105.2	70.9	71.1	50.6	118.2	48.1	22.1	187.7	97.3	52.8	57.5	308.0	88.9	148.4	120.7	180.6	207.9	186.5	237.7	245.3	236.7	210.9	120.7	126.9	319.6	174.8	277.6	108.0	142.6	199.9	251.3	293.4	245.5	100.2	279.0	141.8	148.7	212.8	507.3	376.5	224.6	186.5	230.7	219.2	140.5	268.1	143.2	287.3	191.6	335.6	177.2	262.8	222.6	146.3	179.7	180.3	192.5	292.0	158.8	207.9	221.3	102.2	109.6	274.3	246.9	192.6	118.2	127.8	441.6	305.8	192.8	191.6	317.7	292.2	135.0	134.2	359.8	331.4	381.5	450.4	396.9	254.5	319.7	172.1	385.9	194.5	198.3	188.8	209.1	207.9	145.0	105.4	171.0	524.7	145.9	434.0	164.6	252.5	369.9	42.5	43.6	46.4	51.7	40.5	49.7	51.6	49.3	51.2	49.1	50.6	57.5	59.5	28.9	49.0	59.4	186.0	180.9	73.7	87.4	63.2	31.2	73.3	35.3	22.0	54.3	69.0	101.2	25.0	138.8	194.9	152.4	92.0	94.9	380.4	62.1	95.4	78.0	61.1	104.5	48.3	111.9	206.8	72.1	59.1	86.0	92.0	48.8	83.2	74.5	233.1	43.7	47.8	101.5	52.9	320.0	361.0	210.2	57.2	211.9	122.7	54.4	236.5	33.5	125.7	55.8	73.7	168.9	135.7	55.3	137.2	105.7	89.0	88.8	71.4	31.2	65.7	42.8	79.6	166.3	67.7	110.2	237.8	184.0	196.7	73.9	110.3	147.0
CARNMT1	"C9orf41, FLJ25795"	ENSG00000156017	"Carnosine N-methyltransferase 1"	Q8N4J0	9	74980790-75028423	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 256.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 24.6"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026756	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026756: AB_1845824"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.62e-2)"	5.1	6.1	1.8	7.0	13.8	8.3	7.0	24.6	6.0	5.8	0.1	9.2	12.7	6.1	8.3	10.0	6.2	6.8	5.4	3.7	0.4	12.2	17.1	5.4	9.7	0.1	2.5	6.1	9.0	11.3	3.9	5.3	1.8	6.4	8.5	7.8	9.1	5.3	8.7	8.4	12.4	6.1	0.2	6.7	7.8	16.4	1.0	8.4	13.6	8.5	8.5	9.1	5.1	3.5	27.6	16.1	6.6	17.0	10.3	22.4	24.6	24.4	10.0	9.0	8.2	4.1	17.9	43.7	12.9	17.4	19.2	26.7	20.0	25.3	25.5	40.0	17.4	22.3	15.5	18.4	12.6	40.7	21.2	15.0	12.4	17.0	17.3	13.3	18.6	15.6	19.1	36.9	17.4	7.3	29.8	10.8	31.4	33.0	14.7	14.4	20.2	25.4	23.5	19.0	6.5	3.6	18.7	46.2	9.2	11.8	23.5	11.7	14.8	14.8	19.9	18.2	21.3	28.2	38.3	13.1	22.9	27.6	9.8	0.0	0.4	1.0	1.3	0.8	1.9	1.7	1.3	2.0	0.6	0.9	1.6	1.5	0.1	1.5	0.4	0.6	2.0	0.7	1.8	13.8	24.6	6.0	3.7	0.4	0.1	2.5	1.8	0.2	1.0	3.5	8.5	6.4	11.7	0.0	10.2	0.0	11.6	0.0	21.6	14.5	16.6	8.0	0.0	11.5	6.8	27.6	10.4	7.0	18.6	4.5	25.4	7.5	256.8	11.2	19.6	9.4	7.3	6.3	0.0	11.9	13.0	6.6	13.7	14.8	2.5	8.7	8.9	29.8	8.1	20.2	0.0	12.8	0.0	9.1	0.0	44.3	7.5	8.5	0.0	0.0	8.9	5.6	17.5	0.0	0.0	9.3	8.8	10.9	17.4	17.7	22.6	37.3	4.4	10.4	0.0	9.3	5.6	17.7	10.3	33.5	0.0	5.1	17.1	16.2	13.2	15.0
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CAT		ENSG00000121691	Catalase	P04040	11	34438934-34472060	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1217.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 722.4;Hepatocytes: 443.4;Proximal tubular cells: 333.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	13	"eosinophil: 4736.8"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 4736.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 391.4;THP-1: 321.2;U-937: 265.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		760000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	281.3	115.1	27.1	52.1	29.6	407.7	123.6	27.9	35.5	82.0	39.4	82.6	145.1	53.1	34.8	40.1	86.8	59.8	58.1	26.6	29.4	296.6	1217.3	163.2	58.4	35.2	29.4	46.7	86.3	43.2	13.6	78.0	34.3	66.8	71.3	9.8	83.7	64.0	103.8	70.6	136.3	59.4	29.6	78.6	74.1	11.4	29.5	74.9	122.6	136.6	56.7	105.8	39.9	40.8	31.7	34.3	24.5	38.9	233.2	100.6	52.3	39.3	49.8	43.3	47.1	19.7	30.9	78.3	37.5	79.2	63.9	73.9	42.3	42.9	47.3	68.8	38.8	65.6	34.0	113.7	27.6	391.4	31.1	54.5	29.3	13.2	5.1	59.9	53.2	46.2	139.3	31.3	55.1	30.2	81.1	77.4	0.1	148.7	82.6	56.5	117.9	64.9	120.2	117.2	13.1	19.8	44.5	70.6	60.0	0.0	101.4	321.2	38.3	25.9	24.9	65.4	23.8	25.0	15.2	16.8	51.3	265.6	19.3	256.5	324.7	4736.8	54.4	265.1	64.6	133.9	63.7	61.0	353.5	124.1	61.7	66.7	290.2	105.7	298.5	235.8	92.7	397.9	27.1	29.6	27.9	35.5	26.6	29.4	35.2	29.4	34.3	29.6	29.5	40.8	196.9	227.6	275.9	41.1	53.8	28.9	93.7	44.9	27.9	13.5	42.6	36.1	44.9	82.9	66.9	73.5	27.1	96.8	92.0	59.4	225.0	36.0	2.7	72.2	41.4	43.8	48.0	722.4	12.6	26.2	30.0	53.1	54.6	29.3	24.0	38.7	57.1	443.4	138.5	0.0	1.2	56.9	91.6	125.5	95.8	6.2	78.3	93.9	26.6	16.9	253.4	19.5	28.8	22.6	45.6	15.3	44.8	77.5	25.4	37.0	151.6	333.2	96.9	19.4	78.9	46.6	68.0	6.3	11.3	24.4	27.1	40.5	37.7	57.7	95.6	97.5
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 10.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.9;Exocrine glandular cells: 10.9;Gastric mucus-secreting cells: 11.7;Glandular and luminal cells: 6.2;Pancreatic endocrine cells: 7.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;OE19: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035134			Uncertain	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.5	0.2	0.5	0.6	0.5	0.3	0.8	1.0	0.5	0.4	0.1	0.6	0.4	0.2	0.4	0.5	0.4	0.8	0.4	0.3	0.2	0.2	0.1	0.6	0.9	0.3	0.1	0.3	10.7	0.3	0.2	0.2	0.3	0.6	0.5	0.8	2.5	0.2	1.2	2.3	0.9	0.2	0.1	0.6	1.4	1.1	0.2	0.3	0.5	0.0	0.5	0.2	0.2	0.8	0.2	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	1.2	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.6	0.1	0.4	0.7	0.0	0.5	0.2	0.1	0.2	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.3	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	1.2	0.3	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.3	0.2	0.3	0.1	0.3	0.1	0.2	0.8	0.1	3.2	1.5	0.3	0.1	0.1	0.3	0.2	0.0	0.0	3.3	1.0	0.2	0.0	2.1	0.0	0.0	0.1	0.3	2.2	0.0	2.7	22.9	1.6	0.9	0.6	0.0	0.0	4.9	10.9	0.1	0.6	11.7	6.2	0.0	0.1	0.0	0.1	0.0	0.0	1.3	3.0	0.0	0.3	0.3	3.2	0.6	0.1	0.0	1.9	0.6	0.0	1.0	0.5	1.8	7.5	2.5	0.0	0.4	0.9	0.1	0.5	1.5	0.0	0.0	0.9	0.3	4.5	0.2	0.8	0.0	0.3	0.7	0.1	1.4	0.8
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 87.6;retina: 52.5;testis: 185.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 780.2;Late spermatids: 2032.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.5;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010646, HPA071015"	Enhanced	Approved	Approved	"Nuclear membrane,Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"	"Nuclear membrane, Plasma membrane"	"HPA010646: , HPA071015: AB_2686334"	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	1.8	3.7	37.2	1.9	24.4	0.8	1.7	42.7	39.9	5.2	6.2	20.1	1.6	9.3	2.2	1.7	3.3	2.2	5.7	24.2	34.7	0.7	0.3	1.1	2.7	30.5	54.2	2.8	0.8	1.6	6.4	1.4	26.3	12.1	3.1	52.5	1.6	13.6	4.4	0.9	4.8	11.6	34.9	1.5	4.6	185.7	87.6	5.2	1.3	4.0	1.7	13.1	3.9	30.6	1.1	1.5	11.7	7.9	6.3	5.4	2.0	4.7	6.0	4.6	4.3	1.8	1.0	6.5	0.5	6.2	18.4	2.5	7.8	0.9	4.3	17.2	7.7	10.7	3.1	0.0	2.2	1.5	22.2	6.0	0.8	5.0	0.4	4.1	2.7	10.0	4.0	6.0	1.9	2.3	8.0	3.4	16.3	0.1	5.1	19.5	2.3	2.9	0.3	2.4	7.4	20.4	2.9	3.3	5.1	4.1	0.3	3.1	2.4	7.4	4.2	3.7	3.5	3.4	1.6	6.1	30.5	46.2	1.9	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	37.2	24.4	42.7	39.9	24.2	34.7	30.5	54.2	26.3	34.9	87.6	30.6	1.6	0.0	0.5	11.4	1.1	0.5	0.9	0.1	1.8	306.0	0.6	3.8	7.5	1.5	0.7	0.0	98.0	0.1	2.2	0.0	0.0	0.7	780.2	0.3	2.2	2.0	0.0	0.4	23.3	1.5	0.3	2.6	1.5	0.1	0.0	1.9	1.1	0.0	6.8	40.4	48.0	0.1	0.0	0.6	1.6	2032.0	18.0	2.3	0.0	10.3	0.7	22.5	2.1	28.6	13.3	0.6	0.1	7.5	1.1	0.9	0.0	0.2	2.0	20.7	6.6	1.6	6.1	321.9	17.2	0.1	0.4	0.4	3.4	0.3	0.0	0.3
CCDC169	"C13orf38, LOC728591, RP11-251J8.1"	ENSG00000242715	"Coiled-coil domain containing 169"	A6NNP5	13	36222008-36297840	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 59.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 830.4;Late spermatids: 2135.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 15.0;U-937: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (9.12e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.51e-2)"	"unprognostic (7.26e-4)"		"unprognostic (6.91e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.14e-2)"	0.5	0.4	1.2	0.4	1.0	2.8	0.7	2.2	2.7	0.4	0.0	0.9	0.5	1.2	2.5	0.7	0.4	0.5	0.6	0.9	0.0	0.6	0.3	0.2	0.4	0.1	0.2	0.4	0.4	1.9	0.1	0.5	0.3	1.3	0.5	2.7	0.2	1.2	0.5	0.6	0.4	1.5	0.1	0.4	0.7	59.2	0.3	0.2	0.4	0.6	0.1	1.0	0.1	2.4	0.2	0.4	0.8	0.4	1.5	2.7	4.7	0.8	1.2	0.7	0.5	0.2	0.3	0.6	0.5	0.3	2.6	0.5	5.5	0.3	1.5	0.7	0.5	4.9	1.2	0.3	3.5	15.0	0.5	1.9	1.3	0.5	1.1	1.2	3.3	0.4	4.3	1.5	2.7	0.2	0.5	6.0	0.4	0.1	0.3	0.4	1.4	0.3	0.7	1.9	0.7	2.2	0.3	0.7	0.2	4.9	0.5	6.5	1.1	0.9	1.9	0.6	1.5	0.7	0.6	0.2	0.6	9.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.2	1.0	2.2	2.7	0.9	0.0	0.1	0.2	0.3	0.1	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.2	0.3	2.3	1.4	0.8	0.0	1.0	1.8	4.2	2.8	0.0	0.0	0.0	0.1	830.4	0.8	1.2	1.0	1.2	3.8	0.0	0.0	4.0	0.4	0.0	1.4	0.0	4.1	0.0	0.0	0.5	3.3	0.0	0.1	2.0	0.0	0.0	2135.2	13.1	1.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	7.2	0.0	1.2	0.0	5.2	0.2	0.2	13.1	0.5	0.3	124.0	14.9	0.3	0.1	5.6	0.3	3.9	0.2	0.7
CCDC169-SOHLH2	C13orf38-SOHLH2	ENSG00000250709	"CCDC169-SOHLH2 readthrough"		13	36168794-36297842	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	22	"testis: 10.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Inhibitory neurons: 1.2;Late spermatids: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;HL-60: 2.6;NB-4: 1.5;U-937: 2.0"									HPA029182			Uncertain	Vesicles		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA029182: AB_10602409"					"unprognostic (5.56e-2)"			"unprognostic (3.93e-1)"		"unprognostic (3.60e-2)"		"unprognostic (4.66e-1)"	"unprognostic (2.17e-1)"		"unprognostic (1.84e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC32	"C15orf57, MGC20481"	ENSG00000128891	"Coiled-coil domain containing 32"	Q9BV29	15	40528683-40565057	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041688	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"	Vesicles	"HPA041688: AB_10796779"	"unprognostic (7.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.25e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.47e-2)"	16.0	20.5	16.2	17.0	14.8	20.2	15.5	13.9	18.1	16.0	16.9	17.3	17.0	14.6	17.3	9.3	18.2	17.8	18.1	18.3	17.1	22.8	13.0	14.2	28.7	16.1	17.6	25.0	17.9	20.0	13.6	21.3	18.6	13.9	19.8	15.1	13.0	14.9	15.5	10.3	14.9	15.4	15.6	21.5	18.0	8.3	18.2	19.4	20.9	11.1	25.8	19.2	12.1	16.2	15.4	10.8	14.1	22.8	28.8	29.9	8.4	12.0	17.8	20.9	21.8	16.4	20.9	5.6	32.9	18.0	30.2	28.3	13.8	13.8	14.8	35.0	16.2	62.6	18.1	20.6	19.6	24.0	31.5	25.4	14.1	16.3	11.0	19.8	26.7	22.0	35.0	36.9	16.1	13.3	11.2	20.4	5.6	35.3	13.6	19.1	18.5	19.1	39.6	36.3	15.8	15.5	17.9	18.5	9.3	16.6	19.6	43.4	29.8	19.5	17.0	34.1	17.5	21.1	21.1	18.4	20.7	37.2	27.8	58.2	32.4	33.9	32.6	34.2	25.9	147.1	35.6	35.3	43.0	167.2	35.8	30.7	34.0	29.1	35.7	57.6	50.6	42.1	16.2	14.8	13.9	18.1	18.3	17.1	16.1	17.6	18.6	15.6	18.2	16.2	32.1	12.8	13.4	0.0	24.6	0.0	0.0	0.0	0.0	0.0	18.6	20.8	0.0	0.0	9.9	20.2	0.0	80.5	19.6	0.0	29.4	27.0	0.0	22.7	13.7	10.2	0.0	0.0	0.0	29.2	32.5	11.3	0.0	14.4	6.3	15.5	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	10.3	0.0	0.0	0.0	0.0	38.3	0.0	0.0	7.8	0.0	0.0	30.0	12.4	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	81.4	10.1	35.0	0.0	0.0
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621837	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	2.7	3.1	3.8	3.6	3.7	3.0	5.2	3.7	4.3	4.8	4.2	4.0	3.0	4.1	5.3	2.5	5.7	3.4	2.9	3.7	4.2	4.1	2.0	3.6	4.9	3.8	3.7	6.0	3.3	5.4	4.5	3.3	3.9	4.0	4.1	7.8	3.3	3.6	4.5	2.5	2.8	4.9	3.8	4.3	3.2	3.7	3.7	5.1	4.9	2.6	4.9	3.7	3.1	3.8	5.6	2.0	5.8	3.7	8.9	5.2	4.6	6.8	6.4	9.1	7.8	4.3	4.3	15.6	1.6	3.8	5.8	2.8	3.4	6.5	10.1	5.6	4.0	9.5	9.0	4.6	6.2	12.8	3.3	4.9	8.8	7.7	5.1	8.0	6.0	7.7	9.3	2.4	7.2	4.7	10.0	7.5	9.7	4.8	7.5	3.4	5.2	8.6	5.3	1.9	2.2	4.2	8.7	5.5	5.2	4.9	1.9	5.2	3.1	6.6	5.2	6.3	9.9	4.7	5.3	8.0	4.9	14.3	5.5	10.0	1.5	3.5	4.1	2.0	5.4	2.7	7.0	5.0	1.1	1.6	8.0	5.8	0.3	5.1	2.4	1.0	14.8	2.6	3.8	3.7	3.7	4.3	3.7	4.2	3.8	3.7	3.9	3.8	3.7	3.8	39.7	22.4	22.6	42.7	41.3	28.2	20.1	30.5	15.9	68.5	18.5	21.0	30.5	30.0	29.0	22.0	108.4	23.0	51.5	7.7	29.4	23.7	202.5	58.1	33.5	28.8	21.0	40.8	93.2	10.5	14.6	29.9	18.8	13.9	34.2	38.3	37.9	8.5	18.4	52.2	95.8	11.4	22.4	35.8	27.9	109.6	54.0	20.7	26.6	51.5	56.1	36.8	105.0	70.9	96.7	14.1	9.8	47.8	28.1	25.5	11.5	20.3	51.5	111.5	32.9	38.6	30.9	55.8	46.8	12.1	29.5	16.4	51.7	33.6	14.5	11.4
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	9.4	9.6	5.3	9.6	5.5	29.4	9.9	7.3	6.4	7.1	7.8	7.7	6.7	9.2	8.2	7.8	8.2	7.1	6.8	4.7	8.6	8.9	8.4	8.3	11.7	5.7	5.8	10.8	8.8	11.5	6.7	7.9	5.7	7.6	8.3	12.2	6.3	7.0	10.2	9.6	7.8	7.9	6.1	10.5	7.3	11.5	6.3	13.0	11.7	9.9	11.3	7.5	6.9	7.5	15.1	21.8	20.6	19.8	14.9	18.2	23.8	20.0	16.6	15.3	11.8	26.0	17.3	40.4	25.6	13.4	10.4	19.3	35.6	13.7	22.6	24.0	20.5	43.9	34.2	11.2	18.4	45.1	20.0	14.1	19.6	21.4	25.3	21.0	11.9	23.5	44.7	18.1	18.9	9.9	24.6	20.9	20.7	8.7	16.1	21.8	33.4	17.0	14.0	26.2	23.0	24.0	32.0	15.5	23.5	14.9	21.3	25.8	12.5	16.1	17.0	11.7	17.1	25.8	37.0	35.3	19.1	64.9	9.4	9.0	2.6	7.7	3.3	1.7	4.5	4.3	2.7	3.2	1.6	5.3	3.9	3.6	13.6	3.5	2.0	4.4	1.8	0.9	5.3	5.5	7.3	6.4	4.7	8.6	5.7	5.8	5.7	6.1	6.3	7.5	41.4	16.0	18.9	16.0	38.0	38.5	19.4	11.8	48.9	23.5	21.9	19.0	14.4	12.8	16.1	12.9	22.9	13.8	58.7	13.1	3.9	8.2	131.4	18.9	23.7	26.4	12.0	24.0	18.9	6.9	16.7	23.9	29.0	26.1	29.8	27.3	27.8	15.2	10.2	38.7	18.5	15.8	14.2	17.5	33.0	27.9	16.8	29.9	21.4	19.7	12.1	16.2	18.6	18.6	22.6	8.1	9.2	14.7	37.8	26.2	13.3	9.8	25.1	16.3	6.6	23.3	28.5	18.3	14.4	32.1	44.9	17.4	45.0	27.3	13.7	33.3
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.0;lung: 17.7;lymphoid tissue: 28.9"	"Group enriched"	"Detected in some"	5	"granulocytes: 22.8;Hofbauer cells: 20.6;Kupffer cells: 33.2;Macrophages: 47.0;monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 234.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 63.8;granulocytes: 234.2;monocytes: 193.0"	"Group enriched"	"Detected in some"	6	"THP-1: 25.6;U-937: 48.6"					"Low region specificity"	"Detected in some"			HPA013712	Supported					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	1.9	0.6	0.9	13.5	1.1	27.0	0.8	6.2	4.2	1.3	0.7	3.4	3.8	0.6	0.2	0.5	0.7	2.7	0.5	1.0	1.3	0.6	2.2	17.7	8.8	2.6	1.8	0.2	0.5	0.4	0.4	1.7	2.4	0.7	3.5	0.2	0.8	0.5	0.3	0.1	3.6	3.3	1.7	28.9	1.6	0.4	2.8	2.0	0.4	0.8	5.4	3.0	0.4	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	2.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	48.6	0.0	48.4	96.3	234.2	0.3	165.3	0.5	0.2	0.1	0.2	63.8	0.2	0.2	0.1	74.7	3.7	193.0	6.7	0.4	44.8	0.9	1.1	6.2	4.2	1.0	1.3	2.6	1.8	2.4	1.7	2.8	3.2	0.1	0.0	6.4	0.0	1.3	0.1	0.0	0.1	0.0	0.4	0.1	0.4	0.2	1.5	3.3	0.0	2.1	0.1	2.7	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.0	1.7	2.7	0.0	0.2	0.3	0.0	0.0	22.8	0.0	1.1	0.3	20.6	0.0	2.1	0.1	0.0	33.2	0.7	0.2	0.0	47.0	0.0	3.7	39.9	0.0	1.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1017.1;dendritic cells: 694.0;granulocytes: 1455.3;Plasma cells: 308.8;T-cells: 1185.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 30.0;JURKAT: 19.5;K-562: 58.4;MOLT-4: 20.9;U-266/70: 22.5;U-698: 25.6;U-937: 97.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"	14.0	6.2	0.9	48.1	0.7	169.1	18.9	1.2	1.0	9.3	2.2	8.9	8.2	6.0	2.9	11.9	7.7	27.3	3.5	0.7	1.7	4.9	12.9	22.6	94.4	1.7	1.1	2.6	1.7	2.0	4.0	2.6	1.6	10.4	21.3	0.2	5.1	2.9	0.7	4.3	19.5	14.3	2.2	43.6	11.8	1.3	1.0	57.0	6.9	4.6	60.1	18.0	7.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	12.1	0.0	0.0	1.5	30.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	19.5	58.4	0.0	0.0	0.0	20.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.9	8.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.5	2.7	25.6	0.0	97.8	0.0	1.3	0.1	5.9	22.9	0.1	30.8	6.0	14.5	16.9	0.1	6.2	20.6	15.6	0.3	26.7	0.0	0.0	7.9	7.3	0.9	0.7	1.2	1.0	0.7	1.7	1.7	1.1	1.6	2.2	1.0	2.4	13.5	41.7	116.7	0.0	1017.1	18.5	3.8	0.0	10.8	0.1	11.8	14.7	2.0	7.2	5.0	1.8	0.0	0.9	694.0	1.1	0.0	1.1	0.4	5.7	3.6	14.3	0.0	33.7	0.0	0.0	0.3	15.4	63.7	16.7	1455.3	0.0	14.6	2.4	16.6	0.0	0.0	0.2	0.0	15.4	77.1	0.3	0.0	80.1	33.8	10.3	3.2	0.1	57.7	0.0	0.1	0.0	0.1	0.0	308.8	2.2	0.4	2.1	1.5	0.6	0.0	4.3	9.2	0.1	0.3	4.2	18.2	1.9	1185.9	0.0	0.9	3.3
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974634	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 98.4;lymphoid tissue: 96.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 73.5;Sertoli cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 273.1;U-937: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	98.4	23.2	21.6	9.1	23.6	36.0	30.6	22.6	31.4	17.5	20.3	19.3	13.4	20.4	11.8	11.1	15.2	15.5	24.2	21.6	23.0	10.4	7.2	9.9	22.5	23.0	22.4	47.6	17.4	19.9	7.8	7.3	24.0	9.9	12.6	7.8	8.8	24.9	20.5	18.9	14.2	22.2	21.2	11.1	7.4	5.2	22.2	96.2	9.7	8.6	23.4	13.1	16.3	30.3	67.6	32.9	5.9	99.6	108.0	16.4	1.5	61.8	76.2	121.8	107.8	1.8	25.7	140.3	58.5	63.5	41.6	8.2	71.4	9.8	63.4	78.4	90.7	102.5	254.6	21.5	5.5	74.0	42.8	5.6	1.9	32.8	14.6	45.6	32.7	115.0	45.0	0.0	76.2	22.0	91.1	40.4	0.1	31.6	71.3	108.6	86.8	0.4	42.9	34.1	49.6	114.3	88.1	67.5	23.6	0.6	31.3	273.1	21.6	130.8	44.1	76.3	0.9	128.1	131.9	113.2	0.0	284.5	118.3	22.4	3.7	17.9	7.3	2.2	8.4	4.9	10.8	9.7	9.3	4.3	6.0	5.8	0.4	10.5	0.9	11.5	22.0	5.6	21.6	23.6	22.6	31.4	21.6	23.0	23.0	22.4	24.0	21.2	22.2	30.3	9.5	0.0	3.9	2.0	5.6	10.1	2.6	8.1	23.9	8.2	3.8	29.5	14.3	5.7	6.1	3.7	16.7	4.9	11.3	2.8	17.6	6.3	4.9	1.1	18.2	8.1	8.4	73.5	0.6	3.4	12.1	31.0	3.1	1.2	16.5	12.6	20.3	8.8	28.3	5.0	0.6	10.2	14.2	20.5	16.0	7.1	39.4	11.0	7.2	1.9	17.1	26.9	17.5	2.0	3.3	3.1	10.2	47.8	14.0	1.8	24.6	40.8	3.2	9.9	85.5	38.9	26.7	32.0	15.0	22.0	11.2	1.9	18.2	28.6	9.1	1.2
CEACAM4	CGM7	ENSG00000105352	"CEA cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 21.3;lymphoid tissue: 32.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 41.1;Macrophages: 20.9;monocytes: 9.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 122.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 122.7"	"Cell line enriched"	"Detected in single"	6	"U-937: 4.1"															NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	2.1	0.5	0.1	4.8	0.1	21.3	0.5	0.1	0.2	0.4	0.2	0.7	0.3	0.3	0.8	1.0	1.0	1.0	0.8	0.1	0.1	0.8	1.0	5.7	0.9	0.2	0.2	0.2	1.2	0.0	0.3	0.3	0.2	1.1	0.2	0.0	0.8	0.0	0.2	0.3	1.8	1.0	0.1	32.6	0.8	0.1	0.2	0.3	0.4	0.6	0.6	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	30.1	5.6	0.0	23.1	0.1	0.7	1.2	0.0	23.3	0.0	0.7	0.0	122.7	0.0	9.9	0.2	11.3	12.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	3.9	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	0.0	41.1	1.6	0.2	0.0	20.9	1.8	1.9	9.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0
CENPS	"APITD1, CENP-S, FAAP16, MHF1"	ENSG00000175279	"Centromere protein S"	Q8N2Z9	1	10430433-10442808	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.7;Distal tubular cells: 37.2;Proximal tubular cells: 86.1;Respiratory ciliated cells: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.64e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.06e-3)"	"unprognostic (2.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.72e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.21e-2)"	3.5	8.9	4.7	5.8	4.7	9.1	5.1	4.3	6.4	5.7	5.8	6.8	12.5	4.6	12.3	7.4	9.9	7.6	4.5	4.5	4.5	28.0	8.3	5.1	6.4	4.5	4.5	4.0	7.9	14.5	14.1	4.5	4.3	6.5	7.4	8.8	6.8	4.8	3.6	4.4	9.6	4.2	4.4	3.9	6.3	48.6	4.8	9.5	12.0	3.7	6.4	5.6	4.2	4.4	38.9	25.1	17.4	25.2	13.6	11.3	9.1	21.2	22.4	27.8	21.4	11.5	26.4	29.3	19.3	19.0	15.6	29.5	16.1	24.0	30.0	25.1	17.4	17.2	21.0	24.2	8.7	58.5	21.5	7.0	12.0	29.5	18.3	10.8	16.6	31.2	24.3	24.9	27.0	29.6	27.7	35.1	24.5	33.0	26.6	29.7	19.9	34.5	34.1	13.6	22.0	20.1	23.1	25.4	25.7	14.4	30.9	31.6	9.9	29.2	35.6	26.6	37.1	6.6	16.8	35.5	27.3	65.4	38.5	0.0	1.4	0.8	2.8	2.3	3.8	6.9	4.1	3.1	1.8	6.1	4.5	3.8	0.8	2.1	6.0	5.0	4.5	1.8	4.7	4.7	4.3	6.4	4.5	4.5	4.5	4.5	4.3	4.4	4.8	4.4	2.5	6.4	13.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.0	0.0	8.1	5.5	0.0	23.7	2.3	0.0	37.2	16.5	0.0	15.0	3.7	3.6	0.0	0.0	0.0	10.9	12.0	3.5	0.0	3.6	3.8	7.4	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.5	0.0	0.0	86.1	27.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	6.7	2.0	9.3	0.0	0.0
CENPS-CORT	APITD1-CORT	ENSG00000251503	"CENPS-CORT readthrough"		1	10430102-10452153	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	4	"testis: 36.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Proximal tubular cells: 3.5;Respiratory ciliated cells: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 33.0"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (2.73e-1)"	"unprognostic (8.54e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (9.73e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.97e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.32e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (5.06e-2)"	0.4	0.9	2.8	0.6	3.3	8.4	0.9	2.5	5.6	0.5	2.0	0.9	1.6	0.6	0.8	1.4	0.8	0.7	0.3	2.5	3.9	2.3	1.2	0.7	1.1	2.3	2.3	0.5	1.2	1.4	2.5	0.3	2.4	0.8	0.1	2.4	0.9	0.1	0.3	0.5	0.7	0.1	1.8	0.7	1.2	36.2	3.1	2.1	1.5	0.9	0.9	0.3	0.7	2.9	13.4	18.5	10.1	1.2	1.4	1.3	1.9	13.5	3.0	17.5	7.8	8.2	5.0	12.5	6.5	2.5	4.3	8.3	6.4	4.7	1.5	11.6	7.6	23.3	3.9	14.6	0.3	31.6	12.7	0.0	2.8	14.3	1.4	3.6	2.0	5.2	6.2	8.3	0.6	5.6	11.2	8.0	4.6	2.8	6.1	11.5	10.6	12.8	3.2	2.2	4.7	6.4	15.7	6.7	3.4	2.8	5.0	6.6	4.7	9.8	20.8	6.3	12.1	1.4	5.7	19.6	8.2	33.0	8.7	0.0	0.6	0.6	0.5	0.9	0.8	4.3	0.9	1.6	0.8	4.8	1.0	0.6	1.1	2.4	0.6	1.9	2.6	1.3	2.8	3.3	2.5	5.6	2.5	3.9	2.3	2.3	2.4	1.8	3.1	2.9	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.6	0.0	0.0	0.8	0.7	0.0	0.0	0.7	0.0	0.9	0.4	0.3	0.0	0.0	0.0	0.8	0.3	0.3	0.0	0.4	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	3.5	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961245-66975149	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.2;liver: 52.5;skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.8	0.5	3.1	3.2	2.7	0.9	2.3	2.5	2.9	1.3	1.3	38.2	30.0	0.7	0.2	4.2	2.9	0.9	0.7	3.8	2.0	12.2	52.5	0.7	0.3	3.3	2.7	0.6	4.1	1.0	1.9	0.6	3.5	0.5	31.3	0.6	12.0	0.3	24.7	1.2	23.7	1.2	1.4	0.4	7.7	1.1	2.2	0.2	0.4	1.5	0.2	0.1	0.8	2.2	0.4	3.1	0.3	7.4	0.2	0.2	1.2	0.2	0.2	0.3	0.5	0.5	3.8	8.5	2.4	0.0	0.2	0.6	1.1	0.5	0.1	1.5	5.5	4.3	1.3	2.6	0.0	0.9	0.7	0.3	0.9	0.8	0.1	0.2	0.0	13.5	2.8	1.7	0.3	1.1	1.4	1.4	1.5	2.6	0.4	1.3	0.7	1.3	0.1	0.4	0.4	0.8	0.2	5.8	0.2	0.6	5.0	6.5	0.3	0.4	2.4	0.7	0.2	0.9	3.6	1.3	0.3	7.2	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	3.1	2.7	2.5	2.9	3.8	2.0	3.3	2.7	3.5	1.4	2.2	2.2	0.1	3.2	6.7	0.7	0.4	0.5	0.0	1.3	1.2	0.2	9.1	5.7	1.4	2.8	0.9	0.0	0.0	0.0	0.0	120.1	0.0	0.2	0.5	3.2	0.3	0.2	19.7	0.0	1.8	0.9	0.0	0.2	11.7	4.4	1.3	58.5	0.4	53.4	0.3	0.0	2.9	32.0	0.0	3.2	0.9	5.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	1.5	0.1	1.0	67.0	1.2	0.1	0.1	66.0	9.9	4.8	0.2	0.0	0.6	0.2	2.3	2.9	1.1	0.3	0.0	0.4	0.1	44.3	0.2
CHRFAM7A	"CHRNA7-DR1, D-10"	ENSG00000166664	"CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion"	Q494W8	15	30360566-30393849	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.2;parathyroid gland: 5.5"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 11.8;Inhibitory neurons: 4.1;Proximal enterocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.6;HEK 293: 1.8;HEL: 3.8;RH-30: 2.6;SH-SY5Y: 2.0;U-937: 3.5"															NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.61e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.53e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.71e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	0.7	0.8	0.3	0.6	0.5	4.2	0.4	0.3	0.9	0.4	0.5	0.5	0.5	0.3	0.1	0.2	0.3	0.2	1.2	0.4	0.8	0.2	0.0	0.9	0.2	1.5	1.7	0.5	0.7	5.5	0.6	0.0	1.3	0.7	0.0	0.3	0.3	0.2	0.2	0.3	0.7	0.3	0.7	0.7	0.7	3.2	0.6	0.2	1.7	0.3	0.2	0.4	0.4	0.6	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.4	0.0	3.6	0.0	0.0	0.0	1.8	3.8	0.1	0.1	0.1	0.7	1.0	0.2	0.0	0.0	0.0	1.6	0.3	0.8	0.4	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.6	0.0	1.0	0.1	0.1	2.0	0.0	0.0	0.0	0.3	0.0	0.2	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.9	2.8	0.1	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.1	0.3	0.3	0.5	0.3	0.9	0.4	0.8	1.5	1.7	1.3	0.7	0.6	0.6	0.1	0.0	0.0	1.0	0.9	0.0	1.2	0.0	1.8	1.5	0.1	0.4	2.1	1.5	0.6	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.2	0.4	0.2	0.4	1.2	2.1	1.6	1.1	0.0	0.6	2.0	0.9	1.3	0.3	0.4	0.0	0.7	11.8	4.1	3.1	0.0	0.8	0.0	0.5	0.0	1.2	0.0	0.0	1.6	0.8	1.0	0.0	0.3	0.7	0.3	1.5	0.7	0.5	4.1	0.0	0.0	0.0	0.0	0.3	0.6	3.2	1.9	0.6	0.0	0.0	0.2	0.0	0.9	1.5
CIAO2A	"CIA2A, FAM96A, FLJ22875"	ENSG00000166797	"Cytosolic iron-sulfur assembly component 2A"	Q9H5X1	15	64072565-64093857	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 262.4"	"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	27.8	68.6	23.1	53.6	26.0	70.7	48.5	25.7	26.7	31.5	39.1	82.8	107.9	22.6	41.1	30.1	32.1	43.0	78.0	22.0	24.6	81.3	262.4	43.4	105.3	26.1	24.0	20.6	59.8	75.5	24.6	65.5	26.6	39.1	68.4	24.7	44.0	26.8	125.5	19.4	86.8	23.8	26.4	52.8	68.8	20.7	26.9	60.3	80.2	97.4	66.9	46.3	20.3	32.0	114.6	168.6	104.3	71.7	91.7	110.7	61.2	92.7	105.4	120.2	133.5	157.7	172.9	186.9	157.4	56.2	155.7	118.3	197.9	90.2	95.4	171.3	124.2	156.2	137.7	161.2	70.7	240.5	123.1	90.8	87.2	76.7	67.6	84.5	130.1	118.5	222.3	148.8	89.5	197.8	100.1	202.8	144.6	148.9	96.3	154.5	139.8	410.4	154.3	127.0	112.2	87.5	76.8	150.9	180.6	113.9	120.6	243.6	83.0	98.2	129.4	104.7	193.6	144.4	353.8	186.4	109.5	429.3	96.9	122.4	255.8	117.0	67.3	254.1	83.0	346.0	94.8	88.1	231.6	345.5	75.5	74.4	132.0	86.9	228.3	386.5	146.1	269.0	23.1	26.0	25.7	26.7	22.0	24.6	26.1	24.0	26.6	26.4	26.9	32.0	10.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	0.0	116.5	10.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	100.6	13.2	0.0	0.0	0.0	0.0	0.0	0.0	218.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	88.8	2.0	0.0	0.0	0.0
CIDEB		ENSG00000136305	"Cell death inducing DFFA like effector b"	Q9UHD4	14	24305096-24311430	"Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 310.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 258.9;Proximal enterocytes: 301.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HEL: 11.0;Hep G2: 24.0;HL-60: 15.5;Karpas-707: 10.6;U-266/84: 14.8;U-937: 17.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA001272	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001272: AB_2666255"	"unprognostic (2.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.35e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.64e-1)"	13.2	37.2	1.6	5.6	1.6	12.3	11.6	2.3	2.2	17.3	2.2	10.7	70.6	8.6	4.4	35.5	12.9	3.8	7.5	1.5	2.2	31.1	310.8	10.5	4.8	2.0	2.0	25.3	19.3	1.9	12.2	2.0	1.9	11.2	3.5	0.2	14.2	4.8	2.5	22.6	58.1	4.0	1.9	88.9	8.0	2.2	2.6	3.6	7.6	1.3	7.2	8.6	20.1	1.9	0.0	0.0	0.0	0.0	1.4	0.6	0.2	0.4	0.1	0.2	0.1	1.4	0.5	0.0	0.0	0.6	0.0	2.0	0.0	0.2	0.0	21.5	0.0	11.0	0.0	24.0	0.1	15.5	0.0	0.5	0.0	0.0	0.0	0.0	4.8	0.0	0.0	10.6	0.0	0.0	0.1	7.3	0.0	5.6	0.0	1.8	0.1	5.5	0.0	0.7	4.5	0.0	5.9	0.1	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	8.4	14.8	0.1	0.0	17.9	0.0	0.9	5.2	6.9	3.4	1.8	3.2	0.5	2.2	2.1	5.2	0.4	1.4	1.7	2.9	5.2	0.9	1.3	1.3	2.0	1.6	1.6	2.3	2.2	1.5	2.2	2.0	2.0	1.9	1.9	2.6	1.9	8.8	0.0	1.7	0.0	6.9	7.0	6.4	5.6	29.6	0.4	4.6	5.6	0.0	11.5	3.3	1.8	2.1	0.1	15.0	14.4	9.8	1.5	0.1	4.3	2.0	7.0	1.8	13.0	0.0	9.6	0.2	4.0	5.1	1.2	8.8	0.3	12.5	258.9	7.9	0.0	0.1	11.7	8.2	30.5	2.6	0.5	6.2	13.2	5.4	1.0	8.8	0.6	21.6	0.0	0.1	15.4	24.4	3.0	7.2	0.7	301.5	51.6	10.5	0.6	0.0	0.9	2.8	0.2	2.3	33.4	6.1	0.3	11.1	3.6	8.6	1.8
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 79.9;lymphoid tissue: 22.1"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 121.9;Macrophages: 141.6;monocytes: 154.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	37	"dendritic cells: 72.6;granulocytes: 202.6;monocytes: 136.6"	"Group enriched"	"Detected in some"	6	"HL-60: 21.8;U-937: 66.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 6.2"	"Not detected"	"Not detected"			HPA048515	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favorable (9.33e-4)"	6.4	2.6	0.3	13.9	0.2	79.9	1.1	0.3	1.0	2.0	1.3	2.8	1.0	1.0	1.2	1.2	1.0	5.1	1.9	0.2	0.2	0.7	6.4	16.6	6.6	0.6	0.2	0.4	0.7	0.6	0.4	2.4	0.3	0.9	3.0	0.3	1.3	0.4	1.3	1.4	4.5	7.7	0.2	22.1	1.8	0.6	0.3	2.5	1.1	0.7	2.1	4.9	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	21.8	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.5	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	66.5	0.0	23.9	136.6	202.6	0.2	114.6	0.5	0.2	0.1	0.1	72.6	0.1	0.4	0.5	47.2	3.7	130.2	6.4	0.2	61.6	0.3	0.2	0.3	1.0	0.2	0.2	0.6	0.2	0.3	0.2	0.3	0.3	0.7	3.2	5.0	0.0	2.8	0.4	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	3.1	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	7.2	0.3	0.0	1.0	1.5	0.5	0.1	30.3	0.0	0.7	0.8	19.2	0.0	0.3	0.0	0.0	121.9	16.9	0.0	0.0	141.6	0.0	0.0	154.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.9	0.9	0.2	0.6	1.4	4.2	0.0	0.0	0.0
CLEC12B		ENSG00000256660	"C-type lectin domain family 12 member B"	Q2HXU8	12	10010627-10018796	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 5.1;skin 1: 4.2;testis: 13.1"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 80.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"GAMG: 2.8;U-937: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.60e-1)"		"unprognostic (1.81e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.14e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.02e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.48e-1)"	"unprognostic (8.95e-4)"	0.4	0.0	0.0	0.5	0.1	5.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.8	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	4.2	0.1	0.1	0.0	1.6	0.1	13.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.8	9.5	0.3	2.2	80.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.0	0.9	0.0	0.1	0.0	0.0	0.0
CLEC2A	"INPE5792, KACL, PILAR, UNQ5792"	ENSG00000188393	"C-type lectin domain family 2 member A"	Q6UVW9	12	9898673-9932370	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"skin 1: 57.6"	"Group enriched"	"Detected in some"	11	"Basal keratinocytes: 18.7;Suprabasal keratinocytes: 37.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 22.0;U-937: 54.6"									"HPA048530, HPA072407"	Approved		Uncertain	"Plasma membrane"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA048530: AB_2680429, HPA072407: AB_2686518"		"unprognostic (3.10e-1)"							"unprognostic (5.29e-2)"						"unprognostic (2.23e-1)"			0.0	0.0	0.1	0.0	0.2	0.0	3.5	2.1	0.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	57.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.3	0.2	0.3	0.5	0.3	0.5	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	37.1	0.0	0.1	0.0	0.0	0.1
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852369-9869386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 113.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;dendritic cells: 255.7;NK-cells: 265.7;Suprabasal keratinocytes: 240.8;T-cells: 276.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 221.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.7;ASC TERT1: 87.7;fHDF/TERT166: 49.5;HSkMC: 50.3;U-937: 229.5"					"Low region specificity"	"Detected in all"			HPA008194	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	32.4	7.4	10.7	21.9	10.8	113.0	23.5	13.1	20.0	23.1	12.5	9.4	7.2	19.9	6.5	17.4	15.5	20.5	14.6	10.7	10.4	8.2	16.3	39.3	32.2	12.2	11.2	33.1	2.5	2.9	4.2	17.6	12.3	9.8	13.5	2.4	12.7	6.0	17.2	80.0	14.0	14.5	11.2	44.7	9.1	3.0	12.8	16.3	10.4	20.6	16.0	19.8	23.9	11.8	0.3	2.6	0.0	0.2	56.7	87.7	0.4	1.6	11.0	0.8	2.9	0.1	1.8	1.2	0.9	49.5	32.8	17.4	8.0	0.1	0.2	1.8	0.1	2.3	0.1	0.1	19.9	2.0	0.4	50.3	18.1	2.2	0.4	2.9	29.1	9.0	0.1	7.4	13.0	0.1	15.2	4.1	0.3	0.0	2.0	20.9	0.4	0.1	0.1	18.3	0.1	0.0	0.8	0.2	13.9	0.2	3.6	0.6	41.8	0.4	9.2	1.6	5.3	13.2	1.2	1.7	13.5	229.5	16.8	54.8	37.8	14.6	68.2	58.1	55.4	12.6	42.3	69.7	34.5	20.0	40.2	62.2	221.4	67.2	75.6	12.6	36.0	84.4	10.7	10.8	13.1	20.0	10.7	10.4	12.2	11.2	12.3	11.2	12.8	11.8	216.3	3.2	23.1	0.0	102.0	201.6	76.4	393.1	106.4	0.1	4.4	7.7	3.6	7.2	122.3	0.0	0.0	0.9	255.7	0.5	0.0	5.1	0.3	5.8	84.2	179.5	1.8	32.8	0.0	0.8	2.0	97.1	3.6	5.5	54.4	1.3	142.8	3.6	74.4	0.0	0.0	1.0	61.1	141.5	208.2	2.4	49.7	183.2	80.0	15.0	59.2	1.1	265.7	0.0	0.2	1.9	0.0	17.7	102.8	23.9	0.3	1.1	17.4	0.7	6.6	45.8	26.4	0.3	0.5	99.9	240.8	1.9	276.6	16.7	1.1	140.9
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 41.3"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 18.0;Langerhans cells: 67.5;Macrophages: 58.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"classical monocyte: 9.1"	"Lineage enriched"	"Detected in many"	8	"monocytes: 9.1"	"Group enriched"	"Detected in some"	23	"HL-60: 40.9;U-937: 157.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.1	1.8	1.1	7.3	1.2	41.3	0.6	1.3	2.6	0.7	2.1	0.2	0.1	0.3	0.0	1.2	0.5	1.8	0.5	1.0	3.3	0.5	1.8	4.0	0.1	2.2	3.3	0.3	1.3	1.2	0.5	0.9	2.2	0.4	0.3	1.0	1.2	0.5	0.0	2.6	0.0	1.3	1.6	1.1	0.2	0.5	4.9	0.6	0.7	0.0	0.1	2.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.3	0.0	0.0	9.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	1.8	1.1	1.2	1.3	2.6	1.0	3.3	2.2	3.3	2.2	1.6	4.9	2.4	0.1	0.0	4.8	0.7	0.6	1.9	0.0	0.0	0.0	0.2	0.1	0.1	0.3	1.5	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	2.5	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	4.7	67.5	0.7	0.0	58.1	1.8	7.5	6.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.9	0.4	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.3	0.4	0.0	0.0	0.0
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876792	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA051398: AB_2681468"	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.41e-4)"	62.3	39.9	35.5	38.4	36.5	118.3	46.5	37.0	43.3	42.0	47.4	41.2	33.5	33.8	36.9	26.6	29.5	29.9	26.1	34.5	35.1	28.9	29.2	49.3	58.7	37.7	36.5	30.2	22.8	40.0	18.3	42.2	38.4	28.8	46.6	25.0	35.1	28.1	21.7	41.7	37.0	32.0	38.8	49.8	30.8	39.0	39.4	69.7	35.6	26.0	53.1	35.9	29.8	40.6	33.4	36.6	64.3	71.2	60.6	55.1	49.1	51.4	55.9	54.8	83.9	47.7	73.5	58.9	61.8	43.6	43.2	36.2	45.2	62.3	61.8	29.3	47.4	49.8	55.7	42.9	38.5	114.3	86.5	37.5	54.5	49.0	42.2	57.0	68.5	81.5	44.6	43.1	58.4	39.4	100.3	118.5	35.6	39.4	21.4	85.7	55.2	61.6	43.7	44.5	50.9	74.4	68.0	54.2	64.9	35.7	50.4	92.7	52.9	57.1	35.3	32.2	34.0	41.4	56.8	91.0	40.1	89.5	36.1	277.6	127.3	269.5	72.3	91.6	79.8	79.9	87.4	86.9	133.2	81.5	115.5	84.6	126.2	91.7	74.6	70.5	107.8	169.6	35.5	36.5	37.0	43.3	34.5	35.1	37.7	36.5	38.4	38.8	39.4	40.6	29.1	19.2	39.7	14.7	39.8	31.9	16.5	37.4	23.9	12.1	23.4	17.5	12.8	12.8	31.5	16.5	0.0	32.5	37.5	17.8	17.6	25.1	124.5	21.5	36.7	35.1	27.6	37.0	15.2	20.2	44.6	28.8	18.8	23.0	17.7	33.2	28.2	13.8	27.1	18.5	11.4	32.1	26.4	49.1	47.1	54.6	45.4	32.5	28.4	26.2	51.2	12.1	23.7	15.1	23.3	31.5	18.7	38.0	21.3	24.2	22.6	13.0	19.9	8.0	6.6	19.6	25.7	29.6	23.1	21.1	41.8	22.8	38.1	29.8	27.7	27.2
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074753-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.0;testis: 35.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.7;Spermatocytes: 385.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 81.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020468, HPA020480, HPA051583"	Approved		Approved	"Centriolar satellite,Centrosome,Cytosol"		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centrosome, Cytosol"	"Centriolar satellite"	"HPA020468: AB_2670455, HPA020480: AB_2670457, HPA051583: AB_2681542"	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	5.3	3.7	2.5	13.8	3.6	28.0	5.0	4.0	3.2	4.4	6.9	4.6	4.0	6.7	2.7	4.1	7.8	5.4	2.8	2.1	3.3	2.8	4.1	6.7	23.3	5.4	5.5	7.5	3.9	2.8	3.1	6.3	4.1	4.5	5.6	7.5	3.6	3.8	1.1	4.9	5.2	4.9	3.7	12.6	7.8	35.3	3.4	23.9	4.8	1.8	21.7	6.5	2.8	5.3	12.6	8.3	22.5	16.4	3.3	4.9	4.2	8.4	6.2	6.6	5.6	4.7	13.2	55.7	3.3	6.3	11.8	25.2	7.6	5.2	10.4	34.3	5.5	29.4	15.2	6.1	4.5	81.0	34.1	3.1	3.8	6.9	16.5	2.8	14.6	22.7	19.2	31.0	6.5	7.9	31.2	21.5	8.1	16.0	6.6	30.1	33.4	17.4	3.1	5.7	8.5	12.9	28.4	5.2	6.3	3.9	11.0	36.0	10.3	6.7	11.6	10.8	15.8	22.0	25.6	37.8	5.6	32.2	16.1	16.2	7.0	17.0	7.2	4.3	5.5	11.7	7.5	5.5	3.7	11.9	9.0	6.4	2.7	5.0	6.5	10.6	11.5	2.8	2.5	3.6	4.0	3.2	2.1	3.3	5.4	5.5	4.1	3.7	3.4	5.3	19.8	28.9	32.8	34.9	78.7	3.3	13.8	6.8	9.1	33.5	7.4	12.2	8.9	10.0	29.5	3.7	37.5	2.7	58.2	2.7	3.9	5.1	131.7	61.8	12.3	14.8	8.4	33.2	35.4	6.0	3.0	15.1	14.8	10.9	53.0	20.6	14.6	3.9	27.2	30.3	43.8	8.4	4.1	33.9	16.5	44.3	13.7	50.7	8.8	52.5	55.2	8.2	49.4	37.2	53.1	6.3	4.5	12.0	39.1	4.3	2.2	1.4	114.6	59.6	39.5	33.8	14.5	385.0	114.1	10.9	5.7	0.8	57.0	13.1	6.4	6.2
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555649-17583162	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 76.2;Hofbauer cells: 91.0;Kupffer cells: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No		9700	"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	38.6	14.3	5.9	38.1	6.9	32.9	27.5	7.9	8.4	31.1	10.6	27.7	16.2	28.4	4.4	17.9	26.5	19.0	22.4	7.1	9.1	12.7	16.3	34.9	29.7	12.1	9.3	23.5	15.8	9.0	10.1	40.9	12.3	15.5	15.2	3.2	15.9	16.3	15.1	23.9	24.7	35.4	7.6	39.5	18.2	11.9	18.9	9.9	14.7	7.5	15.8	28.1	22.8	12.6	103.1	118.0	56.7	79.8	222.3	136.3	90.9	95.9	55.1	121.8	125.9	90.4	159.6	53.0	164.7	166.9	104.2	91.5	58.4	110.6	73.4	29.5	94.9	51.2	147.4	87.9	121.6	123.0	147.8	115.2	97.6	136.7	56.7	49.7	138.8	33.3	105.5	25.8	45.1	45.6	61.9	81.1	43.0	75.8	115.3	65.2	73.8	80.9	26.4	67.2	41.2	29.9	102.8	80.6	97.0	36.7	41.9	177.7	98.7	240.8	67.7	215.3	156.2	45.4	125.1	58.3	142.7	232.4	113.0	1.7	25.7	12.5	5.2	28.1	2.8	3.5	4.8	4.9	18.1	3.3	3.4	5.3	3.6	2.1	20.8	7.0	3.1	14.5	5.9	6.9	7.9	8.4	7.1	9.1	12.1	9.3	12.3	7.6	18.9	12.6	35.0	19.2	23.5	11.1	10.3	19.5	7.0	10.4	10.8	3.7	8.8	9.5	11.2	10.0	15.5	11.0	6.2	7.9	28.6	14.7	0.0	13.1	3.6	8.5	28.5	29.3	5.4	10.3	10.9	8.2	76.2	30.9	20.9	13.6	8.8	20.3	7.9	14.2	91.0	13.5	9.9	15.1	4.1	70.7	24.1	3.1	19.0	59.6	17.8	19.7	26.6	2.3	10.3	6.6	12.8	10.4	7.6	21.8	6.0	9.5	9.5	4.4	8.7	3.6	13.1	9.5	24.3	2.5	13.1	13.8	20.9	8.3	12.0	24.9	18.2	8.4
COMMD3	"BUP, C10orf8"	ENSG00000148444	"COMM domain containing 3"	Q9UBI1	10	22316386-22320306	"Predicted intracellular proteins"	"Ion transport, Sodium transport, Transcription, Transcription regulation, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 432.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 307.8;U-937: 403.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036584	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA036584: AB_10670803"	"unprognostic (3.11e-2)"	"unprognostic (5.97e-3)"	"unprognostic (6.43e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (5.46e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.71e-2)"	"unprognostic (2.88e-3)"	30.9	35.3	33.3	38.3	35.7	38.1	52.6	36.8	45.0	29.1	33.9	38.2	37.5	31.0	47.8	38.1	34.6	32.9	79.8	34.7	35.8	38.7	62.8	28.2	45.4	36.3	34.2	23.4	51.7	53.5	24.9	22.8	35.6	36.7	36.8	29.5	51.8	30.7	75.4	36.6	36.8	38.9	37.0	32.5	33.0	32.1	33.7	61.2	33.1	76.2	43.4	39.6	21.0	41.0	53.8	65.0	23.5	14.4	91.0	97.0	22.7	48.1	48.3	45.8	60.4	16.9	77.8	61.6	47.7	58.8	41.8	33.4	37.8	68.5	34.8	307.8	44.1	80.2	23.1	62.7	87.8	29.0	66.5	86.3	74.6	35.7	35.2	67.8	92.5	93.7	55.0	70.6	103.5	47.8	126.2	29.6	5.7	69.0	101.5	54.9	57.5	89.0	64.8	30.2	14.4	54.3	38.1	71.8	85.8	20.2	48.8	199.1	82.4	30.3	77.3	73.0	42.1	94.4	93.0	63.9	67.5	403.0	28.7	154.6	98.0	73.1	48.5	97.8	56.8	93.2	63.3	52.0	117.8	85.2	39.9	48.8	15.2	83.2	87.6	140.3	83.2	118.3	33.3	35.7	36.8	45.0	34.7	35.8	36.3	34.2	35.6	37.0	33.7	41.0	37.6	41.7	31.7	0.0	59.0	38.2	48.4	148.4	18.2	42.0	52.7	82.5	98.8	30.0	73.0	33.1	14.6	61.0	55.2	20.9	117.4	83.0	432.9	42.2	35.7	37.9	41.3	69.2	0.0	82.9	53.4	42.6	19.4	27.4	54.5	43.7	30.7	61.5	99.0	45.4	0.0	43.4	118.0	51.8	48.3	97.0	58.7	47.6	53.4	0.0	103.6	71.4	52.5	0.0	0.0	67.0	36.7	56.8	63.2	29.1	67.1	102.2	72.1	65.2	46.0	45.7	66.6	35.6	42.9	20.5	51.1	26.1	34.7	51.4	40.7	44.7
COMMD7	"C20orf92, dJ1085F17.3"	ENSG00000149600	"COMM domain containing 7"	Q86VX2	20	32702699-32743467	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 225.9;Syncytiotrophoblasts: 264.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 331.1"	"Low region specificity"	"Detected in all"							HPA054119			Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA054119: AB_2682388"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (5.31e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.52e-2)"	"prognostic favorable (3.53e-4)"	34.6	38.7	60.2	23.0	62.5	40.5	36.6	59.3	87.1	27.9	58.6	41.4	18.1	29.1	49.1	27.2	27.3	25.7	61.7	62.2	59.7	52.7	44.5	29.4	29.9	59.4	62.5	24.1	36.7	40.7	17.7	38.5	59.1	35.6	30.3	24.7	31.7	31.2	66.4	37.1	26.4	33.2	58.9	36.8	36.0	11.5	61.9	25.8	49.7	54.4	34.0	38.3	28.3	58.8	69.9	45.2	43.6	30.9	32.4	58.7	80.3	59.8	96.8	96.4	66.0	88.0	44.0	55.3	51.1	71.4	80.3	30.6	38.0	49.7	72.0	22.3	25.2	154.8	25.3	65.6	83.6	63.5	84.2	45.6	61.1	73.9	43.3	76.1	95.9	30.1	55.8	26.7	62.4	51.4	55.4	133.2	37.4	68.6	43.9	51.4	4.2	19.0	103.2	46.6	26.8	41.3	59.1	81.6	101.3	47.5	48.3	101.6	65.3	97.3	54.0	61.8	61.3	29.8	25.6	18.6	119.0	331.1	39.6	116.9	105.8	162.7	76.5	144.0	67.7	63.5	61.4	70.9	122.7	61.2	67.7	64.6	10.4	99.9	165.2	82.2	75.1	166.2	60.2	62.5	59.3	87.1	62.2	59.7	59.4	62.5	59.1	58.9	61.9	58.8	71.3	22.4	17.9	10.1	43.2	16.6	31.4	44.4	23.9	56.8	58.7	50.2	48.3	47.1	32.1	36.8	68.8	225.9	70.5	33.6	88.0	102.8	3.1	27.7	25.8	54.8	33.0	36.6	19.6	118.5	116.5	36.8	31.1	31.1	53.3	49.2	44.3	39.8	124.3	67.3	25.4	44.4	59.0	46.4	30.9	4.6	37.6	69.6	56.9	16.9	92.7	81.8	123.6	4.5	10.3	118.7	47.0	47.8	35.3	32.8	27.6	124.3	23.3	74.3	46.0	27.0	49.3	13.1	19.1	36.8	28.8	264.5	75.6	36.9	45.8	37.9
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347182-93348356	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"testis: 76.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"U-937: 27.4"	"Low region specificity"	"Detected in many"							HPA003127	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	76.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.5	0.2	0.3	0.5	0.4	0.5	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.6	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	865.6	1.2	0.0	0.8	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1864.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.3	1.2	0.0	19.7	0.0	0.1	424.3	124.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949269-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 1095.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 1094.4;Langerhans cells: 541.7;monocytes: 659.7;NK-cells: 1385.2;T-cells: 544.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 1287.0"	"Group enriched"	"Detected in all"	27	"granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 77.8;HMC-1: 204.6;NB-4: 212.1;U-937: 380.4"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		26000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	18.0	3.6	1.3	24.2	1.6	1095.6	5.7	2.8	5.1	4.5	1.7	5.7	5.9	4.6	4.8	5.4	10.4	17.7	5.6	1.5	1.4	5.4	12.7	49.3	73.4	2.4	1.4	2.5	3.9	1.0	2.2	4.4	2.0	4.3	5.1	0.2	6.6	2.0	1.9	4.5	13.9	5.0	1.6	148.1	8.7	1.7	1.6	17.3	5.6	4.4	16.4	19.2	5.2	1.4	0.3	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.3	1.7	0.0	0.4	0.0	77.8	204.6	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	2.8	0.0	0.2	2.0	212.1	0.1	0.0	0.2	0.5	7.7	0.1	0.0	0.1	0.3	0.2	0.0	0.1	1.0	0.1	0.0	13.3	0.2	0.1	0.8	0.2	0.5	0.1	0.1	0.2	0.1	380.4	0.1	74.3	3.0	10.4	1287.0	3.4	720.2	3.7	186.8	904.7	28.4	3.9	38.8	531.2	342.2	655.3	3.5	7.2	123.0	600.8	1.3	1.6	2.8	5.1	1.5	1.4	2.4	1.4	2.0	1.6	1.6	1.4	8.1	9.6	14.1	0.0	14.5	22.8	0.3	0.0	0.0	0.0	2.5	2.4	1.4	4.3	0.6	0.0	0.0	0.2	1094.4	0.3	0.0	1.3	0.0	1.3	0.7	3.2	0.0	46.7	0.0	3.7	0.1	5.2	11.2	1.2	60.0	0.0	11.0	3.8	1.4	0.0	0.0	0.1	0.0	16.2	541.7	0.0	0.0	61.9	24.9	1.9	659.7	0.0	1385.2	0.0	0.1	0.2	0.1	0.0	90.9	0.1	0.4	2.3	2.2	0.0	0.0	2.2	3.6	0.0	0.2	0.5	23.9	1.1	544.5	0.0	0.6	0.6
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CYP46A1	CYP46	ENSG00000036530	"Cytochrome P450 family 46 subfamily A member 1"	Q9Y6A2	14	99684298-99727301	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.1;Cone photoreceptor cells: 66.7;Excitatory neurons: 53.0;Inhibitory neurons: 41.6;Rod photoreceptor cells: 28.4"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 3.4"	"Group enriched"	"Detected in some"	4	"AF22: 2.4;U-937: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (2.16e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.50e-5)"	"unprognostic (9.48e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.21e-2)"	"unprognostic (2.44e-4)"	"unprognostic (5.97e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.88e-3)"	1.9	2.0	45.7	0.3	96.2	0.0	0.8	20.1	66.7	1.4	17.5	0.7	0.2	1.5	0.9	0.2	1.0	0.4	4.7	52.7	34.0	1.4	1.3	0.6	0.6	25.3	32.0	1.6	2.1	1.9	16.6	0.0	26.2	1.4	0.2	5.1	1.4	0.6	1.1	0.4	0.5	0.8	23.5	0.2	0.7	2.5	38.2	0.4	1.7	0.5	0.1	0.9	0.7	39.0	0.0	0.0	2.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	45.7	96.2	20.1	66.7	52.7	34.0	25.3	32.0	26.2	23.5	38.2	39.0	3.5	3.2	6.0	58.1	0.7	1.7	6.4	0.0	1.2	11.5	1.8	3.3	7.0	2.8	1.8	1.8	66.7	0.2	8.7	0.0	1.9	0.2	0.7	0.9	5.0	7.6	0.0	0.0	53.0	1.1	0.3	4.0	0.5	0.6	1.3	2.1	2.9	3.4	0.6	8.4	41.6	0.0	0.0	2.1	3.0	1.3	4.7	0.9	3.6	6.5	1.1	20.8	0.0	23.6	11.8	0.1	0.1	4.1	2.2	4.1	0.0	7.4	0.9	28.4	0.0	8.1	3.9	9.4	5.3	0.0	1.4	0.1	1.5	2.7	0.1	3.5
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 171.0;Late spermatids: 177.8;Microglial cells: 301.7;Oligodendrocyte precursor cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	10.7	3.3	3.7	6.4	6.4	17.7	7.0	0.0	4.3	10.6	17.3	8.6	4.3	5.5	3.5	7.7	6.7	5.7	5.4	6.4	3.1	3.1	12.3	8.2	3.8	0.6	0.9	7.7	4.9	7.0	2.0	12.5	1.0	6.1	8.7	3.0	6.6	7.6	12.0	5.3	5.3	7.4	0.2	3.8	7.4	9.4	1.5	6.0	3.9	9.1	3.9	7.4	9.8	1.8	0.0	6.5	3.1	6.3	17.1	28.3	0.0	11.2	11.8	5.9	12.4	5.5	12.3	18.5	8.7	9.7	11.3	0.0	16.6	1.7	7.6	0.5	9.5	0.0	7.4	5.9	14.2	24.3	8.2	14.3	6.0	8.0	24.6	8.0	11.6	13.6	0.0	14.9	11.2	5.3	9.2	10.0	24.4	0.1	9.4	0.0	16.5	0.0	3.4	9.8	0.0	6.3	0.0	3.2	9.0	18.8	2.7	13.2	14.8	12.6	5.8	10.6	7.3	0.2	0.0	15.3	10.7	24.1	7.6	0.0	3.1	3.3	1.1	2.8	0.9	1.7	1.2	1.4	2.3	1.3	0.8	0.7	0.3	0.7	2.5	2.2	0.7	0.6	3.7	6.4	0.0	4.3	6.4	3.1	0.6	0.9	1.0	0.2	1.5	1.8	61.7	32.1	51.1	21.2	18.8	10.8	6.8	11.9	11.4	5.5	9.9	8.1	20.2	15.7	15.0	20.2	0.0	65.2	21.5	36.6	7.9	18.6	80.5	51.2	46.2	31.2	24.6	6.1	171.0	23.4	16.8	35.2	41.8	41.7	7.6	36.1	8.2	26.1	21.0	0.0	90.0	32.3	4.1	29.6	19.3	177.8	45.1	34.7	8.8	301.7	32.7	13.0	10.3	281.0	41.2	38.4	39.3	20.3	11.6	8.0	11.9	9.4	57.1	13.7	26.3	46.7	32.7	7.5	12.9	17.6	18.3	118.3	19.0	19.0	32.5	6.0
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.2;Late spermatids: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	13.8	9.9	5.3	12.4	5.7	20.4	15.8	9.1	6.7	11.3	7.1	10.0	8.5	11.2	11.5	12.4	9.9	10.4	11.6	5.2	5.9	12.8	16.6	11.4	17.6	5.2	5.6	13.4	8.9	11.9	8.9	12.0	5.3	12.3	10.9	12.1	9.4	10.5	10.2	11.1	9.9	11.0	5.5	12.2	9.9	21.3	6.3	14.1	15.0	10.4	17.3	14.1	10.8	6.9	29.5	13.4	25.9	21.9	26.9	31.9	17.0	25.5	31.0	25.6	31.1	20.7	23.8	35.6	21.6	26.3	16.2	23.8	35.7	29.4	40.9	29.3	26.3	41.8	27.8	18.7	33.4	71.4	23.2	33.4	20.1	29.0	37.9	25.5	27.8	26.6	28.3	14.4	31.4	10.3	30.5	34.8	24.3	44.7	15.7	24.2	19.7	16.2	25.4	23.2	23.3	30.8	20.9	17.3	25.4	26.8	16.7	32.1	26.1	15.4	12.5	17.5	27.4	27.6	33.2	28.0	42.9	33.2	22.7	8.4	3.6	5.2	4.0	6.3	5.6	4.2	5.0	4.5	4.3	3.7	4.9	4.5	2.1	6.9	5.2	2.7	6.7	3.2	5.3	5.7	9.1	6.7	5.2	5.9	5.2	5.6	5.3	5.5	6.3	6.9	51.6	35.3	37.2	12.4	35.3	25.5	36.5	24.5	18.2	38.8	27.6	26.4	27.6	21.5	40.2	9.2	29.2	23.8	45.0	19.0	23.5	21.7	169.2	26.2	37.6	41.2	30.5	18.7	21.5	20.1	23.5	33.3	19.9	45.6	33.6	26.3	26.7	23.7	14.4	32.0	24.0	17.2	18.3	19.2	13.8	135.5	28.9	21.4	12.4	24.4	38.2	23.6	25.7	17.6	24.2	25.4	8.1	28.2	30.2	27.4	16.3	17.2	35.4	41.6	6.6	58.3	27.0	28.9	37.7	31.4	31.3	22.6	33.7	29.1	21.2	53.9
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
EEF1AKMT1	N6AMT2	ENSG00000150456	"EEF1A lysine methyltransferase 1"	Q8WVE0	13	20728731-20773961	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Breast myoepithelial cells: 19.9;Cytotrophoblasts: 19.8;Distal tubular cells: 27.4;Endometrial ciliated cells: 20.9;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040417, HPA042543"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA040417: AB_2676973, HPA042543: AB_2678045"	"unprognostic (4.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.31e-2)"	9.6	10.3	11.1	5.3	11.6	3.4	9.8	11.8	16.8	11.2	10.5	9.5	4.5	10.8	14.3	5.8	11.1	6.3	9.9	11.2	12.6	9.5	13.5	6.4	6.8	11.1	11.6	10.4	6.3	9.5	9.9	6.5	11.8	10.2	6.0	10.2	7.9	8.9	11.1	5.9	5.6	9.2	12.0	5.8	7.1	4.3	12.0	9.2	9.5	12.2	6.8	8.8	7.5	12.3	11.1	8.5	6.9	11.4	28.3	29.2	16.9	14.4	11.0	12.4	6.4	11.9	12.1	18.0	10.5	15.8	5.8	9.0	9.4	12.2	12.8	11.7	8.4	23.3	3.8	22.8	15.6	46.3	4.6	20.1	10.7	9.2	20.4	13.8	22.4	15.7	13.6	2.4	35.5	30.7	15.6	41.0	12.0	20.2	6.2	19.2	7.6	3.5	17.8	12.7	15.8	9.4	12.5	6.1	16.5	5.9	6.4	42.4	13.3	8.5	0.0	19.1	6.4	3.3	6.7	19.9	7.3	31.4	6.1	0.0	5.2	0.9	8.6	4.1	9.6	13.1	10.3	9.0	8.9	5.4	13.0	11.3	0.7	16.3	4.4	10.8	12.0	6.7	11.1	11.6	11.8	16.8	11.2	12.6	11.1	11.6	11.8	12.0	12.0	12.3	15.0	22.4	9.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.3	19.9	0.0	0.0	8.1	7.3	0.0	19.8	3.1	0.0	27.4	12.6	0.0	20.9	16.2	6.0	0.0	0.0	0.0	10.4	15.2	8.9	0.0	7.0	3.8	13.2	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	36.5	7.3	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	15.7	2.2	9.9	0.0	0.0
EFCC1	"C3orf73, CCDC48, FLJ12057"	ENSG00000114654	"EF-hand and coiled-coil domain containing 1"	Q9HA90	3	129001629-129040742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 5.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Endothelial cells: 6.5;Enteroendocrine cells: 9.5;Fibroblasts: 10.7;Microglial cells: 9.4;Peritubular cells: 7.5;Sertoli cells: 6.6;Theca cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 1.3;HL-60: 3.7;U-266/84: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042798, HPA050888"	Uncertain					NA	NA				"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"			"HPA042798: AB_2678173, HPA050888: AB_2681263"	"unprognostic (1.74e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (9.70e-4)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.20e-1)"	1.7	0.4	0.8	0.4	0.2	0.1	1.8	1.8	1.0	1.2	0.0	3.5	1.9	1.9	0.1	0.9	1.6	0.5	2.3	2.2	1.4	1.2	0.5	5.6	0.1	1.7	1.0	3.4	0.5	0.1	1.3	0.3	1.8	2.0	0.4	0.0	0.7	0.2	1.0	1.1	2.5	0.1	0.5	2.7	2.1	0.4	1.1	0.2	2.2	0.5	0.0	2.0	1.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	1.8	1.0	2.2	1.4	1.7	1.0	1.8	0.5	1.1	0.0	7.1	0.0	1.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	1.4	0.2	0.3	6.5	9.5	3.6	1.3	0.6	0.0	10.7	0.0	0.2	0.0	0.4	3.6	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.8	5.3	4.7	0.1	1.8	9.4	0.0	0.0	2.1	0.0	0.1	0.1	0.0	7.5	0.0	0.1	0.0	0.2	0.0	0.0	6.6	1.1	2.4	0.2	0.4	0.0	0.4	0.1	0.3	22.0	0.2	0.1
EIF3A	"EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32"	ENSG00000107581	"Eukaryotic translation initiation factor 3 subunit A"	Q14152	10	119033670-119080823	"Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038315, HPA038316"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No		110000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA038315: AB_10672588, HPA038316: AB_10673168"	"unprognostic (8.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.07e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.89e-2)"	83.0	53.2	27.5	73.7	30.9	120.7	62.5	28.4	31.8	48.8	38.0	62.9	65.8	60.1	34.9	69.3	44.8	50.1	69.0	25.7	33.7	58.1	77.9	49.5	75.1	34.8	30.0	61.7	155.1	70.2	24.4	57.0	35.4	55.5	63.9	31.6	73.3	46.3	178.2	69.9	60.0	62.8	31.6	57.4	72.8	44.8	32.4	78.3	70.3	89.8	74.6	76.4	51.8	32.4	258.5	190.9	154.0	211.6	163.6	235.0	119.4	228.9	235.9	144.0	143.7	181.2	165.5	300.2	83.2	190.3	113.3	252.0	202.5	175.7	203.5	166.1	166.3	258.3	143.6	203.2	186.2	382.3	183.9	204.6	193.0	212.7	362.8	240.7	165.7	119.8	269.7	191.9	188.7	152.5	159.4	179.8	147.8	99.4	96.3	162.1	332.1	143.7	137.0	213.9	71.6	151.3	180.2	166.9	244.9	132.0	107.2	241.1	245.6	138.7	128.0	147.1	335.8	164.9	194.0	286.9	147.2	368.2	97.6	49.0	38.2	23.9	27.4	41.8	31.7	25.6	33.1	25.2	36.1	24.7	22.6	24.7	10.0	26.6	58.1	20.5	50.9	28.3	27.5	30.9	28.4	31.8	25.7	33.7	34.8	30.0	35.4	31.6	32.4	32.4	122.1	233.9	323.8	24.5	147.3	304.2	279.1	129.0	203.7	60.1	155.8	133.7	320.7	111.5	198.5	64.4	62.6	169.1	181.1	130.2	27.4	157.2	199.4	230.3	248.6	145.3	141.2	270.0	32.7	185.4	159.5	152.5	159.0	371.8	145.4	132.6	74.3	184.5	126.3	43.7	34.9	168.2	87.5	200.3	169.0	119.1	108.7	196.5	147.7	29.0	235.9	78.2	135.9	24.6	38.9	192.8	105.4	117.8	258.6	253.6	98.5	58.7	158.3	54.1	59.2	209.7	221.6	158.0	112.9	255.3	363.8	252.3	171.1	145.0	227.7	302.3
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 515.2;Inhibitory neurons: 464.4;Microglial cells: 255.8;Oligodendrocyte precursor cells: 425.8;Oligodendrocytes: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol		NA	NA		68000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	21.3	20.7	5.2	20.5	6.2	32.3	17.9	1.6	19.7	18.5	57.9	22.7	15.0	21.1	17.1	19.8	18.8	19.9	18.3	4.8	12.7	16.1	14.9	16.4	17.4	5.0	1.5	17.2	12.1	39.5	26.5	15.6	4.9	17.4	24.4	26.4	12.6	20.6	42.2	18.5	17.4	27.5	0.0	17.1	17.3	74.3	3.7	17.1	35.7	23.4	19.9	22.6	16.7	16.6	31.8	25.2	78.3	32.0	80.1	77.9	16.4	66.8	70.4	46.5	46.1	27.2	33.4	60.7	41.1	73.2	42.6	34.5	48.4	53.9	64.3	50.4	48.2	31.6	47.7	18.9	38.5	53.1	56.5	86.4	39.9	47.8	61.2	69.0	59.2	22.3	23.9	42.0	66.3	25.1	16.6	19.2	23.3	36.7	21.3	31.7	29.8	21.4	40.8	16.4	46.1	35.4	70.0	29.6	35.9	46.3	20.7	58.0	60.7	51.4	19.1	73.5	30.2	18.8	22.5	0.3	63.5	78.7	48.4	0.5	0.5	0.9	0.7	0.0	0.3	0.6	0.3	0.3	1.0	0.8	0.2	0.3	1.2	0.4	0.3	0.6	0.5	0.5	5.2	6.2	1.6	19.7	4.8	12.7	5.0	1.5	4.9	0.0	3.7	16.6	50.9	19.2	30.5	181.5	29.5	20.6	19.9	15.0	17.1	52.0	19.2	17.4	44.5	14.3	28.2	16.5	66.7	4.6	51.1	51.3	0.0	20.6	173.9	66.6	81.2	42.7	16.3	26.1	515.2	19.4	8.8	33.8	46.4	46.8	26.6	44.9	46.1	14.7	23.1	50.5	464.4	21.6	4.1	31.5	11.3	121.8	44.7	39.3	14.2	255.8	18.0	18.6	28.8	425.8	483.4	24.8	32.1	44.8	27.3	21.0	15.7	10.3	51.1	40.5	32.9	36.6	31.3	100.6	51.2	33.8	26.3	3.4	23.7	68.4	29.6	28.0
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.4	14.2	8.6	21.4	10.5	76.2	21.4	9.5	10.1	27.5	10.3	37.0	40.4	21.8	17.6	32.8	31.6	16.3	11.0	9.6	9.4	27.2	114.1	19.1	14.5	8.6	8.2	30.4	19.2	19.4	5.4	42.2	9.0	17.7	38.2	10.8	15.1	16.4	8.6	22.5	30.2	22.4	8.8	16.6	36.8	28.0	9.0	15.6	26.2	13.6	21.2	28.6	19.1	9.7	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.6	10.5	9.5	10.1	9.6	9.4	8.6	8.2	9.0	8.8	9.0	9.7	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
EXOSC8	"bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p"	ENSG00000120699	"Exosome component 8"	Q96B26	13	36998816-37009614	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034240, HPA039702, HPA043942, HPA075230"	Uncertain		Supported	"Nucleoli fibrillar center,Mitotic chromosome,Vesicles"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center, Mitotic chromosome, Vesicles"		"CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: "	"unprognostic (8.67e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (8.39e-7)"	"unprognostic (9.58e-3)"	"unprognostic (7.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.51e-1)"	15.0	14.2	16.6	19.1	17.6	27.5	18.8	17.9	24.3	16.8	16.6	17.0	12.6	14.2	14.4	18.2	16.8	8.4	19.4	16.9	17.8	17.9	19.8	13.5	21.2	17.5	17.1	16.4	13.9	11.6	10.8	15.6	18.1	14.2	19.0	15.3	11.3	13.2	24.2	16.6	14.0	16.6	17.3	17.5	15.3	27.8	17.0	31.5	12.3	24.8	25.1	16.2	14.7	19.7	47.5	33.5	97.7	66.4	28.4	30.1	73.8	68.9	48.8	93.2	74.2	72.7	93.6	65.1	29.8	38.2	91.4	64.7	92.7	67.1	111.5	96.3	73.9	174.8	34.2	87.4	37.0	148.3	58.9	17.4	51.3	62.6	100.2	24.1	72.8	93.6	86.6	41.3	66.4	59.1	78.6	116.6	101.4	113.2	44.0	48.5	98.6	53.5	51.1	30.8	23.8	46.1	38.1	44.5	65.3	51.1	35.4	117.6	37.2	35.5	49.1	42.9	95.5	23.3	29.4	135.7	56.0	104.1	66.8	28.9	29.8	23.5	42.8	39.6	44.8	66.0	54.1	50.5	33.9	57.2	67.1	62.7	6.0	46.2	41.7	54.8	54.6	52.4	16.6	17.6	17.9	24.3	16.9	17.8	17.5	17.1	18.1	17.3	17.0	19.7	43.5	32.1	38.9	15.7	40.1	36.1	51.6	109.6	25.0	20.8	25.0	50.0	50.2	18.6	69.5	11.0	8.4	86.8	46.8	13.1	56.7	58.1	115.7	21.5	31.4	39.4	13.2	57.9	7.0	52.1	92.3	41.8	19.4	20.6	103.6	46.2	18.5	17.4	46.8	28.6	8.6	19.1	79.3	13.6	34.2	54.6	40.7	26.0	26.6	10.3	32.6	27.1	35.0	17.1	22.0	36.1	16.4	36.5	38.8	29.0	18.0	26.6	53.4	32.0	26.3	38.8	52.1	163.3	85.9	29.0	36.2	67.0	38.7	42.7	30.2	37.7
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAM122B	"DKFZp686L20116, RP11-308B5.5"	ENSG00000156504	"Family with sequence similarity 122B"	Q7Z309	X	134769566-134797232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000266	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"HPA000266: AB_1078801"	"unprognostic (2.10e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.26e-3)"	"unprognostic (2.60e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.19e-3)"	16.0	19.5	23.9	18.4	25.4	31.6	15.8	20.6	32.8	18.7	27.1	18.1	15.4	20.8	26.0	17.6	22.6	13.1	14.6	23.9	24.3	20.1	11.2	17.6	29.8	22.8	23.5	28.8	16.8	21.1	21.3	15.5	22.1	17.6	22.7	8.8	18.8	16.0	7.8	19.4	22.1	19.5	24.3	27.4	20.1	35.3	29.2	25.9	21.0	7.1	27.3	18.8	17.6	25.2	51.0	46.2	36.2	25.9	18.2	23.6	25.4	39.5	34.5	43.9	41.3	41.1	44.3	49.7	76.2	28.9	61.3	33.5	54.0	32.6	79.2	61.8	37.4	50.2	94.6	13.4	11.2	92.9	61.2	15.5	31.6	48.3	21.0	28.5	25.9	50.0	33.2	61.9	46.8	68.8	58.1	80.1	19.8	58.3	49.1	58.0	39.5	43.6	26.6	52.1	32.9	23.3	21.2	28.3	14.8	31.1	15.2	47.4	18.6	36.4	23.5	93.3	87.1	34.1	42.2	63.2	39.0	105.8	46.2	0.0	0.4	2.6	0.8	0.2	1.1	0.7	0.7	1.0	0.5	0.6	0.9	1.2	0.5	1.2	0.5	1.5	0.8	0.5	23.9	25.4	20.6	32.8	23.9	24.3	22.8	23.5	22.1	24.3	29.2	25.2	4.7	12.8	10.4	6.2	17.4	13.5	15.0	9.2	12.0	4.0	11.8	7.6	10.8	2.8	11.7	16.5	12.5	9.3	15.3	14.4	17.6	8.0	1.3	10.4	6.7	12.5	6.0	32.6	15.2	13.8	10.2	11.0	15.3	11.5	23.6	32.9	9.7	7.4	14.7	13.5	10.5	13.2	18.3	21.4	21.7	5.8	10.5	17.9	17.8	12.2	16.6	6.4	20.6	8.0	16.8	12.2	20.2	6.4	13.8	14.7	12.9	8.0	8.2	5.5	0.0	6.6	8.8	3.7	4.4	14.4	11.2	8.8	20.1	17.7	12.2	19.1
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.7;testis: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	2.9	2.0	3.8	13.8	5.6	21.7	1.7	3.6	6.3	1.4	1.8	2.4	2.7	1.5	0.3	1.7	1.3	3.1	26.5	5.1	3.7	1.6	1.5	6.1	24.5	5.6	4.1	1.4	1.1	1.1	1.2	5.3	4.9	1.4	1.6	4.6	2.7	0.9	53.7	1.2	8.9	1.8	4.6	21.6	3.8	31.9	5.8	21.1	1.6	20.2	14.9	3.5	1.1	5.7	0.7	0.3	2.5	5.6	1.7	0.5	39.3	0.3	0.3	0.5	0.2	0.3	0.2	17.1	0.2	0.3	0.8	0.1	16.0	0.2	0.1	4.4	1.4	38.6	0.6	0.3	0.6	38.7	1.5	0.4	0.8	0.0	0.1	0.5	22.2	10.8	13.8	4.7	0.5	6.0	1.7	60.7	2.6	0.3	0.6	4.0	2.3	23.7	0.2	0.1	1.5	2.1	2.3	0.8	2.4	0.9	1.4	53.5	0.6	2.3	2.4	1.3	0.1	3.4	1.9	9.7	0.3	35.9	0.6	0.5	9.7	17.6	9.2	12.6	7.4	14.2	8.9	10.1	6.0	15.9	11.0	9.3	9.8	3.1	9.9	2.7	9.5	8.7	3.8	5.6	3.6	6.3	5.1	3.7	5.6	4.1	4.9	4.6	5.8	5.7	3.2	0.0	1.5	0.0	15.5	0.9	0.0	0.0	0.0	55.7	0.4	0.5	17.6	0.0	0.0	1.8	0.0	1.1	19.0	0.0	0.0	0.1	90.6	0.1	0.2	6.8	0.0	3.4	5.0	0.0	37.6	3.1	0.5	0.1	1.3	167.2	6.4	0.5	25.7	0.0	1.7	0.0	0.0	21.7	10.6	120.3	5.0	14.8	1.8	15.9	15.6	0.8	30.9	1.0	0.1	0.1	0.0	3.4	12.0	0.0	0.0	0.2	0.0	1.8	0.0	0.6	6.3	2.2	1.2	0.0	0.9	1.4	17.4	1.0	0.0	0.1
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
FASTKD1	FLJ21901	ENSG00000138399	"FAST kinase domains 1"	Q53R41	2	169528508-169573875	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 91.8;Inhibitory neurons: 89.9;Oligodendrocyte precursor cells: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043719	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043719: AB_2678635"	"unprognostic (3.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-3)"	"unprognostic (8.03e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.58e-2)"	"unprognostic (7.62e-3)"	6.0	7.8	8.2	10.0	9.2	7.1	7.7	15.2	12.6	4.4	20.5	17.5	17.8	6.4	10.5	11.9	5.3	5.3	27.2	8.6	8.4	10.8	10.1	6.5	10.2	10.0	7.6	2.5	8.7	15.4	8.2	8.3	10.4	5.6	22.1	17.8	9.8	6.3	15.4	7.3	16.8	9.0	7.5	8.9	9.7	10.5	7.0	10.0	10.8	26.4	12.4	9.1	6.5	11.3	10.9	12.2	15.6	18.1	10.4	14.6	27.0	18.2	10.5	14.4	17.5	19.4	17.5	33.6	16.8	11.4	25.0	29.4	43.9	19.8	23.2	30.7	23.6	48.6	18.8	22.7	7.9	45.7	14.7	10.0	17.3	21.9	12.5	12.0	20.9	28.7	36.0	18.6	18.9	7.8	35.9	37.5	30.9	30.6	14.9	28.2	17.1	40.8	21.2	18.4	34.3	11.2	16.4	30.9	26.8	26.9	5.7	42.7	14.1	16.8	16.8	16.7	18.7	16.5	34.3	24.8	14.3	39.5	11.6	20.6	4.7	2.2	3.3	5.5	4.7	4.9	4.4	3.7	6.3	4.3	4.7	4.0	0.5	7.1	2.6	6.2	3.1	2.5	8.2	9.2	15.2	12.6	8.6	8.4	10.0	7.6	10.4	7.5	7.0	11.3	5.2	16.0	8.7	46.0	12.7	5.4	6.4	9.8	13.1	16.5	5.7	4.3	30.4	10.0	9.2	3.7	25.0	10.1	10.6	18.3	1.9	6.1	13.4	6.9	8.8	6.6	15.0	21.7	91.8	4.8	10.2	4.7	13.3	7.2	18.3	10.2	5.7	8.0	13.1	11.8	89.9	12.1	10.2	10.0	4.2	5.1	0.9	11.3	1.8	36.5	10.6	3.7	5.2	64.8	46.3	5.8	13.1	2.6	52.9	5.6	16.7	7.4	5.4	19.4	0.0	7.3	3.9	27.2	6.5	19.4	4.4	8.1	9.6	9.0	17.2	7.7
FBXO4	FBX4	ENSG00000151876	"F-box protein 4"	Q9UKT5	5	41925254-41941743	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003362			Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA003362: AB_2666918"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.25e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.39e-2)"	"unprognostic (8.27e-2)"	10.0	7.5	2.3	6.8	2.8	8.4	12.4	3.0	3.6	8.8	2.2	6.8	7.9	6.2	15.8	6.3	8.3	6.6	5.3	2.4	2.9	7.4	11.2	6.6	11.6	2.5	2.5	7.3	11.8	7.0	4.4	6.0	2.8	8.3	8.0	4.9	7.3	8.1	4.1	7.0	7.0	5.9	2.8	9.3	8.0	8.3	2.5	11.1	12.7	4.9	12.5	6.3	5.5	3.3	9.0	6.5	1.2	16.4	8.5	13.9	9.6	7.4	13.9	12.3	16.8	3.2	23.9	22.6	9.7	10.5	2.8	2.3	3.9	2.5	10.3	8.0	1.5	11.5	22.8	8.2	16.6	19.4	7.4	8.4	5.4	6.3	23.6	4.6	9.4	10.2	10.8	7.1	14.4	3.6	12.6	3.9	0.5	12.9	5.4	2.3	2.5	5.9	8.5	8.7	2.5	4.8	29.0	2.3	11.2	0.6	14.6	22.2	6.8	13.9	3.8	9.3	5.9	10.7	9.8	1.6	13.9	21.7	7.2	2.9	5.4	1.3	8.9	8.7	10.2	12.5	9.7	9.4	10.6	12.0	9.8	9.2	0.4	9.4	20.1	9.4	8.4	7.3	2.3	2.8	3.0	3.6	2.4	2.9	2.5	2.5	2.8	2.8	2.5	3.3	12.3	9.6	11.9	12.1	18.5	12.6	13.3	20.1	13.6	6.1	14.8	10.7	3.7	15.7	9.6	11.0	0.0	26.4	11.4	2.9	11.7	13.7	0.7	12.9	12.0	10.2	1.8	20.4	14.7	16.0	27.9	13.1	9.7	13.7	5.1	12.9	16.1	17.6	16.3	3.3	15.6	10.8	12.2	6.5	12.3	1.5	10.5	10.0	19.6	5.6	5.8	8.7	8.2	25.1	26.7	9.8	6.8	10.5	17.4	5.1	9.7	24.8	14.7	8.7	6.6	11.4	18.9	24.9	23.8	15.8	14.2	12.4	12.7	16.5	10.5	9.4
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 158.9;lung: 46.2;lymphoid tissue: 96.3"	"Group enriched"	"Detected in many"	10	"Kupffer cells: 504.4;Macrophages: 542.4;monocytes: 1017.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1699.8;intermediate monocyte: 1195.1"	"Lineage enhanced"	"Detected in all"		"monocytes: 1699.8"	"Group enriched"	"Detected in some"	5	"NB-4: 4.7;U-937: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	NA	NA	1060000000	36000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	15.9	1.4	0.6	47.7	0.5	158.9	5.1	0.8	0.7	2.0	0.5	3.2	0.5	1.5	0.0	1.6	6.4	3.9	5.1	0.5	0.3	4.1	7.2	46.2	3.2	0.5	0.5	1.0	2.5	0.1	1.0	2.4	0.6	2.3	1.6	0.1	2.8	0.5	1.6	1.2	2.8	12.1	0.2	96.3	3.7	0.7	0.7	2.4	2.2	1.1	1.3	10.1	2.3	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.1	0.0	7.2	0.1	9.3	1699.8	18.0	2.9	1195.1	3.5	5.9	1.4	1.6	492.6	1.5	1.7	1.6	277.1	2.8	582.2	13.0	2.1	1796.8	0.6	0.5	0.8	0.7	0.5	0.3	0.5	0.5	0.6	0.2	0.7	0.5	2.1	6.4	17.1	0.0	6.6	1.9	0.2	0.0	0.0	0.0	0.3	0.0	2.6	1.5	5.0	1.8	0.0	0.8	6.0	0.1	0.0	0.0	0.1	0.2	0.2	2.7	0.0	5.2	0.0	0.0	1.5	3.6	1.5	0.1	12.6	0.1	3.9	2.6	68.4	0.0	0.0	0.0	0.0	504.4	68.3	0.0	0.0	542.4	0.0	0.0	1017.8	0.0	27.8	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	2.1	0.7	0.0	0.0	1.0	0.5	0.0	0.1	0.2	0.4	1.1	6.1	0.3	0.0	0.2
FP565260.6		ENSG00000280433	"Novel protein, similar to trafficking protein particle complex 10 TRAPPC10"		21	5155499-5165472	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.3;Collecting duct cells: 3.7;Glandular and luminal cells: 2.4;Pancreatic endocrine cells: 3.9;Proximal tubular cells: 3.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.36e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.71e-6)"	6.5	6.2	12.7	5.1	13.3	4.9	5.6	12.9	20.1	5.3	12.1	10.5	6.7	5.5	7.2	6.7	5.1	4.3	6.6	12.9	12.9	10.6	10.6	6.3	12.3	13.1	13.1	4.9	6.0	5.8	8.2	3.3	13.2	5.6	7.5	7.2	5.6	3.0	6.2	6.4	11.9	3.0	12.6	15.2	6.9	6.3	12.9	10.0	8.2	3.8	5.4	5.0	5.1	14.3	7.0	2.1	5.8	4.0	6.7	3.9	3.5	2.3	2.4	1.0	2.0	1.2	3.3	3.3	2.2	5.7	7.4	4.3	5.6	3.8	2.1	2.3	2.9	12.0	3.9	5.2	6.3	9.2	8.6	6.2	8.7	4.6	4.8	4.3	5.8	4.8	5.8	3.8	4.8	6.2	4.8	16.6	7.4	8.3	3.3	4.8	2.8	3.7	10.4	6.1	4.2	7.6	4.2	7.7	8.7	2.6	5.3	16.6	3.7	4.5	3.1	0.9	7.0	3.3	3.8	6.1	4.3	12.6	3.1	0.2	0.1	1.2	1.9	0.4	3.9	1.5	1.0	1.8	0.2	1.2	0.9	1.2	0.6	2.0	0.9	0.4	0.3	0.7	12.7	13.3	12.9	20.1	12.9	12.9	13.1	13.1	13.2	12.6	12.9	14.3	0.8	0.0	3.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.2	0.6	0.0	0.0	1.8	3.7	0.0	1.1	2.1	0.0	0.0	1.3	0.0	1.3	1.2	0.9	0.0	0.0	0.0	1.3	0.6	0.8	0.0	2.4	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	1.0	0.5	0.0	0.0
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
FRAT2		ENSG00000181274	"FRAT regulator of WNT signaling pathway 2"	O75474	10	97332497-97334729	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 15.0;neutrophil: 58.2"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 58.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.3	3.6	7.2	10.4	7.1	31.0	8.0	7.7	7.4	6.0	9.8	17.1	25.1	4.1	6.2	14.4	7.1	4.0	6.0	6.3	6.8	7.8	18.3	9.7	8.7	7.7	7.6	2.8	14.0	5.2	3.0	7.4	6.8	7.9	15.5	3.3	15.1	4.3	10.1	20.4	15.9	4.1	7.0	28.9	13.2	14.6	7.5	8.9	5.3	9.1	10.8	6.7	8.1	6.0	10.9	4.3	6.9	31.2	4.9	4.0	25.7	2.4	8.9	3.7	3.7	6.8	12.5	13.3	8.4	2.5	2.2	20.3	18.3	9.5	2.9	20.0	28.0	17.9	9.2	15.0	2.8	28.9	20.6	3.2	20.0	3.6	11.4	7.9	9.3	11.7	15.8	4.2	1.8	17.9	12.6	36.5	42.9	36.2	17.5	12.8	2.9	19.1	8.9	9.8	12.5	10.2	3.1	19.1	12.6	28.0	28.8	44.8	4.2	2.2	2.7	1.7	6.4	11.4	12.5	6.6	2.6	49.3	0.8	8.3	7.2	15.0	1.1	4.8	0.6	1.1	1.3	1.8	3.8	3.2	2.2	1.3	58.2	1.6	7.9	1.0	0.7	2.3	7.2	7.1	7.7	7.4	6.3	6.8	7.7	7.6	6.8	7.0	7.5	6.0	18.2	0.0	3.9	2.9	15.7	31.7	25.3	6.6	46.1	19.7	24.7	19.6	6.4	20.0	5.0	14.7	4.2	6.1	26.1	31.0	11.7	2.2	40.7	39.6	9.7	10.3	13.8	14.5	2.0	5.3	18.5	6.4	37.2	46.3	1.3	16.7	8.6	11.3	8.6	11.8	2.8	30.6	4.1	28.3	9.0	42.3	2.1	25.2	10.6	7.5	24.7	5.0	14.4	2.0	1.1	3.4	21.6	2.6	8.4	30.0	13.5	3.7	4.5	18.1	0.0	14.9	8.7	2.3	4.4	37.7	52.7	7.8	18.8	20.1	31.6	32.3
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	8.9	7.6	8.2	10.3	13.0	14.3	8.8	9.8	10.4	9.6	10.4	10.6	8.9	11.0	17.8	12.1	8.6	9.4	8.5	7.8	9.2	9.4	13.3	20.4	10.0	12.4	11.1	13.0	8.4	11.3	7.9	8.0	13.2	8.5	12.4	9.7	14.5	8.7	12.9	10.1	9.8	9.8	10.0	11.9	8.5	12.3	10.8	10.3	12.1	10.6	10.2	8.3	9.3	19.2	9.0	4.9	10.7	11.6	12.3	17.2	7.1	19.2	19.7	19.7	16.4	6.4	6.2	4.9	10.2	18.6	14.3	18.3	12.6	19.5	13.6	12.3	6.0	11.9	12.1	12.8	10.4	11.6	10.1	11.8	11.4	8.1	13.6	11.7	13.5	12.0	12.6	13.0	15.8	1.7	7.9	12.7	6.7	4.3	5.5	14.7	12.4	17.0	14.7	8.4	8.2	11.7	10.8	9.4	7.0	5.6	3.3	27.0	13.6	21.6	5.7	17.8	12.1	13.9	20.7	9.7	10.4	20.9	12.1	16.8	11.8	10.2	4.5	13.1	6.2	19.6	7.2	8.6	15.5	23.1	8.9	5.4	6.7	5.7	10.9	12.3	7.3	6.5	8.2	13.0	9.8	10.4	7.8	9.2	12.4	11.1	13.2	10.0	10.8	19.2	6.2	19.2	47.9	35.6	14.5	10.5	17.1	7.9	12.0	5.6	5.6	6.2	8.2	4.3	8.9	1.8	10.4	5.3	4.0	9.5	5.9	5.9	18.6	7.7	11.1	5.0	4.2	5.0	18.9	3.8	5.1	8.1	9.7	11.9	10.8	8.1	5.7	12.4	6.5	3.3	28.5	5.7	10.2	11.7	5.4	4.7	7.2	10.9	14.2	36.5	14.0	9.5	7.2	31.7	86.7	5.4	15.7	6.4	7.1	9.1	7.9	7.7	9.8	8.5	13.1	9.2	7.0	20.5	15.7	18.9	5.3	2.9	6.9	6.4	8.5	20.7
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 16.9;lymphoid tissue: 42.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 84.8;dendritic cells: 160.1;granulocytes: 55.0;Macrophages: 43.0;monocytes: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 1000.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 1000.3"	"Cell line enhanced"	"Detected in some"		"HEL: 71.5;HL-60: 41.8;NB-4: 43.3;THP-1: 33.7;U-937: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.7	0.8	0.7	28.5	0.7	16.9	2.3	0.7	1.1	2.7	1.3	2.7	3.7	1.3	1.1	2.1	1.6	5.7	0.7	0.7	1.0	0.8	2.0	4.2	25.3	1.3	1.1	0.4	1.1	1.1	0.6	1.0	1.3	1.8	3.8	0.5	1.9	1.2	0.2	0.8	6.6	4.7	1.0	18.2	3.7	0.7	1.1	6.9	0.6	0.7	42.7	6.0	0.5	1.8	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	71.5	0.2	0.0	0.0	41.8	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	43.3	0.0	0.0	0.0	17.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	33.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	118.4	0.0	125.5	66.7	1000.3	0.4	46.5	0.5	97.0	0.4	0.4	76.8	97.4	0.3	0.3	82.0	1.4	59.3	205.4	0.3	32.0	0.7	0.7	0.7	1.1	0.7	1.0	1.3	1.1	1.3	1.0	1.1	1.8	0.4	3.2	1.9	0.0	84.8	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.2	0.0	0.6	0.0	0.0	0.0	160.1	0.0	0.0	0.0	1.6	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.1	0.4	0.5	0.0	55.0	0.0	0.4	0.0	14.3	0.0	0.0	0.0	0.0	19.4	6.0	0.5	0.0	43.0	0.0	1.9	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.7	3.3	0.4	73.9	0.5	34.9	4.6	0.4	1.7	3.1	1.5	6.9	5.8	2.3	1.4	2.6	3.1	11.5	2.0	0.4	0.5	2.0	11.1	19.1	54.4	2.9	0.7	2.7	1.1	0.7	1.0	2.8	1.2	2.3	8.0	0.2	4.8	1.2	0.7	1.0	9.0	6.1	0.5	42.7	9.2	4.0	0.8	12.4	2.3	0.9	23.3	12.7	1.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	1.2	1.2	0.0	0.1	0.1	6.5	5.3	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.6	3.0	0.3	0.0	0.0	10.0	1.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.6	1.3	0.1	0.0	0.0	4.0	0.1	0.5	0.5	0.0	2.2	20.7	0.5	0.1	0.2	31.5	0.0	0.9	15.3	1.1	97.5	38.0	150.4	4.8	63.1	89.3	6.7	6.0	23.2	35.8	97.9	53.4	44.9	0.7	243.8	38.4	0.4	0.5	0.4	1.7	0.4	0.5	2.9	0.7	1.2	0.5	0.8	0.7	2.1	6.4	5.1	0.0	12.4	0.0	0.2	0.5	0.6	0.0	0.4	0.4	0.7	1.5	4.2	0.0	4.2	0.1	39.2	0.1	0.0	0.0	0.4	3.7	0.4	2.8	0.0	0.8	0.0	1.1	0.0	1.5	2.0	3.9	10.8	0.2	4.6	0.6	4.0	0.0	0.7	0.0	0.0	18.9	1.4	0.2	0.0	17.1	0.0	2.8	10.4	2.9	75.2	0.0	0.0	1.3	0.0	0.0	22.9	0.4	0.0	0.3	8.0	0.4	0.0	0.9	0.9	0.1	2.9	0.9	0.0	0.1	72.9	11.0	0.1	0.1
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.0	0.5	0.1	5.1	0.2	53.7	0.9	0.1	0.1	0.6	0.3	3.6	4.7	0.6	0.5	0.5	0.7	1.9	0.3	0.1	0.1	0.5	1.0	2.8	6.9	0.3	0.1	0.5	9.4	0.2	0.5	0.2	0.2	0.8	4.5	0.0	1.0	0.3	0.2	0.3	5.7	0.4	0.2	7.0	3.2	0.9	0.2	31.2	0.9	0.0	4.4	1.7	0.6	0.2	1.4	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.1	1.0	10.3	0.1	0.7	0.0	0.5	0.4	1.2	0.0	0.2	0.0	2.5	1.6	0.2	5.3	0.1	61.9	47.5	0.0	0.0	0.1	0.1	0.3	0.1	17.1	0.4	15.3	0.1	2.1	39.5	64.7	0.0	0.1	0.2	7.8	2.7	3.4	0.0	0.7	0.1	0.1	0.3	0.1	0.3	0.1	0.0	127.7	0.0	0.0	1.5	0.1	0.2	22.2	1.6	4.0	0.0	261.3	0.0	0.0	0.0	0.4	2.1	0.0	1.0	0.0	0.9	1.4	0.0	0.0	0.3	1.9	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.1	0.2	0.0	0.1	1.4	0.0	0.1	0.0	0.1	12.4	0.0	0.8	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	11.3	0.0	0.1	0.4	0.0	0.0	8.6	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.2	0.5	3.9	0.0	0.0	0.0	16.4	0.1	0.4	0.0
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 39.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 102.2;Excitatory neurons: 97.8;Inhibitory neurons: 91.5;Oligodendrocyte precursor cells: 72.9;Rod photoreceptor cells: 148.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA031446: AB_2797222, HPA031448: AB_2673888"	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	3.4	4.6	3.6	6.1	4.7	7.5	7.0	6.8	5.8	4.8	4.1	4.7	3.6	6.0	5.7	6.5	3.8	4.0	5.3	4.6	3.3	4.5	3.9	3.8	8.3	2.5	2.9	5.0	3.0	5.3	3.7	5.6	2.7	5.1	4.9	39.1	2.7	3.8	5.2	9.4	4.5	4.7	2.9	4.4	3.8	8.2	2.8	8.6	6.2	4.4	8.8	5.4	4.2	4.1	21.5	8.8	26.7	14.6	9.1	14.2	25.0	15.0	12.5	18.6	16.2	16.2	8.3	22.1	23.4	8.9	27.1	16.2	14.3	13.5	25.4	16.8	20.7	29.1	16.5	16.5	9.0	38.7	14.7	11.2	7.5	21.1	9.3	7.3	19.7	19.6	24.9	12.9	23.7	4.8	23.7	27.8	40.2	10.9	17.4	19.1	36.7	14.9	20.6	20.9	24.3	12.7	25.3	24.1	15.6	15.4	11.5	34.9	13.9	12.8	12.5	22.3	22.4	11.7	18.1	28.6	4.8	36.8	7.7	0.0	0.6	1.2	3.0	1.4	5.5	2.6	3.0	3.6	2.1	1.8	2.8	3.2	0.1	7.4	0.7	1.6	2.6	1.5	3.6	4.7	6.8	5.8	4.6	3.3	2.5	2.9	2.7	2.9	2.8	4.1	6.8	9.6	8.3	29.7	16.7	8.9	13.7	16.2	12.0	28.3	7.6	6.7	10.0	7.2	8.5	12.9	102.2	15.1	31.6	2.9	1.9	5.9	1.7	4.9	13.6	7.9	10.7	12.8	97.8	5.2	12.1	10.5	9.2	5.4	8.2	10.7	5.7	2.1	8.3	26.9	91.5	4.4	10.2	3.9	7.7	1.1	12.5	7.1	8.8	28.1	6.8	14.2	37.0	72.9	46.0	5.3	3.3	7.9	12.2	9.6	2.3	9.7	4.0	148.1	6.6	10.5	18.9	19.8	30.1	9.4	8.9	15.7	28.3	15.0	5.5	7.7
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"kidney: 571.8;liver: 698.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 346.7;Proximal tubular cells: 1261.0"	"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.4"	"Not detected"	"Not detected"							"HPA040251, HPA044094"	Enhanced					NA	NA		21000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favorable (1.31e-6)"	"unprognostic (2.69e-1)"				47.0	0.1	0.0	0.1	0.1	0.1	8.5	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	571.8	698.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	11.5	0.0	31.3	0.0	0.1	0.0	0.0	123.3	0.0	6.0	0.0	0.0	0.6	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	346.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	8.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1261.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0
GOLGA8K		ENSG00000249931	"Golgin A8 family member K"	D6RF30	15	32392782-32403292	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"testis: 6.6"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.0;JURKAT: 1.0;THP-1: 1.7;U-937: 2.4"															NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.47e-1)"	"unprognostic (3.27e-1)"			"unprognostic (4.01e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.62e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.81e-2)"	0.7	0.2	0.1	0.1	0.7	0.6	0.4	0.2	0.6	0.5	0.1	0.4	0.0	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.4	0.2	0.1	0.5	0.0	0.5	0.2	0.4	0.9	0.1	0.5	0.0	0.6	0.3	0.0	0.2	0.3	0.1	0.1	0.3	0.4	0.1	0.1	0.3	0.2	6.6	0.4	0.0	1.3	0.0	0.1	0.5	0.4	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.6	0.1	0.4	0.5	0.2	0.6	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GOLGA8M		ENSG00000188626	"Golgin A8 family member M"	H3BSY2	15	28701954-28738384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.3;thyroid gland: 13.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.8;Early spermatids: 24.7;NK-cells: 7.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 2.6;U-937: 6.4"															NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"			"unprognostic (2.04e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.16e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.66e-4)"	"unprognostic (8.24e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.60e-1)"	3.0	0.7	0.2	0.0	0.3	0.6	2.6	0.0	0.5	1.5	0.1	0.4	0.0	0.7	0.5	0.2	1.2	0.3	0.9	0.2	0.2	1.4	3.3	0.7	0.1	0.8	0.3	4.1	0.7	0.0	1.9	1.7	0.2	0.6	0.0	0.0	0.3	0.2	0.3	0.3	0.3	0.1	0.1	0.4	0.3	6.3	0.2	0.0	13.9	0.0	0.0	0.6	1.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.2	0.8	0.3	0.2	0.1	0.2	0.5	1.7	3.2	2.2	8.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	3.0	0.0	1.9	0.0	24.7	0.3	0.2	0.5	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.3	0.1	3.3	1.5	0.0	0.0	0.0	0.3	2.9	0.0	0.4	0.0	1.9	0.5	0.2	7.2	3.0	2.9	0.0	0.0	0.7	0.3	0.0	0.0	0.8	0.7	0.1	0.0	0.8	0.3	3.9	0.8	0.0	0.0	0.1	1.4	0.2	0.0	0.1
GOLGA8N		ENSG00000232653	"Golgin A8 family member N"	F8WBI6	15	32593456-32607310	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 92.7"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"gdT-cell: 1.1;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.3;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.6;THP-1: 38.1;U-937: 33.2"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	10.8	6.7	1.7	1.9	2.8	6.3	9.7	1.8	2.4	12.9	2.9	10.1	1.2	10.2	4.9	6.0	12.6	0.7	11.8	1.4	2.3	8.0	12.0	8.5	1.9	2.7	2.6	19.4	31.3	3.0	22.9	0.5	2.3	8.7	0.5	2.4	8.0	2.4	6.8	7.1	8.6	1.2	1.5	9.6	8.2	16.2	3.3	0.9	34.2	1.8	1.2	10.1	10.2	2.7	0.0	0.0	0.1	0.5	2.2	3.0	0.1	1.0	0.5	0.2	0.3	0.0	0.8	0.8	0.3	0.7	0.2	0.0	0.4	0.1	0.4	0.1	0.5	61.6	0.0	0.0	0.6	1.0	0.1	0.9	1.2	0.0	0.8	3.1	0.0	0.0	0.2	0.0	0.3	1.0	0.0	10.9	0.1	0.1	0.0	0.1	1.5	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.0	0.0	0.0	38.1	1.5	1.2	0.2	0.0	0.0	3.1	3.2	0.5	0.3	33.2	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	2.3	0.0	0.2	0.0	0.1	1.7	2.8	1.8	2.4	1.4	2.3	2.7	2.6	2.3	1.5	3.3	2.7	7.4	19.2	18.6	6.2	1.6	0.0	0.4	0.0	0.0	1.8	0.9	1.4	10.9	1.5	6.2	1.8	0.0	0.2	8.3	1.3	0.0	0.4	92.7	15.9	3.7	3.6	3.5	4.2	2.9	2.0	0.0	4.9	3.6	6.5	6.3	3.3	2.2	5.3	0.6	13.5	3.3	1.1	0.0	1.3	0.0	10.1	5.6	6.2	0.0	1.9	3.2	1.8	15.5	4.5	5.4	0.6	0.8	2.2	2.5	0.3	1.4	0.8	6.6	1.9	0.0	3.4	5.6	11.5	0.9	2.0	0.0	0.1	5.4	1.4	1.3	0.2
GOLGA8O		ENSG00000206127	"Golgin A8 family member O"	A6NCC3	15	32441914-32455634	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 20.0;epididymis: 33.0;testis: 11.5;thyroid gland: 27.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Endometrial ciliated cells: 1.3;granulocytes: 1.3;NK-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 1.0;NK-cell: 2.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 2.4;T-cells: 1.0"	"Group enriched"	"Detected in many"	8	"HEL: 70.0;THP-1: 38.6;U-937: 133.7"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (2.68e-2)"	"unprognostic (4.10e-1)"			"unprognostic (1.20e-1)"			"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (8.25e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.06e-2)"		4.6	1.2	3.2	2.8	3.8	20.0	3.7	3.4	3.9	2.1	3.9	1.5	1.8	3.4	33.0	1.3	2.8	3.1	3.3	3.4	3.4	1.7	2.9	2.7	2.4	3.8	3.8	4.2	3.4	3.5	1.9	1.4	3.7	2.3	1.9	3.6	3.0	1.6	4.4	4.0	1.5	2.2	3.5	3.6	1.9	11.5	3.6	1.3	27.5	2.0	1.4	1.5	1.2	4.5	0.3	0.5	1.0	0.0	2.6	3.8	0.1	1.7	1.0	0.4	0.8	0.0	0.2	0.4	0.5	0.3	1.0	0.1	0.7	0.1	0.4	0.1	0.6	70.0	0.0	0.0	1.1	1.5	2.6	0.9	1.0	0.5	0.3	4.4	0.8	1.3	0.2	0.0	1.0	0.8	0.0	10.2	0.3	0.0	0.3	0.2	2.1	0.0	1.6	0.3	0.0	1.0	0.4	0.1	0.0	0.5	0.6	38.6	3.8	0.8	0.3	0.1	0.6	1.7	2.5	0.6	0.4	133.7	0.8	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.1	3.2	3.8	3.4	3.9	3.4	3.4	3.8	3.8	3.7	3.5	3.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0
GOLGA8Q		ENSG00000178115	"Golgin A8 family member Q"	H3BV12	15	30552078-30562501	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"thyroid gland: 10.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.4;NK-cells: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"THP-1: 4.9;U-937: 6.0"															NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.65e-2)"				"unprognostic (6.48e-2)"			"unprognostic (2.24e-1)"			"unprognostic (5.52e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.31e-1)"		0.9	0.3	0.2	0.1	0.2	1.6	0.6	0.0	0.3	1.2	0.6	0.7	0.0	1.1	2.1	0.3	0.7	0.2	0.7	0.5	0.1	0.3	0.4	0.6	0.0	0.5	0.1	1.2	1.1	1.7	1.2	0.1	0.1	0.4	0.2	0.4	0.5	0.2	0.5	0.4	0.5	0.5	0.1	0.3	0.5	4.1	0.2	0.1	10.6	0.9	0.0	0.6	0.6	0.6	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.3	0.0	1.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.5	0.1	0.5	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.5	0.0	0.8	0.0	0.3	0.1	0.0	0.7	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	44.4	1.5	0.3	0.3	1.2	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	1.0	0.4	0.5	0.5	5.0	0.0	0.1	0.0	1.0	0.5	2.3	2.1	0.6	1.8	0.0	1.6	0.3	19.6	0.0	0.0	0.0	0.1	1.5	0.3	0.1	0.2	0.1	0.1	1.0	6.6	0.8	0.6	6.2	1.9	0.0	0.1	0.0	1.1	0.8	0.2	0.2
GPBAR1	"BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5"	ENSG00000179921	"G protein-coupled bile acid receptor 1"	Q8TDU6	2	218259496-218263861	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.9;breast: 17.8;gallbladder: 17.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.3;Enteroendocrine cells: 46.0;Hofbauer cells: 16.3;Kupffer cells: 50.6;Macrophages: 19.9;monocytes: 45.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"classical monocyte: 288.1;intermediate monocyte: 712.0;non-classical monocyte: 695.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 712.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HHSteC: 1.7;U-937: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA062890	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA062890: AB_2684896"	"unprognostic (8.47e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.76e-3)"	"unprognostic (4.32e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.40e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.29e-1)"	31.9	1.6	0.1	2.7	0.2	2.2	17.8	0.4	0.7	0.6	0.2	3.8	1.0	0.9	0.0	0.5	1.2	17.3	5.1	0.2	0.1	5.3	1.9	2.2	0.8	0.1	0.1	1.8	1.7	0.0	0.8	3.9	0.1	1.1	0.5	0.0	0.8	0.3	0.5	1.4	4.9	10.1	0.1	7.5	6.4	2.4	0.3	0.4	1.7	0.7	0.2	4.8	0.8	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	1.7	0.1	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.9	0.8	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	1.9	0.1	0.6	288.1	0.4	0.7	712.0	0.7	0.2	0.5	0.7	140.2	0.7	0.6	0.4	6.5	0.5	695.6	6.0	0.9	156.5	0.1	0.2	0.4	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	6.2	0.0	3.4	0.0	1.1	0.3	0.2	0.2	0.0	0.0	0.1	0.3	0.5	1.5	0.1	3.7	0.0	0.5	1.8	0.2	11.7	0.2	8.2	1.0	20.3	1.5	46.0	0.0	0.0	0.5	4.5	2.8	6.6	0.8	1.3	6.2	1.8	0.0	16.3	0.0	0.0	2.7	0.0	50.6	1.2	1.9	3.4	19.9	0.0	1.9	45.3	0.0	0.0	0.0	0.0	0.5	1.5	2.6	0.3	0.3	0.4	0.2	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.4	1.6	0.8	0.1	0.2	0.4
GXYLT1	"FLJ43151, GLT8D3"	ENSG00000151233	"Glucoside xylosyltransferase 1"	Q4G148	12	42081845-42144874	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		3200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.22e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.96e-2)"	"prognostic favorable (3.91e-4)"	5.8	4.8	4.0	5.9	4.3	7.5	4.9	4.6	3.4	4.0	4.2	4.1	4.0	3.9	3.7	3.2	4.5	4.0	3.0	3.4	5.7	6.4	12.2	5.5	5.2	5.0	4.6	5.5	4.2	6.0	3.6	11.1	4.7	4.1	4.9	6.1	3.5	3.3	2.4	4.2	5.6	3.7	5.0	6.7	4.6	9.5	4.5	6.8	8.9	3.9	4.6	4.6	3.4	4.9	12.9	10.8	12.2	11.9	8.5	22.1	45.6	28.4	19.0	20.7	20.9	25.1	25.9	11.2	21.7	15.8	14.9	6.0	20.6	9.2	38.1	18.7	23.2	18.4	9.1	20.5	13.4	20.1	16.9	17.1	7.8	31.6	13.9	12.3	27.7	12.6	11.8	19.3	26.7	8.9	13.0	12.2	14.8	4.9	10.2	6.1	24.6	10.0	12.5	19.1	6.2	10.5	20.2	11.4	16.8	22.6	23.4	15.6	23.9	14.7	49.8	8.7	18.1	25.2	30.4	14.1	19.9	53.8	9.2	0.1	0.6	1.8	0.4	1.2	0.2	0.4	0.6	0.5	1.0	0.4	0.5	0.5	0.4	0.9	1.5	0.2	0.7	0.3	4.0	4.3	4.6	3.4	3.4	5.7	5.0	4.6	4.7	5.0	4.5	4.9	22.1	16.0	15.0	10.1	21.5	3.2	14.3	7.9	8.6	9.0	13.3	8.6	7.4	7.2	8.8	35.0	8.4	42.7	34.2	10.5	1.9	9.5	1.6	7.2	11.9	16.4	3.0	8.0	14.3	10.4	39.8	15.7	6.6	10.7	19.1	57.6	24.3	27.8	13.8	15.2	16.1	9.5	6.1	16.2	7.4	3.4	11.8	13.2	5.4	25.3	20.5	10.3	15.5	16.6	17.8	8.9	12.5	7.5	21.5	14.5	12.3	3.9	12.1	15.5	13.1	13.3	11.7	25.2	33.4	11.0	4.4	45.6	22.2	13.9	9.1	12.7
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373062	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	5.9	18.7	9.6	5.5	10.4	31.5	5.0	11.1	10.9	6.0	9.2	6.5	3.9	6.5	5.3	4.4	6.5	5.5	12.4	9.4	9.8	7.7	6.4	6.0	5.2	10.0	12.8	9.2	5.2	6.7	7.9	6.4	9.9	5.9	4.1	10.5	5.0	6.8	9.4	4.7	4.8	5.7	10.6	5.3	5.4	13.3	11.7	5.5	7.0	8.1	4.4	5.8	4.6	10.4	8.2	14.2	8.9	9.0	10.3	10.0	7.1	9.8	9.0	9.9	9.2	10.9	6.4	16.6	8.5	8.5	19.3	14.3	10.3	13.2	11.2	2.8	6.7	15.4	6.0	14.7	13.4	9.3	9.0	10.1	9.6	10.7	16.3	13.8	6.7	11.4	10.6	25.2	14.3	10.9	14.5	11.6	6.6	11.5	19.3	9.5	21.3	11.6	7.4	8.2	13.7	7.8	8.7	15.4	20.9	7.3	10.2	13.4	8.7	16.0	9.2	12.1	10.6	20.5	9.0	14.4	4.7	41.8	8.8	0.0	1.6	0.8	0.7	0.9	0.5	1.0	1.0	1.0	1.6	0.6	0.9	1.0	1.2	0.5	1.2	1.3	0.3	0.9	9.6	10.4	11.1	10.9	9.4	9.8	10.0	12.8	9.9	10.6	11.7	10.4	9.8	6.4	9.6	5.5	12.6	10.8	3.1	3.8	8.6	12.6	6.0	6.9	19.7	1.5	4.7	3.7	18.8	4.9	8.7	3.9	7.9	3.6	18.9	10.4	9.7	8.4	5.4	4.0	6.6	3.3	3.2	8.3	7.1	17.8	13.9	8.2	2.2	5.2	8.7	6.7	7.6	4.2	4.1	13.2	28.8	27.5	9.3	23.9	1.8	1.0	2.5	10.3	5.2	4.5	5.6	4.0	4.6	8.2	11.6	3.2	2.8	3.8	7.7	13.4	0.0	8.8	11.5	20.7	8.9	7.6	8.4	5.6	7.9	14.0	3.7	1.8
H3C3	"H3.1, H3/c, H3FC, HIST1H3C"	ENSG00000287080	"H3 clustered histone 3"	P68431	6	26045384-26045869	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.2;brain: 1.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 6.5"									HPA042570	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 32: U-937 - Innate immune response"				"HPA042570: AB_2678056"																		0.1	0.0	0.6	0.0	0.4	4.2	0.0	0.3	0.5	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.0	0.1	0.1	0.6	0.7	1.8	0.0	0.0	0.0		0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.7	1.8	1.1	0.0	0.0	0.1	0.2		1.1	1.7	0.3	0.8	0.0	0.3	0.0	0.0	1.2	0.5	3.3	2.8	0.0	0.2	0.0	0.0	0.5	1.8	0.7	0.0	0.2	2.4	2.3	0.2	2.5	0.2	2.0	0.2	1.6	1.0	0.3	0.2	1.0	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	2.7	3.3	1.4	1.8	2.7	2.8	0.0	0.2	0.7	3.6	0.0	1.0	3.1	1.8	0.3	0.1	0.8	1.0	0.0	0.0	0.0	1.2	2.1	1.5	0.1	0.0	0.8	6.5	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.3	0.3	0.5	0.1	0.6	0.1	1.1	0.0	0.2	1.1	0.5	0.6	0.4	0.3	0.5	0.4	0.7	0.7	1.8	1.6	0.4	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C11	"H4/e, H4F2iv, H4FE, HIST1H4J"	ENSG00000197238	"H4 clustered histone 11"	P62805	6	27824092-27824480	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 2.5;Extravillous trophoblasts: 8.0;Hofbauer cells: 4.4;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"basophil: 80.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.0;U-266/70: 2.4;U-266/84: 1.1;U-937: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042201	Supported					NA	NA		25000000	"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.4	10.0	0.0	0.0	0.4	0.0	4.1	0.0	0.4	4.7	0.2	6.7	0.0	4.1	0.0	4.9	4.9	1.2	3.9	0.1	0.2	4.3	20.6	4.4	0.0	0.2	0.1	4.8	1.2	0.0	4.2	0.0	0.2	8.6	0.0	0.0	1.9	0.0	0.4	2.9	5.4	1.4	0.0	11.5	3.2	2.7	0.2	0.0	8.7	0.0	0.0	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.1	0.0	0.0	6.3	0.0	80.9	2.3	13.5	8.6	9.9	3.0	6.1	8.1	9.9	0.0	6.0	3.6	4.4	0.2	13.6	14.3	6.7	9.0	8.6	0.0	0.4	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902529-35904377	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 253.7;lymphoid tissue: 115.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 993.2;Hofbauer cells: 571.1;Kupffer cells: 396.6;Langerhans cells: 584.5;Macrophages: 392.7;NK-cells: 1687.0;T-cells: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 239.9;HL-60: 139.6;HMC-1: 154.3;THP-1: 177.8;U-937: 272.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	27.2	9.5	14.0	53.6	13.8	253.7	14.1	13.7	18.5	9.6	16.6	12.7	11.3	8.3	4.7	5.5	9.9	11.5	8.3	13.5	17.0	10.6	14.5	40.3	68.0	18.3	14.7	5.7	6.7	2.5	9.6	24.7	17.6	9.4	8.6	2.2	10.7	8.2	4.2	6.6	28.2	11.2	17.1	115.6	15.4	3.4	18.2	59.6	7.9	3.0	37.8	16.4	8.0	22.2	0.9	0.0	0.3	0.5	1.1	0.0	0.3	1.9	1.1	0.0	0.6	0.8	1.2	26.9	1.7	2.0	0.4	0.9	0.0	0.2	0.0	0.6	0.0	239.9	0.5	0.7	0.9	139.6	154.3	1.6	0.3	0.0	0.0	0.7	0.0	14.8	2.1	33.4	0.4	0.4	16.9	54.7	0.3	0.3	0.7	0.8	0.5	2.0	0.4	0.1	0.9	0.4	1.3	0.7	0.9	0.2	0.5	177.8	0.5	1.4	1.8	0.2	0.2	1.6	1.1	39.5	1.4	272.2	0.3	124.7	725.8	105.8	1583.4	546.1	1172.3	78.6	664.6	1293.3	409.8	51.0	550.6	1108.0	196.1	1290.7	314.4	823.7	629.9	1421.2	14.0	13.8	13.7	18.5	13.5	17.0	18.3	14.7	17.6	17.1	18.2	22.2	12.3	6.4	43.3	0.0	85.3	28.6	1.3	1.7	2.8	0.4	11.4	12.8	1.2	15.7	7.1	9.2	0.0	3.8	993.2	1.8	0.0	2.8	1.3	4.0	2.5	18.3	0.0	84.2	0.1	1.2	4.7	9.5	14.8	5.5	240.4	0.3	21.0	14.3	571.1	1.7	0.1	0.9	2.0	396.6	584.5	3.0	2.1	392.7	44.4	5.6	309.9	0.7	1687.0	0.0	0.1	1.0	1.4	0.0	97.7	0.6	2.0	6.1	5.1	2.2	19.7	4.2	6.2	2.2	4.9	2.7	21.0	6.0	769.9	1.0	2.7	1.2
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 72.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"cerebellum: 9.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	5.4	2.9	8.6	8.0	8.9	13.3	8.0	6.8	9.2	8.5	4.9	6.5	5.0	3.9	4.7	2.7	2.3	6.5	1.8	8.9	9.6	3.4	2.0	4.7	13.5	8.0	8.1	5.2	2.1	0.9	5.3	5.6	8.9	3.7	9.5	3.0	3.0	3.4	3.2	3.8	7.6	3.6	7.8	11.1	4.7	72.0	10.6	18.7	2.2	6.2	11.3	6.2	2.0	8.6	16.9	8.5	0.7	0.0	0.7	0.5	0.1	4.0	1.5	9.4	1.5	24.7	26.0	0.0	8.9	7.5	0.0	0.1	0.0	0.2	5.9	5.5	0.0	42.4	31.7	0.0	8.1	25.4	36.4	7.8	0.5	2.1	0.0	0.0	1.9	71.4	0.0	18.5	0.4	42.8	68.2	75.3	24.0	13.5	3.7	29.3	0.0	1.5	0.0	18.0	40.1	0.0	35.3	9.8	0.1	2.4	0.0	55.7	0.5	0.0	31.4	17.5	0.1	11.2	15.0	0.1	0.0	98.6	0.3	43.3	19.7	43.2	61.8	24.0	55.6	12.6	30.0	56.4	24.6	7.1	24.7	45.1	19.6	55.6	29.8	19.5	31.2	39.9	8.6	8.9	6.8	9.2	8.9	9.6	8.0	8.1	8.9	7.8	10.6	8.6	2.4	0.0	1.1	2.3	5.4	1.7	1.4	6.6	1.2	5.2	8.1	7.1	1.8	14.3	4.0	5.5	0.0	12.8	28.0	4.0	3.9	3.0	12.2	2.2	3.6	3.0	4.9	13.9	5.2	1.3	21.5	5.2	2.6	2.4	7.0	2.9	6.1	0.5	15.8	0.0	3.7	4.0	4.1	11.7	3.3	20.1	5.0	7.5	1.8	3.7	11.2	3.6	58.7	4.0	2.7	2.8	7.4	3.0	8.0	1.2	5.5	0.8	2.8	2.4	6.6	3.0	3.5	178.5	107.7	2.9	1.6	5.2	23.0	8.5	6.1	3.3
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899346	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 129.3;lymphoid tissue: 76.6"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.1;Hofbauer cells: 34.5;Kupffer cells: 43.9;Macrophages: 38.8;monocytes: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 1.4;cerebral cortex: 1.6;thalamus: 2.4"	"Immune cell enhanced"	"Detected in many"		"basophil: 569.7"	"Group enriched"	"Detected in many"	13	"granulocytes: 569.7;monocytes: 200.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 20.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		2000000	"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	8.4	4.5	0.0	19.0	0.2	129.3	2.6	1.4	1.6	0.8	0.2	2.5	2.0	1.0	0.1	0.9	5.1	2.1	4.0	0.2	0.0	1.8	5.2	25.1	4.2	0.0	0.0	1.0	1.5	0.1	0.7	2.8	0.0	1.1	1.4	0.1	1.5	0.3	0.9	0.5	3.1	7.9	0.0	76.6	2.1	1.3	2.4	1.4	1.3	0.5	0.7	4.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.5	0.1	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.6	0.0	569.7	92.5	204.8	0.3	179.4	0.2	0.4	0.2	0.1	30.2	0.2	0.1	0.1	32.2	0.2	200.9	1.4	0.2	43.6	0.0	0.2	1.4	1.6	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	11.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.4	1.3	0.0	0.4	0.2	34.5	0.0	0.4	0.0	0.0	43.9	0.9	1.8	0.0	38.8	0.0	1.0	14.6	0.0	2.1	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.0
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472440-26476642	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		640000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: AB_2686835"	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	216.3	225.6	180.2	254.5	187.3	1137.3	234.8	179.6	251.3	328.1	162.5	280.3	176.3	283.8	359.3	291.1	293.4	142.9	192.5	170.6	183.1	259.7	212.9	259.2	436.5	185.1	178.8	394.6	252.5	160.4	328.7	214.9	188.4	281.6	301.1	285.0	217.1	162.8	251.8	242.8	270.0	235.8	188.7	324.3	224.7	160.4	175.8	916.1	306.1	133.5	534.0	245.1	250.7	211.6	1074.5	304.8	1192.5	496.5	112.0	251.6	390.8	517.2	331.2	1089.4	835.7	305.8	1073.1	1107.2	443.1	482.3	338.4	627.8	1564.6	565.6	1001.7	684.2	906.7	1222.2	401.5	360.2	197.7	2793.6	738.7	254.9	303.4	602.1	369.1	245.1	541.7	866.8	964.3	643.0	623.0	690.8	1906.1	1363.3	922.7	1463.0	619.6	1384.3	1598.6	776.5	380.3	278.6	1064.5	641.1	1384.3	498.7	651.4	304.9	759.0	1508.9	322.3	536.9	920.4	977.1	943.6	641.2	899.2	1266.9	338.9	2989.0	1056.9	331.8	530.8	1430.5	279.2	622.3	267.3	532.2	379.7	343.3	531.5	505.6	412.4	337.7	462.4	355.5	690.4	704.7	746.7	1084.6	180.2	187.3	179.6	251.3	170.6	183.1	185.1	178.8	188.4	188.7	175.8	211.6	128.7	342.9	394.4	28.1	459.3	288.6	323.8	383.2	211.1	180.2	353.0	241.3	93.4	221.6	314.8	261.1	141.8	898.7	325.2	227.2	371.7	218.4	204.3	328.9	291.1	190.3	576.9	980.4	14.4	268.7	606.4	435.4	263.5	278.1	383.0	375.0	185.6	147.5	763.0	94.2	22.2	564.5	193.3	434.3	467.9	53.5	185.8	477.5	227.7	15.0	655.6	376.0	399.6	15.1	36.9	93.7	304.4	151.9	669.5	250.4	238.0	320.4	495.6	370.2	124.9	249.0	325.7	306.4	412.0	585.8	213.4	923.4	369.5	351.9	613.2	314.0
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HRH4	"AXOR35, GPCR105, GPRv53, H4R, HH4R"	ENSG00000134489	"Histamine receptor H4"	Q9H3N8	18	24460637-24479961	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;Early spermatids: 1.2;granulocytes: 1.3;Late spermatids: 1.3;Melanocytes: 1.8;Spermatocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"basophil: 212.9;eosinophil: 61.1"	"Lineage enriched"	"Detected in many"	191	"granulocytes: 212.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035009	Uncertain					NA	NA			"Cluster 2: Granulocytes - Unknown function"		"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035009: AB_10671507"	"unprognostic (1.88e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.68e-2)"	"unprognostic (9.83e-6)"	"unprognostic (1.31e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.65e-7)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.03e-4)"	"unprognostic (7.70e-2)"	0.1	0.1	0.2	0.4	0.1	0.8	0.0	0.3	0.3	0.1	0.3	0.1	0.5	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.3	0.6	0.5	0.1	0.0	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.0	1.3	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	212.9	0.1	61.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.2	0.5	0.5	0.2	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.3	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	1.8	1.0	0.0	0.3	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.8	0.3	1.3	0.3	0.0	0.6	0.0	0.5	0.2	0.0	0.4
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 78.5;dendritic cells: 101.3;Gastric mucus-secreting cells: 40.2;NK-cells: 82.4;Plasma cells: 134.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.0;HL-60: 43.5;HMC-1: 56.4;NB-4: 140.1;RPMI-8226: 63.2;U-266/84: 41.9;U-937: 137.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"	1.6	0.7	0.5	16.8	1.1	47.0	3.3	1.1	1.1	3.0	1.2	9.8	12.7	1.3	1.8	1.7	3.2	5.4	0.4	0.5	0.4	1.5	2.2	5.6	27.2	1.5	0.7	0.5	4.3	2.3	4.0	1.5	1.1	5.1	9.3	0.3	9.5	2.9	0.4	0.4	20.5	1.0	0.7	37.7	12.7	0.4	1.0	8.7	2.6	1.2	35.7	7.5	0.7	2.8	15.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	2.2	21.3	41.0	0.6	0.0	0.8	0.7	0.0	0.6	0.0	2.3	0.1	0.6	0.5	2.6	0.0	43.5	56.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	37.4	0.0	9.0	0.1	140.1	0.0	5.5	0.0	3.0	0.0	63.2	0.4	5.6	0.1	0.1	0.0	1.3	0.3	0.0	0.3	15.9	0.2	0.1	0.1	0.2	0.2	5.7	41.9	23.6	0.2	137.3	0.0	232.1	15.5	100.9	17.1	22.0	15.8	56.4	7.6	11.2	25.5	35.8	6.9	9.2	182.6	85.2	38.8	7.6	13.0	16.7	0.5	1.1	1.1	1.1	0.5	0.4	1.5	0.7	1.1	0.7	1.0	2.8	1.0	3.2	8.9	0.0	78.5	0.3	1.2	3.0	0.6	0.0	3.6	1.9	0.6	5.7	11.3	5.5	0.0	2.6	101.3	18.9	0.0	6.7	0.0	4.5	1.5	0.8	8.4	32.2	0.5	5.1	4.1	0.7	40.2	7.9	6.3	0.1	1.4	0.6	1.1	0.0	0.4	19.1	2.0	3.4	2.4	0.1	0.0	7.3	10.6	1.0	10.7	0.0	82.4	1.0	0.3	9.7	18.0	0.0	134.0	2.6	17.9	0.3	7.9	0.0	0.0	1.1	0.7	0.1	0.5	0.1	0.1	3.4	31.0	0.2	9.3	4.1
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 173.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	38.9	99.7	53.4	31.0	54.1	54.7	35.7	56.0	60.6	33.5	45.9	34.8	25.4	39.4	59.1	30.3	35.1	28.6	65.4	51.5	74.1	43.3	30.8	26.9	34.5	60.8	56.4	60.2	27.7	52.8	144.7	36.4	56.7	35.3	35.3	56.1	28.4	39.6	181.8	35.1	26.0	34.6	56.1	28.5	32.5	41.5	79.9	43.0	47.6	109.2	35.7	35.1	27.8	55.3	151.4	79.3	99.9	70.5	72.1	54.0	87.1	71.5	60.4	57.2	55.5	47.6	66.0	114.1	163.1	68.1	66.3	66.0	120.5	52.3	75.0	86.5	106.9	70.9	99.9	59.2	40.8	138.1	57.7	48.4	66.1	63.2	39.3	40.8	60.3	166.3	67.4	81.0	76.5	114.3	135.7	115.4	58.7	139.4	115.7	104.2	123.7	103.3	62.0	105.9	69.0	106.9	66.7	54.4	56.4	83.9	39.8	96.5	57.4	69.2	52.2	79.5	126.1	47.6	69.1	92.7	44.4	192.4	50.3	48.4	20.6	33.2	41.0	21.5	44.5	33.9	44.4	42.2	28.5	33.3	44.8	40.7	6.7	49.7	35.3	20.6	47.9	27.9	53.4	54.1	56.0	60.6	51.5	74.1	60.8	56.4	56.7	56.1	79.9	55.3	28.2	51.3	42.9	11.4	36.8	29.6	38.0	28.0	38.7	52.5	25.8	23.5	173.3	20.0	53.1	49.7	10.4	95.3	37.6	26.2	49.0	36.7	6.8	51.0	39.3	29.8	81.2	55.5	10.2	34.3	69.8	42.1	42.3	32.9	34.8	48.4	10.4	22.8	38.2	42.1	12.1	37.8	28.5	19.5	19.2	11.7	45.1	30.3	32.0	7.5	34.4	78.0	25.7	8.0	13.6	32.5	18.5	53.8	54.3	37.2	20.4	32.1	44.4	56.7	46.0	46.9	41.0	29.4	92.2	42.7	26.6	116.8	51.6	45.8	32.6	36.8
IGHV1-24		ENSG00000211950	"Immunoglobulin heavy variable 1-24"	A0A0C4DH33	14	106276548-106277043	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 186.8;salivary gland: 76.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 231.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		3100000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (9.01e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.93e-3)"		"prognostic favorable (3.61e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.07e-7)"	"unprognostic (5.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.78e-2)"	6.8	1.4	0.1	33.7	0.0	0.0	8.5	0.0	0.3	56.3	0.1	30.5	0.0	5.7	0.0	46.2	6.5	4.6	1.8	0.0	0.1	7.0	6.4	17.7	0.0	1.2	0.1	19.6	1.4	0.1	0.4	0.3	0.0	3.1	14.0	0.0	76.3	0.0	0.1	0.8	24.0	2.1	0.0	186.8	37.0	14.2	0.0	0.4	14.5	0.0	18.4	63.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.8	0.1	0.0	0.0	2.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	3.6	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	231.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGKV2D-24		ENSG00000241566	"Immunoglobulin kappa variable 2D-24 (non-functional)"	A0A075B6R9	2	90004797-90005629	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.7;lymphoid tissue: 25.5;urinary bladder: 15.3"	"Cell type enriched"	"Detected in single"	207	"Plasma cells: 165.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.8"	"Group enriched"	"Detected in some"	48	"memory B-cell: 6.7;naive B-cell: 2.7"	"Lineage enriched"	"Detected in single"	68	"B-cells: 6.7"	"Cell line enriched"	"Detected in single"	8	"U-937: 1.0"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.21e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.09e-2)"		"prognostic favorable (2.11e-4)"		"unprognostic (2.33e-1)"		"unprognostic (2.29e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.74e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.47e-1)"	0.6	0.8	0.0	4.3	0.0	2.7	6.1	0.0	0.7	0.5	0.0	16.8	19.7	0.1	0.0	1.5	0.4	3.5	0.1	1.8	0.0	0.6	0.5	1.8	6.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	7.2	0.0	9.6	0.5	0.0	0.3	7.0	0.1	0.1	25.0	5.2	0.1	0.1	1.7	0.4	0.0	25.5	15.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3D-15		ENSG00000224041	"Immunoglobulin kappa variable 3D-15"	A0A087WSY6	2	90114838-90115402	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 126.7;lymphoid tissue: 203.0;salivary gland: 54.1;stomach 1: 87.4;urinary bladder: 58.0"	"Cell type enriched"	"Detected in some"	622	"Plasma cells: 3673.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	191	"memory B-cell: 181.1;naive B-cell: 155.6"	"Lineage enriched"	"Detected in single"	206	"B-cells: 181.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;HL-60: 2.6;SiHa: 1.7"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		4800000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.11e-4)"	"prognostic favorable (7.46e-4)"	"unprognostic (9.16e-3)"	"unprognostic (1.74e-1)"		"unprognostic (1.90e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.93e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (8.99e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	3.1	4.4	0.1	93.5	0.4	11.1	17.1	0.1	0.5	5.9	0.3	111.6	63.0	1.0	0.0	16.4	5.2	10.1	2.3	0.1	0.2	3.6	2.0	18.0	43.6	0.4	0.2	17.9	4.0	0.3	0.1	0.0	0.2	1.7	126.7	0.0	54.1	1.1	0.1	0.6	46.7	4.3	0.3	56.3	87.4	0.2	0.1	13.0	4.5	0.0	203.0	58.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.0	0.6	0.0	0.1	0.8	0.0	0.0	0.0	0.0	181.1	0.0	0.0	0.1	155.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1	27.5	0.1	0.4	0.1	0.5	0.1	0.2	0.4	0.2	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3673.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 3.6;lymphoid tissue: 3.2"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 8.9;Breast myoepithelial cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	NA	NA	40500000			"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.3	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.1	0.0	0.0	0.0	8.9	9.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1
INAFM2	"LINC00984, OGU1"	ENSG00000259330	"InaF motif containing 2"	P0DMQ5	15	40323692-40326715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (1.88e-7)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	11.3	8.4	16.1	9.9	17.9	12.7	7.6	15.5	17.1	8.5	15.2	49.9	6.7	12.2	5.8	8.1	21.3	11.0	28.8	16.4	18.4	7.9	6.7	11.5	5.8	19.3	16.9	10.0	11.5	12.2	10.4	17.6	16.9	10.8	13.4	12.6	9.4	22.5	13.6	6.5	12.9	17.3	18.2	10.7	28.2	10.2	17.0	5.2	26.9	15.0	6.2	14.4	7.8	22.2	18.7	1.8	16.8	10.7	14.2	6.9	38.6	23.0	11.5	18.0	14.8	6.9	3.7	1.6	19.8	12.6	10.6	41.7	26.3	27.1	25.1	5.5	8.8	50.4	6.9	3.9	18.3	27.0	34.3	18.2	9.8	6.7	18.8	26.5	18.7	12.9	27.6	39.6	25.4	2.7	7.9	21.5	12.3	14.5	14.1	3.9	20.2	44.8	13.2	21.3	35.9	14.2	8.2	9.7	8.3	28.6	9.4	33.1	24.5	24.8	18.4	12.6	16.8	10.2	2.7	4.8	18.4	43.5	24.1	0.6	1.0	2.6	0.1	1.1	0.1	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.7	0.1	1.0	1.1	0.2	0.6	16.1	17.9	15.5	17.1	16.4	18.4	19.3	16.9	16.9	18.2	17.0	22.2	6.4	0.0	3.7	3.9	2.3	0.0	1.2	0.0	0.0	7.8	6.8	5.5	18.0	4.3	0.6	3.7	4.2	3.3	3.1	4.3	0.0	2.3	25.3	2.2	3.8	6.0	2.4	1.7	3.4	2.6	0.6	2.4	3.6	2.3	1.3	1.8	12.1	2.7	19.5	8.4	4.5	1.4	0.0	14.1	0.0	4.6	1.2	13.8	0.0	6.5	8.0	6.7	4.1	4.0	1.4	2.3	1.9	4.9	0.4	3.2	1.4	0.8	1.5	4.8	0.0	2.4	9.8	32.4	4.4	1.1	0.0	1.4	1.7	4.9	1.5	2.4
INKA1	"C3orf54, FAM212A"	ENSG00000185614	"Inka box actin regulator 1"		3	49803261-49805030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.9;Breast myoepithelial cells: 9.7;Endothelial cells: 8.4;Hofbauer cells: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 59.6;memory B-cell: 65.9;naive B-cell: 64.4"	"Group enriched"	"Detected in many"	7	"B-cells: 65.9;granulocytes: 59.6"	"Cell line enhanced"	"Detected in many"		"HEL: 68.5;HMC-1: 45.1;NB-4: 38.5;THP-1: 42.1;U-937: 34.9"	"Low region specificity"	"Detected in all"							HPA041879	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Vesicles"		"HPA041879: AB_10797269"	"unprognostic (1.36e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.96e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.35e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.40e-2)"	5.1	2.3	4.8	2.0	5.0	3.5	4.1	5.2	7.6	6.2	2.8	3.2	0.8	4.7	1.4	19.7	2.8	1.5	5.2	5.3	5.5	5.8	1.1	5.4	4.1	6.2	5.3	2.2	1.3	0.5	2.1	3.1	5.7	6.4	0.5	0.2	4.9	2.1	11.7	24.1	4.3	1.8	5.8	6.7	2.4	2.9	6.5	1.6	2.1	2.3	3.9	5.5	10.3	7.0	1.3	1.1	1.5	1.1	1.8	4.1	0.0	3.0	1.9	1.4	1.7	0.1	0.0	14.9	0.4	2.2	1.5	8.7	0.5	10.4	0.1	2.6	0.0	68.5	0.7	0.2	2.6	10.4	45.1	5.4	14.5	2.9	2.6	0.9	6.1	1.0	4.7	1.2	1.2	0.6	0.9	38.5	1.1	0.0	5.8	13.9	0.8	3.3	0.1	16.9	0.8	5.3	2.7	0.5	1.5	0.4	0.3	42.1	3.8	7.3	0.9	3.4	1.3	1.7	1.7	1.2	3.2	34.9	1.8	59.6	2.4	11.6	1.3	5.9	0.3	65.9	1.5	1.8	0.7	64.4	2.2	3.6	1.3	0.0	8.5	9.3	1.6	6.4	4.8	5.0	5.2	7.6	5.3	5.5	6.2	5.3	5.7	5.8	6.5	7.0	19.9	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.7	0.0	0.5	1.6	8.4	0.0	0.0	0.0	1.2	0.7	3.0	0.0	0.1	0.0	0.1	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (4.42e-5)"	8.6	6.5	4.0	13.6	4.6	10.0	8.9	4.5	5.1	7.9	5.1	7.9	9.1	6.8	7.0	10.5	7.0	8.8	5.4	3.9	4.6	8.0	9.2	8.5	17.5	5.5	4.7	5.6	15.1	6.9	6.2	8.3	5.4	7.5	8.4	12.3	8.4	7.0	3.0	13.3	11.9	7.2	4.8	18.6	10.5	5.8	4.9	18.5	10.9	3.2	16.3	7.8	7.9	5.3	9.3	6.8	4.7	6.2	16.5	27.6	6.7	12.9	9.1	10.0	9.1	5.8	8.7	15.8	12.4	10.7	6.6	7.5	5.3	8.3	14.2	22.8	4.9	15.2	5.2	3.7	9.4	21.2	17.7	14.7	12.7	12.7	7.4	17.4	15.0	15.1	14.4	11.6	27.8	5.1	18.6	11.7	1.7	0.0	7.9	12.2	5.8	8.4	7.8	8.8	3.4	3.3	6.3	7.9	6.2	6.4	9.9	18.5	13.4	12.2	2.3	15.1	9.0	14.0	19.4	13.7	12.7	56.2	6.9	20.8	4.0	8.7	6.1	4.6	6.3	3.3	4.9	5.3	3.7	4.4	4.4	4.8	7.9	7.9	5.9	5.1	6.7	4.6	4.0	4.6	4.5	5.1	3.9	4.6	5.5	4.7	5.4	4.8	4.9	5.3	24.1	19.2	15.6	5.2	36.5	10.8	11.3	10.7	17.1	5.8	15.2	11.2	4.5	17.2	11.3	33.1	20.9	14.9	52.1	15.7	21.5	12.7	18.4	14.1	12.4	17.3	3.6	12.0	2.9	17.8	8.4	13.7	33.6	15.2	22.1	10.7	16.1	8.7	16.9	8.4	3.4	11.9	14.2	24.7	20.2	23.2	12.5	25.1	10.6	20.6	28.2	9.9	60.8	2.5	14.7	13.3	7.2	11.3	33.2	8.9	18.6	13.8	9.5	27.2	6.6	9.5	11.0	28.2	12.5	17.2	11.8	27.9	41.1	15.0	9.2	13.5
IRGM	"IFI1, IRGM1, LRG-47, LRG47"	ENSG00000237693	"Immunity related GTPase M"	A1A4Y4	5	150846523-150900736	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.4;granulocytes: 4.5;T-cells: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.4;JURKAT: 1.8;NB-4: 2.4;THP-1: 1.2;U-937: 3.1"															NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (8.73e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.12e-10)"	"unprognostic (5.93e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.11e-1)"	0.0	0.1	0.2	0.3	0.4	0.5	0.1	1.2	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.3	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.2	0.7	0.4	0.2	0.2	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.3	0.1	0.0	1.4	0.4	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.2	0.4	2.4	1.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	1.2	0.0	0.1	0.4	0.2	0.1	0.2	0.2	0.2	0.2	3.1	0.0	2.1	0.1	0.1	0.2	0.1	0.4	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	0.1	0.1	0.1	0.2	0.2	0.4	1.2	0.5	0.3	0.2	0.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.1	0.1	2.3	0.1	0.0	0.1
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653211-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: AB_2676046"	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.32e-4)"	11.9	11.4	6.0	8.2	7.0	41.8	12.2	8.6	8.0	13.9	7.3	11.8	8.1	14.1	11.5	13.3	12.6	7.7	13.4	6.5	6.9	12.2	9.8	10.9	13.9	7.0	6.5	16.3	9.7	12.2	9.3	12.2	6.7	11.1	9.3	11.8	13.0	8.3	40.7	13.4	11.9	9.8	6.7	13.2	10.8	14.6	6.8	14.2	11.5	23.1	13.8	12.4	12.8	8.8	19.5	26.5	21.8	12.8	25.6	22.0	48.1	20.8	17.6	35.9	19.5	45.2	25.1	31.9	39.0	25.5	14.0	18.3	37.1	23.5	29.5	30.4	22.5	37.1	20.2	12.9	29.2	40.0	13.9	20.8	31.2	25.5	46.2	18.0	17.2	24.8	43.7	20.9	25.0	18.7	39.2	29.2	28.6	28.1	26.0	33.4	21.3	35.9	17.2	27.1	25.1	17.6	43.2	30.0	25.7	21.8	40.2	43.4	12.8	25.5	18.9	10.9	19.7	29.8	50.7	46.2	12.4	89.5	13.6	35.3	19.7	23.5	25.1	21.2	23.7	27.3	23.9	25.9	25.8	23.8	27.9	26.9	9.0	24.3	23.0	20.2	32.2	24.0	6.0	7.0	8.6	8.0	6.5	6.9	7.0	6.5	6.7	6.7	6.8	8.8	18.0	3.2	14.3	9.8	24.7	11.9	14.7	17.9	32.5	15.6	15.7	15.5	10.9	8.6	15.0	14.7	29.2	22.5	36.5	10.2	9.8	13.3	24.4	8.2	13.9	13.7	9.0	14.1	11.5	9.8	12.5	15.1	12.2	12.4	11.4	19.8	14.6	9.6	11.9	15.2	13.8	9.1	10.2	11.9	13.2	13.8	12.5	13.7	16.0	7.5	14.8	8.2	11.3	15.1	18.8	12.2	4.7	10.1	16.9	12.1	10.8	15.6	10.2	22.8	26.3	15.7	16.6	38.5	34.8	19.9	11.2	25.3	30.6	15.9	12.4	9.8
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.8;HEL: 8.1;NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	4.9	3.6	1.5	2.2	1.8	1.1	4.6	1.7	1.9	3.5	1.6	4.0	1.5	3.2	1.5	2.0	2.9	1.7	3.5	1.5	1.7	4.8	5.5	3.0	2.2	1.9	1.7	3.2	5.3	1.2	3.3	4.2	1.8	4.2	1.5	2.3	3.1	1.1	1.3	2.4	3.5	1.4	1.3	7.5	3.7	3.9	1.7	0.9	3.2	0.5	1.9	3.7	2.7	1.7	2.2	0.5	0.8	0.0	0.9	0.8	1.3	0.6	0.3	0.9	0.4	4.8	1.9	0.1	2.1	0.4	1.8	0.8	0.0	0.1	1.0	2.7	0.3	8.1	2.6	1.8	0.8	0.1	2.5	1.3	0.4	0.6	0.0	0.7	0.8	0.0	0.3	0.0	1.1	1.5	0.1	5.7	0.0	0.9	1.6	2.4	0.0	0.1	0.7	1.5	1.1	0.2	0.7	0.8	0.5	0.7	2.1	4.4	0.5	0.4	0.7	0.2	0.6	0.7	0.3	2.6	0.4	3.1	0.6	0.8	0.1	0.1	0.3	0.1	0.2	1.2	0.2	0.3	0.0	0.6	0.2	0.2	0.6	1.1	0.0	0.1	0.4	0.0	1.5	1.8	1.7	1.9	1.5	1.7	1.9	1.7	1.8	1.3	1.7	1.7	4.2	0.0	3.6	3.9	2.9	0.3	1.4	0.3	0.0	2.5	2.1	1.3	1.1	2.8	1.5	0.0	14.6	1.2	0.6	3.8	0.0	5.0	11.2	1.5	2.3	5.3	4.9	0.8	3.4	3.6	1.3	1.5	0.5	2.0	2.5	3.4	2.9	1.4	1.1	0.0	4.6	1.4	0.0	2.1	1.9	13.3	2.8	1.4	0.0	5.6	1.4	1.8	1.0	4.0	6.4	3.3	0.8	3.0	0.9	1.7	1.9	0.3	1.1	7.8	6.6	1.6	1.6	2.0	2.6	0.3	0.1	1.2	1.0	2.3	1.4	1.0
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	9.2	7.4	3.6	4.9	4.5	4.4	8.2	3.9	4.7	7.7	2.1	8.9	4.5	10.4	3.5	6.5	7.8	5.4	9.8	3.4	4.0	7.0	4.9	5.7	6.4	4.4	4.3	11.0	7.5	8.1	4.7	6.4	4.4	9.0	5.1	5.8	7.0	6.2	17.4	7.0	6.5	7.4	3.7	6.4	7.0	3.1	4.1	9.2	8.4	9.0	7.2	8.1	6.5	6.0	8.3	5.3	14.7	10.2	9.8	15.1	7.3	9.3	13.1	11.7	11.9	5.3	7.2	20.2	6.9	9.8	5.6	5.6	17.5	9.9	15.4	11.2	5.9	14.7	9.6	6.5	6.7	18.6	9.9	10.9	11.7	12.0	11.3	13.0	9.9	12.3	21.2	10.8	11.6	4.7	20.9	13.1	13.9	8.7	6.8	8.5	14.0	11.5	7.5	7.0	7.3	12.5	10.9	8.3	7.5	9.8	13.9	15.8	11.5	6.5	5.8	17.2	10.7	6.9	21.1	12.1	12.0	17.8	9.7	2.6	2.3	4.0	2.8	2.5	2.4	2.5	2.4	2.2	2.2	2.3	2.5	2.4	2.3	3.1	3.8	1.5	2.1	1.9	3.6	4.5	3.9	4.7	3.4	4.0	4.4	4.3	4.4	3.7	4.1	6.0	35.8	38.5	39.4	5.9	32.9	34.5	31.6	44.1	25.0	20.0	24.5	24.0	28.4	32.9	43.6	23.9	8.4	40.6	32.5	18.8	68.4	45.5	245.7	29.0	32.4	34.6	15.6	27.3	5.4	62.6	55.8	28.9	18.3	29.3	38.6	17.6	37.1	26.4	35.0	15.2	6.0	24.6	26.4	42.9	27.3	84.4	37.6	30.3	14.2	5.6	37.7	44.8	41.2	5.5	10.1	48.9	24.0	49.2	19.1	51.0	23.5	45.2	30.5	14.0	0.0	43.3	28.3	53.8	40.5	22.3	27.8	57.2	35.3	25.7	25.7	46.7
KLRF1	"CLEC5C, NKp80"	ENSG00000150045	"Killer cell lectin like receptor F1"	Q9NZS2	12	9827481-9845007	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.8;lymphoid tissue: 18.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 302.0;NK-cells: 963.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	7	"NK-cell: 664.4"	"Lineage enriched"	"Detected in all"	7	"NK-cells: 664.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;HAP1: 1.5;U-937: 4.4"									HPA054038			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA054038: "	"unprognostic (2.96e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.95e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.89e-3)"	1.5	0.1	0.6	1.4	0.6	12.8	0.8	0.6	1.4	0.7	0.6	0.7	0.3	0.9	3.8	0.6	1.5	1.4	0.6	0.6	0.6	1.2	4.5	4.4	3.4	0.8	0.6	0.1	1.3	0.3	0.5	1.0	0.6	0.5	1.0	0.1	1.4	1.1	1.2	0.5	0.8	0.8	0.6	18.0	1.2	0.6	0.6	0.4	0.8	0.4	3.5	0.9	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	0.6	0.4	0.8	0.9	71.5	1.5	94.4	3.4	3.6	35.2	1.5	1.5	1.4	35.4	5.8	664.4	1.1	2.3	1.2	83.0	0.6	0.6	0.6	1.4	0.6	0.6	0.8	0.6	0.6	0.6	0.6	0.6	3.2	0.0	2.2	0.0	2.3	1.5	1.1	0.2	0.6	0.0	1.3	0.1	0.3	5.7	1.3	0.0	0.0	0.9	302.0	0.1	9.8	0.5	0.5	0.5	0.5	2.2	0.0	24.0	0.1	0.2	0.7	1.2	0.0	1.0	1.3	0.1	8.9	1.8	1.4	0.0	0.2	0.1	0.0	9.1	6.6	1.1	0.0	2.1	12.4	2.8	3.9	0.4	963.0	0.0	0.3	0.4	0.0	0.0	12.7	0.9	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.2	2.0	0.2	1.1	0.5	80.6	0.0	0.3	3.1
KLRF2	NKp65	ENSG00000256797	"Killer cell lectin like receptor F2"	D3W0D1	12	9881489-9895833	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"skin 1: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"NK-cell: 3.1;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 3.2;NK-cells: 3.1"	"Cell line enriched"	"Detected in single"	47	"U-937: 31.5"															NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"					"unprognostic (1.04e-1)"				"unprognostic (1.25e-1)"		"unprognostic (6.24e-2)"		"unprognostic (1.63e-1)"	"unprognostic (5.57e-2)"		"unprognostic (3.40e-5)"	"unprognostic (9.03e-2)"		"unprognostic (3.16e-1)"		0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.9	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479601	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 9.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.3;Excitatory neurons: 3.5;Late spermatids: 7.4;Spermatocytes: 19.3;Spermatogonia: 3.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HL-60: 11.0"															NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.1	0.5	0.2	0.3	0.3	1.0	0.1	1.6	0.4	0.0	0.0	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.3	0.3	0.0	0.1	0.2	0.3	0.1	0.1	1.1	0.2	0.2	0.1	0.9	0.5	0.0	0.0	0.3	0.3	9.8	0.1	0.1	0.5	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.7	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.3	0.6	0.1	0.0	0.1	0.3	0.0	0.2	0.3	0.5	0.5	0.4	0.7	0.3	0.0	11.0	0.5	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.3	0.7	0.0	0.2	0.3	0.8	0.2	0.1	0.4	0.5	0.3	0.2	0.1	0.7	0.3	0.3	0.3	0.2	0.1	0.3	0.2	1.5	0.5	0.4	0.1	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.6	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.2	0.7	0.3	0.1	0.0	0.3	0.1	0.2	0.3	1.6	0.4	0.2	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	13.3	0.1	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	7.4	0.9	0.1	0.0	0.0	0.0	0.9	1.0	1.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.2	0.0	19.3	3.5	0.0	0.0	0.3	0.0	0.3	0.0	0.0
LILRA1	"CD85i, LIR-6, LIR6"	ENSG00000104974	"Leukocyte immunoglobulin like receptor A1"	O75019	19	54593582-54602381	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 11.9"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 42.3;Macrophages: 38.7;monocytes: 39.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 126.8;non-classical monocyte: 169.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 169.2"	"Group enriched"	"Detected in some"	8	"THP-1: 1.0;U-937: 1.5"															NA	NA		94000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (4.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.28e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.79e-4)"	"unprognostic (2.53e-1)"	"unprognostic (9.83e-2)"	0.7	0.5	0.3	8.2	0.3	2.6	0.2	0.4	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.3	0.8	0.3	0.2	0.4	0.3	0.9	1.8	1.1	0.9	0.6	0.1	0.2	0.1	0.2	0.4	0.7	0.3	0.6	0.0	0.2	0.2	0.1	0.0	0.5	0.7	0.8	11.9	0.2	0.0	0.7	0.3	0.2	0.6	1.1	2.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	47.0	36.0	0.0	126.8	0.0	0.0	0.0	0.1	32.6	0.1	0.1	0.1	35.8	0.4	169.2	4.2	0.1	22.7	0.3	0.3	0.4	0.3	0.2	0.4	0.9	0.6	0.7	0.8	0.7	1.1	0.1	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.4	4.9	0.0	0.0	0.0	0.0	42.3	0.7	0.0	0.0	38.7	0.0	2.8	39.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 22.0;Kupffer cells: 79.9;Macrophages: 39.1;monocytes: 48.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 31.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 31.6;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.7;REH: 2.0;THP-1: 4.0;U-937: 9.1"														"Secreted to blood"	NA	NA		140000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	5.2	3.2	0.9	2.8	1.0	15.5	1.8	1.0	1.5	0.9	0.9	1.5	0.2	1.0	0.2	0.9	4.0	0.4	1.9	1.0	1.0	1.4	3.4	10.3	0.2	2.0	1.2	0.8	1.4	0.1	0.8	0.1	2.0	1.4	0.2	0.2	1.7	0.1	0.5	0.7	1.7	0.4	1.1	57.4	1.6	0.8	1.6	0.2	0.8	0.2	0.3	2.2	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	5.3	7.6	3.0	0.1	11.6	0.1	0.1	0.1	0.1	3.3	0.3	0.1	0.1	31.6	0.4	11.3	0.7	0.1	6.1	0.9	1.0	1.0	1.5	1.0	1.0	2.0	1.2	2.0	1.1	1.6	1.8	0.2	3.2	3.0	0.0	0.3	0.3	1.6	0.0	0.0	0.9	0.4	0.1	0.5	1.5	1.8	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.0	0.2	0.2	0.6	0.0	0.1	6.3	0.1	0.4	0.4	22.0	0.0	0.0	0.0	0.0	79.9	5.9	0.6	0.0	39.1	0.0	8.4	48.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.0	0.1	1.5	0.6	0.0	2.1	0.3	0.3	0.3	0.0	0.1	0.4	1.4	0.0	0.0	0.6
LINC02218		ENSG00000249662	"Long intergenic non-protein coding RNA 2218"		5	17444010-17486829	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"neutrophil: 8.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.6"	"Cell line enriched"	"Detected in single"	9	"U-937: 2.0"															NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 32: U-937 - Innate immune response"																						0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPN	"bA186O14.3, LIPL4"	ENSG00000204020	"Lipase family member N"	Q5VXI9	10	88759982-88779626	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	Ichthyosis	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 26.7"	"Group enriched"	"Detected in some"	4	"Macrophages: 7.5;monocytes: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 2.9;eosinophil: 10.3;intermediate monocyte: 7.5;neutrophil: 5.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 10.3;monocytes: 8.5"	"Cell line enhanced"	"Detected in single"		"HL-60: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.13e-1)"		"unprognostic (2.99e-1)"	"unprognostic (1.08e-1)"		"unprognostic (3.27e-1)"	"unprognostic (1.07e-1)"		"unprognostic (2.03e-2)"		"unprognostic (9.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.65e-1)"	1.3	0.3	0.0	2.8	0.0	2.8	1.7	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	26.7	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.9	10.3	0.0	7.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.4	0.0	8.5	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	7.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation factor"	Q9BRT6	12	66116555-66130750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	21.6	34.4	12.3	24.4	13.5	50.3	18.6	12.7	16.0	13.2	11.2	20.1	19.2	15.2	18.6	19.5	13.2	14.7	23.2	12.8	13.7	20.9	21.2	15.5	26.3	13.5	14.3	17.6	17.2	17.0	10.7	17.5	13.7	15.3	20.3	7.4	14.5	14.1	29.7	13.8	18.2	19.4	13.0	18.2	19.1	22.1	13.5	22.1	17.3	25.3	25.6	27.3	14.0	14.2	77.0	61.1	36.4	44.2	42.6	40.8	44.5	87.0	56.4	63.9	53.6	52.8	31.0	87.0	70.6	58.6	50.7	63.6	57.2	52.9	85.7	78.4	48.8	94.5	41.7	47.3	49.8	162.5	61.8	41.9	53.6	53.7	58.3	50.1	56.6	44.1	81.5	60.9	76.1	81.3	74.1	110.4	77.9	61.6	63.0	61.9	67.2	62.7	63.3	90.8	36.3	45.1	57.0	58.3	97.4	38.0	77.4	89.5	60.5	48.3	71.3	60.9	80.4	45.7	77.6	130.2	65.4	76.0	76.8	34.3	32.0	35.5	27.8	38.0	32.0	29.2	32.3	30.6	31.3	27.5	27.4	29.2	43.8	27.4	48.4	27.0	38.9	28.8	12.3	13.5	12.7	16.0	12.8	13.7	13.5	14.3	13.7	13.0	13.5	14.2	34.2	12.8	33.9	2.9	47.6	27.1	53.9	86.3	30.1	15.9	24.5	28.4	25.1	41.5	64.3	31.3	4.2	66.3	49.4	34.1	66.5	68.3	63.3	40.5	45.4	32.5	13.8	33.4	5.0	71.3	70.4	34.8	35.7	46.6	89.4	61.2	35.7	60.2	64.2	21.9	4.4	31.1	85.5	50.4	26.5	17.0	43.8	45.6	35.6	3.7	84.1	30.8	59.8	3.0	5.8	96.3	43.3	30.1	27.3	46.3	44.0	86.5	35.8	15.2	26.3	29.7	36.8	126.6	48.6	30.6	30.5	72.7	43.8	126.4	36.1	60.6
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 944.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	7.2	4.5	0.6	17.8	0.5	31.4	4.3	1.2	2.6	8.7	1.1	7.3	6.7	1.9	5.9	22.7	10.0	15.5	1.2	0.6	0.6	9.8	944.2	7.8	0.8	0.7	0.7	1.5	44.1	0.1	1.6	1.9	1.9	4.4	4.7	0.1	20.9	6.2	1.0	4.8	3.3	2.2	0.5	16.2	13.6	0.3	0.9	1.2	1.3	1.4	6.5	13.3	3.8	0.9	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.2	2.6	0.6	0.6	0.7	0.7	1.9	0.5	0.9	0.9	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
LYG2	LYGH	ENSG00000185674	"Lysozyme g2"	Q86SG7	2	99242246-99255282	"Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.8;retina: 3.5;skin 1: 8.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.7;Cone photoreceptor cells: 14.6;Excitatory neurons: 19.6;Horizontal cells: 15.2;Inhibitory neurons: 17.5;Rod photoreceptor cells: 29.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 4.8"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.7;U-937: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039179	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA039179: AB_10794633"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-5)"	"unprognostic (1.40e-3)"	"unprognostic (1.08e-13)"	"unprognostic (9.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.24e-3)"	0.2	0.1	0.4	0.1	0.5	0.5	0.0	4.8	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	3.5	0.3	0.0	0.3	8.8	0.1	0.0	0.0	0.2	0.2	1.4	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.4	0.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.3	0.9	0.2	0.0	1.0	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	1.0	0.2	0.6	0.3	0.0	1.2	0.2	0.6	0.4	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.4	0.3	1.7	0.6	0.6	0.4	0.1	0.4	0.2	0.8	0.1	0.3	2.5	0.4	0.0	0.2	0.1	0.3	0.0	0.2	0.6	0.8	0.4	0.0	1.1	0.3	0.3	0.1	0.2	0.0	0.9	0.1	0.0	0.4	0.5	4.8	1.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.9	0.0	0.0	5.5	1.2	0.6	0.5	0.3	0.0	13.7	0.8	0.9	0.3	5.7	0.1	0.0	14.6	0.9	1.6	0.1	0.0	0.1	6.1	0.6	0.9	0.7	0.0	0.0	19.6	0.0	0.2	0.8	0.0	0.3	0.0	0.5	1.1	0.0	0.2	15.2	17.5	0.0	0.0	0.9	0.3	2.2	0.0	0.2	1.8	0.0	0.2	6.9	4.1	7.5	8.9	0.1	0.0	0.7	0.0	0.7	0.3	0.3	0.0	29.9	0.0	2.0	0.9	1.8	1.6	0.0	0.4	0.3	0.9	0.2	0.4	0.1
LYSMD2	MGC35274	ENSG00000140280	"LysM domain containing 2"	Q8IV50	15	51723011-51751585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 164.4;monocytes: 97.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040460	Approved		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria	"Nuclear bodies"	"HPA040460: AB_10794874"	"unprognostic (7.71e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.98e-1)"	"unprognostic (4.17e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.03e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	11.6	19.7	33.0	22.2	34.0	15.1	8.7	30.9	42.0	10.4	22.3	12.7	15.8	10.7	11.1	8.7	10.9	11.4	7.1	33.8	39.6	11.5	21.1	14.4	29.0	34.1	33.2	8.5	12.9	10.7	22.8	9.5	39.3	9.4	9.7	7.6	7.3	13.8	18.3	5.6	13.6	11.7	32.4	21.3	12.0	11.0	35.0	17.9	8.1	13.1	25.7	12.8	8.8	29.4	14.6	10.6	1.7	13.2	4.4	8.4	0.1	16.8	9.2	20.0	25.8	1.3	13.0	56.9	2.4	9.0	23.1	21.0	11.0	11.1	14.0	55.1	5.4	15.9	8.9	0.2	9.3	38.2	6.9	8.4	22.0	8.2	8.6	9.0	12.1	20.5	0.7	0.0	6.5	21.0	14.8	47.6	4.6	0.6	14.5	23.1	0.2	20.6	19.9	11.5	45.3	11.5	16.2	0.4	29.8	2.5	11.7	28.5	7.8	19.8	11.1	20.9	23.7	0.0	0.0	0.2	10.1	77.4	15.1	0.3	39.5	76.6	29.8	48.8	42.3	47.0	29.1	36.3	33.4	49.7	35.6	29.4	112.5	34.9	62.0	54.4	19.4	40.4	33.0	34.0	30.9	42.0	33.8	39.6	34.1	33.2	39.3	32.4	35.0	29.4	45.7	3.2	4.8	18.3	70.8	19.4	31.2	8.0	20.5	16.7	17.5	23.4	3.3	22.8	6.4	14.7	0.0	1.2	89.1	4.1	25.4	16.7	164.4	2.6	2.8	32.3	79.8	17.2	25.4	18.3	0.8	15.6	15.3	0.9	12.7	4.3	27.8	14.6	38.0	32.0	28.7	16.2	8.2	46.4	24.7	71.2	16.1	49.0	7.2	23.4	97.4	7.0	45.3	15.1	7.3	10.8	17.1	15.8	5.1	38.5	32.6	29.0	9.9	4.1	26.3	14.1	24.0	5.0	8.3	31.7	16.2	0.8	51.3	12.4	21.2	24.6
MACROH2A1	"H2AFY, macroH2A1.2"	ENSG00000113648	"MacroH2A.1 histone"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 67.2;Cytotrophoblasts: 151.6;Extravillous trophoblasts: 148.8;Hofbauer cells: 419.5;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm		NA	NA		2700000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357, HPA050962: AB_2681292"	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	64.4	58.7	44.3	97.0	45.2	247.8	55.6	46.8	49.0	59.4	52.2	111.5	115.0	48.0	49.1	146.1	61.5	70.6	56.4	45.6	51.7	52.7	50.4	72.7	126.0	45.0	48.5	39.3	31.2	85.6	57.2	78.7	49.2	54.1	118.7	114.1	64.6	36.3	90.8	95.7	117.4	61.4	47.7	75.1	81.3	26.0	48.3	219.4	53.2	73.4	130.9	99.6	76.2	51.6	303.5	208.8	314.9	217.5	144.5	85.6	282.8	124.2	133.1	215.8	151.8	331.3	295.6	356.5	206.5	101.2	182.8	200.7	239.2	526.1	160.8	194.4	237.7	426.3	227.7	226.0	105.7	205.0	179.7	91.3	140.0	180.5	192.3	132.0	140.6	239.0	150.9	142.4	124.4	264.5	594.1	388.7	123.7	359.4	110.5	528.3	179.2	252.5	270.7	339.4	441.1	277.6	241.8	232.2	204.4	164.2	275.8	558.0	114.7	188.1	158.2	140.1	259.1	67.9	296.2	334.5	157.0	455.0	135.5	16.1	178.7	84.3	40.3	122.6	34.0	47.2	51.1	49.8	203.0	67.8	49.2	40.4	93.2	87.8	80.1	147.2	65.3	138.4	44.3	45.2	46.8	49.0	45.6	51.7	45.0	48.5	49.2	47.7	48.3	51.6	57.6	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	151.6	38.3	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	148.8	30.4	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	183.5	5.8	0.0	0.0	0.0
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784918-64803241	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	5.0	3.9	8.9	6.9	7.2	15.5	4.1	9.8	9.9	4.6	4.9	5.6	3.3	4.8	2.5	2.7	3.8	4.2	4.3	7.6	7.0	5.4	2.0	9.7	17.6	7.8	8.0	3.4	5.0	3.2	5.8	8.9	8.1	4.7	3.0	5.3	6.6	5.8	2.5	3.5	8.9	3.7	6.6	18.0	5.2	4.6	9.7	7.4	7.0	1.5	14.2	4.6	3.5	8.8	9.4	8.4	5.4	9.8	4.7	2.9	12.7	7.0	6.5	8.2	5.8	3.7	4.3	16.4	12.6	8.0	14.5	2.8	6.5	6.8	4.9	21.5	3.1	28.9	12.0	7.9	5.8	15.3	10.4	2.9	3.4	6.4	4.1	5.7	20.3	28.0	2.5	1.5	2.5	11.8	9.2	15.2	3.6	5.6	11.2	18.8	0.6	18.9	4.6	4.7	6.4	9.3	6.0	7.8	6.4	6.1	15.5	23.2	15.8	6.8	15.0	6.3	2.9	1.8	3.8	18.1	6.0	22.8	5.1	2.2	4.3	5.9	4.9	12.5	4.9	9.9	6.5	4.4	4.4	6.6	7.7	6.0	8.0	2.5	15.8	5.0	9.5	7.3	8.9	7.2	9.8	9.9	7.6	7.0	7.8	8.0	8.1	6.6	9.7	8.8	21.6	3.2	4.8	6.8	32.9	1.3	2.8	1.8	6.2	20.6	8.1	10.4	4.7	7.2	2.4	1.8	25.0	7.6	9.4	6.8	3.9	1.7	33.8	2.6	3.8	20.0	6.0	5.0	5.9	1.7	11.3	4.9	9.2	6.0	1.3	7.7	24.3	2.0	11.0	11.8	4.6	1.8	6.1	8.9	3.1	46.8	4.1	16.2	1.8	18.7	13.4	7.2	14.4	2.0	7.2	0.9	16.2	7.2	15.6	1.8	1.6	3.6	1.5	14.6	6.6	3.7	4.3	2.1	13.8	5.2	1.4	5.1	19.9	22.6	2.2	2.0
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;neutrophil: 24.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 79.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		970000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	29.9	26.1	15.2	31.5	16.5	89.3	23.8	19.2	17.1	30.8	19.3	26.6	27.9	37.2	15.8	32.3	25.7	23.5	25.7	17.2	18.2	23.9	41.4	28.3	28.0	11.5	11.7	22.2	18.3	20.6	19.3	44.6	12.1	19.6	29.0	14.8	21.0	24.4	33.5	34.4	26.2	39.0	13.0	44.9	22.5	9.1	18.1	38.6	31.1	31.9	33.3	32.3	29.2	13.8	49.7	26.7	28.3	44.9	60.0	59.8	62.2	50.2	64.8	58.7	60.3	67.3	24.8	40.4	49.6	54.9	28.0	34.8	47.2	43.7	60.9	47.3	37.6	94.9	37.2	53.1	33.2	60.3	54.9	43.1	40.5	42.2	40.9	47.6	67.1	67.2	52.4	49.1	40.3	21.1	62.2	62.5	17.0	29.9	26.2	71.7	45.5	37.5	38.5	67.6	21.8	17.2	46.0	33.5	50.3	34.1	40.8	99.9	47.9	52.5	29.8	33.6	47.7	24.3	59.8	39.5	23.2	112.1	43.9	79.0	10.3	6.3	4.5	7.2	5.5	3.1	4.4	5.1	8.2	5.3	4.6	4.7	24.9	6.1	10.8	4.0	5.8	5.1	15.2	16.5	19.2	17.1	17.2	18.2	11.5	11.7	12.1	13.0	18.1	13.8	24.4	32.1	13.9	37.2	22.6	15.9	11.0	13.9	28.5	18.9	14.0	11.7	25.0	14.3	18.5	18.4	31.3	45.4	26.8	29.0	1.9	13.9	3.6	18.7	25.8	22.6	16.8	47.1	104.9	11.3	18.7	25.9	21.9	30.7	21.0	17.7	28.9	52.9	25.3	11.8	79.2	25.4	10.2	51.7	24.9	5.2	24.5	38.5	10.6	52.5	58.7	10.9	39.1	46.8	69.6	22.8	16.2	26.7	27.7	10.3	33.7	17.2	20.9	22.5	13.1	20.4	15.7	9.9	8.5	27.1	19.0	23.9	28.0	12.3	18.8	10.7
MAPKAPK3	"3pK, MAPKAP3, MK-3, MK3"	ENSG00000114738	"MAPK activated protein kinase 3"	Q16644	3	50611520-50649291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 106.5;heart muscle: 256.3;skeletal muscle: 224.2;tongue: 284.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 226.6;Hofbauer cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 142.8;granulocytes: 126.3;monocytes: 341.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058275			Supported	Nucleoplasm		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA058275: AB_2683663"	"unprognostic (6.46e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.96e-2)"	"unprognostic (8.77e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.90e-8)"	"unprognostic (2.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.69e-1)"	15.3	43.3	18.0	29.8	19.6	106.5	15.8	19.2	19.2	15.0	21.3	19.7	30.2	11.3	10.3	49.6	15.1	12.1	256.3	18.0	19.7	40.0	18.7	28.2	21.7	23.6	20.5	14.2	36.2	47.2	23.5	13.9	22.5	18.4	20.0	4.7	27.7	12.6	224.2	53.4	24.2	15.9	21.6	25.3	27.6	9.2	21.1	42.0	41.2	284.3	24.2	20.3	22.2	21.6	99.6	30.3	12.4	35.9	18.4	45.7	27.9	23.8	33.7	35.7	30.3	47.1	90.2	39.8	23.5	79.5	88.5	34.6	85.9	92.7	31.9	88.3	22.3	209.5	40.6	43.5	36.8	152.1	106.4	36.9	57.0	83.1	112.2	35.6	31.9	70.2	59.7	25.4	76.1	40.5	65.3	153.3	46.4	34.6	127.0	28.5	29.9	60.1	165.5	56.2	23.0	16.5	21.3	58.9	27.7	20.6	37.8	93.4	23.8	28.1	64.5	146.4	59.5	17.2	33.7	33.1	148.3	234.7	11.8	45.3	169.5	126.3	27.6	271.6	27.3	15.1	30.9	32.1	142.8	8.8	23.9	27.8	104.4	42.1	341.5	91.2	28.0	132.6	18.0	19.6	19.2	19.2	18.0	19.7	23.6	20.5	22.5	21.6	21.1	21.6	3.5	9.6	14.0	8.5	8.6	11.3	26.9	14.0	19.4	1.1	15.3	12.3	226.6	15.7	10.4	11.0	0.0	6.0	38.1	16.2	64.6	45.6	34.5	3.4	2.7	7.1	6.0	19.1	0.3	30.4	7.4	14.9	11.7	5.4	36.2	8.3	5.3	14.2	102.1	0.0	0.7	15.4	10.2	68.0	23.9	86.2	7.2	59.4	7.2	0.0	76.6	17.1	41.2	0.5	2.0	76.2	15.6	3.4	12.7	30.9	30.7	35.4	5.7	2.3	26.3	9.7	12.0	4.1	4.6	34.2	20.2	5.1	24.3	22.0	28.2	33.5
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 40.7"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 145.1;monocytes: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	8.6	3.7	1.5	14.1	1.4	40.7	10.7	0.9	1.6	7.3	1.1	8.0	8.4	10.2	5.3	7.1	6.7	7.7	3.8	1.4	1.7	3.7	4.1	9.5	23.2	2.1	1.9	12.2	4.6	2.3	1.3	10.6	2.4	6.3	10.1	1.2	6.7	5.8	1.3	8.6	9.6	9.6	1.9	15.2	8.5	13.5	1.5	24.4	6.8	3.8	21.7	7.8	3.9	2.8	54.1	20.0	40.7	18.0	12.1	17.2	30.0	36.4	19.2	29.7	36.5	10.7	50.7	73.6	15.5	18.5	12.8	37.0	23.9	18.5	55.3	39.5	15.3	44.5	23.2	13.8	8.1	103.7	39.7	12.5	7.4	17.6	16.5	19.4	36.7	14.1	19.7	17.2	29.1	19.9	44.1	45.9	30.8	26.5	24.9	51.5	16.4	28.5	15.3	22.3	28.4	12.3	16.2	24.6	13.1	24.1	29.5	58.1	20.4	15.7	47.4	19.5	16.6	15.3	21.5	34.5	8.8	42.6	22.8	64.5	28.8	35.8	7.9	28.5	8.5	28.5	7.5	6.8	21.5	25.5	5.0	5.1	17.8	10.8	53.8	31.0	10.9	9.1	1.5	1.4	0.9	1.6	1.4	1.7	2.1	1.9	2.4	1.9	1.5	2.8	54.6	25.6	27.8	6.8	87.7	20.1	11.6	17.7	19.4	8.4	24.3	27.3	13.3	7.2	26.1	9.2	16.7	40.9	91.6	17.1	5.9	14.0	3.5	29.2	47.6	43.5	27.6	72.6	34.5	11.1	42.5	32.5	35.7	28.0	43.6	145.1	30.4	7.3	35.4	0.0	7.6	25.8	18.3	89.8	30.9	6.8	55.3	115.7	5.4	74.0	150.1	5.1	55.6	9.5	11.1	13.5	47.7	60.5	73.5	25.0	12.1	5.0	20.9	7.6	0.0	13.9	23.3	80.0	105.4	32.5	26.3	19.4	54.5	77.9	29.9	24.6
MLEC	KIAA0152	ENSG00000110917	Malectin	Q14165	12	120687149-120701859	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Undifferentiated cells: 397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA		880000	"Cluster 52: Eosinophils - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (9.60e-6)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.39e-1)"	"unprognostic (9.77e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-2)"	"prognostic favorable (8.77e-4)"	"unprognostic (1.98e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	51.7	93.1	35.4	51.8	36.7	34.6	44.3	33.0	34.5	52.8	40.3	127.0	78.3	37.2	138.1	24.5	48.5	48.5	65.9	34.7	40.0	73.5	78.2	34.9	30.3	42.3	39.4	49.2	62.7	101.2	36.7	45.7	37.8	62.4	117.3	25.3	50.7	64.9	79.8	27.8	86.0	50.0	40.0	30.1	45.3	69.1	42.9	33.3	101.0	82.9	37.3	34.1	17.4	37.6	122.7	177.9	113.6	151.8	196.3	107.4	127.9	144.5	126.3	108.9	80.1	127.5	75.1	100.3	129.0	142.2	85.4	101.9	140.4	87.4	138.7	86.5	76.9	142.4	79.4	100.6	72.1	199.3	123.1	82.2	82.7	116.0	91.4	174.1	97.2	93.9	85.9	112.2	116.3	127.8	106.4	122.2	158.1	156.6	91.7	115.7	82.0	109.1	132.2	204.0	58.2	69.2	166.5	85.9	86.0	143.0	127.0	144.6	79.2	115.8	108.5	112.8	100.3	83.3	165.0	76.8	147.6	147.9	120.1	0.5	6.0	8.0	3.8	7.5	4.1	4.7	2.3	3.4	5.0	6.9	4.0	3.4	1.6	3.9	6.5	18.6	2.4	2.2	35.4	36.7	33.0	34.5	34.7	40.0	42.3	39.4	37.8	40.0	42.9	37.6	151.4	25.6	62.2	23.2	65.7	72.8	70.6	32.0	55.2	40.9	99.7	76.3	145.3	97.2	40.0	86.5	45.9	88.4	105.7	155.3	37.2	134.2	243.3	78.3	127.6	94.1	80.3	68.5	21.4	183.7	176.9	90.5	69.3	80.2	49.5	99.8	27.1	206.1	126.8	84.1	24.7	199.2	30.5	61.7	73.2	228.0	82.6	70.1	193.9	34.7	56.4	81.8	74.2	32.2	23.0	95.8	86.0	108.0	217.4	152.6	135.4	121.7	41.9	45.3	85.5	61.4	78.5	165.6	153.4	52.8	58.7	115.6	51.2	142.5	397.0	82.2
MOSPD3	"CDS3, NET30"	ENSG00000106330	"Motile sperm domain containing 3"	O75425	7	100612102-100615384	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1472.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041137, HPA048240"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA041137: AB_10803996, HPA048240: AB_2680325"	"unprognostic (1.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.20e-2)"	16.7	36.6	14.9	5.6	14.1	13.8	16.8	12.6	19.0	22.1	11.2	17.2	6.8	18.7	3.1	33.5	16.2	8.3	15.1	13.4	14.0	21.0	38.9	13.6	8.0	15.5	13.6	19.2	18.4	7.8	15.6	4.1	13.7	18.1	3.0	2.1	19.6	7.0	10.7	41.8	12.8	5.1	13.3	16.3	19.6	57.9	14.4	7.1	14.9	5.4	5.3	17.4	23.4	13.3	12.6	16.2	13.0	22.9	6.6	4.9	9.3	9.3	10.7	9.3	9.3	15.4	16.1	7.7	20.2	8.3	13.3	9.5	7.5	12.9	1.7	20.4	9.9	8.0	12.1	23.2	8.5	6.1	30.0	13.8	10.8	7.9	4.6	8.2	15.8	12.7	19.2	15.4	9.4	35.9	17.4	47.4	11.9	16.0	24.9	16.4	13.6	18.9	14.8	17.9	7.1	42.8	17.5	26.3	9.8	5.3	16.2	18.3	19.0	18.5	28.3	38.2	9.2	12.2	12.4	5.5	18.3	69.5	22.7	38.7	29.1	40.3	31.3	22.7	36.9	21.7	36.0	36.7	31.7	22.4	21.3	22.2	21.3	37.5	15.9	21.1	57.2	14.8	14.9	14.1	12.6	19.0	13.4	14.0	15.5	13.6	13.7	13.3	14.4	13.3	18.5	9.6	7.0	4.6	10.9	12.1	20.0	31.0	21.1	5.7	28.0	25.8	3.6	21.5	16.9	20.2	6.2	6.6	19.8	9.3	43.0	43.2	324.0	15.7	12.8	16.4	21.6	21.7	4.7	42.8	26.3	16.4	12.8	11.2	3.8	11.5	23.6	31.3	29.8	6.7	7.6	14.2	22.4	25.1	14.8	1472.9	27.7	15.6	26.6	1.9	17.4	19.0	25.7	8.5	4.9	43.9	17.3	21.8	7.8	16.2	15.1	48.7	15.9	4.0	13.1	10.7	17.5	20.3	31.1	26.7	19.6	6.2	24.4	16.7	17.0	25.3
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3543.0;liver: 6959.4;thyroid gland: 2886.6"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	250.2	21.5	434.9	105.8	515.9	2.9	28.1	469.3	912.6	21.9	396.7	821.1	513.8	8.4	2.4	255.4	75.5	12.0	9.3	430.3	455.6	3543.0	6959.4	49.9	5.6	494.0	474.4	3.2	1806.7	0.3	21.7	2.1	465.6	425.3	516.5	42.6	44.2	5.9	8.4	58.4	1096.4	76.3	431.0	3.9	1262.3	4.0	466.6	0.9	2886.6	0.9	2.6	14.2	25.8	430.1	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	434.9	515.9	469.3	912.6	430.3	455.6	494.0	474.4	465.6	431.0	466.6	430.1	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 6.4;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	0.8	0.5	0.4	3.6	0.3	16.3	1.0	0.4	0.6	0.6	0.2	2.9	2.8	0.5	0.3	2.6	0.3	0.3	0.3	0.4	0.3	0.6	0.4	1.2	6.4	0.4	0.5	0.3	0.4	0.0	0.4	1.8	0.3	0.4	3.8	0.5	0.8	0.2	1.2	1.9	2.3	1.1	0.4	2.2	1.2	7.0	0.4	6.2	0.3	0.1	5.3	0.8	0.9	0.4	15.2	11.5	9.7	18.2	1.6	2.8	17.4	19.6	13.6	22.8	31.7	20.7	12.2	39.2	11.7	7.9	30.1	23.1	22.3	14.4	33.8	22.1	17.1	31.0	7.8	18.9	1.0	57.4	28.1	2.3	3.1	25.5	16.1	2.7	12.4	33.8	33.9	29.6	17.2	20.2	32.5	47.8	9.8	20.2	14.1	29.3	15.5	19.7	9.9	11.6	7.7	7.6	12.4	21.5	11.3	11.9	9.1	39.1	6.8	11.3	11.8	40.2	30.4	11.2	28.3	26.1	6.5	38.5	17.6	0.0	0.2	0.0	0.3	0.9	0.1	0.4	0.4	0.7	0.9	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.7	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.4	0.5	0.3	0.4	0.4	0.4	2.0	0.0	1.1	0.0	2.2	1.0	0.6	3.1	0.0	0.0	3.4	3.6	0.4	0.0	2.3	0.0	0.0	8.4	1.3	2.2	0.0	1.1	7.9	2.4	1.3	1.7	0.0	9.9	0.5	2.5	23.6	1.5	2.6	2.5	1.3	3.5	0.7	0.5	6.6	0.0	0.4	2.1	4.1	3.8	2.1	5.9	0.3	2.5	0.0	1.0	2.3	0.0	1.0	0.5	0.0	1.3	0.4	0.0	7.4	1.2	1.3	1.4	2.5	0.0	0.0	5.3	1.8	27.6	13.0	5.3	0.3	3.0	3.1	0.8	4.6	0.9
MUC19	FLJ35746	ENSG00000205592	"Mucin 19, oligomeric"		12	40393395-40570832	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"salivary gland: 13.1;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.1;Excitatory neurons: 1.3;Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HL-60: 2.0;SCLC-21H: 4.9;SK-BR-3: 2.2;SuSa: 1.8;U-937: 8.7"	"Not detected"	"Not detected"												"Intracellular and membrane"	NA	NA					"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (7.80e-3)"	"unprognostic (2.84e-1)"		"unprognostic (1.69e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.25e-3)"		"unprognostic (8.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.63e-2)"	"unprognostic (6.99e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.35e-3)"	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0		0.1	0.1	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.1	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.2	0.1	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYBPC3	"CMH4, cMyBP-C, FHC"	ENSG00000134571	"Myosin binding protein C3"	Q14896	11	47331406-47352702	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	584	"heart muscle: 1725.4"	"Cell type enriched"	"Detected in some"	42	"Cardiomyocytes: 1876.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-937: 6.4"	"Region enriched"	"Detected in some"	33	"cerebellum: 34.4"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced					NA	NA		21000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.4	2.9	0.0	0.7	0.0	1.5	0.7	0.2	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.4	1725.4	0.0	0.0	0.3	0.3	2.0	0.5	0.2	0.1	0.1	0.7	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.6	0.0	0.4	0.2	0.3	0.1	0.0	2.8	2.8	1.4	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.9	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1876.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	28.3	0.0	0.0	14.3	0.0	0.0	0.2	0.0	0.0	43.9	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.2	0.8	0.0	0.8	0.0	19.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.9	0.0	0.0	0.3	0.0	17.4	0.6	0.0
MYCBP	AMY-1	ENSG00000214114	"MYC binding protein"	Q99417	1	38862493-38873368	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 106.0;Respiratory ciliated cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041188, HPA078331"	Supported		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Mitochondria	"HPA041188: AB_10794405, HPA078331: AB_2686882"	"unprognostic (2.42e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (7.59e-2)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.34e-3)"	"unprognostic (5.81e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.41e-2)"	11.5	11.0	2.6	16.9	3.4	16.1	18.7	3.4	4.3	12.5	3.7	22.6	16.3	9.6	17.4	23.1	27.1	11.3	8.4	2.4	2.9	18.0	11.5	12.4	16.3	5.6	7.4	6.7	16.1	18.6	8.7	19.3	4.5	14.9	22.5	8.6	16.8	16.1	12.1	13.2	21.6	11.7	2.7	11.2	16.1	15.5	3.2	12.6	18.5	5.6	17.9	16.8	11.7	5.6	51.3	22.5	18.0	13.0	10.7	18.4	74.4	38.9	12.9	38.6	29.7	27.8	56.5	42.1	43.3	18.3	6.5	35.8	29.1	51.9	46.0	52.3	49.7	44.1	29.5	26.7	2.8	107.7	38.9	16.4	38.9	32.3	20.3	14.7	28.3	45.6	64.1	35.8	41.4	31.3	35.1	54.9	47.3	75.3	53.4	33.4	54.4	58.0	50.3	40.6	34.9	23.5	37.0	47.5	25.7	42.4	33.5	52.6	23.2	20.4	33.5	31.2	45.6	25.3	48.7	45.1	20.5	63.9	26.0	51.6	32.8	85.2	18.8	39.7	21.6	22.0	22.1	22.5	40.9	17.7	18.8	21.4	64.4	27.2	38.0	54.3	33.8	22.6	2.6	3.4	3.4	4.3	2.4	2.9	5.6	7.4	4.5	2.7	3.2	5.6	9.2	9.6	13.1	0.0	18.7	10.6	15.7	31.8	22.2	0.7	25.9	14.1	7.9	20.0	37.5	27.6	0.0	106.0	26.7	35.1	64.6	27.0	68.3	84.1	11.4	11.8	9.6	38.7	0.0	27.2	86.2	9.5	21.9	17.9	26.1	9.3	8.9	15.3	21.0	10.1	0.0	25.2	26.4	15.0	14.8	25.2	7.2	20.5	19.6	0.0	31.0	5.5	18.6	0.0	0.0	29.7	40.2	9.1	69.6	18.2	31.2	50.3	142.2	5.0	6.6	6.7	14.8	29.9	64.5	53.4	17.8	88.1	19.3	14.0	31.5	22.4
MYCBP2	"FLJ10106, KIAA0916, PAM, PHR1"	ENSG00000005810	"MYC binding protein 2"	O75592	13	77044657-77327094	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 425.4;Inhibitory neurons: 471.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 110.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA058807: AB_2732627"	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	69.9	22.2	42.3	19.0	46.2	32.8	49.3	37.3	52.4	43.4	18.8	29.4	9.0	27.2	29.8	45.9	29.2	12.5	32.9	48.6	35.9	22.6	24.5	28.3	40.0	34.6	29.6	43.1	30.9	14.9	32.3	10.9	36.9	28.0	12.5	28.9	29.1	13.3	26.5	79.7	34.8	11.9	30.1	56.4	24.9	26.3	33.9	34.6	27.2	18.1	37.8	30.4	41.5	38.7	21.6	10.8	12.9	14.1	62.9	27.9	7.5	13.4	19.8	11.5	14.7	9.7	11.0	61.4	8.3	26.6	11.2	19.5	22.4	24.7	15.5	24.5	22.2	52.2	22.2	20.1	21.4	110.8	17.7	31.5	20.2	10.6	20.8	11.4	26.5	22.3	11.3	18.8	20.7	13.1	30.5	74.3	6.8	28.7	13.6	34.2	13.1	15.0	19.6	21.1	20.2	9.4	16.2	23.1	12.8	13.0	8.6	83.8	35.0	10.9	9.1	7.3	13.0	20.3	15.0	42.7	22.1	89.2	11.3	1.4	2.0	2.0	3.2	2.1	2.8	4.9	3.6	2.8	1.9	4.3	4.1	3.2	1.8	2.8	1.6	2.7	4.5	1.4	42.3	46.2	37.3	52.4	48.6	35.9	34.6	29.6	36.9	30.1	33.9	38.7	92.2	38.5	52.2	158.7	170.3	82.3	39.9	32.6	63.7	229.3	36.8	38.4	69.7	25.8	30.9	35.0	104.3	46.1	109.2	14.2	1.9	26.1	56.0	50.9	61.1	83.8	32.6	46.9	425.4	33.1	31.5	80.6	38.2	66.6	48.2	34.0	44.6	52.4	41.8	218.7	471.3	19.7	26.4	106.9	48.2	23.4	65.9	100.4	32.0	282.9	116.7	121.5	120.5	338.8	212.5	30.2	15.8	96.3	121.9	53.7	15.2	13.2	19.5	94.8	105.2	76.7	76.0	81.5	71.6	129.1	150.7	43.9	121.5	67.4	28.1	42.4
MYO7A	"DFNA11, DFNB2, NSRD2, USH1B"	ENSG00000137474	"Myosin VIIA"	Q13402	11	77128246-77215241	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Leber congenital amaurosis, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 41.9;choroid plexus: 53.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Cytotrophoblasts: 42.3;Hofbauer cells: 30.1;Kupffer cells: 17.8;Rod photoreceptor cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.6;intermediate monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;CACO-2: 9.0;RH-30: 19.5;RPMI-8226: 13.8;SK-BR-3: 10.5;U-937: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB034059	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB034059: AB_2148626"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.03e-2)"	5.2	41.9	2.5	3.0	2.9	1.0	3.1	2.2	2.7	1.9	53.2	2.8	2.2	1.5	1.2	1.0	2.7	2.8	2.5	4.0	8.6	4.3	23.3	2.3	2.9	5.0	8.3	5.2	5.4	0.5	19.1	16.0	8.4	2.4	1.2	27.4	1.5	0.8	1.4	0.8	2.8	2.2	3.5	15.8	2.2	24.5	5.1	1.4	2.0	0.7	1.1	2.0	1.6	4.4	0.0	1.3	0.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	9.0	2.0	0.0	2.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.7	0.0	0.3	5.7	0.2	0.4	0.0	0.1	0.0	0.0	0.5	0.0	3.9	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.6	1.2	0.3	0.0	19.5	13.8	0.0	0.3	2.9	0.9	0.1	10.5	0.1	2.2	1.3	1.3	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	2.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.8	2.5	2.9	2.2	2.7	4.0	8.6	5.0	8.3	8.4	3.5	5.1	4.4	1.7	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	14.2	0.5	0.5	4.4	4.3	0.0	0.0	47.9	42.3	0.3	0.2	0.0	0.6	1.9	0.1	0.5	2.2	1.2	0.0	0.7	1.7	10.5	1.4	5.6	0.3	0.0	0.8	16.4	16.1	30.1	0.0	0.8	0.7	0.0	17.8	0.9	6.4	3.1	7.3	0.0	6.5	0.8	17.0	0.0	3.0	0.1	0.7	0.2	0.4	0.1	0.1	1.7	2.7	0.1	31.4	0.0	5.2	0.3	0.4	0.6	0.1	0.3	16.1	1.4	3.2	0.6	0.2
MZT1	"C13orf37, FLJ21869, LOC440145, MGC150539, MOZART1, RP11-11C5.2"	ENSG00000204899	"Mitotic spindle organizing protein 1"	Q08AG7	13	72708367-72727629	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063299, HPA066715"	Approved					NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA063299: AB_2684980, HPA066715: AB_2685709"	"unprognostic (1.52e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.38e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.65e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.28e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (9.01e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.26e-1)"	9.0	15.1	11.8	11.6	15.5	26.3	11.6	12.6	18.4	8.6	10.2	8.8	8.3	8.3	9.1	9.8	6.1	6.1	12.0	12.3	12.7	11.1	5.5	8.1	17.2	10.4	11.3	7.3	5.8	8.2	6.7	10.6	10.1	10.3	10.0	9.9	9.5	6.3	19.2	9.6	7.4	7.2	11.3	9.8	9.2	6.4	13.1	17.5	12.1	15.0	13.1	9.3	6.1	10.8	97.5	15.4	53.1	39.4	10.8	18.0	43.5	77.1	31.9	47.7	54.8	28.9	62.3	66.9	57.5	30.9	30.1	30.8	53.6	28.7	86.1	80.6	54.5	86.9	30.0	44.0	15.0	147.1	68.1	9.8	28.8	28.9	59.4	28.8	49.1	76.7	48.7	51.1	95.1	17.5	75.2	81.9	40.5	58.7	28.7	52.6	60.7	33.2	42.9	23.8	62.3	56.9	32.7	47.8	48.4	29.0	36.1	72.1	33.5	41.9	47.7	59.5	94.8	46.5	77.0	53.1	98.2	88.8	87.6	16.2	3.8	8.5	4.8	6.9	6.0	7.7	6.5	6.0	4.8	7.3	8.3	6.7	2.0	7.2	7.6	6.3	9.9	3.8	11.8	15.5	12.6	18.4	12.3	12.7	10.4	11.3	10.1	11.3	13.1	10.8	29.3	0.0	15.2	5.5	49.9	55.1	27.6	32.2	30.7	29.3	32.8	24.5	17.8	12.8	18.7	31.3	14.6	57.3	38.3	10.3	58.7	25.9	4.5	20.5	18.0	26.5	21.7	122.3	15.2	24.4	98.8	23.1	18.3	18.8	18.4	27.0	20.7	8.8	41.3	63.9	17.1	17.6	38.7	32.3	46.4	4.2	19.9	33.1	60.5	3.7	36.0	31.1	23.7	6.0	10.0	25.1	15.2	16.6	47.9	33.7	8.1	46.5	12.9	27.7	32.9	21.4	26.8	52.0	38.2	51.9	57.4	30.2	43.8	17.6	24.2	32.3
NIPA2	SLC57A2	ENSG00000140157	"NIPA magnesium transporter 2"	Q8N8Q9	15	22838644-22869362	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	24.0	26.9	15.5	35.0	15.4	30.6	20.7	14.8	16.3	21.2	19.1	40.5	39.7	21.1	18.5	25.5	17.1	24.7	18.9	15.5	17.3	31.0	27.3	23.0	36.3	15.3	17.4	15.0	24.2	25.5	18.5	28.7	17.1	26.4	38.9	15.9	26.6	17.1	27.5	15.3	35.7	24.4	16.3	27.1	28.5	16.9	16.5	28.7	26.8	27.2	42.9	34.8	15.3	16.6	103.6	103.7	51.7	61.7	55.9	58.1	57.3	117.3	99.1	78.4	90.4	76.5	64.3	101.0	70.6	71.7	88.6	82.6	99.9	58.3	77.3	109.7	61.0	89.9	66.4	61.2	72.3	127.0	81.8	54.9	61.2	64.2	65.5	51.6	87.7	79.2	137.4	117.1	99.8	39.2	40.1	56.0	60.2	109.9	99.9	88.3	87.0	74.9	71.6	120.9	69.4	71.7	95.6	84.8	98.9	48.4	74.4	114.3	91.4	104.0	65.6	73.2	237.5	90.0	153.3	107.4	76.3	129.9	88.2	72.1	44.5	38.9	41.1	55.4	46.9	76.3	36.9	45.4	54.9	67.1	34.2	34.6	32.7	48.6	55.7	82.0	52.8	49.2	15.5	15.4	14.8	16.3	15.5	17.3	15.3	17.4	17.1	16.3	16.5	16.6	26.0	16.0	23.1	10.7	62.9	45.0	41.3	26.1	20.5	9.4	25.2	16.5	3.8	22.8	25.0	12.9	12.5	39.9	45.0	53.7	21.5	39.6	10.7	21.7	24.5	28.5	24.4	29.2	14.7	43.8	65.4	23.4	26.0	27.6	10.1	26.2	22.9	22.1	48.3	21.9	15.4	30.2	38.7	30.3	41.3	3.3	13.4	35.5	23.2	14.0	31.4	27.3	35.0	9.5	13.3	57.8	31.1	21.1	60.8	56.5	31.8	23.3	20.6	13.0	13.1	17.6	28.6	32.8	35.2	28.8	57.8	84.4	37.3	38.7	38.1	89.7
NIPSNAP3A	"DKFZp564D177, FLJ13953, HSPC299, MGC14553"	ENSG00000136783	"Nipsnap homolog 3A"	Q9UFN0	9	104747683-104760120	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042491	Approved					NA	NA		13000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA042491: AB_2678023"	"unprognostic (1.03e-1)"	"unprognostic (9.13e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	27.6	38.9	18.0	15.1	18.0	40.2	28.0	19.6	25.5	26.3	16.7	38.3	25.4	19.5	19.7	25.2	20.4	16.3	31.2	18.1	21.0	29.6	51.1	22.8	17.1	23.8	20.8	13.8	12.8	15.1	18.0	33.1	21.2	21.4	38.9	8.6	14.1	21.5	13.5	21.2	24.3	25.4	21.7	22.7	29.4	15.7	18.2	20.5	23.2	17.6	17.2	20.8	19.4	26.5	18.8	16.3	9.4	8.5	16.9	29.9	19.5	57.9	22.4	56.6	48.0	19.0	29.8	29.8	24.2	47.7	17.4	31.9	30.5	25.2	30.7	17.4	28.3	52.5	22.3	22.0	30.6	65.3	38.8	36.2	65.5	23.5	17.6	31.7	64.7	44.0	56.3	19.2	44.2	40.3	54.4	37.1	10.6	44.9	29.1	42.8	32.9	30.1	49.8	11.1	32.4	21.4	36.4	22.8	16.7	26.0	55.0	55.4	47.1	28.9	16.8	30.9	17.2	13.5	16.8	16.2	29.4	55.1	15.9	43.0	51.5	36.2	11.5	63.7	14.2	19.5	11.6	12.7	88.5	13.8	14.2	14.0	3.5	32.5	56.7	45.3	12.7	38.2	18.0	18.0	19.6	25.5	18.1	21.0	23.8	20.8	21.2	21.7	18.2	26.5	23.7	22.4	15.5	3.9	16.2	28.2	18.8	55.6	18.2	7.9	18.1	16.3	13.3	22.8	34.9	29.5	2.1	37.9	14.4	27.4	103.7	28.1	3.8	30.9	14.4	22.5	25.2	47.3	9.9	27.6	31.2	18.4	16.3	30.7	52.0	19.9	24.3	45.5	84.9	3.3	9.8	35.5	46.8	40.5	48.1	4.3	19.0	37.5	37.4	8.4	68.9	9.7	13.4	3.0	15.7	28.1	17.5	21.8	9.5	11.6	21.0	52.9	26.2	6.0	26.3	6.9	24.5	13.0	13.7	41.4	38.8	30.8	11.3	40.2	35.3	22.2
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265732	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.3;lung: 6.2;lymphoid tissue: 11.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 11.9;Kupffer cells: 21.0;Macrophages: 14.5;Microglial cells: 10.3;monocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"classical monocyte: 49.3;intermediate monocyte: 56.9;myeloid DC: 32.2;neutrophil: 24.6;non-classical monocyte: 44.2"	"Group enriched"	"Detected in many"	32	"dendritic cells: 32.2;granulocytes: 24.6;monocytes: 56.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.1"	"Not detected"	"Not detected"							"HPA006592, HPA075894"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA006592: AB_2667620, HPA075894: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	3.4	1.4	0.4	8.7	0.5	8.3	0.7	0.4	0.8	0.6	0.6	0.9	0.9	0.4	0.0	0.6	0.8	1.4	1.2	0.4	0.4	0.5	1.6	6.2	2.3	0.6	0.5	0.3	0.8	0.1	0.6	2.1	0.6	0.4	0.8	0.6	0.5	0.2	1.0	0.3	1.3	2.3	0.5	11.4	0.6	0.4	0.9	0.7	0.4	0.3	1.2	2.0	0.3	0.8	0.1	0.2	0.3	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.3	0.5	0.1	0.4	0.0	3.1	0.5	0.0	0.3	0.0	1.4	0.4	0.0	0.1	0.3	0.2	0.0	0.0	0.2	1.4	0.1	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.3	0.7	0.2	0.2	1.2	0.5	0.1	1.4	0.1	0.3	0.3	0.2	0.4	0.3	0.8	1.2	0.4	1.3	0.4	0.5	49.3	5.8	0.1	56.9	0.4	0.6	0.0	0.0	32.2	1.1	0.0	0.1	24.6	0.3	44.2	0.4	0.2	18.6	0.4	0.5	0.4	0.8	0.4	0.4	0.6	0.5	0.6	0.5	0.9	0.8	0.2	0.0	1.8	1.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	4.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	11.9	0.0	3.3	0.0	0.0	21.0	1.0	0.0	0.0	14.5	0.0	10.3	18.4	0.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.0
NME8	"CILD6, NM23-H8, SPTRX2, TXNDC3"	ENSG00000086288	"NME/NM23 family member 8"	Q8N427	7	37848597-37900397	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"bone marrow: 12.3;testis: 10.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.8;Early spermatids: 46.3;Late spermatids: 23.4;NK-cells: 17.5;Oligodendrocytes: 9.8;Spermatocytes: 26.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;NB-4: 2.0;NTERA-2: 1.7;THP-1: 1.7;U-937: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016416, HPA019259, HPA029572"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear speckles"	"CAB016416: , HPA019259: AB_1858475, HPA029572: "	"unprognostic (7.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-8)"	"unprognostic (5.90e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	0.1	0.1	0.4	0.6	0.9	12.3	0.1	0.5	0.7	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.1	0.5	0.0	0.3	0.7	0.0	0.1	0.4	0.5	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.1	0.7	1.0	0.2	10.4	0.9	0.3	0.0	0.0	0.3	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.1	0.9	0.3	0.2	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	2.1	0.1	0.0	4.6	0.0	0.4	0.4	0.9	0.5	0.7	0.3	0.7	1.1	0.6	0.9	0.7	0.9	1.0	0.1	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	22.8	0.0	0.0	0.0	46.3	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.9	5.1	23.4	0.0	3.3	0.0	0.0	2.6	0.0	17.5	0.0	9.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.5	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270470-151289894	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 207.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	20.6	15.7	7.3	44.5	7.1	74.5	23.3	7.0	10.4	15.2	7.4	25.9	33.7	13.9	16.6	19.0	19.8	24.0	7.5	7.1	7.7	14.0	35.5	28.6	43.4	8.6	7.7	16.8	7.8	6.3	4.2	34.2	8.2	13.2	26.7	1.4	20.2	17.2	4.8	19.4	33.8	20.9	8.2	47.5	24.9	6.6	7.9	44.4	16.9	8.3	33.5	27.9	10.5	8.2	53.2	25.7	1.3	0.0	14.4	39.4	49.3	14.6	36.8	74.1	112.0	5.9	119.9	51.0	55.4	23.5	24.5	29.6	5.6	13.8	18.6	110.0	3.0	144.9	27.3	3.1	63.1	139.9	40.2	25.7	18.3	44.1	10.0	32.1	91.8	56.4	74.0	12.6	14.4	41.6	116.4	207.7	29.5	10.9	37.6	125.5	2.9	45.8	60.9	46.1	7.4	0.3	32.0	35.1	20.5	5.1	5.6	157.9	47.5	10.5	23.3	33.8	22.3	1.8	2.0	3.2	24.5	166.4	11.3	251.3	121.3	140.5	62.7	172.8	74.3	64.8	66.1	63.4	108.8	58.5	52.1	54.3	466.8	98.1	170.0	43.3	62.3	104.3	7.3	7.1	7.0	10.4	7.1	7.7	8.6	7.7	8.2	8.2	7.9	8.2	37.3	25.6	24.9	2.9	22.9	16.7	21.1	47.0	15.4	0.3	13.8	15.1	7.0	18.6	35.6	12.9	0.0	76.4	33.4	21.4	15.6	66.6	3.4	36.2	9.0	41.1	18.0	55.5	0.4	41.1	69.4	19.1	15.3	23.8	36.1	17.7	27.5	17.8	80.2	0.0	0.2	25.1	8.2	49.7	25.6	1.7	19.6	51.5	1.8	12.2	86.5	7.4	57.7	5.0	0.7	40.2	34.5	13.9	12.9	19.1	35.3	35.3	47.4	0.1	6.6	11.7	15.2	3.6	2.2	19.4	17.8	54.5	36.2	23.1	24.9	23.3
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949712-156973176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	5.0	4.4	2.5	4.7	2.6	6.8	4.4	2.7	3.3	4.7	2.5	5.1	3.4	4.8	3.3	5.2	4.6	2.7	3.7	2.5	2.4	3.7	5.0	3.9	5.7	3.2	2.3	5.2	5.9	4.3	3.1	4.0	3.1	3.8	3.7	3.2	4.2	3.0	7.5	6.1	4.4	4.6	1.8	4.7	4.3	4.1	2.8	4.2	3.8	4.3	5.0	4.8	4.7	3.1	13.5	11.4	8.2	12.3	8.1	8.4	11.3	13.2	6.5	10.5	8.5	12.4	11.1	23.4	12.9	10.8	10.7	10.7	14.9	15.9	12.8	10.7	12.9	19.6	9.9	11.5	6.5	34.7	11.6	6.0	7.7	9.4	12.1	6.1	8.9	12.9	30.3	12.2	9.6	17.7	22.1	28.9	19.9	11.9	12.2	15.7	12.4	18.1	6.8	15.8	10.0	12.3	12.0	9.4	9.2	9.2	4.6	18.5	14.5	11.2	3.7	21.1	17.2	15.7	12.1	21.1	14.4	24.4	10.8	0.8	0.8	0.4	0.6	0.5	0.3	1.3	0.7	0.8	0.8	1.8	0.9	0.5	0.2	0.7	0.7	0.8	0.3	0.3	2.5	2.6	2.7	3.3	2.5	2.4	3.2	2.3	3.1	1.8	2.8	3.1	15.3	9.6	18.3	7.2	16.1	39.4	46.9	10.5	12.0	16.8	9.5	7.9	11.7	8.6	15.5	5.5	20.9	16.2	19.3	20.0	3.9	19.2	9.6	17.9	20.7	16.0	7.8	19.1	9.6	13.6	20.5	16.9	13.3	18.6	21.5	21.2	6.8	13.6	14.3	11.8	10.8	16.2	6.1	10.4	26.0	4.4	17.4	13.3	24.9	13.1	18.3	7.5	21.6	7.1	10.2	15.9	14.1	13.2	15.3	36.3	8.7	6.3	15.3	29.8	0.0	28.9	18.0	33.5	37.6	20.0	42.5	7.3	21.0	26.6	21.8	37.3
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"	P80303	11	17208153-17349980	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 758.3;salivary gland: 771.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 690.6;Late spermatids: 508.5;Respiratory ciliated cells: 618.8;Syncytiotrophoblasts: 1158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 1867.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000	690000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	56.2	75.7	23.9	62.1	27.8	619.9	141.1	28.8	32.1	137.2	58.0	68.3	57.3	60.8	458.2	146.3	107.2	60.8	95.7	22.8	34.7	43.2	102.2	49.8	60.2	25.7	28.2	56.0	758.3	479.1	113.0	90.9	26.8	70.9	68.4	64.5	771.4	190.9	38.5	21.1	40.7	78.5	26.2	42.2	92.9	119.2	28.4	334.2	153.9	30.4	78.5	61.8	44.9	26.6	119.9	49.0	53.7	163.4	118.9	162.3	65.0	260.5	381.0	115.1	203.0	48.7	26.8	182.9	63.5	250.7	107.1	50.1	34.4	66.8	178.7	126.7	76.3	135.8	57.8	85.2	340.5	1867.0	238.6	71.1	86.8	82.9	200.9	284.9	143.3	672.1	120.1	361.1	114.9	105.9	656.2	670.3	12.9	194.0	50.5	239.8	130.4	15.1	51.9	37.5	63.5	35.4	114.6	114.2	61.4	78.0	93.5	498.1	128.1	120.9	110.9	369.1	112.1	70.3	41.3	101.1	140.5	646.1	106.4	210.5	43.5	168.2	94.1	30.5	122.9	22.7	88.5	173.7	40.6	14.5	246.7	271.2	39.3	277.9	25.6	426.0	42.7	119.8	23.9	27.8	28.8	32.1	22.8	34.7	25.7	28.2	26.8	26.2	28.4	26.6	118.7	44.8	70.4	16.3	54.8	27.5	60.2	156.3	14.8	71.0	152.8	87.0	193.8	55.8	176.5	42.3	54.2	127.1	136.5	17.6	27.4	91.1	690.6	112.4	92.9	94.7	42.4	137.8	21.9	132.6	319.1	148.8	40.2	97.0	67.6	80.0	108.5	141.8	70.7	35.3	23.5	189.0	189.2	29.4	40.0	508.5	149.8	37.6	69.4	18.7	24.1	111.2	95.8	13.6	10.8	75.2	13.2	114.3	256.5	108.7	3.9	28.5	618.8	99.3	46.0	50.8	75.4	174.9	61.3	87.7	30.1	1158.2	92.3	88.3	45.3	61.2
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042761			Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.35e-4)"	5.1	11.7	4.0	4.1	4.1	8.4	4.6	3.9	4.5	3.9	9.4	6.9	7.1	3.6	5.4	11.1	3.6	2.9	10.6	4.1	5.1	6.3	6.9	6.4	5.8	4.6	4.3	3.7	8.4	7.1	4.0	4.5	4.8	7.5	7.3	8.3	6.9	3.5	23.9	8.9	6.2	4.3	4.3	5.2	8.1	2.8	4.6	3.1	3.6	13.0	5.1	6.3	5.6	4.6	21.5	24.7	2.7	24.0	8.1	10.5	0.2	11.9	4.4	8.7	8.2	14.0	11.6	0.1	14.0	13.8	6.7	13.7	16.7	13.9	11.4	24.8	10.0	27.7	9.3	5.0	11.2	20.9	8.2	8.5	18.1	7.4	17.8	10.1	13.0	4.2	21.6	15.3	15.9	14.3	0.1	19.3	2.9	5.9	11.5	0.1	5.2	12.1	14.4	15.7	10.7	15.4	21.2	17.7	15.9	4.7	9.8	25.4	10.4	11.9	7.7	12.0	21.5	17.8	16.3	6.9	14.4	20.0	11.2	11.1	26.5	15.4	18.2	36.7	20.0	13.0	18.9	22.6	19.5	9.4	14.9	20.4	5.1	32.2	42.4	15.9	23.6	11.9	4.0	4.1	3.9	4.5	4.1	5.1	4.6	4.3	4.8	4.3	4.6	4.6	5.9	12.8	14.5	7.5	6.4	21.9	9.4	4.6	8.0	14.5	12.0	6.6	22.8	2.8	6.2	7.3	12.5	11.0	9.1	10.6	27.4	2.9	7.7	8.5	9.3	7.3	12.1	10.3	5.9	11.5	11.5	6.6	3.1	10.7	1.3	11.3	13.2	12.5	14.3	3.3	6.7	12.7	8.2	17.6	11.6	3.7	4.1	10.2	12.4	4.7	10.7	4.6	4.1	6.6	7.4	12.0	13.1	9.4	4.1	12.0	15.7	18.8	6.5	30.4	0.0	6.9	7.4	1.6	2.2	9.9	31.5	7.8	9.1	22.3	18.4	10.6
NUDT6	"FGF-AS, FGF2AS, gfg, gfg-1"	ENSG00000170917	"Nudix hydrolase 6"	P53370	4	122888697-122922968	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 27.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 37.2;Early spermatids: 36.7;Proximal tubular cells: 46.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039202, HPA066115"	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039202: AB_10795032, HPA066115: AB_2685620"	"unprognostic (7.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.91e-6)"	"unprognostic (1.13e-5)"	"unprognostic (2.32e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-1)"	4.9	10.7	8.2	2.8	9.4	2.2	5.3	5.8	10.6	4.2	6.6	7.7	4.4	4.1	7.1	3.3	6.7	3.6	13.0	8.4	8.2	19.4	27.3	3.2	3.9	6.0	7.3	4.2	4.0	7.4	6.4	3.2	6.1	3.7	6.2	8.3	5.2	4.3	10.0	4.2	3.7	3.5	5.9	4.5	3.3	7.1	9.0	4.8	7.3	10.9	2.3	3.2	3.2	7.8	5.4	7.9	11.5	10.3	10.3	10.7	4.1	6.1	8.1	5.3	7.3	3.4	12.1	5.6	4.5	3.3	11.7	2.7	5.1	4.8	5.4	13.5	3.4	5.0	7.6	9.2	3.8	10.4	3.0	6.6	2.1	4.6	4.0	9.8	7.0	9.7	12.8	13.8	9.0	6.3	14.5	11.2	4.3	20.8	9.9	4.9	14.6	6.4	12.7	3.2	6.1	7.6	6.3	8.5	12.5	13.3	5.6	8.3	4.4	12.8	6.7	11.2	5.6	15.4	12.9	10.7	7.7	15.4	5.8	0.0	2.0	0.0	1.5	2.8	1.9	4.0	2.0	2.6	4.4	1.2	1.5	1.7	0.3	1.3	2.5	1.7	2.3	1.8	8.2	9.4	5.8	10.6	8.4	8.2	6.0	7.3	6.1	5.9	9.0	7.8	7.0	16.0	7.8	10.7	2.0	0.9	3.1	9.3	4.6	12.5	4.7	6.9	5.3	4.3	5.4	5.5	0.0	16.4	1.3	4.1	37.2	6.2	36.7	8.9	7.4	5.4	7.2	3.0	8.9	5.6	3.7	5.3	5.6	3.4	1.3	12.8	4.6	21.3	8.7	15.2	9.6	6.0	6.1	4.6	2.0	6.1	6.2	5.0	5.4	4.7	1.5	14.0	0.0	13.6	10.8	4.7	5.2	9.1	3.8	1.2	2.5	46.2	10.4	11.9	0.0	6.3	5.0	28.5	3.7	3.9	1.8	4.0	3.3	20.8	10.1	2.1
NWD1		ENSG00000188039	"NACHT and WD repeat domain containing 1"	Q149M9	19	16719847-16817963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"choroid plexus: 192.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 41.4;Endometrial ciliated cells: 83.9;Respiratory ciliated cells: 92.0"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075476			Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli, Cytosol"		"HPA075476: "	"unprognostic (5.29e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.05e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.20e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.25e-1)"	0.0	0.0	5.4	0.0	6.2	0.1	0.2	7.6	4.9	1.3	192.4	0.5	0.0	0.2	0.4	0.2	12.6	0.2	0.0	12.2	5.2	0.2	0.0	1.3	0.0	6.2	8.8	0.0	1.5	0.0	0.7	0.0	6.1	6.8	0.1	1.1	1.3	1.8	0.0	0.2	0.0	0.0	3.2	0.0	0.8	0.2	10.1	0.2	0.7	0.0	0.0	0.1	0.0	3.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	6.2	7.6	4.9	12.2	5.2	6.2	8.8	6.1	3.2	10.1	3.7	0.0	0.0	1.5	41.4	0.3	0.3	1.7	3.5	0.0	0.2	0.5	0.3	0.9	0.0	4.5	0.0	0.0	0.1	0.0	0.4	0.0	0.1	17.9	83.9	0.8	0.3	1.2	0.0	2.4	0.0	0.2	0.3	0.0	3.7	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.6	2.0	0.0	0.4	3.3	0.6	0.3	0.0	0.0	0.0	8.9	0.0	1.5	1.2	0.2	0.4	0.0	0.0	4.0	0.0	0.1	92.0	0.6	0.0	1.1	1.4	0.0	0.2	0.0	0.1	1.1	0.4	0.0	0.4	1.4
NXF3		ENSG00000147206	"Nuclear RNA export factor 3"	Q9H4D5	X	103075810-103093143	"Predicted intracellular proteins"	"mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 25.0;testis: 57.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Early spermatids: 2.4;Endometrial ciliated cells: 8.4;Hepatic stellate cells: 2.9;Kupffer cells: 2.6;Late spermatids: 4.2;Paneth cells: 3.9;Undifferentiated cells: 2.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 48.6;HL-60: 46.6;NB-4: 43.0;THP-1: 33.0;U-2197: 135.9;U-937: 101.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003132, HPA046757"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA003132: AB_1079514, HPA046757: AB_2679789"	"unprognostic (1.20e-3)"	"unprognostic (6.72e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.86e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-10)"	"unprognostic (1.90e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.56e-1)"	0.6	0.8	0.0	0.1	0.0	3.9	0.2	0.0	0.1	1.4	0.1	0.3	0.6	0.1	10.9	0.1	25.0	7.2	0.4	0.0	0.0	1.1	1.1	4.9	0.1	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.9	0.0	1.1	0.1	0.0	0.1	3.0	0.0	0.0	0.6	0.1	57.8	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.2	0.0	0.0	0.1	0.5	0.2	0.0	48.6	0.5	0.0	0.0	46.6	0.0	0.0	0.0	1.9	0.0	0.6	0.0	2.2	0.0	8.6	1.0	0.0	0.2	43.0	0.0	0.4	0.2	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.0	0.0	0.0	0.1	135.9	0.1	0.1	0.0	0.0	0.7	101.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	2.4	8.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.9	0.0	0.5	0.0	0.1	0.9	0.0	2.6	0.0	4.2	0.3	1.4	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.6	3.9	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.8	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0
NXT1	"MTR2, P15"	ENSG00000132661	"Nuclear transport factor 2 like export factor 1"	Q9UKK6	20	23350791-23354771	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 235.3;Suprabasal keratinocytes: 253.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 200.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047471			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 28: Keratinocytes - Keratinization"	Nucleoplasm	Cytosol	"HPA047471: AB_2680061"	"unprognostic (6.44e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.89e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.15e-7)"	"unprognostic (2.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.11e-3)"	"unprognostic (9.31e-2)"	26.4	14.2	10.4	12.4	10.4	46.8	20.6	11.0	11.7	18.7	11.0	16.0	6.9	17.8	16.7	19.6	22.8	10.1	15.7	9.9	11.0	19.8	13.7	18.9	13.7	11.1	11.1	23.9	12.5	9.6	17.9	13.0	11.3	14.9	10.1	9.4	12.8	11.6	11.6	22.7	13.8	14.9	11.2	17.6	15.2	17.6	11.2	18.3	14.4	9.5	18.3	21.5	16.9	11.1	46.3	50.6	29.9	31.4	20.7	20.0	27.9	27.7	31.0	44.3	44.5	33.7	44.2	55.0	40.3	27.7	73.0	52.8	35.6	72.6	43.3	26.5	33.2	40.5	10.4	60.4	30.9	43.6	29.5	17.9	47.6	42.8	60.4	17.5	35.7	39.5	54.7	52.6	34.7	60.1	90.7	76.4	25.2	82.3	110.9	61.9	48.4	64.7	27.0	38.5	48.4	28.4	25.4	66.7	53.3	18.2	37.5	50.1	22.7	44.6	36.9	37.7	54.1	35.9	37.2	64.0	12.6	200.8	33.9	43.6	46.7	34.5	80.2	68.7	99.2	141.5	80.4	84.3	69.5	131.4	97.9	88.3	11.5	107.9	51.1	113.5	62.1	87.8	10.4	10.4	11.0	11.7	9.9	11.0	11.1	11.1	11.3	11.2	11.2	11.1	63.4	16.0	13.1	1.0	67.0	235.3	141.0	82.9	132.1	10.1	73.1	91.4	7.6	17.2	36.1	20.2	4.2	75.4	64.7	8.2	41.1	39.7	20.3	34.0	39.3	62.1	18.7	41.9	1.5	31.2	77.1	63.7	5.6	37.8	76.2	23.5	27.5	13.4	45.3	11.8	2.2	23.9	59.0	16.6	141.2	12.8	51.6	36.9	108.5	1.9	23.9	24.5	35.0	2.5	2.8	41.3	11.0	40.3	46.0	111.3	8.3	24.1	24.0	18.3	6.6	89.5	70.5	89.6	76.4	87.4	253.5	40.2	66.7	27.8	27.9	118.1
NXT2	P15-2	ENSG00000101888	"Nuclear transport factor 2 like export factor 2"	Q9NPJ8	X	109535781-109544698	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 157.3;U-937: 166.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024199, HPA072010"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA024199: AB_1854738, HPA072010: AB_2686483"	"unprognostic (1.72e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.59e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.90e-2)"	7.6	4.8	5.3	8.0	5.6	17.5	15.2	6.0	6.8	9.2	4.0	7.8	9.2	5.6	7.2	8.9	7.0	6.1	2.7	4.8	5.8	9.3	11.9	8.0	12.3	6.0	5.8	6.5	4.3	7.3	1.2	8.4	6.4	6.4	8.5	2.2	7.7	4.3	1.9	12.2	7.5	4.5	6.8	7.5	8.7	27.6	5.4	14.8	7.9	3.4	14.1	8.8	4.4	6.9	14.2	12.2	11.6	20.3	17.1	13.5	25.6	8.8	14.9	11.1	14.4	9.6	19.5	18.1	27.1	11.1	30.0	10.5	15.4	13.8	16.9	23.5	9.5	15.1	10.6	15.8	7.0	157.3	60.9	9.9	11.8	10.6	6.6	8.3	10.0	18.7	16.1	72.2	11.0	14.6	23.9	16.6	18.6	19.8	18.0	9.4	16.4	21.6	10.4	13.9	4.6	14.6	37.7	21.2	12.0	10.1	9.0	52.1	7.5	15.9	9.0	21.2	9.3	14.8	19.5	27.7	13.9	166.9	16.6	4.7	7.2	3.6	9.2	9.8	6.0	6.3	6.7	7.5	9.7	6.2	6.6	6.5	1.4	10.8	8.1	5.9	8.4	8.0	5.3	5.6	6.0	6.8	4.8	5.8	6.0	5.8	6.4	6.8	5.4	6.9	4.8	3.2	6.5	2.0	10.1	19.2	21.0	10.4	9.6	1.4	18.0	11.3	30.0	2.8	12.8	3.7	0.0	15.1	12.9	7.9	21.5	12.5	21.5	9.3	6.0	5.4	1.2	12.4	0.5	14.0	24.8	7.5	7.1	15.0	5.7	6.0	4.6	5.4	11.4	0.0	0.4	4.4	10.2	10.1	20.0	5.9	4.7	9.9	1.8	1.0	31.9	9.2	26.8	1.5	2.5	9.0	7.6	4.5	12.3	20.3	7.6	16.6	10.5	1.4	13.1	5.3	5.2	31.7	33.7	17.0	23.3	29.1	9.4	6.6	6.4	21.3
OBI1	"C13orf7, FLJ13449, RNF219"	ENSG00000152193	"ORC ubiquitin ligase 1"	Q5W0B1	13	78614289-78659155	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.5;Cardiomyocytes: 19.5;Cytotrophoblasts: 15.8;dendritic cells: 8.0;Extravillous trophoblasts: 12.2;Hofbauer cells: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034785, HPA034786"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA034785: AB_10601496, HPA034786: AB_2674331"	"unprognostic (2.99e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.84e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (6.87e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.53e-2)"	5.8	4.8	5.4	6.1	5.8	2.4	6.7	6.6	6.7	5.9	3.0	4.8	4.8	7.1	4.5	5.0	5.6	4.5	7.1	5.6	6.1	4.6	4.4	5.2	9.9	5.5	5.9	7.6	4.1	4.1	2.9	7.4	5.0	5.5	5.3	9.6	4.2	6.1	4.8	5.5	4.7	6.5	6.1	7.3	4.5	14.8	7.2	13.3	5.9	6.4	11.3	6.0	4.5	5.9	23.7	9.1	39.1	23.1	13.5	12.9	17.8	19.3	14.5	18.7	23.3	18.3	17.3	39.8	9.2	12.4	12.2	23.0	31.2	15.3	32.6	24.9	22.8	61.0	11.4	16.1	11.3	59.6	18.2	12.4	16.7	15.7	16.8	10.6	15.6	19.9	16.1	5.3	24.6	6.6	36.5	20.2	0.0	25.1	10.0	42.0	32.2	15.4	12.7	12.5	28.4	15.9	13.4	16.9	14.8	22.2	8.6	47.3	12.9	16.2	14.7	10.7	16.3	5.5	6.6	37.9	25.9	35.6	17.8	4.9	5.4	7.5	7.9	8.8	9.5	8.8	8.8	9.8	6.3	8.9	10.8	9.8	1.8	11.1	10.3	5.3	9.6	6.6	5.4	5.8	6.6	6.7	5.6	6.1	5.5	5.9	5.0	6.1	7.2	5.9	14.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	15.8	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	12.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.1	1.1	0.0	0.0	0.0
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288811-71309059	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	25.2	11.2	32.9	16.1	28.1	26.7	51.0	40.5	26.3	7.9	7.8	9.3	3.6	10.4	13.7	33.2	6.5	10.8	6.8	40.9	47.7	7.1	6.4	11.5	14.5	50.8	60.5	6.6	8.0	6.2	7.6	13.5	51.5	8.4	5.3	13.2	46.3	12.8	5.1	20.1	6.8	33.4	55.3	16.8	6.3	2.8	47.9	11.4	5.3	12.1	25.5	7.4	12.5	69.6	9.7	2.9	10.0	0.0	26.5	24.1	3.6	42.2	26.5	16.9	17.0	3.7	1.8	59.1	56.3	18.5	15.6	4.7	7.8	29.4	59.5	12.5	6.1	13.0	10.0	1.5	21.4	6.2	4.4	24.4	24.7	12.5	38.8	14.2	13.7	0.0	0.8	4.5	58.8	8.1	0.0	9.7	4.0	3.8	2.3	4.2	30.4	13.8	38.8	0.7	33.8	15.3	12.6	7.8	2.8	14.3	13.4	48.0	21.1	41.3	20.5	4.3	14.1	6.0	0.4	7.6	13.8	41.0	7.2	3.4	2.6	0.1	0.4	1.7	0.4	0.3	0.3	0.4	2.1	0.5	0.0	0.3	11.1	0.5	1.3	0.8	0.1	0.6	32.9	28.1	40.5	26.3	40.9	47.7	50.8	60.5	51.5	55.3	47.9	69.6	40.3	6.4	18.6	175.3	17.4	38.9	22.3	18.4	22.8	42.8	79.4	86.4	8.7	11.5	14.1	11.0	25.0	23.2	31.7	1.4	1.9	17.0	0.5	8.0	14.2	30.2	14.4	11.1	29.1	32.9	11.0	50.8	5.6	19.1	6.3	6.6	8.9	5.1	61.7	38.7	28.0	2.2	8.2	95.5	144.0	1.2	16.4	155.7	32.0	71.2	133.5	87.0	18.6	13.0	4.0	19.3	2.4	33.1	11.6	16.2	0.1	4.9	3.2	6.0	26.3	26.8	31.3	0.6	1.2	57.9	46.5	19.0	19.3	3.4	4.4	19.3
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OR2AP1	OR2AP1P	ENSG00000179615	"Olfactory receptor family 2 subfamily AP member 1"	Q8NGE2	12	55572468-55575612	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 1.0;U-937: 1.0"															NA	NA					"Cluster 32: U-937 - Innate immune response"																						0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.3	0.2	0.3	0.1	0.3	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR9A4		ENSG00000258083	"Olfactory receptor family 9 subfamily A member 4"	Q8NGU2	7	141916399-141920625	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 29.7;Excitatory neurons: 4.2;Inhibitory neurons: 5.9;Microglial cells: 3.7;Oligodendrocyte precursor cells: 14.6;Oligodendrocytes: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"																		"unprognostic (2.77e-1)"			0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	14.6	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OSCAR		ENSG00000170909	"Osteoclast associated Ig-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 13.6;lung: 28.4;lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 35.6;Kupffer cells: 27.8;Macrophages: 42.9;monocytes: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	36	"classical monocyte: 43.0;eosinophil: 26.6;intermediate monocyte: 28.8;myeloid DC: 20.3;neutrophil: 40.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	79	"dendritic cells: 20.3;granulocytes: 40.0;monocytes: 43.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.9;HHSteC: 9.4;hTERT-HME1: 5.0;NB-4: 5.9;U-937: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	3.7	1.8	0.9	2.3	0.7	13.6	1.8	0.1	1.6	2.2	0.0	1.5	0.0	1.3	0.0	1.5	3.2	1.3	1.9	0.1	0.7	1.5	2.4	28.4	0.3	1.3	0.7	1.1	1.3	0.1	1.0	0.6	0.9	1.7	0.3	0.0	2.2	0.3	0.5	2.1	1.6	1.7	0.7	29.8	1.2	0.9	0.8	0.2	1.1	0.6	0.6	2.2	2.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.0	13.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.4	0.6	0.0	0.0	0.2	0.6	5.0	0.8	0.0	0.0	0.0	0.4	0.1	0.1	0.0	5.9	0.3	0.1	1.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.5	17.9	0.0	0.0	43.0	26.6	0.3	28.8	0.1	0.0	0.2	0.4	20.3	0.0	0.1	0.0	40.0	0.0	27.0	0.8	0.2	16.8	0.9	0.7	0.1	1.6	0.1	0.7	1.3	0.7	0.9	0.7	0.8	1.7	0.2	3.2	5.9	0.3	0.3	0.8	0.6	0.7	0.6	0.0	0.7	0.4	0.3	1.5	2.1	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.1	0.3	0.9	0.0	1.7	1.9	0.0	0.4	0.6	0.0	0.1	1.3	0.3	0.0	0.0	35.6	0.0	1.0	0.3	0.0	27.8	11.6	0.2	0.0	42.9	0.0	1.0	66.4	0.0	1.0	0.0	0.3	0.4	0.0	0.0	0.4	0.3	0.1	0.2	3.7	0.4	0.0	0.2	0.1	0.6	0.5	0.4	0.1	0.3	0.7	0.4	0.1	0.3
P2RX1	P2X1	ENSG00000108405	"Purinergic receptor P2X 1"	P51575	17	3896592-3916476	"Predicted membrane proteins"	"Apoptosis, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.0;pancreas: 65.1;urinary bladder: 75.5"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 185.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 46.3"	"Group enriched"	"Detected in many"	30	"dendritic cells: 15.1;granulocytes: 23.5;monocytes: 46.3"	"Cell line enhanced"	"Detected in some"		"HEL: 13.8;HMC-1: 8.4;Karpas-707: 16.8;THP-1: 14.7;U-937: 7.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.3"	HPA057678			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Endoplasmic reticulum"		"HPA057678: "	"unprognostic (1.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.89e-5)"	"unprognostic (1.77e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.09e-2)"	9.8	2.0	0.5	4.4	0.8	42.0	1.5	0.8	0.7	7.7	0.4	13.4	9.3	7.3	1.8	23.0	3.9	2.0	2.0	0.5	0.7	1.0	0.7	4.8	2.9	0.8	0.9	2.1	65.1	0.1	0.3	3.8	0.8	10.7	9.2	0.1	1.6	34.1	0.5	5.9	9.0	6.0	0.7	13.0	2.8	2.6	0.6	2.0	0.4	0.3	3.2	75.5	8.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.1	1.1	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.1	3.3	0.0	0.4	0.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	7.4	0.0	0.0	10.8	11.9	0.0	20.4	0.0	0.4	0.0	0.0	5.9	0.9	0.0	0.0	23.5	0.0	46.3	15.1	0.0	8.2	0.5	0.8	0.8	0.7	0.5	0.7	0.8	0.9	0.8	0.7	0.6	1.0	0.1	3.2	4.2	0.7	15.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.1	8.9	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	18.5	0.3	2.0	0.1	0.9	0.5	0.0	185.4	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.0	5.1	2.4	0.2	0.0	22.5	0.0	1.0	7.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	36.0	0.0	0.0	0.1	0.7	0.0	0.0	0.4	3.4	0.0	0.1	0.1	0.9	0.0	1.8	0.5	0.3	0.0
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.7;lymphoid tissue: 30.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 56.9;dendritic cells: 51.7;granulocytes: 60.1;Hofbauer cells: 66.7;Kupffer cells: 87.3;Langerhans cells: 53.4;Macrophages: 91.9;monocytes: 62.0;T-cells: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HL-60: 116.4;NB-4: 44.9;THP-1: 64.7;U-937: 53.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	3.5	2.9	3.7	26.7	3.5	49.7	1.8	4.4	7.1	2.6	4.0	3.1	3.6	2.4	0.6	2.5	2.2	6.2	1.3	3.8	4.7	1.8	3.1	10.4	30.1	8.2	4.9	0.8	1.4	0.5	1.3	3.0	6.9	2.1	3.4	0.2	2.6	1.1	1.2	1.7	12.7	2.9	5.9	28.9	4.4	1.7	7.9	18.4	1.9	0.4	26.8	4.7	1.5	9.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	116.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	16.8	44.9	0.1	0.0	0.0	9.2	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	64.7	0.0	0.0	11.5	0.2	0.0	0.3	0.0	0.3	0.0	53.9	1.9	12.5	62.0	71.3	13.9	57.6	13.9	21.4	8.0	15.2	49.2	20.4	8.9	10.3	72.2	13.1	65.9	33.3	12.1	44.6	3.7	3.5	4.4	7.1	3.8	4.7	8.2	4.9	6.9	5.9	7.9	9.4	1.3	6.4	14.0	1.0	56.9	2.4	0.1	0.0	0.6	0.2	0.7	1.5	1.1	0.0	3.1	0.0	0.0	0.6	51.7	0.1	0.0	0.0	4.2	3.7	0.4	2.9	0.0	10.1	3.9	0.2	0.7	2.3	3.6	2.5	60.1	0.0	3.9	1.3	66.7	0.0	2.9	0.0	0.0	87.3	53.4	2.7	0.0	91.9	5.4	10.3	62.0	0.0	26.8	0.0	1.4	0.0	0.0	0.0	15.9	0.0	0.0	0.5	1.5	0.2	0.0	0.5	0.4	1.1	0.8	0.4	1.8	1.0	48.3	0.0	0.1	0.1
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
PIGB		ENSG00000069943	"Phosphatidylinositol glycan anchor biosynthesis class B"	Q92521	15	55318960-55355648	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039929	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA039929: AB_10673539"	"unprognostic (1.91e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.24e-2)"	6.4	4.8	2.3	5.8	2.6	9.1	9.0	2.8	2.6	5.5	3.1	7.0	7.5	6.4	11.0	5.7	7.8	6.3	2.8	2.5	3.3	10.3	9.4	6.3	8.2	2.8	2.7	4.7	5.7	10.6	3.9	4.8	2.6	7.7	7.8	7.9	4.3	6.8	1.5	6.1	5.8	5.6	2.7	6.1	7.6	6.5	2.7	6.3	13.3	1.8	8.6	7.5	3.7	3.1	10.5	12.2	5.8	4.1	6.6	13.2	7.8	9.0	19.9	10.4	17.8	5.1	10.3	10.9	10.4	12.9	15.6	18.3	3.3	9.5	8.6	10.4	6.4	10.9	13.6	6.7	11.9	30.8	8.7	12.5	11.4	7.9	10.7	13.8	13.6	9.2	12.2	6.9	15.0	9.1	3.4	12.8	3.1	7.9	4.8	4.9	5.6	24.1	18.4	12.4	2.5	6.2	8.1	12.2	17.3	5.4	11.7	22.2	9.5	13.6	4.3	3.7	18.6	8.1	15.9	8.6	12.4	34.5	10.2	13.6	7.7	3.3	6.2	9.7	7.0	6.0	6.1	6.9	7.0	3.9	4.8	5.5	14.5	5.3	11.4	5.4	6.5	5.5	2.3	2.6	2.8	2.6	2.5	3.3	2.8	2.7	2.6	2.7	2.7	3.1	3.5	9.6	9.5	17.6	27.5	4.6	9.5	14.9	4.6	3.3	5.6	4.2	3.4	1.5	14.9	0.0	12.5	12.4	11.2	4.8	1.9	7.4	26.8	4.3	3.2	4.7	6.6	8.2	18.3	10.9	12.0	6.0	6.1	6.4	8.2	4.6	6.8	4.4	8.6	1.7	17.7	4.1	4.1	7.5	6.7	5.1	1.5	8.8	3.6	12.2	8.4	2.7	11.3	17.1	14.6	6.9	4.0	1.5	3.8	3.4	6.4	9.7	7.9	9.4	6.6	4.8	4.2	5.9	3.8	5.7	4.0	6.6	12.5	4.2	4.0	7.4
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266255-208358746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 82.0;Oligodendrocyte precursor cells: 80.9;Oligodendrocytes: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042604	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	10.4	7.9	7.6	12.0	7.6	28.8	8.1	14.3	9.3	9.1	10.5	6.1	6.0	9.3	11.9	6.3	6.4	7.2	7.4	7.7	7.3	10.6	10.5	7.8	17.4	8.0	7.4	10.0	22.2	11.1	6.0	9.7	6.9	11.5	7.4	17.3	6.5	8.0	6.5	8.2	7.3	8.9	7.4	15.1	8.0	14.0	8.9	19.3	12.2	9.0	16.1	8.2	5.8	11.1	8.0	7.9	18.3	14.3	18.1	21.4	8.5	9.6	19.5	11.1	15.0	11.3	6.6	9.2	9.8	16.6	21.7	8.0	16.1	10.8	18.8	7.9	10.1	33.0	15.6	10.2	13.7	29.5	28.5	16.0	11.5	13.0	24.1	18.5	18.3	24.1	22.7	16.1	14.0	3.4	26.9	22.1	15.2	6.1	5.9	9.9	14.2	12.7	14.2	11.5	5.8	13.8	10.6	6.8	19.2	21.4	4.3	31.3	21.2	13.8	9.2	9.4	9.0	11.2	14.2	19.2	11.1	25.2	13.9	0.9	0.5	0.4	0.9	0.4	0.5	4.4	1.2	1.4	0.5	3.2	0.9	1.1	0.7	3.2	0.7	1.2	0.9	0.3	7.6	7.6	14.3	9.3	7.7	7.3	8.0	7.4	6.9	7.4	8.9	11.1	18.8	25.6	16.2	58.8	82.0	15.3	6.7	7.8	25.6	21.9	10.5	6.6	17.5	11.5	10.6	11.0	16.7	8.1	14.4	8.1	5.9	5.4	10.4	11.3	19.4	18.8	18.6	25.5	72.6	4.3	5.7	15.7	16.3	21.7	36.1	18.0	18.2	19.4	14.4	10.1	67.9	9.6	4.1	29.9	32.5	8.3	18.6	28.5	10.6	48.7	19.1	13.5	16.5	80.9	81.7	8.5	5.9	13.5	10.3	18.1	14.3	9.9	9.2	19.7	13.1	15.4	18.9	30.5	23.0	14.8	15.3	7.3	21.5	13.3	8.8	11.4
PLA2G2C	UBXN10-AS1	ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20186518	"Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2.9;Late spermatids: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.6;U-698: 2.0;U-937: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.0	0.4	0.1	0.2	0.4	0.0	0.7	0.5	0.1	0.3	1.2	0.2	0.4	0.2	0.7	0.1	0.1	0.1	0.5	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.0	0.1	1.7	0.0	0.5	0.3	0.0	0.4	0.1	0.8	0.1	0.3	0.4	0.5	0.1	0.2	0.1	0.6	0.3	0.0	0.2	0.0	0.1	0.4	0.2	0.7	0.5	0.5	0.3	0.3	0.3	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.3	0.1	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.6	0.0	9.8	0.3	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PLAGL2	ZNF900	ENSG00000126003	"PLAG1 like zinc finger 2"	Q9UPG8	20	32192504-32207743	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.7;Glandular and luminal cells: 47.7;Late spermatids: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 18.3;non-classical monocyte: 34.8"	"Lineage enriched"	"Detected in many"	15	"monocytes: 34.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005900	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA005900: AB_1079629"	"unprognostic (9.40e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.11e-3)"	"unprognostic (8.63e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.09e-1)"	4.4	3.2	4.4	6.6	5.2	32.2	4.6	5.0	5.0	4.8	7.4	7.8	10.4	6.0	5.2	12.8	9.4	4.1	5.2	5.1	4.0	4.9	4.3	6.6	7.7	4.3	4.1	7.7	6.0	8.5	5.5	3.9	3.6	5.3	8.0	13.0	6.8	5.4	10.2	7.5	12.9	7.2	3.7	6.2	7.2	16.4	4.2	8.9	4.8	8.3	10.7	5.6	6.1	4.2	19.4	10.9	28.5	10.4	10.4	8.0	17.8	7.5	11.9	16.0	14.5	82.3	9.5	19.8	10.1	7.8	22.4	18.6	35.7	17.3	21.0	11.9	16.1	80.3	9.4	39.8	12.7	35.5	17.0	9.7	15.1	12.9	9.1	7.5	11.7	20.7	28.7	17.5	8.5	10.8	39.2	24.4	13.4	14.8	12.4	25.0	36.8	12.6	6.9	14.6	12.9	14.2	18.5	9.9	16.1	16.5	14.9	42.8	8.8	19.3	20.5	14.0	15.5	47.5	28.5	25.1	11.2	73.5	12.1	2.2	3.6	0.9	0.7	18.3	1.4	1.4	1.0	1.5	2.2	1.0	1.2	0.7	0.9	0.5	34.8	0.6	0.8	2.5	4.4	5.2	5.0	5.0	5.1	4.0	4.3	4.1	3.6	3.7	4.2	4.2	4.3	12.8	21.1	2.0	6.0	7.5	13.5	6.2	10.8	7.4	8.6	6.5	4.2	2.8	12.2	1.8	31.3	3.2	8.1	13.1	3.9	3.8	56.7	26.1	9.1	5.2	10.7	10.3	4.5	5.2	3.1	5.7	8.2	47.7	2.5	6.4	7.1	3.8	6.0	3.3	3.8	12.4	2.0	8.9	7.8	159.8	2.5	11.9	0.0	4.7	11.1	6.3	0.0	1.5	4.9	6.2	8.9	7.2	7.9	15.0	29.3	3.4	6.8	21.3	6.6	7.1	4.1	11.8	10.8	21.2	11.6	4.1	7.4	6.2	16.7	21.7
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146055-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	5.4	6.0	4.5	8.6	4.8	9.2	9.4	7.3	5.2	9.4	10.1	13.6	8.8	11.8	8.2	8.9	12.9	6.5	8.2	4.5	6.1	9.2	4.8	4.9	11.2	4.6	4.0	22.3	10.7	9.2	8.2	4.8	3.3	25.4	10.1	14.1	7.8	8.5	29.1	12.6	8.9	10.4	3.4	6.1	8.5	3.0	5.9	13.6	12.5	16.3	10.8	10.9	8.1	3.9	30.7	13.4	11.8	18.3	3.8	2.3	0.8	15.1	15.0	22.1	28.2	15.7	14.6	88.3	18.0	3.3	18.8	11.5	24.3	12.1	49.9	27.8	30.8	18.0	8.0	14.9	4.2	52.4	13.9	3.8	8.8	8.4	17.7	18.0	5.4	26.2	7.0	46.3	6.9	4.7	33.3	41.3	4.8	26.4	13.2	54.5	58.5	65.1	24.8	5.7	33.1	23.0	9.1	14.5	15.1	15.3	0.1	45.5	8.8	0.4	13.3	4.6	32.0	24.5	38.3	19.0	6.1	44.3	2.1	0.8	0.3	1.2	0.7	0.2	1.2	1.5	0.9	1.3	0.6	1.0	1.4	1.2	1.0	1.9	0.2	0.9	0.1	0.6	4.5	4.8	7.3	5.2	4.5	6.1	4.6	4.0	3.3	3.4	5.9	3.9	7.3	9.6	10.3	21.5	14.3	30.2	23.8	7.4	17.1	28.5	21.6	16.5	23.4	27.1	11.5	16.5	31.3	2.8	7.1	6.8	5.9	11.9	5.5	15.1	13.6	8.8	10.8	18.3	29.5	10.4	2.4	12.0	15.3	20.6	6.3	17.3	8.9	9.2	3.4	8.4	38.9	21.4	6.1	6.7	17.9	9.0	24.5	6.8	17.8	26.2	14.6	11.1	4.1	32.2	27.3	18.1	7.9	19.2	15.5	44.4	5.2	15.6	12.2	24.3	6.6	26.9	20.3	5.3	6.6	24.4	31.7	1.2	10.5	5.3	28.4	17.4
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477089	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 333.9;epididymis: 594.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.6;Erythroid cells: 227.3;Syncytiotrophoblasts: 646.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 531.3;U-937: 593.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		NA	NA		58000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	78.6	24.8	16.1	46.8	16.6	333.9	34.6	22.6	22.7	25.3	18.9	52.2	120.3	14.2	594.8	87.4	18.2	56.8	29.0	17.7	19.6	206.8	98.0	48.6	46.7	20.3	18.1	5.0	23.2	32.0	19.8	132.6	20.1	15.0	61.8	27.1	22.6	27.4	7.3	29.6	60.3	38.7	23.1	44.5	50.6	7.4	21.1	33.5	17.8	10.0	64.4	100.4	41.5	20.1	86.1	113.4	24.0	53.9	26.0	21.0	71.8	85.2	40.3	68.2	67.0	66.1	76.5	227.1	96.8	45.5	81.5	89.9	125.2	159.8	89.5	75.0	109.6	189.1	89.9	109.3	24.2	531.3	94.7	14.4	57.4	206.0	91.0	37.8	295.9	141.0	95.4	137.4	86.7	79.1	157.6	311.3	67.5	215.7	186.1	130.2	35.9	88.3	243.7	79.6	101.9	22.6	163.4	205.0	13.2	32.6	75.5	92.5	240.0	46.1	62.6	105.1	148.4	63.1	113.3	258.9	39.3	593.0	4.6	12.0	30.6	10.3	39.8	27.3	73.6	25.7	44.2	45.0	48.1	28.8	27.6	35.9	3.7	38.5	26.6	27.3	16.7	31.1	16.1	16.6	22.6	22.7	17.7	19.6	20.3	18.1	20.1	23.1	21.1	20.1	149.6	0.0	23.5	5.9	50.3	84.6	67.4	12.6	112.7	4.7	56.3	62.6	3.5	27.1	13.4	82.8	14.6	360.6	45.2	61.1	39.2	43.2	1.3	36.0	12.7	139.4	46.4	227.3	0.6	51.5	41.8	32.4	106.5	65.3	57.7	5.0	24.3	30.6	70.9	16.8	1.1	51.3	18.3	18.1	58.4	0.8	0.3	83.3	30.2	3.7	13.2	78.8	29.9	3.0	0.9	130.8	83.9	0.7	88.6	27.5	41.2	118.9	10.5	18.1	0.0	23.9	41.3	0.4	0.7	114.7	63.9	646.2	62.3	3.1	51.4	77.1
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36313955	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 23.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 69.8;eosinophil: 18.9"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 69.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.1	0.2	0.1	0.6	0.2	4.3	0.6	0.3	0.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	4.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	23.9	0.9	0.2	0.1	0.7	1.7	1.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	17.6	0.0	69.8	4.0	18.9	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	6.2	0.1	1.1	0.0	0.0	1.1	0.1	0.2	0.3	0.4	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	4.5	0.7	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.3	1.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.1	1.5	3.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.4	0.2	0.2
POFUT1	"FUT12, KIAA0180, O-Fuc-T, O-FUT"	ENSG00000101346	"Protein O-fucosyltransferase 1"	Q9H488	20	32207880-32238658	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Fucose metabolism, Notch signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 20.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 20.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054519, HPA059935"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA		60000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA054519: AB_2682515, HPA059935: AB_2684171"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-3)"	"unprognostic (8.83e-2)"	"unprognostic (5.51e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.86e-3)"	17.6	10.8	7.9	11.7	8.4	10.5	16.5	7.2	7.7	15.2	9.1	20.0	20.4	14.9	14.4	12.4	20.4	11.4	17.5	7.7	7.3	16.1	30.9	12.2	9.1	9.3	8.3	20.0	13.8	23.8	9.1	16.4	8.0	14.5	19.1	5.9	13.0	18.1	12.8	13.7	24.0	18.1	8.0	9.4	11.1	9.5	8.1	10.5	18.9	14.0	10.0	14.0	10.9	8.2	47.1	37.2	31.5	34.7	52.9	51.4	58.8	47.8	56.2	78.8	51.3	111.9	62.1	31.7	69.8	53.5	87.2	51.2	30.5	59.0	68.0	16.5	19.2	47.1	32.1	51.2	41.2	41.0	28.9	45.4	45.7	59.7	38.8	33.5	44.6	30.0	36.3	17.6	55.6	23.1	28.4	31.4	16.2	45.2	59.4	23.3	83.6	29.5	24.2	30.7	20.6	26.5	109.5	30.0	41.0	24.0	44.7	48.5	38.8	113.4	42.2	71.8	82.4	21.4	29.3	28.7	68.5	139.9	73.0	4.3	5.4	2.6	3.2	15.1	3.6	3.2	2.8	3.0	4.6	2.6	3.6	2.5	1.0	2.0	20.9	3.4	3.3	4.2	7.9	8.4	7.2	7.7	7.7	7.3	9.3	8.3	8.0	8.0	8.1	8.2	7.8	9.6	9.5	11.1	5.2	2.9	4.7	8.6	5.2	3.1	7.2	7.1	13.4	8.6	7.9	7.3	2.1	15.2	5.7	17.5	1.9	10.0	0.9	7.1	10.8	9.3	12.0	9.2	9.0	10.4	28.2	12.0	9.2	13.6	5.1	13.1	13.9	39.8	10.7	8.4	9.0	13.4	2.0	8.1	3.8	1.7	10.5	6.5	5.4	6.5	9.3	5.2	3.1	11.1	9.6	9.6	11.9	14.3	8.2	6.7	31.7	5.3	7.2	4.3	13.1	11.1	9.4	2.9	7.3	9.7	1.7	7.7	5.0	26.0	19.0	4.1
POGLUT3	"KDELC2, MGC33424"	ENSG00000178202	"Protein O-glucosyltransferase 3"	Q7Z4H8	11	108472112-108498384	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.8;Cardiomyocytes: 13.1;Cytotrophoblasts: 27.6;Extravillous trophoblasts: 14.5;Fibroblasts: 14.7;Hofbauer cells: 18.0;Syncytiotrophoblasts: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039315, HPA039817, HPA066134"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Vesicles	"HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624"	"unprognostic (1.29e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.56e-3)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (6.04e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.00e-3)"	"unprognostic (4.08e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (6.27e-5)"	24.6	13.2	5.0	17.3	5.0	7.6	16.2	4.6	5.4	33.6	7.0	16.8	9.4	35.0	27.3	21.0	23.0	21.7	15.2	4.2	5.9	15.6	13.2	16.0	10.4	5.5	6.1	36.5	8.3	25.2	5.4	32.7	5.4	28.4	16.9	5.8	13.9	28.4	5.5	13.7	11.2	37.1	5.3	12.4	11.3	5.8	5.5	16.4	12.1	13.9	9.5	22.5	18.8	6.0	10.9	12.4	46.5	47.8	76.5	88.5	44.8	47.0	43.7	66.0	71.1	58.9	78.1	0.1	28.6	61.6	73.1	7.9	35.6	1.2	69.3	19.4	27.4	18.1	12.1	27.2	30.8	47.7	0.2	51.1	14.6	35.0	1.0	40.1	56.6	0.3	41.5	0.3	101.0	7.9	30.9	27.2	20.3	11.5	34.8	1.5	72.5	0.2	12.3	30.3	9.7	29.5	89.1	6.2	13.3	21.4	42.3	18.0	56.8	127.0	24.9	10.8	49.7	0.4	0.1	0.3	32.6	48.9	103.1	0.1	0.1	0.0	2.0	0.7	1.7	0.2	1.0	1.7	0.5	0.3	1.0	1.5	0.1	1.9	0.4	1.0	0.9	0.5	5.0	5.0	4.6	5.4	4.2	5.9	5.5	6.1	5.4	5.3	5.5	6.0	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	27.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	21.2	0.5	0.0	0.0	0.0
POLR1F	"A43, RPA43, TWISTNB"	ENSG00000105849	"RNA polymerase I subunit F"	Q3B726	7	19695461-19709037	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	8.6	7.9	5.8	8.0	6.4	17.2	10.2	6.1	9.2	8.9	5.6	7.3	5.6	11.9	5.1	9.5	6.6	6.2	7.8	6.2	6.8	8.0	8.7	6.3	10.5	6.1	6.8	8.8	7.5	9.1	2.7	10.8	6.1	9.7	7.0	3.2	6.1	8.9	7.1	7.6	5.3	11.8	6.6	7.8	5.8	6.2	6.5	8.6	8.7	8.3	12.9	12.2	4.6	7.6	28.0	20.9	15.1	22.6	17.1	21.1	11.7	15.7	11.8	17.9	20.7	17.2	23.9	31.0	44.6	19.6	22.7	24.6	30.9	29.2	33.3	9.9	23.7	28.8	15.9	13.3	26.2	59.4	20.0	19.2	20.3	19.7	23.4	12.1	29.7	21.3	45.0	27.2	26.1	10.1	32.9	55.3	39.3	28.9	23.4	26.3	26.0	32.6	29.7	14.2	10.9	16.4	14.3	38.3	20.0	24.6	15.5	52.5	25.0	37.0	19.8	34.5	38.4	34.4	22.8	77.5	25.0	86.9	55.5	5.7	4.5	1.4	7.9	6.0	12.0	12.5	9.4	10.5	7.0	13.0	10.7	12.6	0.4	17.4	5.9	9.0	9.3	5.8	5.8	6.4	6.1	9.2	6.2	6.8	6.1	6.8	6.1	6.6	6.5	7.6	21.6	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	40.3	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	34.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	16.6	3.0	0.0	0.0	0.0
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 337.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	26.0	30.5	21.9	34.9	23.2	51.9	33.2	23.4	26.6	27.7	22.1	29.0	23.2	31.0	31.9	28.2	28.3	28.6	35.7	23.3	22.9	30.1	30.5	28.0	58.4	17.7	19.7	34.1	19.2	25.9	22.9	29.8	20.4	26.0	31.7	25.8	25.9	28.3	34.1	25.9	28.8	33.9	18.9	36.2	25.7	56.1	23.5	52.8	27.4	31.2	59.1	37.0	22.4	23.3	60.7	54.7	63.5	53.4	56.0	61.3	55.8	68.3	79.1	71.8	59.1	89.1	74.3	99.0	86.4	74.6	33.9	53.6	66.2	72.4	87.6	87.3	68.9	159.5	53.8	81.9	58.8	190.4	88.0	74.4	71.9	57.5	54.6	80.3	89.5	87.3	79.2	76.0	78.9	46.3	107.8	111.7	55.0	166.0	54.2	90.4	73.7	93.3	111.7	50.7	44.7	66.0	61.1	48.7	60.1	60.7	75.1	90.7	63.1	41.5	74.5	39.9	60.7	87.4	129.9	163.3	69.8	337.5	27.7	51.7	23.9	44.1	32.7	26.7	39.4	44.3	41.9	44.5	43.8	35.8	37.9	38.1	14.9	44.6	25.9	41.5	61.5	22.6	21.9	23.2	23.4	26.6	23.3	22.9	17.7	19.7	20.4	18.9	23.5	23.3	28.9	41.7	51.8	46.0	78.4	75.8	68.1	116.9	44.9	60.2	30.8	31.0	32.5	40.0	70.7	42.3	29.2	88.1	77.4	31.8	37.2	62.3	243.3	47.5	56.1	48.1	33.6	58.5	128.7	68.3	75.4	47.0	24.5	60.7	57.0	238.1	36.0	35.5	52.9	37.0	93.2	35.8	71.2	40.6	65.4	76.7	58.4	49.1	64.0	49.6	92.9	46.3	72.1	64.3	85.0	71.4	42.1	52.3	63.4	46.4	45.8	55.6	58.6	60.5	52.6	44.6	47.9	120.3	58.8	50.3	59.1	44.2	81.8	84.0	42.4	50.7
PPIP5K2	"CFAP160, DFNB100, HISPPD1, KIAA0433, VIP2"	ENSG00000145725	"Diphosphoinositol pentakisphosphate kinase 2"	O43314	5	103120149-103212799	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Hearing	"Kinase, Transferase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037895, HPA038442"	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA037895: AB_2675724, HPA038442: AB_10673173"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (8.80e-2)"	15.7	19.1	6.8	22.0	7.9	51.6	25.1	18.9	13.9	22.2	5.8	28.1	18.3	20.6	21.2	17.1	14.5	20.4	19.5	6.7	8.9	20.3	29.2	16.2	25.5	15.4	11.9	26.1	26.7	23.0	18.1	16.7	15.1	16.3	25.5	19.2	17.1	15.4	4.2	17.2	16.5	18.4	6.1	23.9	22.5	15.1	7.3	27.9	23.3	7.7	24.5	17.8	13.9	10.7	27.4	25.3	50.8	65.2	40.8	53.4	47.8	63.5	39.3	34.2	47.6	20.9	48.3	67.6	56.2	60.9	52.7	16.5	43.9	33.2	57.5	53.7	23.5	84.7	44.3	33.4	29.0	72.1	70.4	34.5	23.4	52.0	46.1	31.2	40.0	42.5	84.9	57.0	53.1	21.3	60.9	44.6	55.4	12.7	64.4	58.6	46.7	89.3	36.8	31.5	29.6	40.1	43.5	39.9	40.7	34.0	33.5	48.9	42.7	55.8	25.7	56.0	45.1	38.1	87.3	91.3	31.5	116.0	51.2	41.7	21.5	39.6	13.0	22.9	15.8	19.5	12.6	14.2	25.6	16.1	16.1	17.0	19.7	17.8	32.4	15.5	12.3	11.1	6.8	7.9	18.9	13.9	6.7	8.9	15.4	11.9	15.1	6.1	7.3	10.7	35.8	48.1	23.1	49.3	39.3	13.6	12.8	13.7	31.9	38.5	26.1	26.4	48.9	18.6	29.6	16.5	45.9	12.7	35.7	29.7	5.9	11.6	5.6	25.4	44.7	28.7	16.3	70.7	88.4	17.0	19.2	33.0	33.6	30.6	43.6	49.2	14.6	20.6	30.6	16.8	160.3	24.2	16.2	39.5	22.4	6.7	29.5	43.3	12.4	49.6	47.5	14.5	27.8	62.8	67.0	16.9	19.1	23.7	56.6	12.1	13.3	22.6	25.1	25.2	6.6	30.3	28.1	39.7	21.6	31.6	15.8	26.0	31.6	38.7	30.1	12.6
PRAM1	PML-RAR	ENSG00000133246	"PML-RARA regulated adaptor molecule 1"	Q96QH2	19	8490056-8502640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 97.0"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 30.0;Kupffer cells: 71.5;Macrophages: 49.0;monocytes: 70.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 95.4;intermediate monocyte: 101.3;myeloid DC: 58.6;neutrophil: 54.0;non-classical monocyte: 121.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 58.6;granulocytes: 54.0;monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 23.3;NB-4: 19.4;THP-1: 39.4;U-937: 127.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045236, HPA050161"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"		"HPA045236: AB_2679267, HPA050161: AB_2681036"	"unprognostic (1.68e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.12e-3)"	1.8	1.4	2.8	10.9	3.5	97.0	1.2	3.5	3.9	2.2	1.3	0.9	2.7	1.4	0.2	0.8	2.0	2.0	0.8	2.7	7.2	1.0	2.6	9.8	1.3	11.1	5.8	1.4	1.2	0.3	1.6	1.0	7.4	3.3	0.5	0.8	1.4	0.4	0.6	1.5	2.9	2.2	4.8	12.8	1.1	1.0	7.0	1.0	1.7	0.3	0.4	1.2	1.2	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	23.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.1	19.4	0.2	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.4	0.3	0.0	0.1	0.1	0.1	0.7	0.8	0.3	0.0	127.6	0.0	2.8	95.4	3.3	0.2	101.3	0.3	0.1	0.1	0.2	58.6	0.0	0.0	0.4	54.0	11.5	121.4	3.0	0.1	41.9	2.8	3.5	3.5	3.9	2.7	7.2	11.1	5.8	7.4	4.8	7.0	6.3	0.3	6.4	5.0	1.3	0.9	0.4	1.1	0.3	0.0	3.2	0.4	1.0	0.8	4.3	3.2	0.0	0.0	0.3	3.1	0.1	0.0	0.0	0.0	0.3	0.4	1.3	0.0	3.8	0.9	0.0	0.4	0.5	0.0	0.3	2.5	0.6	2.9	0.2	30.0	1.7	1.1	0.2	2.0	71.5	2.0	0.4	0.6	49.0	0.0	12.2	70.1	0.4	3.1	0.0	1.6	0.0	0.0	1.5	0.3	0.3	0.0	0.2	0.2	1.3	0.0	0.5	0.2	0.2	1.8	0.4	0.1	0.3	1.9	1.1	0.0	0.8
PROCA1	MGC39650	ENSG00000167525	"Protein interacting with cyclin A1"	Q8NCQ7	17	28703197-28711854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"testis: 177.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 6882.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 5.6;NB-4: 6.0;REH: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023648, HPA030218"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Golgi apparatus"	"HPA023648: AB_1855726, HPA030218: AB_10601152"	"unprognostic (5.78e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.11e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.26e-3)"	"unprognostic (6.90e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.01e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-2)"	2.4	1.7	3.3	1.4	3.2	1.5	1.9	3.8	4.9	3.9	2.9	2.0	1.1	2.9	0.4	1.5	4.3	0.7	2.3	3.1	3.4	8.2	1.2	2.6	2.2	3.7	3.5	6.1	0.9	0.3	2.9	0.6	3.4	3.5	0.4	1.2	1.7	0.5	0.9	1.5	4.0	0.7	3.3	9.8	2.0	177.5	3.2	1.4	1.8	0.5	0.8	2.2	2.7	3.4	0.6	0.9	1.6	5.6	1.0	1.6	1.6	0.9	0.6	0.7	0.6	0.9	2.0	0.0	0.3	0.8	0.1	0.8	1.7	0.2	0.3	1.1	0.4	2.7	1.7	0.4	0.4	4.5	0.1	0.7	0.3	1.2	0.0	0.7	0.1	0.7	2.6	1.6	0.6	0.2	3.3	6.0	4.4	0.3	0.5	7.1	2.4	0.1	0.6	0.2	0.4	0.7	0.4	0.1	0.5	1.0	2.5	3.9	0.5	0.2	1.0	0.6	0.3	0.7	1.0	1.2	0.4	4.1	0.8	4.9	1.1	3.5	0.5	1.6	0.2	1.9	1.1	0.3	0.6	0.5	0.4	0.8	0.7	0.6	1.2	2.5	0.6	0.5	3.3	3.2	3.8	4.9	3.1	3.4	3.7	3.5	3.4	3.3	3.2	3.4	2.3	0.0	1.1	4.6	2.8	1.0	1.2	1.0	0.6	3.7	1.5	1.9	6.6	1.5	1.9	0.0	4.2	0.8	3.9	0.8	0.0	0.6	1682.9	5.3	2.4	2.7	2.4	3.0	0.8	0.2	1.9	2.7	1.1	2.4	15.2	4.2	4.2	0.2	2.8	3.3	1.1	1.5	2.0	5.3	2.9	6882.6	25.4	6.8	0.0	3.7	2.5	7.9	1.0	2.0	0.9	0.6	0.3	19.5	1.2	0.8	2.0	1.2	3.9	4.4	19.7	1.5	2.4	79.2	21.7	1.1	0.3	0.7	2.6	7.5	1.7	0.7
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome 20S subunit alpha 4"	P25789	15	78540405-78552417	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		13000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	92.9	105.0	62.5	106.3	64.4	107.6	87.5	66.2	98.8	78.9	65.6	105.1	108.9	89.6	74.5	118.2	71.6	66.0	108.4	64.7	69.1	98.1	152.1	87.9	136.9	67.6	65.5	64.6	67.3	73.4	54.4	85.8	67.5	97.2	109.6	50.3	70.3	64.2	180.6	78.3	101.3	99.3	69.3	115.3	88.5	109.9	65.6	156.5	70.6	121.6	128.7	118.8	81.2	69.9	274.2	386.9	327.7	290.8	202.1	189.5	256.3	250.2	199.9	301.4	320.6	404.9	386.9	590.8	359.7	232.5	337.4	363.9	669.1	271.8	289.1	244.2	465.7	497.6	271.6	330.1	326.9	512.6	294.5	154.6	166.8	255.0	250.9	185.4	330.7	319.1	544.2	225.0	249.6	392.3	347.5	477.4	309.7	315.3	224.5	297.7	432.9	198.9	309.5	469.4	287.6	209.9	401.3	289.5	327.5	402.2	267.8	414.7	265.8	223.7	298.6	249.3	434.2	204.0	517.9	556.2	209.9	756.7	252.6	126.0	251.9	172.9	136.2	403.9	140.3	156.0	142.0	144.7	327.4	119.9	111.7	137.0	112.8	209.4	394.8	185.4	216.8	405.6	62.5	64.4	66.2	98.8	64.7	69.1	67.6	65.5	67.5	69.3	65.6	69.9	119.0	128.2	118.5	17.3	124.1	231.6	269.6	765.7	84.2	57.8	88.5	95.8	163.7	105.8	327.0	121.4	10.4	478.9	128.4	145.3	311.0	296.2	689.4	158.0	183.6	162.5	146.2	153.2	18.0	292.7	450.6	159.9	78.0	126.0	174.2	152.9	114.9	178.9	320.4	72.3	19.6	216.2	506.6	143.2	201.7	399.0	151.0	176.9	133.4	23.4	308.6	63.5	149.3	11.1	21.5	256.0	165.7	147.4	108.0	249.3	195.8	367.2	280.0	39.8	151.2	95.4	241.1	417.1	181.0	106.4	212.8	447.1	128.6	166.7	234.7	258.4
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	2.6	2.8	11.7	2.7	56.6	2.3	2.7	3.1	2.0	3.4	3.3	2.5	1.6	0.1	2.0	3.1	2.9	2.4	2.7	2.8	3.4	3.4	10.4	13.5	3.1	3.1	1.0	1.3	0.2	1.6	1.8	3.0	2.9	0.8	0.1	2.4	1.0	1.5	1.8	9.4	1.4	3.1	33.9	2.9	0.7	3.6	4.2	2.9	1.0	5.5	4.3	2.7	3.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	55.1	0.0	0.0	0.0	3.3	0.0	14.4	0.1	0.2	0.1	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.4	20.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	4.0	0.6	0.0	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.1	0.0	0.0	1.3	2.4	0.1	59.8	0.0	4.8	71.5	71.4	39.9	33.5	30.8	13.3	27.2	32.7	59.0	18.5	14.3	22.3	85.3	41.6	38.3	5.2	27.0	42.2	2.8	2.7	2.7	3.1	2.7	2.8	3.1	3.1	3.0	3.1	3.6	3.1	1.1	0.0	5.1	1.0	19.2	9.3	1.2	0.4	0.0	1.1	0.9	1.1	1.9	0.0	2.5	0.0	0.0	0.3	60.0	3.1	0.0	0.0	9.6	0.3	0.3	0.8	60.0	4.8	0.4	0.2	0.7	1.9	0.0	0.3	2.5	0.1	2.2	0.9	42.5	0.0	0.1	6.1	2.0	41.8	36.5	18.6	0.9	41.8	7.2	0.0	51.1	0.2	91.6	5.5	1.0	0.1	2.5	2.6	8.5	0.3	0.3	0.4	0.0	0.4	0.0	0.8	3.1	0.2	1.2	0.2	4.8	0.5	68.4	78.1	0.3	1.2
PUS7L	DKFZP434G1415	ENSG00000129317	"Pseudouridine synthase 7 like"	Q9H0K6	12	43718992-43758793	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056203, HPA058750"	Uncertain		Approved	"Nucleoli,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoli	"HPA056203: AB_2683064, HPA058750: AB_2683807"	"unprognostic (3.41e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.11e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	2.7	3.1	3.3	4.9	3.6	3.5	5.4	6.8	5.2	4.1	0.3	3.8	3.8	3.6	3.7	4.8	2.9	3.8	2.7	2.9	2.6	3.1	3.2	2.4	5.7	2.6	2.0	4.7	4.3	4.4	4.1	4.0	2.7	4.0	4.5	11.7	4.0	3.5	1.7	3.7	3.6	3.1	1.1	3.4	3.9	3.0	3.2	5.1	5.7	1.7	5.9	3.4	2.7	3.7	11.2	8.3	7.2	4.1	4.9	17.4	12.8	9.6	8.1	12.6	9.6	29.9	7.9	25.7	11.9	11.9	7.3	9.9	10.5	9.7	21.5	7.9	6.5	18.8	9.2	11.2	6.1	30.3	11.7	7.2	7.1	13.1	13.5	11.6	9.2	14.9	33.3	10.9	29.7	4.5	15.8	7.8	13.3	0.0	8.8	14.7	16.9	15.4	5.6	8.5	12.1	3.9	11.9	12.8	5.1	8.5	15.1	8.4	6.7	12.8	8.4	15.0	15.2	9.6	17.7	25.5	11.8	49.1	4.3	6.4	1.9	2.2	2.1	1.7	2.7	2.1	2.3	2.3	2.1	2.8	2.0	2.9	1.3	2.5	1.6	2.3	1.0	1.5	3.3	3.6	6.8	5.2	2.9	2.6	2.6	2.0	2.7	1.1	3.2	3.7	30.5	9.6	17.2	29.0	41.1	11.6	19.0	30.8	22.8	68.9	24.2	16.0	12.3	14.3	21.2	25.8	68.8	34.3	34.4	13.5	41.1	20.4	2.5	14.9	28.5	23.3	19.3	25.2	49.5	23.2	23.3	26.5	28.5	18.9	17.1	43.7	16.8	20.8	20.4	43.7	79.5	25.2	18.3	25.0	10.5	4.2	20.2	20.3	12.4	15.0	24.6	33.1	35.0	41.7	51.2	18.2	17.0	26.7	48.7	16.9	19.6	22.7	9.2	106.1	19.7	28.1	18.1	25.2	35.3	19.9	11.1	24.2	32.7	36.3	30.0	13.9
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426127	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 320.5"	"Cell type enriched"	"Detected in all"	9	"Oligodendrocytes: 732.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 159.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Supported		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	19.9	16.7	71.6	31.5	161.3	73.1	15.8	112.3	109.2	46.7	20.4	23.3	10.6	23.5	8.4	11.3	17.5	15.5	17.8	84.1	115.0	18.2	11.6	20.6	43.0	158.2	131.3	18.3	15.7	21.2	13.4	29.7	154.1	12.8	10.5	35.6	14.8	11.7	18.8	14.3	19.3	18.7	82.1	25.2	16.3	12.4	119.0	13.7	63.1	14.3	44.9	19.5	30.2	320.5	13.7	6.9	6.8	12.0	79.7	70.0	17.8	22.6	42.5	19.7	27.3	4.0	3.1	74.7	5.1	33.6	28.4	4.2	18.7	13.2	21.8	18.5	12.5	13.1	11.3	5.8	87.5	112.8	22.5	57.4	31.6	24.6	42.0	72.5	17.8	49.1	15.7	26.1	35.7	5.3	26.2	122.2	7.8	4.1	19.7	40.7	9.4	13.4	12.6	8.0	6.0	4.0	14.2	11.0	19.0	10.7	34.8	122.9	17.9	24.9	11.0	48.5	23.9	19.4	21.6	73.7	36.2	159.3	10.7	39.5	44.6	69.1	23.8	37.2	20.7	62.6	17.1	20.3	41.8	69.6	15.3	17.5	73.5	21.6	57.1	32.1	21.1	32.0	71.6	161.3	112.3	109.2	84.1	115.0	158.2	131.3	154.1	82.1	119.0	320.5	20.1	9.6	6.3	28.4	59.8	14.1	5.8	5.6	7.4	31.0	5.9	7.1	13.1	7.2	6.0	23.9	20.9	19.7	31.7	8.3	33.2	7.1	69.7	9.1	33.0	14.2	7.8	19.3	33.8	5.7	6.8	41.5	6.1	16.0	19.7	15.2	16.4	7.5	13.6	20.2	53.7	5.0	2.0	24.5	31.1	38.3	30.7	25.2	17.8	30.0	28.6	32.7	30.9	79.4	732.6	3.0	5.5	25.2	17.6	6.0	8.7	12.2	6.4	22.2	19.7	18.7	18.2	16.8	21.9	10.1	13.1	35.2	16.9	18.3	5.0	3.9
RAD9B	FLJ40346	ENSG00000151164	"RAD9 checkpoint clamp component B"	Q6WBX8	12	110501655-110533556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 11.3"	"Group enriched"	"Detected in some"	21	"Spermatocytes: 91.5;Spermatogonia: 29.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"basophil: 4.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.7;SiHa: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040643	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA040643: AB_10805716"	"unprognostic (2.32e-1)"	"unprognostic (2.55e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.80e-2)"	0.3	0.1	0.3	0.2	0.4	0.3	0.4	0.4	0.4	0.4	0.2	0.3	0.0	0.4	0.4	0.3	0.3	0.1	0.8	0.3	0.3	0.2	0.3	0.3	0.5	0.4	0.3	0.7	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.4	0.1	0.4	0.8	0.2	0.2	0.5	0.3	0.3	0.2	11.3	0.4	0.4	0.2	0.5	0.3	0.3	0.2	0.7	1.6	0.1	0.1	0.4	0.1	0.3	0.1	0.7	0.2	0.7	0.6	1.6	0.1	1.2	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.4	1.5	0.2	0.0	0.2	1.9	0.3	0.2	0.2	0.6	0.5	0.2	0.1	2.7	0.3	0.9	0.9	0.2	0.4	0.5	0.1	0.5	0.5	0.1	0.4	0.3	0.3	0.2	0.3	0.1	2.9	0.3	0.4	0.0	0.6	1.0	0.2	0.3	0.0	0.3	0.2	0.6	0.3	0.7	0.3	1.0	1.0	4.7	0.5	0.2	0.2	0.4	0.2	0.4	0.3	0.1	0.9	0.3	0.2	0.1	0.5	0.2	0.9	0.5	0.1	0.3	0.3	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.7	0.2	0.0	0.0	1.6	0.7	0.5	0.4	0.5	0.0	0.3	0.3	0.3	1.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.9	0.3	2.8	0.2	0.1	0.4	0.0	0.4	0.7	0.0	0.1	0.7	0.0	0.3	0.0	0.9	0.4	0.3	1.3	0.0	0.7	0.0	0.0	1.2	0.3	2.0	1.5	0.5	0.0	1.9	1.9	0.6	1.0	0.5	2.8	0.4	0.0	0.0	0.5	0.2	0.0	0.1	2.4	0.8	0.0	0.5	0.2	91.5	29.0	0.0	0.4	0.1	0.3	0.1	0.1	0.2
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 251.4;Oligodendrocytes: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (3.46e-4)"	"prognostic unfavorable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favorable (8.20e-4)"	21.7	26.0	17.1	28.5	21.8	37.2	25.6	32.0	30.1	24.9	13.7	21.0	18.6	28.2	28.1	20.9	24.2	17.5	18.8	19.5	18.3	20.3	21.1	21.5	40.4	14.2	14.4	32.8	27.9	19.2	30.2	24.2	15.0	21.2	21.9	40.9	23.7	18.6	26.0	32.4	28.5	20.3	13.8	33.7	25.0	30.0	16.7	29.9	25.4	19.4	34.2	20.8	21.5	22.2	55.3	29.1	70.1	35.9	30.7	32.2	38.1	37.0	30.9	37.5	38.7	39.1	45.9	82.1	29.5	27.3	24.7	51.4	53.0	36.3	54.2	49.6	56.3	63.4	68.0	35.8	23.9	119.9	48.6	21.9	29.6	38.6	53.3	34.4	39.8	50.5	49.0	26.8	41.9	18.7	73.3	63.3	43.6	49.3	16.9	72.9	57.5	43.8	34.9	31.4	53.2	35.6	31.8	38.2	23.4	42.4	34.4	99.0	38.0	31.8	31.7	25.9	38.0	38.5	36.0	100.0	51.6	66.0	38.6	3.8	1.4	2.8	2.9	2.0	3.0	3.7	2.8	2.7	0.8	5.5	4.2	3.7	2.0	2.3	1.5	2.6	3.3	1.0	17.1	21.8	32.0	30.1	19.5	18.3	14.2	14.4	15.0	13.8	16.7	22.2	50.2	57.7	83.5	148.9	80.9	34.7	35.1	25.0	47.8	63.7	36.5	31.0	42.1	35.8	35.6	25.8	73.0	34.3	72.4	34.8	9.8	25.4	49.2	29.0	59.9	43.3	49.1	41.9	251.4	26.0	31.5	41.6	32.1	36.6	55.8	75.9	60.0	40.3	32.9	57.2	170.8	39.2	32.6	53.7	23.0	27.3	65.0	41.6	16.0	137.7	58.0	37.9	56.7	217.6	253.0	27.0	31.5	47.4	65.8	51.1	28.4	19.6	37.7	72.0	52.6	71.3	43.1	102.3	78.1	47.3	35.5	23.0	54.8	57.7	37.5	33.7
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819222-36829104	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	SCID	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA032035			Approved	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA032035: AB_2674120"	"unprognostic (2.03e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.14e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.15e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.94e-1)"	"prognostic favorable (4.18e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.99e-3)"	4.3	3.4	3.8	5.0	4.2	6.0	4.7	6.8	5.2	6.3	2.5	5.1	3.1	6.8	5.1	3.0	5.8	4.1	3.5	3.9	3.5	3.3	2.6	4.3	6.7	3.3	3.7	7.0	4.6	6.2	4.6	3.7	3.5	5.2	4.1	5.5	4.8	3.8	4.3	3.5	4.4	5.8	4.0	5.1	4.2	6.5	3.4	8.3	5.8	3.0	5.4	4.0	3.8	4.3	7.4	1.8	10.4	14.7	3.8	5.2	6.7	5.9	6.2	10.9	6.7	5.2	5.9	32.3	4.8	5.4	9.6	6.7	10.8	3.6	12.2	24.4	17.9	15.5	8.6	10.2	6.9	28.7	10.9	4.8	6.3	5.3	4.0	3.1	8.3	24.4	9.0	6.4	3.3	3.6	28.8	20.5	11.1	6.4	3.2	24.9	19.3	9.8	4.6	4.5	8.5	10.6	5.7	3.8	4.7	6.3	3.9	16.9	6.5	2.8	6.1	9.8	5.5	6.0	5.3	24.2	7.9	19.6	4.5	0.0	0.0	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.3	0.2	0.0	3.8	4.2	6.8	5.2	3.9	3.5	3.3	3.7	3.5	4.0	3.4	4.3	6.6	3.2	3.9	11.1	10.4	3.6	3.3	2.5	7.4	14.5	4.9	4.4	3.6	1.5	2.7	3.7	2.1	6.4	11.1	2.0	15.6	4.2	5.3	4.3	7.5	7.0	7.2	16.0	26.4	5.5	2.8	9.8	4.6	3.0	10.2	10.9	7.9	2.2	3.1	23.5	27.5	2.8	2.0	1.9	7.4	4.1	11.1	4.1	7.2	7.5	5.5	20.8	17.5	11.1	23.9	2.8	2.5	10.9	6.4	1.5	3.3	1.4	2.2	18.0	6.6	13.1	10.0	20.1	25.8	2.8	2.0	1.2	11.7	8.2	3.6	0.8
RGL4	Rgr	ENSG00000159496	"Ral guanine nucleotide dissociation stimulator like 4"	Q8IZJ4	22	23688136-23699176	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 164.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 23.8;Early spermatids: 18.1;NK-cells: 52.5;T-cells: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 393.6;neutrophil: 516.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 516.3"	"Group enriched"	"Detected in many"	5	"MOLT-4: 26.3;U-937: 61.0"									HPA035979	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA035979: AB_10673227"	"unprognostic (1.48e-4)"	"unprognostic (2.75e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.93e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.11e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-3)"	3.8	3.1	0.1	7.6	0.2	164.4	0.5	2.0	0.8	0.3	0.3	1.2	4.1	3.1	0.0	1.9	0.9	4.6	2.8	0.2	0.0	1.5	1.3	4.8	11.5	0.6	0.1	3.9	3.4	0.1	0.5	1.7	1.0	1.4	1.1	10.6	4.6	0.2	3.0	5.6	4.1	0.6	0.1	19.8	2.4	3.8	0.1	8.4	3.1	0.9	8.1	3.8	0.5	1.1	1.6	0.5	5.8	2.5	0.0	0.0	2.5	1.8	0.0	0.0	0.0	1.3	1.1	1.9	0.4	0.0	1.0	2.8	0.0	0.0	0.0	2.0	3.6	0.9	2.5	0.3	0.0	3.4	3.8	0.0	0.0	0.0	0.0	2.9	0.0	2.0	2.1	3.0	0.0	1.0	26.3	3.6	0.4	0.6	0.8	9.3	2.0	1.4	0.0	1.7	1.8	2.7	1.7	3.7	0.6	3.1	1.2	2.0	2.5	3.2	1.9	2.2	1.1	5.3	0.8	1.3	1.9	61.0	1.6	98.0	2.9	393.6	57.4	20.8	59.6	6.5	74.1	66.2	5.4	5.2	104.6	93.8	516.3	35.2	84.6	0.7	114.2	37.4	0.1	0.2	2.0	0.8	0.2	0.0	0.6	0.1	1.0	0.1	0.1	1.1	0.7	0.0	4.4	0.3	5.9	0.9	0.0	0.0	0.0	0.5	0.4	0.5	0.5	1.5	1.3	0.0	2.1	0.0	23.8	0.0	0.0	2.4	18.1	0.1	0.3	0.3	0.0	8.8	0.4	1.7	0.1	0.6	2.6	0.2	1.3	0.1	0.4	0.3	0.1	1.7	0.5	0.0	0.0	1.6	0.7	2.0	0.0	3.5	1.8	0.0	2.5	0.0	52.5	0.5	0.4	2.2	0.0	0.0	3.4	0.0	0.0	0.3	0.0	2.8	0.0	0.3	0.5	5.9	0.0	0.0	0.3	0.0	51.8	0.1	0.1	0.1
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158462-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.2;lymphoid tissue: 25.4"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 527.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 353.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 353.1"	"Group enriched"	"Detected in some"	5	"HEL: 60.2;HL-60: 46.7;NB-4: 43.6;U-937: 39.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		340000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	4.3	2.3	0.7	14.1	0.6	13.2	2.3	0.9	0.7	2.4	0.9	2.4	2.9	1.0	0.5	1.9	1.3	5.3	0.8	0.6	1.2	1.0	5.3	4.1	8.4	1.5	1.0	0.8	0.8	0.4	0.3	2.2	1.5	1.1	2.9	0.6	0.7	1.0	0.9	0.4	5.8	2.9	1.3	25.4	1.9	0.4	0.8	4.2	0.8	3.1	4.4	4.8	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	39.9	0.0	195.5	50.7	353.1	0.8	66.7	6.8	0.1	0.8	1.3	51.0	0.2	0.1	0.2	164.8	0.6	82.1	12.0	0.0	94.4	0.7	0.6	0.9	0.7	0.6	1.2	1.5	1.0	1.5	1.3	0.8	1.6	0.3	6.4	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.0	1.8	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	16.0	0.0	0.0	0.0	0.8	0.0	0.0	24.7	0.0	5.7	1.1	7.3	0.0	0.0	0.0	0.0	124.9	27.3	0.8	0.3	527.4	0.0	15.9	128.3	0.1	28.8	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.3	1.5	0.3	13.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	7.6	0.0	0.1	0.0
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955487-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"bone marrow: 1713.7"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 30.7;Kupffer cells: 174.3;Macrophages: 82.2;monocytes: 54.6"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 457.5;eosinophil: 1352.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1352.6"	"Group enriched"	"Detected in some"	303	"HL-60: 539.0;NB-4: 539.8;THP-1: 1405.4;U-937: 1295.9"									HPA044983	Enhanced				"Secreted to blood"	NA	NA		200000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	7.1	6.0	3.0	9.1	2.8	1713.7	1.7	2.9	5.5	2.3	4.4	2.2	0.2	2.1	0.3	0.9	5.7	2.6	4.0	2.8	4.2	1.7	4.6	12.2	1.9	5.4	4.1	1.5	1.7	0.5	1.7	1.8	4.4	1.7	0.7	1.7	1.9	0.2	0.7	2.9	1.4	9.7	4.5	35.1	2.1	0.7	4.2	14.8	0.9	0.6	0.6	5.2	1.4	6.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.1	0.0	539.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	539.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	1405.4	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.7	0.0	1295.9	0.0	457.5	109.0	1352.6	0.4	19.3	0.8	0.3	0.4	0.0	191.8	0.4	0.4	0.4	9.8	0.1	2.8	2.6	0.1	39.9	3.0	2.8	2.9	5.5	2.8	4.2	5.4	4.1	4.4	4.5	4.2	6.3	0.2	3.2	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.4	0.0	1.9	0.0	0.5	0.0	0.0	1.3	0.0	30.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.4	2.2	13.0	0.0	0.0	0.0	0.0	174.3	0.7	1.7	0.3	82.2	0.0	0.0	54.6	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0
RNASE3	"ECP, RAF1, RNS3"	ENSG00000169397	"Ribonuclease A family member 3"	P12724	14	20891399-20892348	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"bone marrow: 934.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.9;Erythroid cells: 5.9;Kupffer cells: 4.5;Late spermatids: 10.9;Macrophages: 3.0;Rod photoreceptor cells: 3.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	22	"eosinophil: 304.6"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 304.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 150.4;NB-4: 51.1;THP-1: 63.6;U-937: 301.8"									HPA056183	Enhanced				"Secreted to blood"	NA	NA	4200000		"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA056183: AB_2683059"	"unprognostic (2.54e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.21e-2)"		"unprognostic (6.45e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"		"unprognostic (8.62e-7)"	"unprognostic (6.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.37e-1)"	0.4	0.4	0.5	0.5	0.5	934.3	0.1	0.5	1.2	0.1	0.3	0.2	0.0	0.1	0.3	0.1	0.3	0.3	0.2	0.5	1.0	0.2	2.0	2.7	0.7	1.1	0.7	0.2	0.1	0.0	0.3	0.6	0.9	0.2	0.1	3.8	1.2	0.1	0.1	1.7	0.1	1.0	1.0	9.8	0.1	1.8	0.5	9.4	0.1	0.0	0.0	0.3	0.1	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	150.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	63.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	301.8	0.0	11.3	8.8	304.6	0.0	1.2	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	4.3	0.0	0.5	1.6	0.0	4.4	0.5	0.5	0.5	1.2	0.5	1.0	1.1	0.7	0.9	1.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	10.9	0.3	3.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 121.3"	"Cell type enriched"	"Detected in all"	7	"Oligodendrocytes: 2136.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-937: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027577, HPA027578"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027577: AB_2672339, HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	7.5	5.9	37.9	7.3	67.0	10.8	6.8	49.1	49.3	7.4	0.4	9.1	7.8	8.9	5.9	6.6	8.1	2.9	8.7	36.2	45.1	6.6	5.2	5.7	5.9	64.1	53.3	7.6	7.0	5.7	7.1	6.2	63.0	5.9	3.9	7.5	7.4	4.5	24.3	8.6	7.7	5.5	38.1	6.9	6.6	8.2	68.3	7.1	6.3	10.1	5.8	7.0	7.0	121.3	11.6	5.4	22.9	7.8	8.7	7.9	17.1	13.4	12.3	10.1	14.9	9.3	11.2	22.3	11.6	10.8	14.4	7.5	25.8	11.0	13.7	28.0	22.9	30.9	17.9	16.3	14.1	22.0	15.2	8.7	24.7	11.3	17.9	8.4	5.9	11.6	23.1	10.7	6.3	8.1	21.8	16.7	24.9	12.6	12.2	18.3	13.5	15.9	6.5	7.1	10.3	12.7	11.4	7.8	17.4	7.9	5.8	38.1	9.1	10.7	11.4	10.2	25.1	24.4	25.2	16.0	8.7	69.5	6.5	0.9	0.8	1.2	1.2	0.7	0.9	0.8	0.3	1.6	1.3	1.2	0.7	0.6	0.6	0.8	0.5	2.5	1.3	0.6	37.9	67.0	49.1	49.3	36.2	45.1	64.1	53.3	63.0	38.1	68.3	121.3	16.2	9.6	13.4	66.3	26.9	15.2	13.4	13.2	30.1	25.1	24.7	20.8	22.0	25.8	10.4	23.9	25.0	17.3	33.7	29.0	17.6	17.9	13.1	23.4	20.7	17.2	18.0	41.9	21.9	28.7	24.5	16.7	19.4	20.5	10.8	18.8	17.9	31.4	25.7	23.5	12.9	24.3	22.4	29.3	9.8	16.2	19.3	21.3	12.4	298.9	23.9	19.2	15.5	7.1	2136.9	25.3	20.9	13.9	26.1	22.5	26.5	35.6	8.2	18.3	6.6	23.5	14.8	30.6	31.3	25.1	17.5	10.1	26.1	17.6	26.7	20.5
RNF24	G1L	ENSG00000101236	"Ring finger protein 24"	Q9Y225	20	3927309-4015558	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 112.5;Inhibitory neurons: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 238.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 238.2"	"Cell line enhanced"	"Detected in all"		"ASC TERT1: 81.7"	"Low region specificity"	"Detected in all"							HPA011900	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA011900: AB_10671089"	"unprognostic (6.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.65e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (2.67e-7)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.24e-1)"	9.0	7.8	9.5	8.0	9.7	51.8	7.0	4.9	10.9	6.6	0.0	5.7	2.5	5.7	14.9	7.5	5.3	5.9	6.5	10.7	9.5	11.3	2.7	13.9	2.3	7.4	7.6	5.1	4.8	2.5	6.2	3.4	7.6	8.7	3.5	4.7	6.9	6.9	2.1	8.8	4.5	5.3	6.6	12.5	5.7	4.1	8.9	5.4	7.3	3.7	3.8	7.9	5.9	7.2	19.8	9.0	12.9	11.2	48.8	81.7	4.6	16.4	35.4	16.5	23.6	6.0	19.3	4.1	3.5	33.7	25.3	12.9	5.2	18.7	27.4	2.8	3.9	36.4	16.2	4.7	42.1	73.8	13.8	27.6	5.7	43.8	36.8	18.3	15.5	12.6	47.1	9.6	26.9	5.2	11.8	15.1	19.5	18.2	12.6	14.0	10.9	3.3	9.3	10.5	12.1	9.8	44.4	26.3	11.6	18.8	9.6	25.3	23.3	39.8	12.9	27.1	19.7	7.5	7.9	1.4	20.2	24.7	12.7	108.9	23.5	51.3	3.7	8.5	3.0	1.4	7.0	5.4	19.3	4.6	4.2	5.4	238.2	7.5	12.7	0.5	3.4	11.5	9.5	9.7	4.9	10.9	10.7	9.5	7.4	7.6	7.6	6.6	8.9	7.2	6.2	3.2	19.1	34.0	7.8	48.8	36.9	24.1	26.2	18.1	26.9	19.3	2.7	4.3	18.6	49.7	16.7	1.9	9.1	5.7	7.9	33.6	16.3	17.2	37.4	13.9	13.1	43.3	112.5	25.6	6.7	42.4	9.7	31.4	4.5	12.6	17.2	1.2	5.7	38.7	127.2	6.6	10.2	24.7	71.6	22.6	36.7	30.9	39.2	16.9	25.2	10.4	7.2	74.4	21.1	29.2	5.8	60.2	5.9	73.8	2.2	1.8	6.8	9.6	19.7	12.4	32.3	21.4	22.4	12.8	54.4	2.9	17.0	7.4	4.8	75.1
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111813	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 406.2;Late spermatids: 505.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	8.0	4.2	3.8	5.7	4.8	18.2	6.0	4.4	3.9	5.3	4.6	5.0	3.6	5.9	4.6	4.2	6.3	4.2	5.5	2.8	3.5	4.4	4.8	7.6	5.5	5.4	4.0	5.4	5.1	2.9	2.9	4.4	4.9	4.4	3.2	4.8	4.4	3.4	2.6	3.7	5.2	3.2	4.4	6.2	5.8	2.6	4.5	5.5	4.5	1.9	4.2	6.6	5.4	5.3	6.5	3.9	3.9	3.8	7.2	7.7	6.3	8.9	4.3	3.9	4.2	6.6	2.7	8.0	6.2	10.5	2.1	5.2	3.6	5.2	7.8	11.4	4.1	6.4	7.3	2.9	3.6	17.9	9.6	5.6	4.6	5.8	4.7	3.2	6.0	3.1	3.7	7.9	4.6	4.1	8.5	3.8	3.2	4.3	6.6	11.9	4.5	3.1	3.7	5.9	4.5	3.5	7.1	4.6	3.6	3.4	4.6	6.7	9.9	7.7	6.4	7.1	7.2	10.7	5.3	9.0	5.8	7.5	4.8	3.0	5.0	6.8	5.0	3.2	4.0	3.9	3.6	3.8	4.2	5.0	3.5	3.5	18.0	2.8	4.0	5.5	3.6	2.5	3.8	4.8	4.4	3.9	2.8	3.5	5.4	4.0	4.9	4.4	4.5	5.3	98.2	96.1	88.7	64.6	112.6	46.3	60.4	30.7	43.9	100.4	32.2	35.6	138.6	28.6	61.4	33.1	131.3	57.5	136.9	36.6	15.6	62.5	406.2	64.8	86.9	94.4	99.0	47.9	81.3	38.0	64.9	78.4	62.7	73.8	72.7	68.5	60.0	47.4	60.3	60.6	74.2	45.8	40.7	135.3	126.7	505.0	97.6	166.2	65.8	106.8	137.1	52.3	204.9	87.0	140.0	70.9	62.8	138.8	83.2	63.2	32.3	21.0	44.6	128.6	170.9	81.4	197.6	107.4	80.9	38.7	36.7	43.0	127.4	70.5	38.9	73.3
RPAP3	"FLJ21908, hSpagh, spag, Tah1"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	10.0	10.6	6.1	19.1	6.0	12.7	15.8	8.4	7.1	12.7	6.5	12.5	13.8	13.9	14.6	13.6	14.6	12.1	16.2	5.7	7.6	13.0	15.4	10.2	29.6	6.2	8.6	19.4	8.5	17.3	8.2	13.1	7.8	12.9	12.8	11.1	9.7	12.5	22.8	11.2	12.6	15.4	6.4	17.4	11.0	15.8	7.9	23.5	13.8	23.7	29.2	16.9	9.2	7.8	42.6	39.1	46.5	32.1	24.5	34.7	39.2	41.4	42.5	51.4	43.8	54.5	47.2	93.9	55.6	37.0	37.0	41.5	40.7	24.6	59.5	50.2	38.0	63.3	25.1	26.6	21.1	68.0	42.4	17.1	29.6	60.2	21.7	41.7	32.6	36.2	70.6	28.0	45.9	30.5	58.7	48.9	49.9	39.1	33.2	46.9	56.1	46.0	41.9	38.3	33.5	24.3	48.5	39.4	41.9	49.0	40.5	40.4	23.5	35.4	47.0	39.3	46.5	21.8	43.7	66.5	33.3	148.5	22.3	3.7	10.6	32.9	10.2	20.5	10.5	20.9	11.5	11.1	14.3	17.9	14.5	13.3	19.7	13.3	25.8	9.9	15.7	9.0	6.1	6.0	8.4	7.1	5.7	7.6	6.2	8.6	7.8	6.4	7.9	7.8	16.8	12.8	17.6	11.4	30.0	13.3	14.8	20.3	24.5	18.1	18.3	19.3	41.7	11.5	21.2	11.0	8.4	23.4	33.7	7.3	23.5	17.3	9.5	51.3	23.4	13.8	13.1	18.3	15.3	19.7	16.3	21.0	15.3	26.9	12.0	22.5	8.6	18.0	18.3	11.8	12.7	12.2	14.2	19.2	16.9	7.1	21.8	24.9	7.2	14.0	44.0	13.4	25.7	16.1	16.8	11.7	16.8	20.7	31.0	7.5	9.6	30.2	30.1	14.8	6.6	16.8	18.2	48.0	37.1	22.7	10.2	17.0	21.3	18.0	14.6	9.1
RPL36A-HNRNPH2		ENSG00000257529	"RPL36A-HNRNPH2 readthrough"		X	101391011-101412297	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 39.9;Club cells: 29.1;Fibroblasts: 8.8;granulocytes: 27.8;Respiratory ciliated cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA077586			Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"HPA077586: AB_2686846"	"unprognostic (3.69e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"		"unprognostic (4.65e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-1)"	155.5	114.7	141.9	147.6	149.9	473.9	371.3	140.5	211.3	169.5	142.0	178.1	120.3	131.9	91.3	82.4	124.0	56.9	68.9	139.2	147.0	103.1	136.9	84.1	206.9	145.8	140.6	430.7	198.7	116.1	0.3	117.0	146.1	111.6	133.6	38.7	163.1	96.2	194.2	115.9	142.0	89.7	152.1	149.1	138.2	32.9	147.3	348.5	82.7	188.2	223.7	208.3	0.5	153.8	479.9	63.6	351.8	196.0	556.6	603.8	207.1	411.5	307.5	363.4	528.3	37.6	249.6	1272.3	379.1	379.3	282.1	312.4	692.9	639.6	308.0	494.4	334.8	589.7	99.9	58.4	726.0	839.5	372.7	837.9	498.0	458.3	744.0	628.2	359.2	413.5	590.6	507.6	266.5	119.0	364.7	535.8	425.9	1038.7	262.3	388.8	984.7	647.3	412.1	29.5	230.9	445.6	512.1	373.3	416.7	288.6	171.7	707.0	594.4	115.8	314.9	330.7	357.0	374.5	651.9	710.4	186.8	1188.4	141.9	97.1	324.6	105.0	284.3	334.8	348.1	373.2	363.3	332.4	450.1	354.6	364.2	357.9	57.5	277.5	292.2	306.2	274.4	605.1	141.9	149.9	140.5	211.3	139.2	147.0	145.8	140.6	146.1	152.1	147.3	153.8	0.0	12.8	39.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0
RPS6KA1	"HU-1, MAPKAPK1, p90Rsk, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.1;monocytes: 81.2;NK-cells: 88.6;Proximal enterocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.6;U-937: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favorable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (1.84e-4)"	"prognostic favorable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (8.33e-4)"	7.4	17.0	7.8	17.5	9.1	23.8	8.3	9.2	9.3	6.0	11.2	37.9	33.1	3.0	1.2	16.9	7.9	5.5	3.8	7.9	9.1	26.2	10.5	33.7	20.2	10.8	9.5	1.9	19.4	12.5	13.4	4.0	10.1	17.2	20.7	1.4	21.5	4.5	1.7	17.8	51.4	3.6	9.4	47.1	20.6	5.4	10.4	11.4	24.5	1.9	20.7	9.0	9.6	11.6	27.1	9.3	7.5	9.9	0.4	0.1	9.9	2.2	4.2	11.0	10.6	10.8	21.9	50.2	11.9	1.3	13.3	31.0	16.9	61.0	7.8	41.8	11.0	55.3	21.6	19.5	3.4	65.8	77.6	1.8	22.1	10.1	18.0	5.0	4.9	19.7	9.6	17.7	0.6	15.0	2.4	64.3	19.1	52.2	29.2	34.8	9.5	22.0	31.7	7.3	10.7	4.4	18.7	17.5	8.4	7.8	11.2	55.5	3.2	0.5	13.9	1.8	9.2	10.9	14.0	27.5	6.5	86.8	10.8	37.6	57.9	131.2	24.2	52.1	20.3	14.2	17.9	21.6	68.8	15.7	11.3	15.8	108.2	26.4	58.4	26.9	19.0	65.2	7.8	9.1	9.2	9.3	7.9	9.1	10.8	9.5	10.1	9.4	10.4	11.6	2.8	16.0	25.0	0.0	23.7	18.6	8.1	19.9	16.5	1.5	12.0	10.4	1.3	11.5	7.7	9.2	4.2	1.6	53.9	91.1	7.9	16.3	1.9	19.9	2.2	6.9	16.3	29.5	1.4	18.7	17.5	1.8	18.3	20.7	31.8	3.3	7.9	3.4	47.5	0.0	2.6	41.6	12.2	53.0	14.2	1.4	0.0	44.1	1.8	12.2	81.2	0.6	88.6	1.0	12.3	28.1	41.9	0.0	14.2	18.8	93.3	17.2	13.6	1.8	6.6	0.8	2.7	1.6	3.4	10.9	11.6	4.1	36.3	2.0	43.6	9.1
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	31.1	21.2	22.3	41.7	29.6	89.6	40.1	38.7	23.7	28.0	36.5	31.6	29.4	34.5	41.2	26.7	26.6	30.9	30.0	19.7	25.2	29.9	42.4	31.0	54.7	30.2	26.5	37.7	23.5	39.8	17.2	31.5	32.5	29.4	34.9	60.8	27.0	24.9	35.2	40.3	31.7	29.2	25.9	43.0	29.6	29.0	26.3	44.4	34.7	38.6	49.8	31.8	23.6	38.3	56.4	49.4	60.6	50.7	41.0	55.7	56.0	64.7	52.6	54.8	39.3	180.3	60.1	116.7	71.0	69.3	32.3	54.0	62.4	52.2	61.9	62.1	42.1	108.8	64.5	47.0	32.3	115.6	70.4	46.4	54.7	47.2	71.1	62.9	57.1	50.0	85.1	62.3	70.3	51.9	87.2	63.4	47.0	0.6	67.4	70.2	81.7	57.9	52.4	70.5	34.2	35.0	71.9	60.8	35.0	47.6	56.4	123.4	71.6	55.9	46.3	42.5	34.9	44.4	36.0	187.9	47.0	245.0	21.8	39.4	19.6	29.5	21.7	19.9	19.9	28.6	20.6	21.3	16.0	28.2	22.2	20.0	51.5	21.3	23.5	30.2	20.8	12.9	22.3	29.6	38.7	23.7	19.7	25.2	30.2	26.5	32.5	25.9	26.3	38.3	180.2	176.3	164.0	91.4	200.4	128.5	127.6	87.4	132.1	134.9	101.8	96.8	187.4	88.6	131.7	79.1	127.2	86.3	229.6	96.1	54.8	117.8	57.7	133.3	148.7	146.2	103.3	118.4	75.3	107.9	72.5	135.3	69.3	152.4	222.7	224.7	114.5	138.9	109.8	107.7	81.7	123.3	67.1	158.0	160.9	39.2	121.8	157.3	67.6	141.5	211.7	105.2	185.3	119.6	122.4	103.4	103.4	103.8	126.4	121.6	97.2	83.5	149.6	198.4	124.9	176.3	129.7	157.6	82.5	116.4	120.5	61.0	170.6	114.2	107.5	145.0
SENP1		ENSG00000079387	"SUMO specific peptidase 1"	Q9P0U3	12	48042897-48106079	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 32.5;testis: 61.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.0	3.6	3.1	9.1	3.9	14.4	5.6	8.3	3.7	6.2	1.9	4.9	4.8	7.5	5.1	7.5	4.7	5.5	3.8	2.7	5.0	3.8	3.8	4.6	12.0	3.0	3.6	5.5	4.4	6.3	3.3	6.5	3.7	4.8	6.8	6.5	32.5	4.7	3.7	6.8	4.7	7.0	2.2	6.3	4.8	61.8	3.4	12.2	5.8	4.3	12.9	6.1	3.9	5.0	13.8	17.7	22.4	16.3	6.4	9.8	15.7	14.9	17.1	25.8	20.7	22.2	22.3	38.0	12.8	13.9	9.9	13.0	28.0	13.0	25.7	34.6	11.4	33.9	17.9	10.9	10.1	32.2	22.4	7.4	10.4	22.7	20.1	11.4	13.7	25.2	30.2	15.9	13.4	12.0	40.1	11.2	20.0	9.5	12.8	36.6	23.6	19.1	7.2	17.3	22.8	15.4	21.9	13.2	8.8	12.7	20.6	14.4	12.2	21.1	18.4	12.5	16.4	18.4	32.5	36.7	13.3	71.4	10.0	0.8	0.8	2.9	1.6	1.1	2.1	1.0	1.6	1.6	1.4	1.8	1.4	1.5	1.6	1.6	0.8	1.5	1.9	1.0	3.1	3.9	8.3	3.7	2.7	5.0	3.0	3.6	3.7	2.2	3.4	5.0	11.2	9.6	8.9	18.9	14.3	3.7	4.7	4.7	6.8	7.9	6.7	4.7	3.2	4.3	7.6	3.7	4.2	4.0	9.1	3.6	3.9	3.9	16.7	5.6	11.6	9.1	3.5	11.1	14.0	6.5	3.4	7.3	7.7	5.0	6.3	9.8	6.8	6.6	4.5	15.2	15.9	4.2	8.2	9.5	4.2	6.0	6.2	7.7	1.8	15.0	7.2	5.2	5.2	17.6	17.8	5.8	1.9	6.8	13.5	4.4	2.8	3.7	4.6	8.7	0.0	9.8	8.3	86.5	31.0	8.5	6.1	2.7	12.2	7.4	4.2	3.8
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"bone marrow: 74.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.4;Club cells: 2.7;Erythroid cells: 1.3;Kupffer cells: 1.2;monocytes: 4.7;Respiratory ciliated cells: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;eosinophil: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"U-937: 104.1"					"Not detected"	"Not detected"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		59000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: AB_2684072"	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	0.3	0.1	0.1	0.1	0.2	74.7	0.0	0.5	0.4	0.3	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.1	1.2	0.1	0.1	0.1	0.7	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.7	0.1	1.5	0.1	0.0	0.0	0.1	0.1	104.1	0.1	0.1	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.3	0.1	0.2	0.5	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793071-2841098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036789, HPA036790"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA036789: , HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	15.3	6.8	17.2	30.0	20.6	48.2	7.9	20.1	16.6	7.0	6.8	12.3	11.4	6.8	9.8	7.1	8.9	8.7	6.7	14.4	22.3	13.1	12.1	17.0	23.2	34.0	30.5	5.8	9.6	4.8	5.0	12.8	25.2	5.3	9.1	5.2	10.4	8.3	16.9	39.7	16.0	10.5	21.5	43.9	16.7	5.2	36.1	8.4	4.7	4.8	13.3	12.3	9.7	14.8	11.2	5.2	7.4	8.7	4.6	14.6	7.2	16.8	13.0	11.1	10.9	6.9	31.6	18.0	20.5	14.2	9.7	5.6	0.3	10.5	7.5	12.2	6.8	41.4	15.2	6.1	17.1	15.4	29.1	27.7	10.5	7.1	5.9	11.8	25.7	13.7	2.5	37.2	15.0	9.6	2.7	24.3	13.3	21.6	13.3	0.6	7.4	9.9	20.1	16.1	25.4	16.4	12.8	10.7	10.3	6.8	15.7	30.8	35.4	12.1	8.9	4.2	13.8	19.5	10.6	4.3	14.1	40.2	14.4	4.1	21.0	13.6	13.8	36.5	8.2	3.0	3.8	8.8	15.9	6.9	1.9	5.0	33.8	8.3	44.6	6.7	6.9	12.1	17.2	20.6	20.1	16.6	14.4	22.3	34.0	30.5	25.2	21.5	36.1	14.8	27.6	3.2	5.8	40.5	19.5	38.1	10.0	35.3	8.6	0.8	19.8	10.0	8.3	7.2	25.3	40.5	0.0	1.3	43.7	42.5	3.9	6.3	8.5	9.7	11.0	31.3	10.2	14.9	0.4	22.0	1.2	11.3	18.3	22.0	9.5	11.6	33.9	59.0	49.3	0.0	2.7	14.2	30.5	81.5	63.3	10.8	13.7	71.9	19.6	18.7	48.9	23.7	57.7	2.5	0.5	25.3	27.1	10.1	18.1	16.1	23.7	43.7	12.3	6.4	39.5	5.2	16.0	1.9	3.7	18.6	83.4	4.2	22.0	25.5	15.4	20.1
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826811-159837492	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	9	"Hofbauer cells: 36.9;Kupffer cells: 19.8;Langerhans cells: 61.8;Macrophages: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 14.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.7;HL-60: 1.4;U-138 MG: 1.9;U-87 MG: 1.0;U-937: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA067601: AB_2685870"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	6.9	3.7	1.7	29.8	1.8	0.9	3.0	1.8	3.6	3.8	2.9	7.6	6.6	1.5	0.7	4.2	2.8	8.0	2.6	1.4	2.3	3.9	3.3	16.1	32.9	4.9	3.9	2.8	2.1	0.6	3.5	5.5	5.3	2.5	9.5	0.3	3.4	1.4	0.9	2.8	9.3	7.6	2.5	11.7	4.9	0.8	9.2	10.5	3.0	0.6	17.7	10.3	2.1	4.9	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	1.0	1.2	0.0	0.0	5.8	0.0	3.5	8.0	0.2	0.0	1.2	4.6	14.3	0.0	0.2	2.7	0.5	8.8	0.5	0.1	0.0	3.1	1.7	1.8	1.8	3.6	1.4	2.3	4.9	3.9	5.3	2.5	9.2	4.9	0.3	0.0	2.3	0.0	1.0	1.8	0.0	0.0	0.0	0.4	0.1	0.4	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.8	0.0	0.4	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.2	36.9	0.0	0.1	0.0	0.0	19.8	61.8	0.0	0.3	41.1	0.0	1.0	1.3	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	2.9	0.1	0.0	0.0	1.0	0.5	1.3	0.0	0.0	0.0
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894401-121944188	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 50.9;epididymis: 39.2;prostate: 39.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Astrocytes: 139.7;Club cells: 64.8;Microglial cells: 49.6;Muller glia cells: 51.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 5.7;U-937: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (4.72e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.3	14.0	3.0	15.0	5.9	4.8	10.1	15.0	50.9	2.4	2.6	2.2	2.0	39.2	3.4	11.3	6.3	2.0	12.9	11.8	11.0	0.9	20.1	6.0	9.4	13.6	0.8	5.5	1.7	3.4	2.2	12.6	39.7	2.9	20.9	24.6	22.0	0.8	0.9	2.0	1.2	9.0	6.0	1.6	4.1	17.1	1.6	6.7	0.4	6.0	4.9	2.3	7.7	1.3	0.6	0.7	0.2	0.8	0.4	0.9	0.1	0.1	0.3	0.4	1.2	2.1	2.4	0.1	0.1	0.4	1.4	0.5	1.2	0.4	2.0	0.5	3.3	1.0	0.6	0.1	3.6	3.2	0.7	3.6	0.4	0.2	0.4	0.2	0.7	0.5	1.0	0.4	1.0	0.7	5.7	3.7	1.4	0.3	0.8	0.3	0.7	0.8	0.8	0.3	0.3	0.3	0.2	0.1	1.1	0.2	3.1	0.1	0.3	0.2	0.2	0.3	1.2	0.4	3.3	0.4	4.8	0.3	0.9	0.4	0.1	0.0	0.1	0.1	1.3	0.1	0.0	0.1	1.3	0.1	0.1	0.2	0.0	1.0	0.6	0.0	0.1	14.0	15.0	10.1	15.0	12.9	11.8	9.4	13.6	12.6	9.0	17.1	7.7	0.4	99.3	22.8	139.7	5.9	0.5	2.8	22.5	1.2	1.0	5.0	2.0	2.6	4.3	64.8	11.0	0.0	2.5	3.2	1.4	3.9	0.6	0.4	8.9	2.0	1.0	0.0	1.7	15.4	8.3	0.6	1.3	0.5	21.3	3.8	1.0	1.4	0.0	2.7	0.0	22.6	1.4	14.2	13.5	3.8	0.6	6.5	5.3	0.0	49.6	3.1	51.4	1.0	16.6	5.0	2.0	1.0	5.3	7.7	14.4	0.2	1.6	28.8	2.9	0.0	0.9	2.4	0.4	0.5	10.4	0.6	1.4	1.2	0.3	1.6	12.7
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740028	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 302.1;Late spermatids: 433.3;Spermatocytes: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 409.6"	"Low region specificity"	"Detected in all"							"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	17.9	27.0	19.0	14.7	22.0	46.3	17.4	18.3	23.6	19.6	14.8	18.4	16.7	25.1	30.5	17.3	23.2	15.3	23.3	23.6	18.5	19.8	32.8	16.3	19.1	20.0	18.0	13.5	20.7	34.7	27.2	12.3	18.7	19.3	14.4	10.2	21.3	17.8	22.9	14.9	16.5	23.0	16.7	22.7	17.4	100.3	20.1	21.8	20.5	24.7	16.1	22.3	14.4	18.6	53.3	44.1	32.5	80.3	66.1	45.0	30.6	38.6	46.5	71.3	72.4	47.8	35.0	32.2	23.6	68.2	56.3	42.9	50.2	52.7	44.3	0.4	37.1	144.4	31.4	48.9	72.1	123.2	209.5	40.6	83.3	53.1	43.3	25.6	36.9	61.8	162.8	147.6	48.6	35.2	61.4	99.0	34.6	48.8	59.4	81.4	20.9	100.7	34.1	42.7	44.1	40.3	33.9	24.4	82.4	20.9	42.4	162.7	22.4	49.5	27.0	75.6	56.4	38.7	66.6	32.6	37.4	409.6	59.7	41.1	36.0	67.9	35.9	35.6	30.1	53.3	30.5	29.2	48.9	53.7	24.5	29.2	16.7	29.7	34.1	83.9	21.2	35.2	19.0	22.0	18.3	23.6	23.6	18.5	20.0	18.0	18.7	16.7	20.1	18.6	18.1	3.2	2.8	2.6	31.6	10.3	16.6	37.1	2.2	19.2	25.5	23.6	7.8	24.3	22.6	7.3	8.4	37.5	16.8	20.2	17.6	50.7	302.1	17.8	16.4	21.8	24.0	57.6	5.0	61.8	56.3	18.4	10.7	13.3	24.8	24.2	21.8	31.0	64.9	48.8	5.9	19.7	32.6	25.7	12.9	433.3	21.5	39.3	24.9	4.7	26.7	33.5	26.8	6.6	5.6	46.9	25.8	27.8	12.9	33.3	23.0	23.6	17.6	22.0	26.3	14.0	23.6	185.8	29.7	10.5	9.8	26.4	14.5	29.4	25.6	17.6
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 41.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 33.7;Proximal tubular cells: 76.9"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.8;non-classical monocyte: 4.8"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.8"	"Cell line enriched"	"Detected in some"	5	"U-937: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052014	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.2	0.2	0.1	0.6	0.1	2.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.0	0.0	41.6	0.5	0.4	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.9	1.4	0.0	0.1	3.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.8	0.3	8.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	33.7	0.0	0.5	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	0.0	0.7	0.1	0.0	76.9	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.6	0.0	0.0	0.0
SLC66A2	"FLJ22378, PQLC1"	ENSG00000122490	"Solute carrier family 66 member 2"	Q8N2U9	18	79902420-79951657	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 185.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.3;Cardiomyocytes: 10.8;Cytotrophoblasts: 14.3;dendritic cells: 9.6;Extravillous trophoblasts: 14.6;Hofbauer cells: 36.1;Syncytiotrophoblasts: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051666	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA051666: AB_2681567"	"unprognostic (6.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-2)"	57.1	24.4	32.1	14.4	30.4	38.3	53.4	25.3	40.0	30.3	33.5	38.0	9.7	27.4	5.6	46.5	27.0	14.5	32.4	37.0	26.9	49.0	185.4	37.4	18.1	34.5	31.2	21.6	33.8	11.5	23.8	10.3	31.9	32.2	7.5	7.2	38.9	9.9	83.9	55.5	24.5	8.5	29.1	34.4	25.6	77.0	34.3	12.3	68.4	25.9	8.9	26.3	34.2	29.2	34.8	11.7	11.9	23.0	26.0	16.6	16.0	22.4	15.1	17.6	16.6	15.6	18.5	14.6	8.5	20.4	10.3	34.8	16.2	23.8	4.7	44.3	23.8	18.2	16.7	42.6	30.9	44.2	44.5	18.6	23.2	16.2	6.2	9.0	15.3	15.8	6.9	11.6	9.2	26.6	22.1	47.6	3.9	4.7	31.5	38.7	12.4	24.6	12.0	24.4	34.8	15.7	16.9	21.3	25.6	3.1	12.7	48.0	19.4	26.8	27.2	14.3	17.2	5.8	10.0	18.8	20.5	53.2	12.1	0.3	1.7	2.0	0.6	1.7	0.4	0.8	0.7	0.3	1.9	0.6	0.9	1.1	1.2	1.0	1.6	3.5	0.8	0.8	32.1	30.4	25.3	40.0	37.0	26.9	34.5	31.2	31.9	29.1	34.3	29.2	20.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	14.3	9.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	14.6	4.6	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	20.8	2.0	0.0	0.0	0.0
SLFN13	FLJ31952	ENSG00000154760	"Schlafen family member 13"	Q68D06	17	35435096-35448837	"Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.6;salivary gland: 32.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 56.3;Endometrial ciliated cells: 59.9;NK-cells: 60.8;Plasma cells: 38.2;Respiratory ciliated cells: 75.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 5.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;NK-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.9;HL-60: 131.9;REH: 75.0;U-266/70: 63.2"									"HPA022532, HPA023064"	Uncertain		Approved	"Cytokinetic bridge"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Cytokinetic bridge"		"HPA022532: AB_1856615, HPA023064: AB_1856616"	"unprognostic (1.11e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	3.1	0.9	1.5	9.1	1.1	25.6	9.9	1.2	0.9	6.2	5.7	5.8	8.5	4.8	2.9	3.5	16.9	6.6	1.8	1.0	1.2	2.6	2.1	6.4	10.5	1.3	1.4	1.1	3.2	14.5	0.5	1.9	1.2	2.1	6.5	0.1	32.5	4.2	0.7	2.3	4.5	4.2	1.0	13.7	11.3	0.6	1.2	10.0	7.9	0.8	11.6	2.5	1.5	1.7	0.2	7.0	13.7	0.1	0.4	1.4	0.2	1.7	0.5	6.7	10.6	0.0	0.1	0.0	38.9	1.3	0.3	11.7	1.4	4.9	7.6	3.9	2.2	37.2	6.5	0.1	0.6	131.9	1.0	0.4	0.6	3.6	0.1	0.0	2.2	0.4	0.1	36.8	0.2	0.1	0.9	28.4	6.8	0.0	0.0	75.0	0.5	3.8	11.6	34.1	0.0	0.0	0.0	6.2	0.3	0.9	9.8	20.9	0.3	0.1	2.0	10.1	0.5	63.2	9.5	0.2	0.2	20.9	1.0	3.7	0.2	4.5	1.2	0.3	1.0	0.9	0.5	0.6	0.2	0.9	0.4	0.3	0.8	5.3	0.1	0.1	0.5	0.4	1.5	1.1	1.2	0.9	1.0	1.2	1.3	1.4	1.2	1.0	1.2	1.7	6.2	0.0	3.7	0.0	7.3	1.0	3.1	4.7	5.7	0.2	14.5	9.1	0.8	27.1	12.5	5.5	0.0	0.8	56.3	2.1	1.9	1.2	0.1	59.9	3.6	3.4	3.0	19.1	0.1	0.4	0.4	1.6	8.2	11.7	3.8	3.8	1.8	0.6	1.6	0.0	0.1	4.5	12.2	1.0	1.7	0.0	0.9	3.2	0.0	2.8	1.8	0.2	60.8	0.0	0.1	1.3	0.6	0.4	38.2	1.0	0.5	1.3	75.4	0.2	0.0	0.4	3.8	0.2	0.6	6.7	1.1	0.0	16.6	3.3	4.2	1.4
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SPAG6	"CFAP194, CT141, FAP194, PF16, Repro-SA-1"	ENSG00000077327	"Sperm associated antigen 6"	O75602	10	22345445-22454224	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 63.5;fallopian tube: 49.0;testis: 96.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 228.6;Endometrial ciliated cells: 73.2;Respiratory ciliated cells: 266.4;Spermatocytes: 372.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"U-937: 105.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 11.1"	HPA038440	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038440: AB_10671742"	"unprognostic (5.02e-2)"	"unprognostic (9.52e-2)"		"unprognostic (8.94e-6)"	"unprognostic (2.21e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.78e-4)"	0.0	0.0	4.2	0.0	4.0	0.4	1.7	1.9	1.4	1.7	63.5	0.0	0.0	0.2	0.4	0.0	49.0	0.0	0.1	3.3	5.0	0.3	0.1	7.0	0.1	17.6	16.1	0.1	0.3	1.8	14.6	0.0	9.9	1.0	0.0	5.8	0.0	0.0	0.0	0.3	0.0	0.0	16.3	0.0	0.0	96.3	6.4	0.4	0.1	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.9	2.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.1	1.7	0.8	0.2	0.0	105.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	4.2	4.0	1.9	1.4	3.3	5.0	17.6	16.1	9.9	16.3	6.4	10.1	0.0	0.0	4.8	0.0	0.1	0.1	0.1	14.0	0.0	0.2	0.5	0.3	0.6	0.0	24.5	0.0	0.0	0.1	0.2	0.1	1.9	0.3	228.6	73.2	0.4	0.2	0.0	0.0	7.1	0.0	0.0	0.7	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	16.2	0.0	0.2	51.4	5.0	0.5	1.8	4.7	0.0	0.3	0.0	0.5	6.0	0.4	0.0	4.9	0.3	1.8	0.0	1.4	266.4	1.2	0.0	0.0	3.7	372.6	4.8	0.0	0.1	0.0	0.5	0.1	0.0	0.1
SPATC1	"MGC61633, SPATA15, SPERIOLIN"	ENSG00000186583	"Spermatogenesis and centriole associated 1"	Q76KD6	8	144012280-144047114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 37.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 358.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.2;medulla oblongata: 1.9;pons: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"U-937: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 13.9"							NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.96e-1)"	"unprognostic (1.41e-3)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.96e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.74e-1)"	0.2	0.1	0.2	1.8	0.2	8.4	0.1	1.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.3	0.8	0.6	1.9	0.2	0.0	0.1	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.1	0.0	2.0	0.2	37.5	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.2	0.4	0.2	0.0	1.9	0.2	1.7	0.0	0.3	0.2	0.0	0.0	0.5	5.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	358.1	2.5	0.5	0.0	0.0	4.3	0.0	0.0	1.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 71.8;lung: 28.3;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 131.6;Erythroid cells: 125.9;Macrophages: 65.8;monocytes: 66.4;NK-cells: 352.2;Plasma cells: 60.3;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 278.8;HL-60: 281.5;HMC-1: 158.3;MOLT-4: 122.2;REH: 98.4;THP-1: 164.1;U-937: 205.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	4.0	0.6	0.8	14.4	1.0	71.8	1.8	1.1	0.9	1.4	0.2	3.9	5.5	1.6	1.1	3.0	2.0	4.3	2.8	0.9	1.4	0.8	2.6	28.3	26.3	3.5	1.3	0.6	1.0	0.6	0.2	0.9	2.5	1.3	5.3	0.3	2.3	1.1	0.8	2.8	6.3	2.3	1.8	19.0	5.0	0.4	2.5	51.1	0.8	0.3	23.0	4.2	0.5	4.1	0.2	0.2	0.1	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.9	0.1	0.6	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	278.8	0.2	2.0	0.0	281.5	158.3	0.0	0.0	0.1	0.0	0.1	0.0	68.0	96.1	76.9	0.5	0.2	122.2	70.1	0.1	0.0	0.0	98.4	1.1	2.2	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.3	0.1	164.1	0.4	0.0	0.2	0.2	0.2	0.3	5.8	40.7	0.3	205.4	0.3	13.6	23.2	14.6	96.3	96.3	51.4	3.7	38.5	65.5	34.0	1.1	26.3	47.6	3.6	69.4	218.0	27.2	34.7	52.1	0.8	1.0	1.1	0.9	0.9	1.4	3.5	1.3	2.5	1.8	2.5	4.1	1.2	9.6	16.9	0.0	10.8	2.2	0.9	0.0	0.0	0.6	1.0	0.8	5.3	1.5	2.5	1.8	0.0	0.2	131.6	0.1	0.0	0.1	0.1	0.5	0.6	3.0	0.0	125.9	0.0	0.0	0.4	3.0	5.1	0.7	43.7	0.8	4.6	1.5	27.0	1.7	0.0	0.3	0.0	28.8	30.3	0.0	0.0	65.8	1.8	1.9	66.4	0.5	352.2	1.5	0.0	0.0	0.1	0.0	60.3	0.5	0.1	0.6	1.5	1.9	0.0	0.8	1.0	0.2	0.6	0.1	2.0	0.3	94.8	0.1	0.2	0.6
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897548	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	9.0	9.7	8.1	8.1	7.9	23.2	7.9	7.0	8.0	10.1	4.2	9.1	5.9	10.6	5.6	6.6	12.8	6.9	6.3	6.9	5.9	7.1	30.6	12.1	9.5	8.6	8.0	8.7	11.7	6.0	6.1	5.3	7.5	7.6	4.8	4.6	10.7	7.9	17.5	8.3	8.0	9.4	6.9	11.1	8.6	6.9	7.8	10.3	8.8	5.1	8.2	10.9	7.7	7.8	9.6	8.2	12.6	22.1	27.9	17.7	24.8	13.3	15.5	18.5	17.0	10.2	10.0	9.2	2.6	16.1	17.8	8.7	15.1	13.7	12.8	20.3	10.6	15.3	10.3	15.9	18.4	23.0	11.3	13.8	18.6	20.7	9.3	11.7	15.4	15.2	5.2	9.3	15.8	7.9	12.7	12.9	11.3	8.0	15.8	6.7	8.5	6.4	8.8	12.5	2.7	9.1	14.1	9.5	12.9	6.9	8.2	20.3	15.5	14.8	8.4	19.7	16.5	16.8	11.9	9.0	13.0	23.2	11.5	0.0	1.6	0.9	1.0	3.1	0.9	0.9	1.6	1.2	2.0	0.7	0.8	0.6	0.1	0.4	2.9	1.1	2.4	0.8	8.1	7.9	7.0	8.0	6.9	5.9	8.6	8.0	7.5	6.9	7.8	7.8	2.4	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.6	7.3	0.0	1.8	1.8	0.0	1.9	2.4	0.0	24.2	1.7	0.5	0.0	0.0	0.0	2.9	6.9	0.8	0.0	1.6	0.0	1.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	15.4	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	1.2	4.6	0.0	0.0
STK26	"MASK, MST4"	ENSG00000134602	"Serine/threonine kinase 26"	Q9P289	X	132023302-132075943	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 70.0;epididymis: 56.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 55.2;dendritic cells: 42.7;NK-cells: 53.5;Syncytiotrophoblasts: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 140.1;U-937: 144.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059921	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		Yes	No		360000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA059921: AB_2684163"	"unprognostic (6.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (4.76e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	6.0	2.5	1.0	15.2	2.7	70.0	6.0	1.7	1.3	6.8	2.5	11.5	9.6	46.6	56.3	13.1	7.4	5.6	1.4	0.7	1.5	3.5	5.2	7.2	26.2	0.8	0.8	2.1	3.7	23.5	5.0	25.2	0.7	20.0	11.6	0.2	7.3	35.8	0.9	7.8	6.9	38.1	0.6	13.2	12.2	2.2	3.8	41.3	3.7	1.2	23.5	11.8	7.4	0.7	32.9	11.3	1.3	0.0	5.2	4.9	72.0	1.0	4.0	0.5	0.6	30.1	29.0	44.6	19.4	7.3	22.1	36.5	80.8	51.1	0.0	39.1	66.6	64.6	25.9	28.4	4.7	135.3	5.1	6.9	30.0	0.1	33.7	15.1	14.2	60.0	29.2	40.4	12.2	29.0	140.1	124.9	64.4	22.0	4.3	99.9	39.7	57.9	32.6	51.8	26.6	29.6	19.2	17.0	0.9	54.9	22.0	35.4	0.3	12.8	13.7	39.0	47.9	31.0	52.0	49.8	11.7	144.8	6.5	59.1	9.5	31.6	22.8	12.4	22.4	14.5	15.2	19.6	11.3	12.6	19.7	20.6	18.2	41.0	22.7	4.2	7.2	20.4	1.0	2.7	1.7	1.3	0.7	1.5	0.8	0.8	0.7	0.6	3.8	0.7	0.9	22.4	15.6	0.0	24.7	0.0	36.4	0.0	6.8	0.0	5.9	10.9	1.3	5.7	8.1	11.0	0.0	55.2	42.7	6.5	3.9	4.5	0.6	7.4	1.8	1.7	1.2	12.8	2.0	7.1	34.7	9.6	15.3	17.9	11.4	0.5	1.4	4.4	11.8	0.0	1.4	4.8	0.0	8.8	0.0	0.4	3.4	17.3	0.0	2.8	13.5	0.0	53.5	0.0	0.2	10.9	4.0	2.2	14.5	33.6	1.9	1.5	6.6	0.0	6.6	6.7	3.6	1.8	2.5	16.1	0.0	59.1	27.4	0.6	6.5	18.2
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 39.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 19.6;Hofbauer cells: 22.0;Kupffer cells: 32.0;Macrophages: 11.8;Proximal tubular cells: 46.3;Smooth muscle cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 53.3;NB-4: 31.0;U-937: 52.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB022745	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	3.5	0.8	0.0	1.3	0.1	8.1	1.0	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.1	0.2	0.1	0.5	0.7	0.0	0.2	39.9	5.2	2.6	1.9	0.2	0.2	0.1	0.0	3.4	0.0	0.2	0.3	0.1	0.8	0.0	0.6	0.1	0.0	1.0	1.0	0.7	0.1	7.0	7.8	0.1	0.4	0.9	9.3	0.1	0.6	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	8.7	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.2	0.3	0.1	0.4	0.2	8.4	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.5	0.1	3.7	0.0	0.1	1.4	0.0	19.6	0.0	0.5	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	4.3	22.0	0.0	0.0	0.2	8.2	32.0	8.1	0.4	0.0	11.8	0.0	8.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	46.3	1.5	0.0	0.0	0.1	11.2	0.0	0.1	0.0	0.3	0.1	0.3	0.0	0.0	0.1
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
TAF1	"BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250"	ENSG00000147133	"TATA-box binding protein associated factor 1"	P21675	X	71366264-71532374	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001075, CAB016283"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"CAB016283: AB_671202, HPA001075: AB_1080179"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (6.54e-4)"	"unprognostic (2.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.56e-2)"	10.9	8.6	10.3	11.4	12.7	12.8	12.3	13.7	11.1	11.1	10.2	10.0	6.6	13.8	12.9	7.5	11.1	7.8	7.0	9.3	14.1	7.5	7.8	9.1	14.1	11.5	11.3	14.4	9.8	12.2	8.4	10.0	10.9	10.0	10.0	27.3	7.7	10.1	10.5	13.3	9.3	10.9	8.2	15.4	10.6	7.2	12.5	14.8	12.7	10.3	12.4	9.2	8.6	16.8	18.6	15.9	18.2	12.4	14.6	23.2	11.0	13.3	12.1	13.7	11.1	12.3	11.3	17.6	11.5	14.9	12.3	17.5	24.1	11.0	17.0	11.2	21.9	20.1	22.1	13.1	11.1	39.7	19.4	14.1	11.3	14.2	27.2	12.8	14.7	13.2	28.2	41.1	14.4	14.5	22.4	25.4	20.9	23.5	20.8	19.8	35.8	21.6	11.1	25.0	9.0	14.5	37.7	13.6	18.7	14.3	9.6	22.9	18.6	16.5	14.2	13.4	9.7	17.5	17.4	21.4	9.0	33.2	12.5	1.6	1.4	0.7	1.4	0.9	1.3	1.0	1.4	1.4	1.5	1.5	1.6	1.8	1.8	1.5	1.6	1.4	1.0	0.7	10.3	12.7	13.7	11.1	9.3	14.1	11.5	11.3	10.9	8.2	12.5	16.8	26.7	32.1	26.7	44.7	21.2	11.9	8.9	10.4	18.2	37.5	12.5	13.3	17.2	10.0	23.9	3.7	81.3	8.6	21.5	7.8	1.9	6.3	2.5	17.0	23.4	24.6	11.4	28.6	54.3	7.0	5.9	17.6	12.2	18.9	23.4	23.9	18.9	12.6	8.8	16.8	52.2	14.6	6.1	16.2	20.0	2.6	22.1	20.4	5.4	47.8	23.9	17.0	29.9	49.3	79.1	7.6	13.3	22.2	18.7	11.2	13.4	5.2	14.8	67.9	0.0	27.4	18.0	9.3	10.7	17.8	17.3	5.7	23.8	25.9	13.6	9.6
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367976-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 48.7;Spermatogonia: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.36e-9)"	"prognostic favorable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	2.2	1.8	2.7	2.8	2.9	4.9	2.3	5.0	3.3	2.5	2.3	3.1	2.9	2.3	1.7	2.4	2.3	1.5	2.0	2.6	2.6	1.7	2.6	1.9	4.4	2.8	2.7	3.0	2.9	1.7	2.1	3.5	2.9	2.0	3.1	3.5	2.0	2.2	3.0	2.5	2.4	2.1	2.7	3.1	2.1	11.2	2.6	7.0	2.0	3.6	4.3	2.2	2.5	3.1	9.7	4.4	10.6	19.2	5.9	4.8	12.4	6.8	7.7	9.6	12.0	8.7	5.0	23.0	3.8	3.6	5.6	9.6	18.1	3.7	12.2	8.5	15.6	10.6	5.0	8.7	2.7	20.6	11.0	2.2	2.7	5.7	6.1	3.9	7.3	10.1	15.4	11.2	6.5	6.4	16.8	26.9	12.9	12.2	5.7	14.2	12.9	7.0	2.7	2.8	7.4	8.2	4.4	3.2	4.1	10.1	3.7	8.5	4.3	5.6	7.1	6.3	12.2	6.3	8.1	14.0	3.1	24.2	3.6	0.2	0.6	0.8	0.4	0.2	0.3	0.1	0.4	0.8	0.3	1.3	1.0	0.5	0.0	0.3	0.3	0.4	1.1	0.2	2.7	2.9	5.0	3.3	2.6	2.6	2.8	2.7	2.9	2.7	2.6	3.1	5.8	6.4	2.6	3.6	6.9	14.4	4.5	1.7	6.2	6.9	3.0	2.7	2.9	1.5	2.5	1.8	6.2	5.6	8.3	2.7	3.9	2.8	19.7	1.8	3.8	5.2	2.4	11.2	4.9	2.2	9.3	5.6	2.0	2.1	8.9	4.1	2.9	2.8	3.8	1.7	5.3	2.9	4.1	2.8	6.3	14.1	1.8	3.6	1.8	3.7	4.9	1.3	4.1	3.5	5.8	1.9	3.3	2.6	14.9	4.3	3.3	1.0	0.7	7.5	0.0	7.2	6.5	48.7	52.3	5.9	14.2	6.8	8.6	3.0	4.0	3.8
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038638, HPA061543"	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: AB_2684556"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	6.5	7.3	9.7	8.9	10.6	6.8	6.6	10.9	11.3	10.1	8.1	10.4	7.3	9.1	7.5	15.4	7.6	5.9	8.1	9.4	10.5	7.8	5.6	7.3	11.7	10.4	10.5	8.9	10.9	7.4	6.4	7.6	10.5	8.6	6.8	9.2	10.5	7.9	9.1	27.4	8.2	7.6	9.2	11.8	8.2	9.3	10.7	10.4	8.6	7.0	11.6	9.3	13.8	11.0	27.6	24.0	12.7	15.3	11.0	11.9	17.3	25.6	13.4	21.8	12.1	15.2	9.4	38.2	7.2	14.9	11.8	22.5	14.0	16.0	19.5	20.7	13.8	27.6	15.3	15.0	13.3	38.0	20.4	9.8	19.1	22.9	17.1	13.7	19.7	23.8	30.5	7.5	18.2	18.9	35.0	38.4	15.3	6.6	24.2	31.7	24.9	32.4	9.9	24.2	18.8	19.8	18.5	19.8	18.2	9.0	17.9	27.2	21.8	22.2	15.5	14.3	32.7	21.8	29.5	27.0	23.5	31.0	23.7	0.0	2.7	2.3	3.6	1.7	2.6	2.0	3.2	4.5	2.1	1.3	3.2	2.5	2.7	5.9	3.7	1.5	4.7	3.1	9.7	10.6	10.9	11.3	9.4	10.5	10.4	10.5	10.5	9.2	10.7	11.0	11.7	19.2	21.4	18.9	10.4	9.8	7.7	9.5	8.0	28.9	11.3	11.4	13.2	17.2	12.0	7.3	18.8	11.2	14.3	12.8	9.8	20.7	32.5	23.0	19.1	15.2	14.8	15.4	8.3	15.1	8.4	11.4	10.2	13.2	13.3	15.7	7.9	7.4	11.6	25.2	12.3	10.7	10.2	13.0	7.8	47.6	11.1	11.4	7.2	1.9	14.3	13.9	35.0	10.1	19.4	18.8	14.4	27.8	15.0	9.1	14.2	6.6	33.6	24.0	13.1	19.6	12.6	25.1	33.2	14.8	24.7	7.0	15.9	30.9	12.2	30.7
TFDP1	"DILC, Dp-1, DP1, DRTF1"	ENSG00000198176	"Transcription factor Dp-1"	Q14186	13	113584721-113641473	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 164.0"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 344.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 31.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 31.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033605, HPA044754, HPA068909, HPA077304"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB033605: AB_783105, HPA044754: AB_2679074, HPA068909: AB_2686056, HPA077304: "	"unprognostic (4.28e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (5.50e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.57e-4)"	"prognostic favorable (6.17e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	28.2	23.5	24.3	38.6	24.0	164.0	27.2	24.5	24.4	33.5	32.5	37.8	30.5	27.6	19.4	50.1	32.8	24.6	34.3	24.1	22.8	23.2	25.9	21.8	67.1	27.5	24.4	19.3	18.4	28.5	21.3	40.6	25.3	26.1	42.4	20.2	26.1	30.8	58.2	42.8	32.3	34.3	26.6	30.8	31.3	49.6	26.8	53.4	33.1	59.0	68.3	37.5	30.1	25.7	343.2	82.5	104.4	89.5	138.4	122.7	118.5	187.8	168.7	238.1	218.6	173.3	155.9	314.6	61.3	181.3	130.3	160.3	183.0	167.1	232.2	215.9	212.8	184.4	129.2	109.8	86.8	468.3	155.7	102.1	147.3	151.3	87.4	85.0	162.7	116.2	154.1	82.6	215.5	117.7	207.0	181.4	96.6	322.7	105.0	138.9	93.0	181.1	91.3	129.1	268.2	79.3	84.8	228.8	58.7	75.1	157.9	371.7	114.4	77.2	122.9	165.6	210.8	69.5	92.4	326.4	171.9	285.2	133.2	31.9	3.0	4.6	3.1	3.8	3.4	4.4	4.1	3.7	5.9	3.6	6.3	3.2	3.8	2.3	5.5	3.0	5.3	2.5	24.3	24.0	24.5	24.4	24.1	22.8	27.5	24.4	25.3	26.6	26.8	25.7	21.4	9.6	15.8	12.7	38.8	59.8	32.1	16.1	33.6	10.3	45.6	35.2	26.6	28.6	14.7	29.5	14.6	83.2	33.8	29.8	80.3	12.3	5.5	34.4	28.2	25.8	40.2	344.3	22.5	11.9	128.0	30.8	38.7	31.0	21.0	23.3	34.6	58.7	49.2	6.7	19.5	36.1	12.2	49.1	51.2	10.7	28.6	41.1	35.6	5.6	24.8	14.7	16.5	9.5	10.2	19.0	24.2	28.2	67.3	35.7	29.4	66.5	21.0	22.5	6.6	20.0	32.7	76.7	52.7	74.6	60.0	66.6	32.1	30.3	47.4	35.8
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TIMM21	"C18orf55, HSPC154, TIM21"	ENSG00000075336	"Translocase of inner mitochondrial membrane 21"	Q9BVV7	18	74148523-74160531	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010587, HPA051543"	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA010587: AB_1851244, HPA051543: AB_2681528"	"unprognostic (4.88e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (9.22e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.55e-3)"	"prognostic favorable (1.38e-9)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.66e-2)"	13.8	14.6	22.7	10.1	23.8	8.1	10.6	25.7	29.6	9.7	23.0	16.2	12.2	10.4	11.9	13.3	9.5	5.6	48.7	22.8	23.2	21.0	22.3	7.4	9.9	22.9	22.5	11.9	9.6	18.0	11.4	10.0	23.0	12.2	13.5	14.8	10.2	9.9	50.8	11.1	11.5	9.5	22.6	13.8	12.4	7.0	23.1	7.7	12.4	47.9	10.1	12.6	10.2	24.3	25.6	26.6	24.4	30.2	19.7	17.4	35.9	38.5	12.8	22.8	19.2	19.5	18.3	34.2	12.1	15.0	19.1	41.6	34.0	32.8	38.1	21.7	19.6	14.7	46.2	53.9	10.0	55.6	23.7	16.2	19.4	29.0	19.9	18.6	17.5	19.0	30.2	23.2	27.9	25.6	29.6	45.6	23.5	15.3	48.6	27.5	28.2	42.6	30.2	35.5	25.9	14.2	14.5	35.9	23.8	19.1	24.9	28.6	12.6	53.3	37.9	17.5	40.3	7.3	60.3	37.2	26.0	59.7	38.0	8.7	9.8	6.3	12.7	15.6	15.2	16.0	12.2	10.7	13.2	12.3	15.3	17.6	1.2	17.1	18.2	15.7	10.0	8.8	22.7	23.8	25.7	29.6	22.8	23.2	22.9	22.5	23.0	22.6	23.1	24.3	8.0	12.8	17.8	8.1	12.1	8.0	9.3	30.2	21.6	17.1	9.0	12.6	165.5	14.3	16.7	5.5	6.2	29.4	10.2	9.4	54.8	13.2	3.1	7.3	13.5	13.1	14.4	16.2	8.6	9.4	28.3	19.0	14.8	6.7	9.5	12.6	11.7	20.2	18.8	16.8	11.1	11.5	8.2	11.7	3.5	1.5	11.5	8.5	1.8	6.5	13.4	20.0	9.2	8.5	9.2	9.1	6.2	12.4	25.7	10.5	12.5	34.5	15.0	20.1	6.6	15.0	16.5	12.8	12.7	20.2	8.0	16.4	7.5	12.9	18.2	7.7
TMEM106C	MGC5576	ENSG00000134291	"Transmembrane protein 106C"	Q9BVX2	12	47963569-47968878	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 876.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047204	Enhanced					NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047204: AB_2679982"	"unprognostic (1.63e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.27e-8)"	"unprognostic (1.05e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.62e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.83e-1)"	28.1	41.9	37.4	36.3	37.5	48.2	66.6	38.2	46.1	52.0	56.7	138.2	113.2	35.8	135.8	42.0	48.5	45.5	58.9	39.7	42.4	80.9	44.7	39.4	38.4	36.4	36.3	55.5	66.5	146.2	62.9	73.4	37.1	41.0	145.3	121.7	59.7	51.7	26.5	37.4	120.1	55.3	35.5	78.1	53.5	40.0	43.4	55.9	49.3	34.3	46.8	28.9	32.8	33.7	243.9	166.4	151.7	167.7	68.5	50.0	143.2	133.6	191.0	238.5	203.8	250.2	243.3	212.2	182.9	147.6	221.8	162.1	239.2	146.1	226.6	203.8	229.1	163.7	217.2	101.7	52.4	172.6	117.9	34.4	98.4	217.8	114.2	163.4	154.2	224.0	113.4	235.6	169.6	174.4	248.2	75.5	27.0	258.7	226.5	217.9	195.9	180.9	127.2	183.2	100.9	120.5	206.8	138.5	142.4	78.4	503.5	136.9	38.3	99.8	168.9	145.0	240.9	130.8	228.9	240.1	127.3	876.5	97.9	39.3	8.8	23.9	44.4	8.6	54.9	36.9	42.8	46.5	12.5	30.8	39.7	44.0	7.6	19.6	10.4	1.9	66.4	41.0	37.4	37.5	38.2	46.1	39.7	42.4	36.4	36.3	37.1	35.5	43.4	33.7	14.5	32.1	20.7	6.8	26.5	47.9	39.2	45.8	36.5	30.2	54.9	78.7	39.1	61.5	21.9	35.0	18.8	75.3	17.7	244.8	86.1	63.8	2.8	35.7	5.7	17.3	36.0	49.2	14.1	45.1	32.8	45.4	37.2	18.6	10.8	86.3	55.0	19.6	54.3	30.3	13.0	150.8	101.7	16.4	20.7	6.8	32.6	21.5	21.4	8.4	10.1	268.4	27.8	4.5	1.2	35.5	208.3	41.3	72.5	22.6	385.7	82.2	11.5	47.2	13.1	46.4	36.9	52.8	36.0	55.4	40.9	14.9	31.5	35.0	220.5	39.4
TMEM150B	"DRAM3, TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"intestine: 64.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	3.7	1.8	0.5	5.8	0.8	0.7	1.1	0.4	1.0	0.3	1.2	10.2	64.1	0.4	0.1	0.6	0.8	2.9	0.8	0.4	0.7	3.2	2.2	11.9	3.5	1.3	0.7	0.3	0.9	0.1	0.2	5.6	1.6	0.3	7.3	0.0	0.6	0.4	0.2	0.2	57.0	4.1	0.5	5.7	1.4	0.5	3.4	0.7	0.3	0.2	1.6	2.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.0	1.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	1.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	18.1	0.1	1.9	5.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.5	0.8	0.4	1.0	0.4	0.7	1.3	0.7	1.6	0.5	3.4	1.3	0.0	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	1.5	0.0	1.8	0.0	0.0	0.0	18.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.7	3.5	0.0	11.8	1.3	0.0	0.0	3.2	0.0	0.0	8.0	0.0	0.0	0.0	0.9	0.3	1.4	0.0	0.9	0.6	68.9	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.7	0.3
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11537749-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.2;Excitatory neurons: 57.3;Inhibitory neurons: 52.3;Kupffer cells: 36.8;Macrophages: 31.5;monocytes: 45.8;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 22.1;U-937: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	7.0	2.8	8.1	4.3	9.0	25.2	2.3	8.6	10.7	1.6	2.2	2.3	0.7	2.4	3.1	1.3	1.6	1.7	2.1	10.2	6.9	3.7	8.7	3.8	1.7	8.4	7.7	2.2	1.9	2.9	2.7	2.5	9.1	1.9	1.1	9.5	1.5	2.0	6.2	0.9	1.2	2.9	6.8	3.9	1.5	3.4	7.7	1.9	2.6	7.3	1.2	1.5	0.9	7.4	0.9	1.5	8.8	7.9	1.6	0.1	1.8	0.8	2.0	1.2	1.4	0.5	0.5	7.3	4.0	0.5	2.3	0.0	10.0	0.6	3.1	2.1	5.3	4.1	1.0	1.2	0.5	6.6	4.1	0.6	0.1	1.3	0.0	2.0	0.8	6.7	0.2	0.1	1.8	1.3	8.0	11.3	2.5	0.8	1.2	4.1	8.4	1.2	0.9	1.8	6.0	5.1	0.5	2.9	3.3	12.4	2.9	22.1	0.1	1.6	1.9	3.2	2.1	6.3	13.4	6.4	1.4	16.6	2.2	0.9	0.8	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.1	8.1	9.0	8.6	10.7	10.2	6.9	8.4	7.7	9.1	6.8	7.7	7.4	2.7	3.2	2.0	39.2	2.9	1.8	0.6	0.2	0.6	13.2	2.2	1.8	6.5	1.5	1.5	0.0	4.2	2.1	11.8	0.5	5.9	0.6	0.5	1.9	1.8	2.3	1.8	0.8	57.3	1.4	0.3	2.3	0.5	2.1	1.3	5.1	2.2	8.4	7.0	25.2	52.3	0.3	0.0	36.8	13.2	0.4	0.9	31.5	0.0	21.5	45.8	13.7	2.1	31.7	27.1	0.9	0.3	1.5	0.5	1.1	0.0	5.4	0.1	8.3	6.6	4.1	3.7	7.5	4.8	0.2	0.9	1.9	1.4	1.7	0.8	0.5
TMEM229B	"C14orf83, FLJ33387"	ENSG00000198133	"Transmembrane protein 229B"	Q8NBD8	14	67447084-67533739	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Late spermatids: 25.7;NK-cells: 15.5;Oligodendrocyte precursor cells: 19.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 12.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 12.9;MCF7: 13.6;SK-MEL-30: 11.6;U-937: 34.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046562	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA046562: AB_10960265"	"prognostic favorable (5.38e-4)"	"unprognostic (6.55e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.21e-5)"	"unprognostic (7.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.79e-5)"	1.5	15.3	10.1	5.6	8.7	1.8	3.7	21.2	15.8	10.8	0.0	4.3	15.7	1.4	10.9	1.3	2.0	4.1	1.3	10.9	10.7	2.0	1.1	3.5	9.1	25.8	10.9	1.1	5.0	12.5	6.9	0.8	27.6	2.7	3.3	5.4	4.0	10.4	0.5	1.4	14.2	3.2	10.4	9.8	4.2	6.1	15.4	11.8	8.3	0.9	6.1	5.0	1.5	11.5	3.2	0.4	0.0	0.8	0.3	0.0	1.2	0.5	0.7	0.8	3.3	0.0	10.1	12.9	0.1	0.3	2.8	0.0	0.2	0.7	0.1	4.2	1.0	7.8	0.0	0.0	1.0	8.5	1.5	0.2	0.4	0.1	0.0	0.2	0.0	0.8	0.1	0.5	0.0	13.6	5.2	3.2	0.1	6.7	0.6	4.7	0.1	1.9	0.1	6.7	1.9	0.4	0.0	4.9	11.6	0.5	10.3	8.1	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.6	34.5	7.0	5.8	5.7	9.1	9.9	6.5	9.5	1.3	5.9	8.0	2.7	0.9	5.0	6.5	0.1	5.5	6.9	1.5	2.5	5.8	10.1	8.7	21.2	15.8	10.9	10.7	25.8	10.9	27.6	10.4	15.4	11.5	1.2	0.0	0.5	1.3	2.6	0.3	0.3	3.6	0.0	4.8	3.5	2.5	1.8	2.8	2.5	0.0	14.6	0.1	8.3	3.6	0.0	2.0	12.6	2.3	0.3	1.4	2.4	0.4	7.1	3.6	0.0	0.6	1.1	0.3	0.0	11.0	2.9	0.2	1.8	0.0	10.6	5.3	0.0	6.2	1.0	25.7	0.0	2.6	7.2	3.7	5.5	0.3	15.5	19.1	6.1	0.5	5.7	0.7	0.4	0.4	11.3	2.2	2.4	4.1	0.0	0.2	0.7	0.7	0.3	0.1	0.1	0.1	4.1	4.9	3.9	1.1
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 211.8;Langerhans cells: 323.4;Syncytiotrophoblasts: 292.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 155.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		470000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	72.4	5.1	4.2	62.3	4.1	65.5	19.3	8.9	7.0	15.9	31.2	17.8	16.1	13.3	17.1	25.3	10.5	16.6	8.5	3.9	4.0	16.4	10.1	19.1	117.8	4.9	4.1	3.5	16.8	14.8	1.6	52.5	4.8	18.9	19.0	2.4	11.2	14.4	3.3	31.6	31.3	15.5	1.7	61.1	28.6	17.5	5.1	100.0	25.3	5.6	115.9	43.6	17.8	6.6	27.7	19.0	10.0	16.1	20.5	17.2	91.2	15.0	40.4	11.1	23.0	10.2	31.6	51.0	4.7	16.7	17.6	38.4	8.3	45.4	15.7	56.6	17.9	81.4	41.1	17.6	9.9	99.6	86.4	19.1	42.0	33.7	15.9	21.2	15.4	99.9	32.0	155.2	15.5	10.7	84.5	128.9	15.0	16.0	8.9	25.6	44.1	75.8	44.5	54.8	5.1	7.8	56.6	10.9	5.5	32.1	9.4	111.4	8.1	20.2	7.8	14.1	17.9	76.0	90.0	103.3	23.3	104.8	11.9	491.9	96.1	305.0	111.0	105.1	217.3	267.2	221.9	164.7	133.6	243.5	260.8	169.7	54.6	111.4	86.7	63.8	188.4	213.0	4.2	4.1	8.9	7.0	3.9	4.0	4.9	4.1	4.8	1.7	5.1	6.6	8.9	9.6	18.7	1.6	174.9	160.5	80.9	81.9	123.5	0.2	14.4	10.8	10.3	12.8	38.3	18.4	0.0	142.6	83.6	2.7	17.6	55.4	4.4	11.8	7.8	23.2	1.2	34.5	0.8	101.0	158.8	30.1	17.9	9.5	211.8	0.7	6.4	1.9	48.9	0.0	2.3	9.9	20.3	59.4	323.4	1.4	2.1	126.0	37.4	24.4	196.6	4.3	111.2	1.0	6.8	125.7	2.7	1.9	45.6	63.9	0.9	19.8	47.2	0.4	46.0	4.0	32.9	1.1	18.0	93.1	119.2	292.7	139.0	35.2	4.3	103.6
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.5;Kupffer cells: 141.1;Langerhans cells: 246.7;Macrophages: 170.4;monocytes: 509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 505.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 206.4;granulocytes: 505.4;monocytes: 350.9"	"Cell line enriched"	"Detected in some"	7	"U-937: 167.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	790000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	8.2	5.3	2.8	25.9	2.6	20.1	4.7	2.7	4.1	2.2	5.8	5.5	10.7	1.4	1.5	4.8	2.4	12.4	3.8	2.7	3.1	1.5	5.3	10.9	20.9	6.3	3.0	1.1	1.5	0.7	1.0	9.0	4.2	1.7	8.4	0.4	3.3	1.2	1.4	1.9	6.4	5.0	4.6	15.9	5.0	1.2	3.5	5.3	3.0	1.6	17.7	11.1	2.1	5.2	0.1	0.4	0.1	0.1	0.7	0.8	0.2	0.3	0.8	0.6	2.1	0.1	1.7	0.3	0.2	0.2	0.3	0.1	0.0	0.1	0.1	11.6	0.0	0.9	0.4	0.0	0.4	10.2	0.3	2.0	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.6	1.2	0.0	0.1	5.3	0.1	1.1	0.0	0.0	0.2	0.0	0.6	0.3	1.3	0.3	0.0	0.0	0.4	0.2	0.1	22.3	0.2	0.3	0.0	0.0	0.4	10.0	0.3	0.1	10.3	167.0	1.7	12.6	350.9	100.1	5.4	272.3	31.5	4.4	21.5	4.4	206.4	7.1	9.9	3.4	505.4	5.0	234.1	77.8	19.4	165.8	2.8	2.6	2.7	4.1	2.7	3.1	6.3	3.0	4.2	4.6	3.5	5.2	3.1	16.0	12.9	6.2	7.0	7.1	0.7	1.3	1.2	0.9	2.4	3.2	0.6	10.0	4.2	5.5	0.0	0.5	40.6	0.6	1.9	2.3	1.2	0.4	0.7	3.6	1.2	14.5	18.1	32.5	1.1	29.6	3.1	0.5	5.1	0.9	3.9	2.8	87.5	0.0	11.2	0.9	0.0	141.1	246.7	0.6	5.3	170.4	8.8	15.0	509.4	0.2	5.2	55.3	5.1	1.7	0.5	1.9	1.5	2.7	2.2	1.3	2.0	0.3	6.6	1.4	4.1	0.1	0.7	0.5	4.7	1.1	10.5	1.2	1.8	3.1
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681957-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003037	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	19.6	21.1	27.6	19.0	28.5	30.4	17.2	29.0	29.7	16.6	29.4	22.6	24.5	15.5	19.2	28.4	20.5	11.5	29.1	27.7	28.7	23.9	28.5	12.7	25.3	28.6	28.2	19.1	21.1	22.5	9.9	15.7	28.9	15.1	27.6	8.6	21.4	12.5	34.6	22.1	19.4	19.4	28.0	17.0	20.3	17.0	29.6	27.0	17.1	31.0	30.5	23.8	17.8	28.3	61.7	35.5	53.4	56.9	38.6	35.7	57.5	49.7	34.3	71.1	53.1	65.0	35.8	62.0	39.9	48.9	48.7	49.7	81.8	75.2	56.7	53.8	89.9	83.4	25.2	63.0	50.2	223.2	56.7	49.0	52.6	64.1	41.6	37.0	52.9	59.5	64.4	48.2	48.1	47.9	67.7	103.3	82.0	80.8	71.5	73.9	69.2	58.8	47.7	44.3	62.4	41.3	58.1	72.7	59.1	36.1	50.5	73.1	54.3	43.4	81.8	40.1	76.2	65.9	85.7	94.3	54.3	76.0	60.6	12.9	50.9	16.6	35.4	51.1	44.9	48.7	37.8	37.5	66.4	37.8	38.0	41.4	5.0	42.7	43.1	58.0	48.7	72.8	27.6	28.5	29.0	29.7	27.7	28.7	28.6	28.2	28.9	28.0	29.6	28.3	62.4	25.6	30.4	4.2	123.3	167.0	134.8	158.7	109.8	30.1	79.5	67.7	70.2	82.9	68.0	71.7	16.7	180.0	89.7	74.8	223.0	135.3	139.6	50.5	58.8	77.1	105.1	98.8	7.3	133.2	232.1	70.4	65.7	50.6	74.3	100.3	69.9	101.4	163.9	28.6	8.4	133.5	99.7	120.2	130.7	143.2	55.3	93.3	113.8	4.7	153.2	76.1	105.0	4.5	8.7	116.2	85.2	54.5	130.3	153.4	116.2	245.9	35.2	33.7	72.3	73.3	76.9	130.1	148.2	185.5	210.3	135.6	102.6	100.9	189.7	158.7
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TRBV27	"TCRBV14S1, TCRBV27S1"	ENSG00000211752	"T cell receptor beta variable 27"	A0A0K0K1C4	7	142715346-142715861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 81.6"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 61.1;memory CD8 T-cell: 112.2;naive CD4 T-cell: 48.2;naive CD8 T-cell: 75.8;T-reg: 94.7"	"Lineage enriched"	"Detected in single"	137	"T-cells: 112.2"	"Group enriched"	"Detected in some"	4	"HAP1: 2.9;JURKAT: 3.3;U-937: 3.6"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.08e-2)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-2)"			"unprognostic (5.85e-4)"	"unprognostic (8.84e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-4)"	"unprognostic (1.49e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.91e-7)"	"unprognostic (4.03e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.43e-2)"	0.6	0.5	0.0	3.5	0.6	1.9	0.8	0.0	0.3	0.7	0.0	1.2	1.0	0.9	0.1	0.8	0.2	1.8	0.2	0.0	0.0	0.4	0.5	1.7	19.7	0.0	0.3	0.5	0.2	0.0	0.1	0.1	0.0	0.5	1.7	0.0	1.7	0.0	0.3	0.2	2.8	0.2	0.0	4.8	1.9	5.7	0.2	81.6	0.6	0.8	10.6	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.4	0.1	0.6	3.3	0.0	10.4	0.1	61.1	112.2	0.1	0.1	48.2	75.8	0.8	0.1	0.2	0.1	94.7	27.3	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0
TRBV6-5	"TCRBV13S1, TCRBV6S5, TRBV65"	ENSG00000211721	"T cell receptor beta variable 6-5"	A0A0K0K1A5	7	142450947-142451448	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 82.3"	"Cell type enriched"	"Detected in single"	121	"T-cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 133.8;T-reg: 137.9"	"Lineage enriched"	"Detected in many"	54	"T-cells: 137.9"	"Cell line enriched"	"Detected in some"	8	"HL-60: 61.1"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.42e-3)"	"unprognostic (7.43e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (5.40e-5)"	"unprognostic (3.12e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.06e-2)"	0.4	0.2	0.0	4.1	0.0	2.3	0.5	0.0	0.1	0.4	0.0	0.9	1.0	0.2	0.0	0.2	0.3	1.6	0.1	0.0	0.0	0.1	0.3	2.4	16.1	0.0	0.0	0.3	7.3	0.0	0.0	0.1	0.0	0.3	1.2	0.2	0.4	0.1	0.0	0.3	2.0	0.3	0.0	3.4	1.6	0.1	0.0	82.3	0.4	0.7	12.0	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.5	0.2	0.2	1.0	0.1	32.8	0.3	78.7	76.2	0.1	0.4	92.0	133.8	2.5	0.2	0.4	0.4	137.9	59.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1
TRBV6-6	"TCRBV13S6A2T, TCRBV6S6, TRBV66"	ENSG00000211724	"T cell receptor beta variable 6-6"	A0A0A6YYG2	7	142469537-142470013	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 81.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 81.4"	"Cell line enriched"	"Detected in some"	10	"HL-60: 10.4"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.69e-4)"	"unprognostic (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.93e-5)"	"unprognostic (4.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.01e-2)"	0.2	0.0	0.0	2.7	0.1	0.8	0.5	0.0	0.1	0.1	0.0	0.8	0.8	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.2	0.0	0.9	5.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.1	1.6	0.0	0.0	0.1	1.2	0.1	0.0	2.9	0.8	0.0	0.0	14.7	0.2	0.0	10.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.5	0.3	14.7	0.0	34.6	47.9	0.0	0.1	48.9	21.3	0.8	0.1	0.2	0.2	81.4	12.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
TRBV7-4	"TCRBV6S8A2T, TCRBV7S4, TRBV74"	ENSG00000253409	"T cell receptor beta variable 7-4"	A0A1B0GX95	7	142455174-142455635	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	17	"lymphoid tissue: 25.5;pancreas: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enriched"	"Detected in some"	7	"HL-60: 90.9"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (8.71e-5)"	"unprognostic (4.23e-3)"				"unprognostic (7.05e-5)"		"unprognostic (8.94e-4)"		"unprognostic (2.75e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.97e-3)"	"unprognostic (3.73e-2)"	"unprognostic (9.93e-3)"		0.0	0.0	0.0	0.6	0.1	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	3.5	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	25.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	90.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	1.0	0.6	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	2.9	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
TRBV9	"TCRBV1S1A1N1, TCRBV9S1"	ENSG00000211716	"T cell receptor beta variable 9"	A0A0B4J1U6	7	142391891-142392412	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.1;testis: 2.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 5.8;Late spermatids: 4.8;T-cells: 7.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 20.0;memory CD8 T-cell: 21.7;naive CD4 T-cell: 14.8;naive CD8 T-cell: 13.2;T-reg: 27.2"	"Lineage enriched"	"Detected in single"	31	"T-cells: 27.2"	"Group enriched"	"Detected in some"	16	"HL-60: 3.4;LHCN-M2: 6.0;U-937: 13.3"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (7.28e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.58e-4)"	"unprognostic (8.88e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.60e-10)"	"unprognostic (1.04e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.46e-3)"	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.3	0.0	0.4	0.2	0.4	0.0	0.6	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.1	2.1	0.0	0.0	3.0	0.6	2.6	0.0	9.1	0.4	0.4	2.9	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	13.3	0.0	0.1	0.8	0.0	0.2	0.2	2.5	0.0	20.0	21.7	0.5	0.0	14.8	13.2	0.1	0.0	0.0	0.4	27.2	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	7	"dendritic cells: 149.1;NK-cells: 90.6;T-cells: 122.0"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.4;JURKAT: 36.6;NB-4: 29.9;SK-BR-3: 9.8;U-937: 53.9"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"	3.6	1.1	8.8	5.1	9.0	30.5	1.8	8.6	19.6	1.5	7.1	3.5	4.5	1.3	3.2	1.1	2.2	3.9	0.9	8.4	8.5	1.6	3.6	9.7	17.5	9.6	8.9	0.5	0.8	0.2	1.0	0.5	9.2	23.7	4.0	0.1	1.8	0.8	0.4	0.6	8.0	1.0	9.3	29.7	3.8	2.2	10.2	34.6	2.1	0.1	7.0	3.4	2.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	3.7	1.2	29.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.9	0.0	1.1	1.3	1.4	720.5	1.2	287.4	0.6	64.8	341.6	1.0	0.3	13.5	212.9	4.9	149.7	1.0	1.2	1.3	167.5	8.8	9.0	8.6	19.6	8.4	8.5	9.6	8.9	9.2	9.3	10.2	9.5	1.2	0.0	2.4	0.0	2.4	0.0	0.2	0.0	0.0	0.0	1.0	1.3	0.7	1.5	0.6	0.0	0.0	0.0	149.1	0.3	0.0	0.2	15.5	0.2	0.1	0.8	0.0	6.6	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.2	3.9	1.0	0.0	0.0	0.0	0.5	0.0	3.5	0.0	6.7	0.0	2.8	0.0	0.0	10.6	0.0	90.6	0.0	0.0	0.0	0.0	0.4	14.2	2.8	0.0	0.5	0.0	0.0	0.0	0.2	1.3	0.8	0.2	0.3	0.0	0.3	122.0	0.0	0.2	0.3
TRGJP1	"JP1, TCRGJP1"	ENSG00000211692	"T cell receptor gamma joining P1"		7	38276259-38276318	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	10	"bone marrow: 271.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"NK-cell: 1153.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 1153.0"	"Group enriched"	"Detected in some"	5	"HL-60: 282.5;U-937: 715.8"															NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"																					3.1	0.0	9.8	7.3	11.1	271.5	4.2	9.8	24.0	4.1	7.2	1.1	5.3	0.3	0.0	0.6	2.1	1.3	0.6	9.1	9.4	0.7	1.7	10.2	8.8	12.1	10.8	0.0	0.0	0.0	0.0	3.9	12.3	1.8	4.3	0.0	0.0	0.0	3.9	0.0	2.0	1.2	9.3	27.9	1.1	0.7	11.3	13.6	0.0	0.0	4.5	1.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	282.5	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	715.8	0.0	13.4	0.4	4.4	241.1	0.9	169.1	0.2	16.2	80.9	0.0	0.7	9.3	44.1	4.2	1153.0	0.1	2.8	0.0	58.9	9.8	11.1	9.8	24.0	9.1	9.4	12.1	10.8	12.3	9.3	11.3	10.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0
TRGJP2	"JP2, TCRGJP2"	ENSG00000211688	"T cell receptor gamma joining P2"		7	38256337-38256396	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"bone marrow: 64.5;brain: 35.9;lung: 28.7;lymphoid tissue: 30.4;prostate: 32.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	14	"prostate cancer: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 367.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 186.9;T-cells: 367.0"	"Group enriched"	"Detected in some"	8	"HL-60: 61.6;NB-4: 66.3;SK-BR-3: 18.3;THP-1: 36.2;U-937: 72.4"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"												"unprognostic (2.09e-1)"				"unprognostic (5.05e-2)"						1.3	0.0	11.9	4.9	13.5	64.5	5.4	11.7	35.9	1.3	4.2	2.8	4.3	1.5	0.0	1.3	1.5	1.3	0.0	10.8	10.6	0.0	4.4	28.7	12.4	19.7	15.0	0.0	0.0	0.0	0.0	0.5	14.0	32.4	2.6	0.7	0.0	0.0	0.0	2.0	8.1	2.6	13.2	30.4	6.2	3.4	17.1	20.6	2.2	0.0	13.5	1.9	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	61.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	18.3	4.6	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.4	0.0	0.3	1.4	1.8	367.0	0.2	94.8	0.2	33.3	142.4	0.4	0.3	3.1	81.3	3.2	186.9	0.5	0.4	1.8	42.1	11.9	13.5	11.7	35.9	10.8	10.6	19.7	15.0	14.0	13.2	17.1	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRGV1	"TCRGV1, V1S1P"	ENSG00000211701	"T cell receptor gamma variable 1 (non-functional)"		7	38367586-38368169	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 1.0;HL-60: 1.6;JURKAT: 1.4;Karpas-707: 2.1;U-937: 2.6"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"																					0.1	0.0	0.2	0.6	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.5	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.4	0.5	1.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.7	2.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.3	0.1	2.6	0.0	0.0	0.6	0.0	1.8	0.1	1.8	0.1	0.8	1.2	0.2	0.0	0.2	0.8	0.0	1.7	0.0	0.6	0.0	0.4	0.2	0.1	0.1	0.2	0.0	0.1	0.5	0.6	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRGV9	"TCRGV9, V2"	ENSG00000211695	"T cell receptor gamma variable 9"	Q99603	7	38317017-38318861	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.9;prostate: 5.5"	"Group enriched"	"Detected in some"	4	"dendritic cells: 14.6;NK-cells: 22.6;T-cells: 37.7"	"Cancer enriched"	"Detected in single"	126	"prostate cancer: 13.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	13	"gdT-cell: 426.5"	"Lineage enriched"	"Detected in many"	13	"T-cells: 426.5"	"Group enriched"	"Detected in some"	6	"MCF7: 7.7;NB-4: 2.4;U-937: 8.6"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 19: Lung - Lung function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.07e-1)"	"unprognostic (1.18e-1)"			"unprognostic (1.30e-1)"	"unprognostic (3.98e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.41e-1)"	"unprognostic (6.60e-4)"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-1)"	0.4	0.0	0.4	0.5	0.7	1.1	0.1	0.4	0.5	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.5	0.0	0.2	0.4	0.5	0.7	0.5	0.0	0.1	0.0	0.0	1.9	0.7	5.5	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.4	1.6	0.3	0.1	0.5	1.5	0.0	0.0	0.4	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.3	0.1	426.5	0.6	29.0	0.1	1.6	19.7	0.4	0.0	0.7	8.4	1.4	33.2	0.1	0.5	0.1	38.8	0.4	0.7	0.4	0.5	0.5	0.5	0.7	0.5	0.7	0.4	0.5	0.8	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.0	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0
TRPC5OS	TRPC5-AS1	ENSG00000204025	"TRPC5 opposite strand"	A6NMA1	X	111876051-111903990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 21.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.3;Inhibitory neurons: 2.0;Late spermatids: 2.2;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.2;U-937: 1.3"	"Not detected"	"Not detected"													NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.77e-2)"			"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"		"unprognostic (2.99e-1)"	"unprognostic (1.47e-2)"		"unprognostic (9.90e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.40e-6)"	"unprognostic (6.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-3)"		0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.6	0.3	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	2.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318204	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	0.5	0.5	0.2	1.6	0.2	19.9	0.3	0.5	0.2	1.1	0.0	0.5	0.3	0.7	0.2	0.4	0.5	1.4	11.4	0.2	0.3	0.2	0.4	2.0	5.5	0.5	0.3	0.5	0.0	0.0	0.0	0.3	0.3	0.2	0.3	0.2	0.9	0.5	0.3	0.6	0.5	0.0	0.1	3.5	0.9	0.2	0.2	0.9	0.2	0.2	2.4	0.7	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	15.0	0.0	0.1	0.6	6.6	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	8.9	0.0	40.5	31.8	4.2	25.8	40.9	16.5	2.4	9.1	22.7	32.2	1.1	7.2	27.1	17.3	58.6	46.0	1.6	13.2	21.7	0.2	0.2	0.5	0.2	0.2	0.3	0.5	0.3	0.3	0.1	0.2	0.5	0.5	0.0	6.7	0.0	4.5	0.9	0.0	0.0	0.0	0.0	0.2	0.1	15.9	0.0	0.6	0.0	0.0	0.1	44.6	0.0	0.0	0.0	0.8	0.1	0.3	0.8	0.0	20.6	0.0	0.0	0.3	1.3	0.5	0.0	30.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	6.5	19.6	4.1	0.9	13.6	1.8	1.0	14.4	0.2	87.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	1.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.6	0.0	21.9	0.0	0.0	0.1
TUBGCP3	"GCP3, SPBC98, Spc98p"	ENSG00000126216	"Tubulin gamma complex associated protein 3"	Q96CW5	13	112485011-112588205	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043913	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA043913: AB_10963220"	"unprognostic (6.12e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.89e-2)"	"unprognostic (8.70e-3)"	"unprognostic (1.62e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.38e-2)"	12.8	10.0	4.8	12.1	6.3	31.2	10.9	6.0	5.2	12.5	5.1	10.7	8.7	13.1	6.5	10.7	11.7	8.9	9.4	4.3	5.6	8.7	14.7	10.6	14.9	5.9	5.1	17.9	10.4	8.7	7.8	9.7	5.9	8.2	10.0	11.7	10.4	8.4	12.1	14.1	11.2	12.5	4.6	14.9	9.6	16.8	5.8	19.1	10.6	8.9	13.3	11.0	11.8	8.8	48.1	20.5	29.6	17.5	12.0	15.0	25.5	21.6	22.8	29.1	25.7	22.4	40.5	34.2	12.0	20.5	29.1	31.2	27.8	24.4	38.2	26.9	34.1	35.8	28.3	18.6	12.4	102.6	32.2	11.7	18.4	19.0	34.1	11.9	23.3	33.0	19.7	23.2	21.9	19.6	41.3	34.9	17.5	51.0	20.7	48.6	26.6	23.0	12.4	19.8	27.4	25.1	26.0	34.2	14.5	17.4	20.7	79.8	18.6	16.6	51.8	19.5	27.1	23.8	18.7	47.7	28.1	68.7	34.4	19.0	33.8	50.0	10.9	28.3	13.4	17.5	11.8	13.7	37.4	11.2	17.9	11.4	31.6	19.0	25.0	19.9	16.2	18.7	4.8	6.3	6.0	5.2	4.3	5.6	5.9	5.1	5.9	4.6	5.8	8.8	14.9	9.6	8.7	25.8	16.6	11.6	5.5	4.9	14.8	18.6	7.6	6.7	9.6	7.2	9.2	9.2	16.7	8.8	18.5	7.5	0.0	6.7	22.9	5.8	12.2	11.9	8.4	23.5	45.9	6.2	11.6	12.0	16.3	7.1	7.0	13.3	12.8	14.7	14.6	28.6	44.4	7.4	2.0	22.5	13.0	24.6	14.9	20.0	19.6	34.7	19.0	11.5	14.4	42.3	49.3	8.6	4.0	10.9	18.5	4.3	7.4	9.7	3.9	16.4	26.3	13.0	11.5	25.0	31.4	12.2	8.2	4.1	13.3	12.0	8.4	3.9
VPS13C	"FLJ10381, FLJ20136, KIAA1421"	ENSG00000129003	"Vacuolar protein sorting 13 homolog C"	Q709C8	15	61852389-62060473	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 272.2;Oligodendrocytes: 291.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043507	Uncertain		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Microtubules		"HPA043507: AB_10960840"	"unprognostic (1.09e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.58e-3)"	9.3	8.3	6.0	13.3	13.8	10.5	9.6	10.2	8.4	11.7	3.1	8.9	6.8	12.0	7.6	4.1	9.4	9.1	6.7	4.4	6.9	8.9	7.2	10.9	17.7	12.9	8.3	16.9	8.6	12.3	5.5	7.9	15.2	7.9	9.1	18.8	8.0	6.1	7.1	5.7	7.7	9.4	8.3	17.8	12.8	6.1	9.9	14.6	11.5	12.8	15.1	9.1	3.5	24.6	8.2	13.9	5.2	5.5	22.8	20.1	6.1	6.4	25.4	6.2	7.5	5.8	5.3	27.9	7.4	12.5	11.6	9.3	18.8	7.2	5.5	20.1	3.4	28.3	7.9	5.4	11.3	13.7	17.6	14.3	4.8	6.7	13.9	14.0	19.2	28.1	8.9	19.5	9.9	3.5	8.1	5.4	3.4	8.7	3.7	19.0	16.1	7.5	10.5	32.5	7.7	9.4	11.5	6.6	7.0	9.1	7.2	19.9	28.9	14.0	7.8	8.5	8.2	9.8	9.4	16.3	11.1	28.8	6.8	3.7	4.2	2.5	3.3	3.1	2.8	4.9	2.7	2.7	3.0	5.3	3.0	2.5	1.1	2.2	5.4	5.9	2.3	1.2	6.0	13.8	10.2	8.4	4.4	6.9	12.9	8.3	15.2	8.3	9.9	24.6	92.5	67.3	61.6	161.6	108.5	18.6	32.3	33.1	26.7	84.9	41.8	24.5	75.2	25.8	83.2	57.0	146.0	14.8	141.1	16.7	9.8	36.7	6.4	92.9	79.6	57.3	53.0	30.7	182.8	29.6	8.3	56.2	83.1	118.9	89.7	51.8	43.2	22.7	31.3	124.5	272.2	29.9	44.7	71.0	58.1	7.3	50.4	107.2	35.6	148.9	118.5	29.6	84.5	217.1	291.3	26.7	21.0	51.6	83.9	25.2	21.6	12.3	113.1	84.5	32.9	86.5	66.9	20.8	20.4	5.9	23.3	8.2	98.8	88.2	23.9	28.3
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	19.4	15.7	10.9	17.3	11.8	42.5	17.5	14.8	14.9	19.1	13.5	20.3	15.2	16.8	12.4	13.5	14.9	16.5	22.0	11.3	11.4	18.0	15.9	17.7	20.2	12.5	12.2	21.6	11.6	21.4	13.9	13.7	12.7	15.6	22.0	14.2	15.3	14.6	17.1	17.6	19.7	19.0	9.6	19.3	15.0	12.9	14.1	21.2	17.1	9.8	18.7	17.7	14.6	14.0	24.5	25.9	20.7	23.5	52.1	45.8	12.4	28.4	45.8	32.4	30.8	16.0	23.3	20.1	18.8	41.7	30.8	21.6	23.2	13.0	32.6	18.9	19.2	20.9	32.3	12.3	55.0	21.4	24.6	43.4	30.4	35.4	26.1	31.6	33.7	16.5	33.9	15.7	40.1	12.8	14.0	35.9	14.8	14.7	3.9	17.4	30.5	10.5	23.8	38.2	10.0	22.3	32.8	16.1	39.4	21.0	22.1	20.6	58.1	16.8	18.0	44.7	19.1	21.5	36.3	19.6	23.5	49.4	9.2	14.1	17.1	11.7	12.2	17.9	11.8	9.9	10.1	12.7	11.7	9.2	10.0	8.9	16.8	12.5	22.8	8.1	10.4	13.3	10.9	11.8	14.8	14.9	11.3	11.4	12.5	12.2	12.7	9.6	14.1	14.0	16.2	35.3	35.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	11.3	8.8	0.0	0.0	11.8	23.9	0.0	6.8	11.8	0.0	3.9	13.5	0.0	11.3	17.9	6.1	0.0	0.0	0.0	14.0	6.4	7.9	0.0	13.9	30.3	13.7	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	3.8	0.0	0.0	12.8	24.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	7.8	7.0	12.1	0.0	0.0
WDR92	"FLJ31741, Monad"	ENSG00000243667	"WD repeat domain 92"	Q96MX6	2	68122936-68157549	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.9;Respiratory ciliated cells: 40.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035335, HPA035336"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA035335: AB_10959456, HPA035336: AB_10964348"	"unprognostic (3.55e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.61e-1)"	"unprognostic (3.56e-3)"	"unprognostic (9.86e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.15e-2)"	6.0	7.0	4.9	6.6	6.4	3.6	8.6	7.6	5.5	5.4	10.4	6.1	6.3	7.4	16.0	7.0	11.1	5.3	9.0	5.0	4.9	5.5	5.2	5.8	9.7	5.7	7.2	6.9	4.3	7.2	4.7	5.7	4.6	8.1	8.0	6.9	6.4	6.8	11.4	10.5	5.3	7.5	5.2	8.2	5.9	8.0	4.7	8.1	8.3	9.1	8.9	5.0	5.1	5.5	15.3	9.4	12.0	12.6	14.5	14.7	10.3	11.6	10.1	12.1	12.8	7.0	12.5	16.5	3.7	10.3	16.5	15.0	13.0	8.8	15.6	11.2	13.8	16.9	13.1	8.0	7.0	18.5	5.2	9.4	11.5	10.0	8.6	12.9	11.7	15.2	11.3	11.1	14.3	7.3	13.2	18.6	12.2	12.8	12.9	15.9	15.3	14.1	12.5	8.6	12.4	10.6	8.6	15.5	9.6	11.8	11.9	12.1	13.6	18.4	7.4	11.6	10.1	7.6	11.6	11.6	17.3	17.6	9.3	0.7	2.3	1.7	3.2	2.5	4.2	5.3	3.4	3.8	2.7	4.9	4.0	5.0	1.0	6.3	1.8	5.1	4.0	2.1	4.9	6.4	7.6	5.5	5.0	4.9	5.7	7.2	4.6	5.2	4.7	5.5	7.8	3.2	10.9	5.9	5.2	3.4	4.7	6.5	2.2	28.7	5.6	5.6	3.1	1.5	11.1	5.5	47.9	13.6	12.2	1.3	1.9	6.7	5.8	26.3	6.8	7.4	0.0	7.0	17.9	6.5	9.2	5.7	1.5	4.3	13.3	9.7	8.2	6.3	7.3	11.8	16.4	3.3	4.1	3.5	1.2	2.8	7.8	3.5	1.8	8.4	7.2	12.0	6.2	14.1	11.6	6.2	2.9	9.4	2.0	3.3	3.7	6.7	40.2	21.9	6.6	9.0	5.9	26.0	15.2	1.8	4.1	5.1	3.6	9.4	6.0	2.1
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
YAF2		ENSG00000015153	"YY1 associated factor 2"	Q8IY57	12	42157104-42238349	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1187.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026867	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA026867: AB_1858911"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.20e-2)"	11.5	9.5	9.7	8.1	10.5	10.8	10.0	13.9	12.0	10.3	4.3	8.1	5.9	9.4	8.7	6.9	8.8	8.6	36.6	11.6	10.4	9.5	18.0	8.1	12.5	9.2	9.1	9.0	6.3	7.8	8.6	9.0	10.3	8.2	7.3	14.2	6.6	8.4	29.4	6.3	7.9	10.3	9.9	10.6	6.9	7.3	10.1	13.5	11.1	21.1	10.0	10.0	8.9	12.6	13.5	10.6	15.3	12.1	19.1	16.9	9.9	19.1	17.1	15.5	15.1	14.4	10.7	8.6	14.0	16.6	6.2	11.5	15.0	10.7	21.7	20.5	14.9	18.0	4.6	6.8	11.0	17.6	11.1	12.1	14.9	12.8	25.3	15.7	16.3	8.3	17.2	20.1	20.1	5.6	20.4	21.2	3.9	16.0	14.1	15.0	16.6	13.9	20.1	10.1	11.6	14.6	16.0	18.3	14.8	6.9	12.4	13.0	14.4	13.6	12.1	16.7	9.5	16.6	26.4	31.7	15.0	82.3	6.8	43.2	15.6	28.9	18.2	18.9	18.6	20.6	17.6	20.9	12.5	24.2	13.4	14.5	56.6	27.1	17.2	19.3	26.5	9.7	9.7	10.5	13.9	12.0	11.6	10.4	9.2	9.1	10.3	9.9	10.1	12.6	41.9	22.4	13.4	68.2	41.1	58.1	40.8	31.0	33.0	75.0	45.2	35.1	1187.5	31.5	27.6	20.2	85.5	40.1	71.2	22.7	62.6	32.2	33.6	27.7	43.1	61.7	38.9	36.2	105.5	45.5	22.4	49.7	18.3	37.0	70.5	88.4	50.7	104.7	27.8	144.7	89.4	33.1	46.8	44.7	61.3	15.9	58.1	37.6	42.7	83.4	48.8	94.6	84.5	97.0	57.8	35.3	26.8	76.8	44.6	37.2	29.9	66.0	20.1	99.7	105.2	44.8	63.8	38.0	38.2	30.5	51.1	45.3	58.7	36.2	27.5	32.7
ZCRB1	"MADP-1, MADP1, RBM36, SNRNP31, ZCCHC19"	ENSG00000139168	"Zinc finger CCHC-type and RNA binding motif containing 1"	Q8TBF4	12	42312086-42326257	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 219.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 889.2;Spermatocytes: 527.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (8.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.28e-2)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (5.33e-7)"	"unprognostic (4.31e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.11e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (1.39e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.32e-3)"	"unprognostic (9.44e-2)"	46.6	52.7	110.2	31.1	117.2	37.4	43.9	114.2	219.4	30.2	99.0	48.7	35.7	35.6	66.8	40.3	38.6	38.9	61.8	106.5	119.6	51.3	57.3	27.5	44.3	123.6	116.6	41.3	62.9	43.9	40.8	33.3	126.9	42.8	30.1	39.7	44.8	40.6	128.9	34.4	35.6	30.1	121.8	31.4	46.9	89.7	114.7	43.5	45.0	91.5	41.1	41.9	30.4	125.6	94.8	69.4	76.0	99.2	67.4	102.2	74.1	77.6	86.8	59.4	57.4	60.6	110.7	59.5	152.2	74.9	83.9	58.6	46.6	78.8	87.2	162.6	96.3	94.4	55.2	58.0	96.8	103.4	81.2	68.4	87.9	58.6	98.7	140.8	81.2	153.7	91.2	120.0	85.6	61.8	146.8	129.7	83.3	233.0	91.5	82.4	140.6	128.8	97.8	52.0	79.9	75.0	105.6	72.9	109.0	84.8	175.1	84.8	76.6	86.8	104.1	82.2	76.2	118.1	120.6	222.3	129.7	366.4	41.2	79.3	33.2	65.0	35.4	42.0	45.0	68.2	47.7	43.8	55.5	60.3	39.8	46.8	22.1	51.1	44.0	67.6	82.7	40.9	110.2	117.2	114.2	219.4	106.5	119.6	123.6	116.6	126.9	121.8	114.7	125.6	58.8	60.9	67.5	13.1	54.5	45.4	82.0	108.8	56.3	43.2	90.1	129.8	152.9	82.9	83.5	57.0	25.0	143.6	53.8	44.1	217.2	139.0	889.2	113.6	76.4	68.8	48.6	35.9	13.5	200.7	141.5	67.2	35.7	88.6	53.7	39.9	61.4	114.0	111.4	38.7	14.7	82.2	73.2	76.8	69.9	159.6	112.8	61.4	71.2	9.4	103.4	122.8	82.4	15.1	27.4	156.1	52.2	100.1	59.1	82.3	62.6	249.8	113.2	51.8	72.3	63.7	129.7	527.1	185.3	53.6	41.2	87.2	56.6	85.7	75.4	90.0
ZDHHC3	"DHHC3, GODZ, ZNF373"	ENSG00000163812	"Zinc finger DHHC-type palmitoyltransferase 3"	Q9NYG2	3	44915257-44976185	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"Early spermatids: 570.7;Late spermatids: 1564.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012465, HPA016616"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"CAB012465: , HPA016616: AB_1859004"	"unprognostic (2.80e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.81e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-2)"	50.1	48.6	23.0	25.7	21.5	82.8	36.3	27.9	22.9	42.2	25.8	70.6	44.1	35.4	24.5	58.0	27.5	32.0	36.3	25.8	21.1	40.3	32.3	41.9	21.9	28.7	25.1	28.9	22.2	46.0	13.4	28.7	29.8	35.6	64.6	16.6	33.3	40.1	43.7	70.0	58.1	36.3	25.8	29.6	55.3	80.8	27.0	26.9	38.6	52.8	33.3	53.6	42.5	25.3	62.5	53.3	41.0	49.1	219.2	100.5	46.8	58.8	80.7	78.3	66.5	61.0	85.1	58.7	31.4	107.9	52.8	80.7	68.4	104.3	74.6	61.7	29.3	55.9	57.9	45.7	50.6	136.3	43.0	92.5	111.6	73.6	67.2	59.8	79.6	63.8	73.8	51.3	78.1	42.9	46.2	73.6	60.7	155.9	96.7	29.9	40.6	47.0	66.7	176.7	14.6	52.8	70.3	70.5	36.4	70.4	57.4	88.2	78.0	55.4	55.2	60.2	66.3	32.2	66.6	59.6	55.2	198.9	39.4	53.7	24.5	32.6	14.6	12.3	13.3	10.7	11.0	16.1	26.8	12.6	10.2	14.4	25.4	14.5	17.5	15.3	17.1	13.6	23.0	21.5	27.9	22.9	25.8	21.1	28.7	25.1	29.8	25.8	27.0	25.3	41.5	41.7	82.1	7.5	17.8	48.2	42.1	40.8	48.9	9.8	24.4	20.8	29.2	24.3	27.1	53.3	6.2	47.7	23.4	105.6	72.4	46.6	570.7	18.8	31.2	34.1	35.9	68.8	15.7	79.0	59.4	26.4	69.3	26.6	19.0	21.5	35.7	29.4	49.5	15.2	15.6	78.2	38.7	34.0	26.7	1564.3	51.9	37.4	24.9	18.7	35.6	25.1	34.0	15.1	11.2	115.8	73.1	44.8	26.2	73.7	112.9	30.1	20.9	10.6	19.7	15.6	31.9	104.5	45.3	70.5	60.2	101.7	25.0	26.1	72.8	128.9
ZDHHC6	"FLJ21952, ZNF376"	ENSG00000023041	"Zinc finger DHHC-type palmitoyltransferase 6"	Q9H6R6	10	112424428-112446917	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014357	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA014357: AB_2304658"	"unprognostic (1.21e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.21e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.22e-2)"	19.5	19.9	15.2	24.6	16.0	21.8	22.7	16.7	18.9	21.2	20.2	24.5	44.6	24.0	33.2	23.7	19.3	23.2	17.0	15.4	16.1	59.3	29.5	20.0	30.6	15.5	15.7	25.7	21.3	21.4	15.4	25.9	15.6	22.4	29.9	21.3	23.9	20.6	14.9	20.5	45.8	17.8	15.9	24.8	25.9	13.6	16.9	25.0	26.2	18.1	30.6	23.9	20.8	17.9	51.7	39.4	40.3	50.2	38.2	28.8	28.5	49.3	46.7	38.2	45.3	37.7	89.6	28.4	22.1	30.2	43.0	60.0	33.8	31.5	44.3	67.0	41.4	29.4	46.4	47.3	24.7	67.9	49.5	21.9	20.7	41.9	48.9	58.7	48.6	42.0	32.4	46.1	41.7	43.3	38.1	75.6	23.6	57.0	32.1	31.4	51.1	26.6	45.3	28.1	15.0	20.9	25.5	40.1	49.1	31.4	22.4	49.2	34.8	43.7	27.6	29.5	47.3	25.7	31.7	37.5	38.7	118.0	29.0	10.4	17.4	21.6	14.7	16.2	18.9	16.7	16.7	18.5	16.6	14.0	14.1	15.9	11.3	16.0	13.7	13.6	23.9	15.9	15.2	16.0	16.7	18.9	15.4	16.1	15.5	15.7	15.6	15.9	16.9	17.9	21.0	22.4	20.1	11.8	35.9	20.3	31.9	23.2	23.9	11.0	21.9	16.1	14.3	31.5	27.4	35.0	8.4	34.8	25.7	31.3	60.7	35.8	72.4	14.9	15.5	18.7	11.4	26.1	15.0	29.8	46.9	17.9	16.3	23.8	23.5	17.8	19.2	21.2	34.4	15.2	15.7	22.7	10.2	20.2	35.9	17.7	16.1	28.6	12.4	12.2	22.2	21.0	23.7	15.1	14.4	31.2	27.9	19.5	23.7	25.7	66.9	39.7	13.4	15.5	6.6	13.9	18.2	11.7	12.5	27.6	22.3	36.5	33.0	10.9	28.5	47.7
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.8;HMC-1: 3.5;THP-1: 2.4;U-937: 6.2"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.8"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	1.8	2.2	2.1	0.5	2.0	3.0	1.1	2.6	1.9	1.7	2.4	0.9	0.3	1.2	2.6	0.2	3.2	0.4	1.1	1.4	2.0	1.2	0.6	2.6	0.4	1.3	1.9	3.8	0.7	4.3	2.6	0.7	1.9	0.9	0.2	0.5	0.2	1.6	0.3	0.2	0.9	1.1	0.5	1.1	0.6	0.7	2.6	0.2	0.7	0.5	0.5	0.3	0.3	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	0.8	0.4	0.0	0.0	0.5	0.6	0.2	0.4	0.3	0.4	0.6	3.8	0.0	1.4	0.0	0.0	1.4	0.4	3.5	0.2	0.5	0.0	0.0	0.0	1.4	0.9	1.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.9	0.0	0.0	0.9	0.0	0.0	2.4	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.9	0.0	6.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.6	1.9	1.4	2.0	1.3	1.9	1.9	0.5	2.6	1.4	3.4	0.0	0.0	1.6	0.2	0.0	0.1	0.0	0.0	0.4	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.1	3.1	0.5	0.0	0.0	1.5	0.0	0.0	0.7	0.0	2.2	0.0	1.1	0.4	0.1	0.8	0.0	1.7	0.0	0.0	0.8	0.0	0.2	2.5	0.5	0.0	0.0	0.5	0.2	1.0	2.0	0.1	0.2	0.0	3.4	0.2	0.0	0.0	0.3	0.0	0.2	19.7	0.8	1.4	0.4	0.8	0.0	0.0	0.0	0.3	0.8	0.0	0.0
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
ZMYM6	"Buster2, MYM, ZBED7, ZNF198L4, ZNF258"	ENSG00000163867	"Zinc finger MYM-type containing 6"	O95789	1	34986165-35031945	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011004, HPA071865"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA011004: AB_1859075, HPA071865: AB_2686464"	"prognostic favorable (1.30e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.11e-6)"	"unprognostic (1.77e-3)"	"unprognostic (4.83e-3)"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.29e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.84e-3)"	5.7	7.5	3.2	8.4	4.5	15.2	6.9	5.2	4.6	5.3	3.3	6.2	6.4	7.1	8.5	6.9	4.8	6.4	6.8	3.3	4.0	6.8	4.6	6.4	9.5	3.8	3.7	9.2	5.0	7.6	6.8	4.9	4.4	6.5	7.5	9.2	5.2	5.4	3.5	8.2	7.1	6.6	3.2	10.6	7.3	9.6	4.5	8.2	9.4	4.8	8.6	5.5	4.9	5.4	8.3	4.8	7.9	8.0	9.3	10.8	5.1	7.5	10.7	7.8	8.6	3.4	8.9	11.3	7.2	10.4	5.8	7.7	9.2	7.3	9.8	7.7	5.4	9.6	6.4	4.4	8.1	14.7	11.8	9.9	9.9	9.3	7.2	5.8	9.2	9.5	15.9	12.2	8.3	3.0	6.5	10.0	7.7	4.8	7.6	8.9	10.9	6.5	7.2	6.1	8.4	8.4	8.1	7.8	9.5	8.0	5.2	7.9	9.7	10.0	8.0	11.0	10.6	7.6	13.0	8.5	10.5	13.6	8.9	3.0	5.5	5.7	5.3	4.6	4.6	4.6	3.6	3.0	5.0	5.5	5.2	3.5	3.1	4.0	5.9	7.7	4.3	2.6	3.2	4.5	5.2	4.6	3.3	4.0	3.8	3.7	4.4	3.2	4.5	5.4	9.2	12.8	16.5	30.0	11.1	6.0	5.5	7.2	10.2	12.0	7.8	6.1	15.7	8.6	7.9	16.5	20.9	3.9	13.5	8.9	5.9	5.1	2.0	5.6	7.7	6.9	3.6	3.4	34.4	5.6	3.3	8.0	13.3	7.1	10.1	10.6	5.0	8.8	7.8	13.5	37.9	8.0	6.1	20.6	15.7	1.8	8.4	15.6	1.8	30.9	19.0	8.5	15.5	22.6	41.4	5.8	7.4	11.3	7.0	4.0	7.5	7.3	8.3	20.9	13.1	8.0	12.0	24.7	18.8	9.0	6.5	5.3	8.5	8.6	8.2	5.7
ZNF280C	"FLJ20095, SUHW3, ZNF633, ZPET"	ENSG00000056277	"Zinc finger protein 280C"	Q8ND82	X	130202707-130268899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.1;Spermatocytes: 27.5;Spermatogonia: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051494, HPA055788"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA051494: AB_2681506, HPA055788: AB_2682921"	"unprognostic (2.97e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.16e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.27e-8)"	"unprognostic (1.71e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.85e-2)"	1.6	1.4	0.6	1.7	1.3	2.6	1.6	1.5	1.3	2.9	0.3	1.5	1.3	2.7	5.1	1.4	1.5	1.8	0.9	0.7	1.3	1.1	1.2	1.5	2.3	0.5	0.8	1.8	1.3	1.7	1.6	1.8	0.7	1.5	1.4	1.8	1.2	1.2	1.3	1.6	1.4	1.8	0.5	1.7	1.1	9.4	0.8	2.2	1.6	1.1	2.6	1.6	1.6	1.1	3.3	4.1	10.7	9.6	3.1	4.3	4.0	3.1	4.0	3.2	4.8	2.5	5.2	7.8	12.0	2.2	6.3	3.2	7.5	2.4	5.7	6.9	2.1	3.4	3.2	1.9	2.5	11.1	3.0	3.2	1.1	4.6	4.7	3.2	3.7	5.0	1.7	4.6	3.8	4.2	6.0	4.5	6.2	4.9	3.4	8.2	3.6	3.0	3.4	5.2	5.2	7.1	3.0	1.7	3.4	4.3	1.9	3.7	3.7	3.5	2.9	5.8	8.2	1.9	1.3	4.3	3.3	9.9	3.3	1.0	0.5	0.6	1.0	0.8	1.7	1.4	1.2	1.2	0.7	1.0	0.9	1.3	0.2	1.8	1.1	0.8	1.8	0.4	0.6	1.3	1.5	1.3	0.7	1.3	0.5	0.8	0.7	0.5	0.8	1.1	3.1	3.2	3.6	8.8	6.8	0.9	2.1	1.3	3.4	2.4	2.1	3.2	1.3	0.0	1.4	1.8	2.1	2.0	8.1	1.2	0.0	1.3	0.3	2.9	7.4	2.8	4.8	3.4	13.1	1.8	1.7	2.9	5.1	3.6	0.0	7.4	3.6	2.7	1.6	5.0	11.2	0.9	4.1	3.2	1.0	0.3	3.4	2.4	0.0	9.4	4.3	0.9	0.0	20.1	11.8	1.1	1.8	3.0	3.2	2.1	1.0	2.1	3.2	3.1	6.6	3.8	3.2	27.5	33.8	4.3	1.6	0.8	4.3	5.0	2.3	2.5
ZNF280D	"FLJ20086, SUHW4, ZNF634"	ENSG00000137871	"Zinc finger protein 280D"	Q6N043	15	56630176-56734086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA030233	Approved		Approved	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Cytosol"	"Golgi apparatus, Centrosome"	"HPA030233: AB_10602590"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.72e-2)"	11.3	11.4	3.4	8.7	3.9	23.1	15.4	9.0	4.6	18.0	4.8	10.2	7.5	20.1	8.1	8.4	12.4	9.6	9.2	3.6	3.8	10.3	13.2	10.1	10.0	3.1	3.0	23.7	13.7	11.1	4.5	11.5	3.6	10.6	11.5	12.4	10.5	9.9	12.6	6.6	9.5	15.1	4.0	10.3	10.3	7.8	3.5	35.9	11.5	11.6	9.9	10.9	8.5	9.8	13.4	7.4	13.6	20.9	13.3	18.7	9.9	20.2	14.3	8.2	9.3	5.4	13.6	22.7	8.4	14.5	7.9	10.0	6.7	5.3	9.9	11.6	4.1	2.4	12.5	8.2	13.3	20.4	6.6	12.8	7.6	5.6	8.0	20.6	18.3	23.0	11.9	25.7	13.0	9.6	14.4	2.3	0.0	15.6	5.8	4.3	22.2	16.1	10.1	15.4	11.2	20.0	16.9	10.5	6.7	0.7	11.4	19.9	16.2	12.1	18.2	11.3	16.1	13.2	21.6	0.0	13.7	31.0	13.2	7.8	2.6	3.5	2.1	2.2	2.0	3.4	1.9	1.7	3.6	3.2	2.0	2.4	0.4	1.8	2.0	3.6	1.9	1.0	3.4	3.9	9.0	4.6	3.6	3.8	3.1	3.0	3.6	4.0	3.5	9.8	32.4	9.6	18.9	176.6	31.1	11.1	18.3	12.9	42.7	79.8	20.5	20.7	37.9	22.8	14.6	3.7	83.4	23.0	25.5	12.2	7.9	12.0	18.3	14.3	33.0	36.5	32.3	27.5	107.2	14.0	21.5	37.5	26.0	14.2	17.7	37.8	34.2	31.1	36.6	69.0	151.3	25.7	16.2	35.6	18.1	49.5	33.2	22.9	16.0	91.8	27.0	24.9	28.8	200.1	293.3	10.5	10.4	21.1	41.4	21.1	26.8	14.2	12.8	84.5	6.6	47.4	30.8	49.4	33.8	26.8	13.9	13.3	21.4	27.7	22.2	16.3
ZNF37A	"KOX21, ZNF37"	ENSG00000075407	"Zinc finger protein 37A"	P17032	10	38094334-38150293	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA003172	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA003172: AB_1080709"	"unprognostic (8.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.09e-2)"	4.9	5.6	5.9	6.2	6.0	3.1	5.7	11.3	7.8	6.3	4.3	5.6	4.8	7.2	5.8	3.7	5.2	4.5	4.3	6.3	8.0	5.8	4.9	4.8	5.9	5.5	5.0	7.5	8.7	9.7	8.6	4.8	5.9	5.7	4.8	16.6	7.6	5.6	3.7	6.3	4.6	5.6	3.6	6.0	5.6	2.4	6.7	5.8	8.1	5.1	6.0	4.4	4.2	8.8	15.8	7.9	7.0	13.2	10.5	10.2	7.6	11.9	4.5	5.4	7.2	6.4	4.5	23.1	3.5	6.6	7.4	6.3	13.2	10.0	8.4	14.9	12.5	23.3	9.7	9.1	9.0	24.7	14.4	7.8	16.4	9.3	7.7	10.8	7.2	10.8	15.4	15.9	11.7	3.7	14.0	3.7	6.1	5.5	13.0	10.0	19.0	4.6	5.7	6.1	5.6	9.6	8.2	6.6	6.7	7.4	12.1	7.6	12.4	10.1	10.9	9.8	11.6	17.8	20.5	8.9	6.7	17.3	6.5	1.3	1.0	1.0	1.5	0.8	2.0	1.5	1.8	1.6	1.0	2.6	2.1	1.8	0.7	2.7	2.3	1.2	1.1	0.7	5.9	6.0	11.3	7.8	6.3	8.0	5.5	5.0	5.9	3.6	6.7	8.8	21.8	25.6	43.6	31.6	26.0	8.2	14.7	11.0	18.8	66.1	14.4	16.4	29.6	15.7	18.8	11.0	54.2	10.2	23.2	7.6	1.9	18.1	3.7	15.0	30.0	26.3	41.9	26.3	46.7	11.8	6.8	27.0	16.3	14.9	40.5	56.9	22.9	10.4	7.1	42.1	57.7	10.4	10.2	11.3	6.4	1.4	28.3	13.8	5.4	40.3	16.6	27.4	30.9	64.3	85.5	11.9	8.3	28.2	34.4	17.0	12.6	7.3	12.6	55.1	13.1	53.5	25.7	22.2	15.2	14.7	6.0	3.8	18.5	48.5	12.5	9.3
ZNF438	bA330O11.1	ENSG00000183621	"Zinc finger protein 438"	Q7Z4V0	10	30820207-31031937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Excitatory neurons: 55.3;Inhibitory neurons: 74.7;Microglial cells: 76.8;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;U-937: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039843	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA039843: AB_10795159"	"unprognostic (1.69e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.50e-2)"	11.9	3.6	5.5	6.4	5.7	5.5	7.4	5.1	7.3	8.5	5.7	11.3	3.8	9.2	6.6	4.6	8.2	5.6	11.0	5.6	5.8	4.4	5.4	8.4	4.0	5.3	5.2	5.9	3.1	3.7	4.9	4.0	5.5	5.4	4.1	4.5	6.2	5.6	24.6	6.8	5.3	8.7	5.3	10.3	6.0	8.4	6.3	7.8	9.7	17.4	3.1	9.3	6.8	6.5	3.7	3.7	3.1	2.7	18.0	12.5	1.7	2.9	4.2	4.5	5.6	0.2	4.4	5.0	3.3	5.2	4.2	1.0	1.6	2.2	6.3	11.6	1.2	2.2	2.0	0.2	10.1	1.7	2.3	6.0	3.7	6.4	3.6	4.1	19.0	5.8	4.3	3.5	6.2	2.7	5.9	9.7	0.3	2.7	1.5	2.6	4.5	2.9	6.4	0.9	2.3	2.5	1.4	0.6	2.1	2.0	1.4	16.2	7.9	2.0	3.5	6.1	3.6	0.8	1.5	0.1	4.0	25.3	1.5	1.3	7.2	3.3	2.0	6.9	1.5	1.0	1.5	2.7	2.2	3.7	3.1	1.7	13.1	3.9	4.3	2.8	3.6	3.5	5.5	5.7	5.1	7.3	5.6	5.8	5.3	5.2	5.5	5.3	6.3	6.5	7.8	3.2	4.8	111.3	3.2	1.0	2.0	1.7	5.2	5.5	2.1	2.2	13.0	5.7	4.2	3.7	6.2	3.5	2.0	1.8	7.9	3.6	25.2	2.7	5.6	6.1	0.0	2.5	55.3	4.2	4.6	9.1	7.1	2.4	12.6	4.1	6.4	1.8	6.9	3.3	74.7	2.6	0.0	12.9	3.5	9.6	4.1	36.3	0.0	76.8	7.3	2.4	7.2	137.2	86.9	3.7	0.8	8.2	3.6	1.3	2.5	3.9	3.9	5.3	6.6	17.0	6.7	12.8	8.0	6.0	2.4	1.6	4.2	2.4	2.3	1.8
ZNF518A	"KIAA0335, ZNF518"	ENSG00000177853	"Zinc finger protein 518A"	Q6AHZ1	10	96129715-96205288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029049			Approved	Nucleoplasm		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA029049: AB_2672885"	"unprognostic (1.48e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-2)"	"unprognostic (6.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-3)"	4.1	3.2	3.8	4.4	4.5	7.6	7.3	5.7	4.7	4.3	2.1	7.1	5.0	5.6	7.8	4.3	4.3	4.1	3.4	3.5	5.1	5.1	4.6	4.5	6.1	5.0	4.5	7.4	4.5	4.0	4.1	4.4	5.4	4.8	7.0	9.3	4.1	4.2	1.9	6.0	6.4	4.4	4.5	5.4	6.7	16.1	4.7	8.1	7.7	2.3	6.1	3.8	2.8	6.8	4.2	9.4	10.3	0.0	5.1	5.8	12.4	4.4	2.5	4.7	4.8	8.9	10.0	15.5	4.1	2.8	6.7	5.9	11.8	4.2	4.3	7.1	6.3	23.2	3.2	14.5	4.5	25.3	13.5	3.8	10.1	4.9	7.8	3.4	5.7	17.8	20.1	10.1	4.7	4.2	15.0	15.3	15.9	4.7	0.6	16.7	11.8	6.2	5.6	8.5	3.0	7.2	6.2	5.8	4.5	17.0	6.9	16.0	3.7	2.2	8.5	3.0	4.8	9.3	24.9	8.8	1.5	19.0	2.4	9.8	2.6	3.2	1.8	2.8	2.7	2.5	2.1	1.8	1.7	2.2	3.0	2.1	2.5	2.3	5.3	2.9	2.5	1.4	3.8	4.5	5.7	4.7	3.5	5.1	5.0	4.5	5.4	4.5	4.7	6.8	31.1	57.7	28.2	136.8	26.1	0.0	17.1	0.0	13.1	65.0	32.5	21.2	26.5	30.0	14.9	40.5	43.8	49.1	31.6	51.0	19.6	24.1	23.6	42.6	38.8	24.0	61.2	17.1	63.9	25.5	30.8	21.6	32.6	41.3	9.5	57.9	35.3	28.3	28.1	75.7	90.5	35.8	0.0	32.8	0.0	15.0	35.1	31.3	0.0	81.5	48.7	29.1	47.4	150.3	173.0	32.9	52.4	25.2	18.3	20.8	39.5	20.4	10.2	56.9	19.7	33.8	23.2	73.1	131.2	16.2	0.0	43.8	23.3	40.9	35.2	17.6